Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — StableX Technologies, Inc.

Accession: 0001493152-26-019257

Filed: 2026-04-28

Period: 2026-04-27

CIK: 0001086745

SIC: 4899 (COMMUNICATION SERVICES, NEC)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Material Modifications to Rights of Security Holders

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-3.1 (ex3-1.htm)

EX-3.2 (ex3-2.htm)

EX-3.3 (ex3-3.htm)

EX-3.4 (ex3-4.htm)

EX-3.5 (ex3-5.htm)

EX-4.1 (ex4-1.htm)

EX-4.2 (ex4-2.htm)

EX-4.3 (ex4-3.htm)

EX-4.4 (ex4-4.htm)

EX-10.1 (ex10-1.htm)

EX-10.2 (ex10-2.htm)

EX-10.3 (ex10-3.htm)

EX-10.4 (ex10-4.htm)

EX-10.5 (ex10-5.htm)

EX-10.6 (ex10-6.htm)

EX-10.7 (ex10-7.htm)

EX-99.1 (ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

--12-31

false

0001086745

0001086745

2026-04-27

2026-04-27

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date

of Report

(Date

of earliest event reported):

April

27, 2026

Fabric.AI,

Inc.

StableX

Technologies, Inc.

(Exact

name of registrant as specified in its charter)

Delaware

001-34643

98-0204758

(State

or other jurisdiction of

(Commission

(IRS

Employer

incorporation)

File

No.)

Identification

No.)

1185

Avenue of the Americas

New

York, NY 10036

(Address

of principal executive offices and zip code)

512-994-4917

(Registrant’s

telephone number, including area code)

StableX

Technologies, Inc.

(Former

name or former address, if changed since last report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

stock, par value $0.0001 per share

SBLX

The

Nasdaq Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☐

If

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

1.01 Entry into a Material Definitive Agreement.

Joint

Development and License Agreement

On

April 27, 2026, Fabric.AI, Inc. (the “Company”), entered into a Joint Development and License Agreement (the “JDA”)

with Kopin Corporation, a Delaware corporation (“Kopin”), pursuant to which the Company and Kopin agreed to collaborate on

the development and commercialization of Kopin’s interface for GPU-to-GPU connectivity and will work together to develop a prototype

and demonstration version of the Project Technology (as defined below) in accordance with one or more statements of work or purchase

orders (each, a “Development Plan”) agreed in writing between the parties from time to time, which shall set out the scope,

deliverables, timelines and other relevant terms of the applicable development activities. Any data communications chip technology that

is to be developed by either party in performance of any Development Plan is herein referred to as the “Project Technology.”

Pursuant

to the JDA, the Company has agreed to pay Kopin up to $15,000,000 for the development of the Project Technology through achievement of

at least one successful prototype demonstrations (a “Successful Demo”) in accordance with the Development Plan(s) and the

funding schedule agreed by the parties (the “Development Funds”). The Company has agreed to issue an initial purchase order

of $5,000,000 within 10 business days after the date on which the JDA was entered into, and payable within ten business days of Kopin’s

receipt of such purchase order. Further, the Company agreed that it will ensure that at least $5,000,000 of funds are available in a

segregated account to cover Development Plan needs. Following this initial purchase order, the Company will pay Kopin the remaining Development

Funds in installments in accordance with a time-based funding schedule agreed by the parties as part of the applicable Development Plan.

Following achievement of a Successful Demo, the parties agreed to negotiate in good faith for a period of one year to agree upon a funding,

development, manufacturing and commercialization plan for production deployment of the Project Technology, as agreed in writing by the

parties (the “Production Plan”), which is expected to include an additional payment by the Company of approximately $15,000,000

to $25,000,000.

Pursuant

to the JDA, Kopin must (i) provide the Company with periodic written reports not less than once per month concerning all material activities

undertaken in respect of the applicable Development Plan, (ii) keep the Company informed on a timely basis concerning all material progress

in the applicable Development Plan, and (iii) at the Company’s reasonable written request, from time to time, provide the Company

with information relating to the progress of the applicable Development Plan.

In

further consideration of Kopin’s contributions to the development of the Project Technology, the Company has agreed to issue to

Kopin shares of the Company’s Series J Convertible Preferred Stock, par value $0.0001 per share (“Series J Preferred Stock”),

constituting 19.9% of the pro forma fully-diluted outstanding shares of the Company’s common stock, par value $0.0001 per share

(the “Common Stock”), excluding shares of common stock underlying unexercised options, warrants, and other common stock equivalents,

subject to certain anti-dilution adjustments upon the sale or issuance of Common Stock or common stock equivalents, or the conversion

or exercise of outstanding common stock equivalents as further described below. Pursuant to the JDA, the Company agreed to take all actions

necessary to give full force and effect to the adjustment provisions set forth in the Certificate of Designations Series J Convertible

Preferred Stock (the “Series J Certificate of Designations”), including through the issuance of additional shares of Series

J Preferred Stock to Kopin in such amounts as may be required to ensure that the number of shares of Series J Preferred Stock issued

to Kopin are convertible into the Maximum Issuance (as defined below) upon each Dilutive Issuance or Dilutive Conversion (as each term

is defined below), as applicable, in accordance with the terms of the Series J Certificate of Designations.

Pursuant

to the JDA, the Company and Kopin have agreed to jointly and equally own all right, title, and interest in the Project Technology developed

under the JDA, while Kopin retains sole ownership of pre-existing technology in its possession on the date of the JDA, and any improvements

and modifications to such technology, excluding Project Technology (the “Background Technology”). Kopin has granted the Company

a non-exclusive, royalty-free, worldwide license under Kopin’s Background Technology for developing and commercializing the Project

Technology within the scope of the Company’s rights under the JDA. The Company has the exclusive worldwide rights to commercialize

the Project Technology in all commercial markets, subject to Kopin’s exclusive worldwide rights to commercialize the Project Technology

for or with respect to: (a) government agencies, departments, instrumentalities or other public sector bodies, including defense, intelligence,

national security and public research bodies; (b) military, defense or government intelligence end users; and (c) defense contractors,

subcontractors, integrators and other entities primarily engaged in supplying products or services to government, military, defense or

government intelligence markets, in each case on a worldwide basis. All products incorporating the Project Technology are required to

be manufactured exclusively by or on behalf of Kopin.

The

JDA provides for the establishment of a joint steering committee (the “JSC”) to oversee and coordinate the performance of

the JDA, consisting of two representatives from each of the Company and Kopin. Michael Murray, Kopin’s Chief Executive Officer,

will serve as one of Kopin’s representatives and as chairperson of the JSC. Members of the JSC may be compensated by the Company

and/or Kopin in a manner to be determined by the parties.

Either

the Company or Kopin may terminate the JDA upon sixty days’ written notice for material breach (subject to a cure period) or immediately

upon a bankruptcy event of the other party. In the event of termination arising from the Company’s breach, failure to fund, or

a bankruptcy event, Kopin has the right to continue to develop, use, and commercialize the Project Technology without restriction, and

the Company has agreed to assign to Kopin all of its right, title, and interest in the Project Technology.

Pursuant

to the JDA, the Company has agreed that, during the term of the JDA and for three years thereafter, neither the Company nor its affiliates

will (a) acquire beneficial ownership of more than 9.9% of the outstanding voting securities of Kopin; (b) make or participate in any

tender offer, exchange offer, merger or other business combination involving Kopin; (c) solicit proxies or consents with respect to securities

of Kopin; or (d) otherwise seek to obtain control of Kopin other than through a transaction approved by Kopin’s board of directors.

The

JDA contains certain representations and warranties, covenants and indemnities customary for similar transactions. The representations,

warranties and covenants contained in the JDA were made solely for the benefit of the parties to the JDA and may be subject to limitations

agreed upon by the parties.

The

foregoing description of the JDA does not purport to be complete and is qualified in its entirety by reference to the full text of the

JDA, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Supply

Agreement

Concurrently

with the JDA, on April 27, 2026, the Company and Kopin also entered into that certain Commercial Supply Agreement (the “Supply

Agreement”). Under the Supply Agreement, Kopin has appointed the Company as the exclusive seller of any products incorporating

the Project Technology and developed under the JDA (the “Products”) to end users located worldwide, excluding countries subject

to comprehensive U.S. trade or economic sanctions (the “Territory”). Kopin has retained exclusive supply and distribution

rights with respect to the sale of Products to the automotive, military, and defense markets, and has the right to prioritize supply

to such markets.

The

Company is required to purchase its entire requirements for Products from Kopin, except following the occurrence of any of the following:

(a) Kopin’s failure to deliver at least 90% of the quantity of Products ordered by the Company in an accepted purchase order within

the applicable lead times agreed by the parties (plus a grace period of 30 days), in each case other than where such failure is due to

(x) supply constraints, component shortages or manufacturing limitations, or (y) compliance with Kopin’s other contractual, legal

or regulatory obligations; (b) Kopin’s written notice to the Company that Kopin will be unable to fulfill a material portion of

any purchase order; (c) Kopin’s failure, over two (2) consecutive quarters, to use commercially reasonable efforts to maintain

manufacturing capacity sufficient to support the Company’s forecasted requirements, as agreed between the parties; or (d) Kopin’s

discontinuation of manufacturing operations for the Products for a period of sixty (60) or more consecutive days (other than for scheduled

maintenance disclosed to the Company in advance), except, with regard to each of the foregoing, to the extent directly caused by (i)

acts beyond Kopin’s reasonable control; (ii) the Company’s failure to perform any of its obligations under the Supply Agreement;

(iii) Kopin’s compliance with any contractual, legal or regulatory obligation to prioritize supply to governmental, military or

defense customers; (iv) any increase in purchase orders or forecasted requirements by the Company that is not consistent with the most

recent forecast provided to Kopin or that exceeds agreed ramp-up parameters between the parties; or (v) any purchase order or requested

delivery date that does not comply with the applicable lead times agreed by the parties (each, an “Inability to Supply Event”).

In the event of an Inability to Supply Event, the Company may, solely to the extent necessary and subject to written agreement with Kopin,

manufacture Products in the Territory. Any such right terminates immediately upon Kopin’s ability to resume supply.

The

Company and Kopin have agreed to cooperate in good faith to develop a mutually acceptable manufacturing ramp-up plan (the “Ramp-Up

Plan”) which will include: (a) identification and procurement of tooling, equipment, and other capital assets required for factory

production of the Products; (b) qualification and sourcing of components and raw materials necessary for manufacture of the Products;

(c) establishment of a timeline for the commencement and scaling of commercial manufacturing operations; (d) a detailed budget setting

forth the estimated costs associated with each element of the Ramp-Up Plan. The parties intend to finalize the Ramp-Up Plan within one

year following successful completion of the product development phase under the JDA.

The

Supply Agreement has an initial term of four years commencing on the effective date, with automatic one-year renewal periods unless either

party provides written notice of non-renewal at least 90 days prior to the end of the then-current term. Upon expiration or termination,

all indebtedness of the Company to Kopin will become immediately due and payable, and the Company will be required to cease representing

itself as Kopin’s authorized representative and return or destroy all confidential information.

The

Supply Agreement also contains customary representations and warranties, indemnification provisions, product warranty provisions, confidentiality

obligations, insurance requirements, non-compete restrictions, and other miscellaneous terms.

The

foregoing description of the Supply Agreement does not purport to be complete and is qualified in its entirety by reference to the full

text of the Supply Agreement, which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference.

Series

J Convertible Preferred Stock

The

terms of the Series J Preferred Stock are as set forth in the Series J Certificate of Designations, attached hereto as Exhibit 3.1 to

this Current Report on Form 8-K, which was filed with the Secretary of State for the State of Delaware on April 27, 2026.

The

Series J Preferred Stock will be convertible into shares of Common Stock (the “Series J Conversion Shares”) at the election

of the holder at any time at an initial conversion price of $2.51 (the “Series J Conversion Price”), which such Series J

Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like.

The

shares of Series J Preferred Stock will rank (i) pari passu to shares of the Company’s Series H-7 Convertible Preferred Stock,

par value $0.0001 per share (“Series H-7 Preferred Stock”), and any other class or series of capital stock expressly designated

as pari passu with the Series J Preferred Stock (“Parity Stock”) and (ii) senior to the Company’s Series A Junior Participating

Preferred Stock, par value $0.0001 per share, the Series H Preferred Stock, par value $0.0001 per share, the Series H Convertible Preferred

Stock, par value $0.0001 per share, the Series H-3 Convertible Preferred Stock, par value $0.0001 per share, the Series H-6 Convertible

Preferred Stock, par value $0.0001 per share, the Series I Convertible Preferred Stock, par value $0.0001 per share (“Series I

Preferred Stock”), and any other class or series of capital stock of the Company that is not expressly designated as Parity Stock

or senior in rank to the Series J Preferred Stock (“Senior Preferred Stock”) (such non-designated stock, “Junior Stock”),

with respect to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company.

The

number of Series J Conversion Shares initially may not exceed 291,049 (the “Maximum Issuance”); provided, however, that (1)

the sale and issuance, in one or more offerings, of any Common Stock or any securities entitling any person to acquire shares of Common

Stock (such issuance, a “Dilutive Issuance”) or (2) the issuance of Common Stock (a “Dilutive Conversion”) in

connection with any conversions or exercises of any common stock equivalents that are (x) outstanding as of April 27, 2026 or (y) approved

for grant by the Board on April 27, 2026, and not yet issued or outstanding as of such date (the “Existing Common Stock Equivalents”),

the Maximum Issuance (b) shall be increased to equal the sum of (i) the Maximum Issuance immediately prior to the date of such Dilutive

Issuance or Dilutive Conversion, plus (ii) 0.1999 shares of Common Stock for each share of Common Stock issued in connection with such

Dilutive Issuance or Dilutive Conversion, as the case may be. Notwithstanding anything to the contrary contained in the Series J Certificate

of Designations, once an adjustment to the Maximum Issuance has been made in respect of (A) Dilutive Issuances, and (B) any exercises

for cash of Existing Common Stock Equivalents, in an aggregate amount equal to $50 million, no further adjustments shall be made for

any subsequent Dilutive Conversions or Dilutive Issuances. For the avoidance of doubt, no adjustment to the Maximum Issuance may be made

with respect to a Dilutive Issuance or Dilutive Conversion to the extent that the shares of Common Stock issued in connection therewith

previously resulted in an adjustment to the Maximum Issuance.

Without

the prior express consent of the Required Holders (as defined in the Series J Certificate of Designations), voting together as a single

class, the Company may not (a) amend or repeal any provision of, or add any provision to, its Amended and Restated Certificate of Incorporation

(as amended, the “Charter”) or its Amended and Restated Bylaws, as amended, or file any certificate of designations or articles

of amendment of any series of shares of preferred stock, if such action would adversely alter or change in any respect the preferences,

rights, privileges or powers, or restrictions provided for the benefit of the Series J Preferred Stock; (b) increase or decrease (other

than by conversion) the authorized number of Series J Preferred Stock; (c) create or authorize (by reclassification or otherwise) any

new Senior Preferred Stock or Parity Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the

terms of the Company’s equity incentive plans and options and other equity awards granted under such plans (that have in good faith

been approved by the Board)); (e) pay dividends or make any other distribution on any shares of any Junior Stock; (f) issue any shares

of Series J Preferred Stock other than as contemplated by the Series J Certificate of Designations; or (g) circumvent a right of the

Series J Preferred Stock under the Series J Certificate of Designations.

The

holders of the Series J Preferred Stock are entitled to dividends of 6% per annum accruing daily, which are payable semi-annually on

each June 30 and December 31 (each, a “Dividend Payment Date”) during the period in which any shares of Series J Preferred

Stock remain outstanding. Dividends are payable in cash; provided, however, that the Company may, at its sole option, elect to pay any

dividend in kind by issuing to the applicable holders of Series J Preferred Stock additional shares of Series J Preferred Stock having

an aggregate stated value equal to the amount of the dividend then due (each such payment, a “PIK Dividend”). If the Company

elects to pay a PIK Dividend, the stated value of the holder of Series J Preferred Stock’s Series J Preferred Stock shall be increased

by the amount of such PIK Dividend, or the Company will issue additional shares of Series J Preferred Stock to the holder of Series J

Preferred Stock reflecting such PIK Dividend. If, on a Dividend Payment Date, dividends on the Series J Preferred Stock have not been

declared and paid in full, such unpaid dividends shall continue to accrue daily from and after the initial Dividend Payment Date and

will compound on a semi-annual basis at the applicable rate for the Series J Preferred Stock on each subsequent Dividend Payment Date

until paid in full.

Pursuant

to the Series J Certificate of Designations, the Company is required to hold a meeting of its stockholders not later than July 26, 2026,

to seek approval under Nasdaq Stock Market Rule 5635(d) for the issuance of shares of Common Stock in excess of 19.99% of the Company’s

issued and outstanding shares of Common Stock at prices below the “Minimum Price” (as defined in Rule 5635 of the Rules of

the Nasdaq Stock Market) on the date of the JDA pursuant to the terms of the Series J Preferred Stock.

Except

as expressly set forth in the Series J Certificate of Designations or as otherwise required by law, the provisions of the Company’s

Amended and Restated Certificate of Incorporation, as amended, the Series J Preferred Stock do not have any voting rights prior to the

conversion thereof into shares of Common Stock; provided, however, that upon any such conversion of the Series J Preferred Stock into

shares of Common Stock, the holders of such converted shares shall be entitled to full voting rights as holders of Common Stock.

The

issuance of the Series J Preferred Stock is exempt from the registration requirements of the Securities Act of 1933, as amended (the

“Securities Act”), pursuant to the exemption for transactions by an issuer not involving any public offering under Section

4(a)(2) of the Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable

state laws. Kopin has represented to the Company that it is an accredited investor within the meaning of Rule 501(a) of Regulation D

and that it is acquiring the applicable securities for investment only and not with a view towards, or for resale in connection with,

the public sale or distribution thereof.

There

is no established public trading market for the Series J Preferred Stock and the Company does not intend to list the Series J Preferred

Stock on any national securities exchange or nationally recognized trading system.

Private

Placement

On

April 27, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited

investors (the “Investors”), pursuant to which it agreed to sell to the Investors (i) an aggregate of 21,500 shares of the

Company’s newly-designated Series K Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000

per share (“Stated Value”), initially convertible into up to 8,565,737 shares of the Company’s Common Stock at an initial

conversion price of $2.51 per share (the “Series K Preferred Stock”) and (ii) warrants to acquire up to an aggregate of 8,565,737

shares of Common Stock (the “Series K Warrants”) at an exercise price of $2.51 per share (collectively, the “Private

Placement”).

The

Private Placement is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”),

pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the Securities Act

and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state laws. Each of the Investors

has represented to the Company that it is an accredited investor within the meaning of Rule 501(a) of Regulation D and that it is acquiring

the applicable securities for investment only and not with a view towards, or for resale in connection with, the public sale or distribution

thereof. The Series K Preferred Stock and Series K Warrants were offered and sold without any general solicitation by the Company or

its representatives.

The

closing of the Private Placement is expected to occur on April 29, 2026 (the “Closing Date”). The aggregate gross proceeds

from the Private Placement are expected to be $21,500,000. The Company expects to use the net proceeds from the Private Placement for

general corporate purposes.

The

Purchase Agreement contains certain representations and warranties, covenants and indemnification provisions customary for similar transactions.

The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the applicable

parties to the Purchase Agreement and may be subject to limitations agreed upon by the applicable contracting parties. Among other covenants,

the Purchase Agreement requires the Company to hold a meeting of its stockholders not later than June 26, 2026, to seek approval for

the issuance of shares of Common Stock in excess of 19.99% of the Company’s issued and outstanding shares of Common Stock at prices

below the “Minimum Price” (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) on the date of the Purchase Agreement

pursuant to the terms of the Series K Preferred Stock and the applicable Series K Warrants (the “Stockholder Approval” and

the date on which such Stockholder Approval is received, the “Stockholder Approval Date”).

In

connection with the Private Placement, pursuant to an engagement letter, dated as of April 23, 2026 (the “GPN Agreement”)

with GP Nurmenkari Inc. (“GPN”), the Company engaged GPN to act as placement agent in connection with the Private Placement,

pursuant to which, the Company agreed to (i) pay GPN a cash fee equal to 8% of the gross proceeds of the Private Placement (including

any cash proceeds realized by the Company from the exercise of any outstanding warrants of the Company), (ii) reimbursement and payment

of certain expenses up to $10,000, and (iii) issue GPN on the Closing Date, warrants to purchase up to an aggregate number of shares

of Common Stock equal to 8% of the aggregate number of shares of Common Stock initially underlying the Series K Preferred Stock issued

in the Private Placement, including upon exercise of any outstanding warrants of the Company, with terms identical to the Series K Warrants.

Series

K Preferred Stock

The

terms of the Series K Preferred Stock are as set forth in the Certificate of Designations of the Series K Convertible Preferred Stock,

attached hereto as Exhibit 3.2 to this Current Report on Form 8-K (the “Series K Certificate of Designations”), which was

filed with the Secretary of State for the State of Delaware on April 27, 2026. All shares of capital stock of the Company rank junior

to shares of the Series K Preferred Stock, with respect to the preferences as to dividends, distributions and payments upon the liquidation,

dissolution and winding up of the Company.

The

shares of Series K Preferred Stock are convertible into shares of Common Stock (the “Series K Conversion Shares”) at the

election of the holder at any time at an initial conversion price of $2.51 per share (the “Series K Conversion Price”). The

Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications, stock combinations and the

like and dilutive issuances (in each case, subject to certain exceptions).

The

holders of the Series K Preferred Stock are entitled to dividends of 7% per annum (“Dividends”), compounded each calendar

quarter, which are payable in arrears (i) on the first trading day of each calendar quarter (each, a “Dividend Date”), with

the first Dividend Date being July 1, 2026, in cash out of funds legally available therefor; provided that a holder of the Series K Preferred

Stock and the Company may mutually agree to convert any Dividends into shares of Common Stock at a price to be mutually determined by

the Company and such holder, which shall not be less than the lower of (x) $0.502, which was 20% of the “Minimum Price” (as

defined in Rule 5635 of the Nasdaq Stock Market) on the date of the Purchase Agreement and (y) 20% of the “Minimum Price”

(as defined in Rule 5635 of the Nasdaq Stock Market) on the Stockholder Approval Date, in each case, subject to adjustment for stock

splits, stock dividends, stock combinations, recapitalizations or other similar events, or, in any case, such lower amount as permitted,

from time to time, by the Nasdaq Capital Market (the “Floor Price”).

The

holders of the Series K Preferred Stock are entitled to vote with holders of the Common Stock on an as-converted basis, with the number

of votes to which each holder of Series K Preferred Stock is entitled to be calculated assuming a conversion price of $2.51 per share,

which was the Minimum Price (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) applicable immediately before the execution

and delivery of the Purchase Agreement, subject to certain beneficial ownership limitations as set forth in the Series K Certificate

of Designations.

The

Series K Certificate of Designations includes certain Triggering Events (as defined in the Series K Certificate of Designations), including,

among other things, the suspension from trading or the failure of the Company’s Common Stock to be trading or listed (as applicable)

on an eligible market for a period of five (5) consecutive trading days and the Company’s failure to pay any amounts due to the

holders of the Series K Preferred Stock when due. Upon the occurrence and during the continuance of a Triggering Event, the Series K

Preferred Stock accrue dividends at the rate of 15% per annum. In addition, in connection with a Triggering Event, each holder of Series

K Preferred Stock will be able to require the Company to redeem in cash any or all of the holder’s Series K Preferred Stock at

a premium set forth in the Series K Certificate of Designations. Further, upon a Triggering Event, a holder of the Series K Preferred

Stock, at such holder’s option, by delivery of a notice of conversion (“Triggering Event Conversion Notice”) to the

Company, convert all, or any number of shares of Series K Preferred Stock held by such holder into shares of Common Stock at a price

equal to the lowest of (i) the applicable Series K Conversion Price as in effect on the applicable date of conversion, and (ii) the greater

of (x) the Floor Price and (y) 80% of the lowest volume weighted average price of the Common Stock of any trading day during the twenty

(20) consecutive trading day period ending and including the trading day immediately preceding the delivery or deemed delivery of the

applicable Triggering Event Conversion Notice.

Notwithstanding

the foregoing, the Company’s ability to settle conversions using shares of Common Stock is subject to certain limitations set forth

in the Series K Certificate of Designations, including a limit on the number of shares that may be issued until the time, if any, that

the Company has obtained the Stockholder Approval. Further, a holder of shares of Series K Preferred Stock may not convert any portion

of such holder’s shares of Series K Preferred Stock to the extent that the holder, together with its affiliates, would beneficially

own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of Common Stock immediately

after conversion, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial

ownership limitation to up to 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion.

The

Company is subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, the existence of liens, the

repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Series K Certificate of

Designations), distributions or redemptions, and the transfer of assets, among other matters. In addition, the Company is required to,

from the Closing Date until the date on which less than 1,050 shares of the Company’s Series I Preferred Stock are outstanding,

at all times, maintain unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 20% of the aggregate

stated value of the Series I Preferred Stock then outstanding.

There

is no established public trading market for the Series K Preferred Stock and the Company does not intend to list the Series K Preferred

Stock on any national securities exchange or nationally recognized trading system.

Series

K Warrants

The

Series K Warrants will be exercisable for shares of Common Stock (the “Series K Warrant Shares”) immediately, at an exercise

price of $2.51 per share and expire five years from the date of issuance. The exercise price of each Series K Warrant is subject to customary

adjustments for stock dividends, stock splits, reclassifications, stock combinations and the like and dilutive issuances (in each case,

subject to certain exceptions). There is no established public trading market for the Series K Warrants and the Company does not intend

to list the Series K Warrants on any national securities exchange or nationally recognized trading system.

A

holder of the Series K Warrants may not exercise any portion of such holder’s Series K Warrants to the extent that the holder,

together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s

outstanding shares of Common Stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder

to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of Common Stock outstanding

immediately after giving effect to the exercise.

Registration

Rights

The

Series K Preferred Stock, the Series K Conversion Shares, the Series K Warrants and the Series K Warrant Shares have not been registered

under the Securities Act.

In

connection with the Purchase Agreement, on April 27, 2026, the Company and the Investors entered into a Registration Rights Agreement

(the “Registration Rights Agreement”), pursuant to which the Company is obligated, among other things, to (A) file a resale

registration statement (the “Registration Statement”) with the SEC to register for resale promptly following the Closing

Date, but in no event later than 30 calendar days after the Closing Date, the sum of (i) 200% of the maximum number of Series K Conversion

Shares issuable upon conversion of the Series K Preferred Stock ((x) assuming for purposes hereof that the shares of Series K Preferred

Stock are convertible at the Floor Price and (y) any such conversion shall not take into account any limitations on the conversion of

the Series K Preferred Stock set forth in the Series K Certificate of Designations) and (ii) 200% of the maximum number of Series K Warrant

Shares issuable upon exercise of the Series K Warrants ((x) assuming for purposes hereof that such Series K Warrants will be exercised

at the initial exercise price as set forth in such Series K Warrants and (y) any such exercise shall not take into account any limitations

on the exercise of such Series K Warrants as set forth therein), in each case subject to the adjustments set forth in the Series K Certificate

of Designations and Series K Warrants, (B) have such Registration Statement declared effective by the Effectiveness Deadline (as defined

in the Registration Rights Agreement and as may be amended from time to time), and (C) maintain the registration until the earlier of

(x) the date on which the holders of the Series K Preferred Stock or Series K Warrants may sell their Series K Conversion Shares or Series

K Warrant Shares without restriction pursuant to Rule 144 under the Securities Act, and (y) the date on which such holders no longer

hold any Series K Conversion Shares or Series K Warrant Shares. The Company will be obligated to pay certain liquidated damages to the

Investors if the Company fails to file the Registration Statement when required, fails to cause the Registration Statement to be declared

effective by the SEC when required, or fails to maintain the effectiveness of the Registration Statement pursuant to the terms of the

Registration Rights Agreement.

The

foregoing descriptions of the Purchase Agreement, the Series K Certificate of Designations, the Series K Warrant, and the Registration

Rights Agreement, do not purport to be complete and are qualified in their entirety by reference to the full text of such documents,

forms of which are filed as Exhibits 10.3, 3.2, 4.1 and 10.4, respectively, to this Current Report on Form 8-K and incorporated herein

by reference.

Omnibus

Amendments and Warrants

On

April 27, 2026, the Company entered into an Omnibus Waiver, Consent, Notice and Amendment Agreement (the “Series H-7 Omnibus Amendment”)

with the Required Holders (as defined in the Certificate of Designations of the Series H-7 Convertible Preferred Stock (the “Series

H-7 Certificate of Designations”), pursuant to which, the Required Holders agreed to amend and restate the Series H-7 Certificate

of Designations by filing an Amended and Restated Certificate of Designations of the Series H-7 Preferred Stock (the “Amended and

Restated Series H-7 Certificate of Designations”) with the Secretary of State of the State of Delaware. The Amended and Restated

Series H-7 Certificate of Designations (i) extends the maturity date of the Series H-7 Convertible Preferred Stock to October 27, 2027,

and (ii) removes the amortization payments and related terms and covenants.

On

April 27, 2026, the Company entered into an Omnibus Waiver, Consent, Notice and Amendment Agreement (the “Series I Omnibus Amendment”

and together with the Series H-7 Omnibus Amendment, the “Omnibus Amendments”) with the Required Holders (as defined in the

Certificate of Designations of the Series I Convertible Preferred Stock (the “Series I Certificate of Designations”), pursuant

to which, the Required Holders agreed to amend and restate the Series I Certificate of Designations by filing an Amended and Restated

Certificate of Designations of the Series I Preferred Stock (the “Amended and Restated Series I Certificate of Designations”)

with the Secretary of State of the State of Delaware. The Amended and Restated Series I Certificate of Designations (i) extends the maturity

date of the Series I Convertible Preferred Stock to October 27, 2027, and (ii) removes the amortization payments and related terms and

covenants.

Pursuant

to the Omnibus Amendments, the Company agreed to issue to the Required Holders, warrants to purchase up to an aggregate of 1,000,000

shares of the Company’s Common Stock (the “Waiver Warrants”), pro rata based on the number of shares of Series H-7

Preferred Stock and Series I Preferred Stock held as of the date of the Omnibus Amendments.

The

Waiver Warrants will be exercisable for shares of Common Stock immediately, at an exercise price of $5.00 per share and expire five years

from the date of issuance. The exercise price of each Waiver Warrant is subject to customary adjustments for stock dividends, stock splits,

reclassifications, stock combinations and the like (in each case, subject to certain exceptions). There is no established public trading

market for the Waiver Warrants and the Company does not intend to list the Waiver Warrants on any national securities exchange or nationally

recognized trading system.

The

foregoing descriptions of the Series H-7 Omnibus Amendment, the Series I Omnibus Amendment, the Amended and Restated Series H-7 Certificate

of Designations, the Amended and Restated Series I Certificate of Designations and the Waiver Warrant do not purport to be complete and

are qualified in their entirety by reference to the full text of such documents, forms of which are filed as Exhibits 10.5, 10.6, 3.3,

3.4, and 4.2 respectively, to this Current Report on Form 8-K and incorporated herein by reference.

Altucher

Consulting Agreement

As

previously disclosed, on August 4, 2025, the Company entered into a consulting services agreement (the “Prior Altucher Consulting

Agreement”) with James Altucher and Z-List Media, Inc. (the “Prior Consultants”), pursuant to which, the Prior Consultants

agreed to provide certain consulting services to the Company.

On

April 27, 2026, the Company and the Prior Consultants agreed to amend and restate the Prior Altucher Consulting Agreement by entering

into an amended and restated consulting services agreement (the “Altucher Consulting Agreement”) by and between the Company

and JD Advisors, LLC, an affiliate of the Prior Consultants (the “Consultant”). Pursuant to the Altucher Consulting Agreement,

the Consultant agreed to provide certain consulting services to the Company, including but not limited to: contributing to product development

and roadmap decisions, leading and advising on marketing strategy, branding and go-to-market execution, assisting with recruiting, hiring

and team-building efforts, managing and guiding social media presence and communications and supporting general management initiatives

across the business and any other consulting or advisory services which the Company reasonably requests that the Consultant provide to

the Company. The Altucher Consulting Agreement has a term of two years unless earlier terminated pursuant to the terms of the Altucher

Consulting Agreement or upon the mutual written consent of the Company and the Consultant in accordance with the terms of the Altucher

Consulting Agreement.

Pursuant

to the Altucher Consulting Agreement, and subject to the Consultant entering into a warrant cancellation agreement for the purpose of

cancelling previously issued warrants to purchase up to 900,000 shares of Common Stock under the Prior Altucher Consulting Agreement,

the Company will issue to the Consultant warrants to purchase up to an aggregate of 900,000 shares of Common Stock, consisting of: (i)

a warrant to purchase up to 300,000 shares of Common Stock at an exercise price of $3.00 per share, which are immediately exercisable

upon issuance (the “First Tranche Warrant”), (ii) a warrant to purchase up to 200,000 shares of Common Stock at an exercise

price of $6.00 per share, which will be exercisable six months from the date of issuance (the “Second Tranche Warrant”),

(iii) a warrant to purchase up to 200,000 shares of Common Stock at an exercise price of $9.00 per share (the “Third Tranche Warrant”),

which will be exercisable twelve months from the date of issuance, and (iv) a warrant to purchase up to 200,000 shares of Common Stock

at an exercise price of $12.00 per share (the “Fourth Tranche Warrant” and together with the First Tranche Warrant, the Second

Tranche Warrant and the Third Tranche Warrant, the “Consultant Warrants”), which will be exercisable eighteen months from

the date of issuance, in each case, with each Consultant Warrant subject to exercisability, forfeiture and such other terms as set forth

therein and will have a term of five years from the date of the applicable issuance.

The

Consultant Warrants and shares issuable upon exercise of such Consultant Warrants were issued pursuant to an exemption from registration

requirements of the Securities Act. There is no established public trading market for the Consultant Warrants and the Company does not

intend to list the Consultant Warrants on any national securities exchange or nationally recognized trading system.

The

foregoing descriptions of the Altucher Consulting Agreement and the Consultant Warrants do not purport to be complete and are qualified

in their entirety by reference to the full texts of the Altucher Consulting Agreement and Form of Consultant Warrant, copies of which

are filed as Exhibits 10.7 and 4.3 to this Current Report on Form 8-K and incorporated herein by reference.

Amendments

to Rights Agreement

As

previously reported in a Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 1, 2025, on July 31,

2025, the Board declared a dividend of one preferred share purchase right for each outstanding share of Company Stock (as defined in

the Rights Agreement (as defined below)) pursuant to the terms of that certain Rights Agreement, dated as of July 31, 2025, as the same

may be amended from time to time (the “Rights Agreement”), between the Company and Equiniti Trust Company LLC, as rights

agent (the “Rights Agent”).

On

April 27, 2026, the Company entered into that certain Amendment to Rights Agreement, by and between the Company and the Rights Agent

(the “Rights Amendment”), to amend the definition of “Exempt Person” under the Rights Agreement to include any

person that the Board has determined in good faith to be deemed an “Exempt Person” by adopting resolutions waiving the applicability

of the Rights Agreement to such person. On April 27, 2026, the Board adopted such resolutions in connection with the transactions contemplated

by the JDA, including the issuance of the Series J Preferred Stock, accordingly, the Rights Agreement does not apply to Kopin or any

of its affiliates or any future acquiror of Kopin in connection with the transactions contemplated by the JDA or the other transaction

agreements entered into in connection therewith.

The

foregoing descriptions of the Rights Amendment, do not purport to be complete and are qualified in their entirety by reference to the

full text of such documents, the form of which is filed as Exhibit 4.4 to this Current Report on Form 8-K and incorporated herein by

reference.

Item

3.02 Unregistered Sales of Equity Securities

The

matters described in Item 1.01 of this Current Report on Form 8-K related to the Private Placement, the transactions contemplated by

the JDA, including the issuance of the Series J Preferred Stock, the issuance of the Waiver Warrants and the issuance of the Consultant

Warrants are incorporated herein by reference.

In

connection with the issuance of the Series K Preferred Stock and Series K Warrants in the Private Placement, the securities of the Company

issued or issuable pursuant to the JDA, the Waiver Warrants and the Consultant Warrants described in Item 1.01, the Company relied upon

the exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder for transactions

not involving a public offering.

This

report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in

any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under

the securities laws of any such state or jurisdiction.

Item

3.03 Material Modification to Rights of Security Holders.

To

the extent required by Item 3.03 of Form 8-K, the information contained in Item 1.01 and 5.03 of this Current Report on Form 8-K is incorporated

herein by reference.

Item

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of

Certain Officers

On

April 27, 2026 (the “Board Approval Date”), the Board of the Company approved grants to Joshua Silverman, the Company’s

Chief Executive Officer, subject to the stockholder approval of an amendment to the Company’s Long-Term Incentive Plan (as amended,

the “Plan”) increasing the authorized share limit under the Plan (the “Incentive Plan Authorized Share Stockholder

Approval”), consisting of (i) restricted shares of Common Stock equal to an aggregate value of $900,000, calculated as of the Board

Approval Date (the “RSA Award”), vesting (i) 25% as of the date of the Incentive Plan Authorized Share Stockholder Approval

(the “Incentive Plan Approval Date”), (ii) 25% on June 30, 2026, (iii) 25% on September 30, 2026, and (iv) 25% on December

31, 2026, provided Mr. Silverman continues to provide services to the Company through the applicable vesting date and subject to the

terms and conditions of the Plan.

On

the Board Approval Date, the Board of the Company also approved grants to each of Sebastian Giordano, Zvi Joseph, Greg Schiffman, and

Wayne Walker, each a director of the Company (the “Directors”), of stock options to acquire the number of shares of Common

Stock equal to an aggregate value of $338,000 or, $84,500 each, as of the Board Approval Date, utilizing the black-scholes valuation

method to calculate the applicable number of shares on such date with an exercise price equal to the fair market value of the Company’s

Common Stock on the Incentive Plan Approval Date (the “Director Stock Options”). The Director Stock Options will be issued

on the Incentive Plan Approval Date and will be issued pursuant to, and be subject to the terms and conditions of, the Plan. The Director

Stock Options will vest (a) 25% as of the Incentive Plan Approval Date; (b) 25% on June 30, 2026; (c) 25% on September 30, 2026; and

(d) 25% on December 31, 2026, provided the Director continues to provide services to the Company through the applicable vesting date.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On

April 27, 2026, the Company filed a Certificate of Amendment to the Company’s Charter (the “Certificate of Amendment”)

to change the name of the Company from “StableX Technologies, Inc.” to “Fabric.AI, Inc.,” effective as of 12:01

Eastern Time on April 28, 2026 (the “Name Change”). In addition, effective before the open of market trading on April 29,

2026, the Company’s Common Stock will cease trading under the ticker symbol “SBLX” and will begin trading on the Nasdaq

Stock Market under the ticker symbol “FABC”.

The

Name Change does not affect the rights of the Company’s security holders. There will be no change to the Company’s CUSIP

in connection with the Name Change.

Pursuant

to Section 242 of the Delaware General Corporation Law, stockholder approval was not required to complete the Name Change or to approve

or effect the Certificate of Amendment. The information set forth herein is qualified in its entirety by reference to the complete text

of the Certificate of Amendment, a copy of which is filed with this report as Exhibit 3.5 and is incorporated by reference herein.

To

the extent required by Item 5.03 of Form 8-K, the information contained in Item 1.01 of this Current Report on Form 8-K is incorporated

herein by reference.

Item

5.08. Shareholder Director Nominations.

On

April 27, 2026, the Board determined that the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”)

will be held on Friday, June 12, 2026. The time and location of the 2026 Annual Meeting will be as set forth in the Company’s definitive

proxy statement for the 2026 Annual Meeting to be filed with the Securities and Exchange Commission.

Due

to the fact that the date of the 2026 Annual Meeting has been changed by more than 30 days from the anniversary date of the Company’s

2025 Annual Meeting of Stockholders, the Company is providing the due date for submission of any qualified stockholder proposal or qualified

stockholder nominations.

Stockholders

of the Company who wish to have a proposal considered for inclusion in the Company’s proxy materials for the 2026 Annual Meeting

pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), must ensure that such

proposal is received by the Company’s Secretary at 1185 Avenue of the Americas, New York, NY 10036, Attention: Secretary, on or

before the close of business on May 8, 2026, which the Company has determined to be a reasonable time before it expects to begin to print

and send its proxy materials in accordance with Rule 14a-5(f) and Rule 14a-8(e) under the Exchange Act. Any such proposal must also meet

the requirements set forth in the rules and regulations of the Securities and Exchange Commission in order to be eligible for inclusion

in the proxy materials for the 2026 Annual Meeting.

In

addition, in accordance with the requirements contained in the Company’s amended and restated Bylaws (“Bylaws”), stockholders

of the Company who wish to bring business before the 2026 Annual Meeting outside of Rule 14a-8 of the Exchange Act or to nominate a person

for election as a director must ensure that written notice of such proposal (including all information specified in the Company’s

Bylaws) is received by the Company’s Secretary at the address specified above no later than the close of business on May 8, 2026.

Any such proposal must meet the requirements set forth in the Company’s Bylaws in order to be brought before the 2026 Annual Meeting.

In

addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other

than the Company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act

by May 8, 2026, which is the 10th calendar date following the date hereof.

Item 7.01

Regulation FD Disclosure.

On

April 28, 2026, the Company issued a press release announcing, among other things, its strategic pivot from its prior digital asset treasury

strategy to AI infrastructure, including the development of a suite of fabless semiconductor technologies, the JDA, Private Placement

and Name Change. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated by reference herein.

In

accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including

Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended

(the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference

in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in

such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute

a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination

of such information is required by Regulation FD.

Item

9.01 Financial Statements and Exhibits.

Exhibit

Number

Description

3.1

Certificate of Designation of Series J Preferred Stock of Fabric.AI, Inc.

3.2

Certificate of Designation of Series K Preferred Stock of Fabric.AI, Inc.

3.3

Amended and Restated Certificate of Designation of Series H-7 Preferred Stock of Fabric.AI, Inc.

3.4

Amended and Restated Certificate of Designation of Series I Preferred Stock of Fabric.AI, Inc.

3.5

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Fabric.AI, Inc.

4.1

Form of Series K Warrant.

4.2

Form of Waiver Warrant.

4.3

Form of Consultant Warrant.

4.4

Amendment to Rights Agreement, dated as of April 27, 2026, by and between the Company and Equiniti Trust Company, LLC.

10.1

Joint Development and License Agreement, dated April 27, 2026, by and between the Company and Kopin Corporation

10.2

Commercial Supply Agreement, dated April 27, 2026, by and between the Company and Kopin Corporation

10.3

Form of Securities Purchase Agreement, dated April 27, 2026, by and among the Company and the investors signatory thereto.

10.4

Form of Registration Rights Agreement dated April 27, 2026, by and among the Company and the investors signatory thereto.

10.5

Form of Series H-7 Omnibus Waiver, Consent, Notice and Amendment Agreement, dated April 27, 2026, by and among the Company and the investors signatory thereto.

10.6

Form of Series I Omnibus Waiver, Consent, Notice and Amendment Agreement, dated April 27, 2026, by and among the Company and the investors signatory thereto.

10.7

Amended and Restated Consulting Services Agreement, dated April 27, 2026, by and between the Company and JD Advisors, LLC.

99.1

Press Release, Dated April 28, 2026.

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Date:

April 28, 2026

Fabric.AI,

Inc.

By:

/s/

Joshua Silverman

Name:

Joshua

Silverman

Title:

Chief

Executive Officer

EX-3.1

EX-3.1

Filename: ex3-1.htm · Sequence: 2

Exhibit

3.1

STABLEX

TECHNOLOGIES, INC.

CERTIFICATE

OF DESIGNATION OF PREFERENCES,

RIGHTS

AND LIMITATIONS

OF

SERIES

J CONVERTIBLE PREFERRED STOCK

I,

Joshua Silverman, hereby certify that I am the Chief Executive Officer of StableX Technologies, Inc. (the “Company”),

a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), and further do hereby

certify:

That

pursuant to the authority expressly conferred upon the Board of Directors of the Company (the “Board”) by the Company’s

Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”), and Section 151(g)

of the Delaware General Corporation Law, the Board on April 27, 2026, adopted the following resolution determining it desirable and in

the best interests of the Company and its stockholders for the Company to create a series of 51,575 shares of preferred stock designated

as “Series J Convertible Preferred Stock”, none of which shares have been issued:

RESOLVED,

that pursuant to the authority vested in the Board, in accordance with the provisions of the Certificate of Incorporation, a series of

preferred stock, par value $0.0001 per share, of the Company be and hereby is created pursuant to this certificate of designations (this

“Certificate of Designations”), and that the designation and number of shares thereof and the voting and other powers,

preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and

restrictions thereof are as follows:

TERMS

OF SERIES J PREFERRED STOCK

Section

1. Definitions. For the purposes hereof, the following terms shall have the following meanings:

“Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.

“Business

Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day

on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

“Buy-In”

shall have the meaning set forth in Section 7(c)(iv).

“Commercial

Supply Agreement” means that certain Commercial Supply Agreement, dated as of April 27, 2026, by and between the Company and

the Holder.

“Commission”

means the United States Securities and Exchange Commission.

“Common

Stock” means the Company’s common stock, par value $0.0001 per share, and stock of any other class of securities into

which such securities may hereafter be reclassified or changed.

“Common

Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire

at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that

is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

“Conversion

Amount” means the sum of the Stated Value at issue.

“Conversion

Date” shall have the meaning set forth in Section 7(a).

“Conversion

Price” shall have the meaning set forth in Section 7(b).

“Conversion

Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance

with the terms hereof.

“Dividend

Payment Date” means each June 30 and December 31 during the period in which any shares of Preferred Stock remain outstanding.

“Dividend

Rate” means six percent (6%) per annum.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Fundamental

Transaction” shall have the meaning set forth in Section 8(e).

“GAAP”

means United States generally accepted accounting principles.

“Holder”

shall have the meaning given such term in Section 2.

“Joint

Development Agreement” means the Joint Development & License Agreement, dated as

of

April 27, 2026, by and between the Company and the Holder.

“Liens”

means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

“Liquidation”

shall have the meaning set forth in Section 6.

“New

York Courts” shall have the meaning set forth in Section 12(d).

“Notice

of Conversion” shall have the meaning set forth in Section 7(a).

“Original

Issue Date” means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers

of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred

Stock.

“Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability

company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“PIK

Dividend” shall have the meaning set forth in Section 4(b).

“Preferred

Stock” shall have the meaning set forth in Section 2.

“Securities”

means the Preferred Stock and the Conversion Shares.

“Securities

Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Share

Delivery Date” shall have the meaning set forth in Section 7(c).

“Stated

Value” shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 4.

“Stockholder

Approval” means such approval as may be required by the applicable rules and regulations of the Trading Market (or any successor

entity) from the shareholders of the Company with respect to the transactions contemplated by the Transaction Documents, including the

issuance of all of the Conversion Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing Date.

“Subsidiary”

means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed

or acquired after the Original Issue Date.

“Successor

Entity” shall have the meaning set forth in Section 8(d).

“Trading

Day” means a day on which the principal Trading Market is open for business.

“Trading

Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date

in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock

Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

“Transaction

Documents” means this Certificate of Designations, the Joint Development Agreement, the Commercial Supply Agreement and any

other documents or agreements executed in connection with the transactions contemplated pursuant to the Joint Development Agreement.

“Transfer

Agent” means Issuer Direct Corporation, One Glenwood Avenue, Suite 1001, Raleigh, NC 27603, and any successor transfer agent

of the Company.

Section

2. Designation, Amount and Par Value. The series of preferred stock shall be designated as its Series J Convertible Preferred

Stock (the “Preferred Stock”) and the number of shares so designated shall be 51,575 (which shall not be subject to

increase without the written consent of a majority of the holders of the Preferred Stock then outstanding (each, a “Holder”

and collectively, the “Holders”)). Each share of Preferred Stock shall have a par value of $0.0001 per share and shall

have a stated value equal to $1,000, subject to increase set forth in Section 4 below (the “Stated Value”).

Section

3. Ranking. Except to the extent that the holders of at least a majority of the outstanding Preferred Stock (the “Required

Holders”) expressly consent to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below) in

accordance with Section 10, the Preferred Stock shall rank (i) senior in respect of the preferences as to dividends, distributions and

payments upon the liquidation, dissolution and winding up of the Company to the Common Stock, all Common Stock Equivalents, the Series

A Junior Participating Preferred Stock, the Series H Preferred Stock, the Series H Convertible Preferred Stock, the Series H-3 Convertible

Preferred Stock, the Series H-6 Convertible Preferred Stock, the Series I Convertible Preferred Stock and any other class or series of

capital stock of the Company hereafter issued that is not expressly designated as Parity Stock or Senior Preferred Stock (collectively,

the “Junior Stock”) and (ii) pari passu in respect of the preferences as to dividends, distributions and payments upon the

liquidation, dissolution and winding up of the Company’s Series H-7 Convertible Preferred Stock and any other class or series of

capital stock expressly designated as pari passu with the Preferred Stock (together, the “Existing Parity Stock”). The rights

of all such shares of Junior Stock of the Company shall be subject to the rights, powers, preferences and privileges of the Preferred

Stock. Without limiting any other provision of this Certificate of Designations, without the prior express consent of the Required Holders,

voting separately as a single class, the Company shall not hereafter authorize or issue any additional or other shares of capital stock

that are (i) of senior rank to the Preferred Stock in respect of the preferences as to dividends, distributions and payments upon the

liquidation, dissolution and winding up of the Company (collectively, the “Senior Preferred Stock”), or (ii) of pari passu

rank to the Preferred Stock in respect of the preferences as to dividends, distributions and payments upon the liquidation, dissolution

and winding up of the Company (collectively with the Existing Parity Stock, the “Parity Stock”). In the event of the merger

or consolidation of the Company with or into another corporation, the Preferred Stock shall maintain their relative rights, powers, designations,

privileges and preferences provided for herein and no such merger or consolidation shall be consummated if it would result in the Preferred

Stock being treated in any manner inconsistently with the foregoing.

Section

4. Dividends.

a)

Accrual

of Dividends. Holders shall be entitled to receive, and the Company shall pay, dividends at the Dividend Rate on the Stated Value

of each share of Preferred Stock, which dividends shall accrue daily from and after the Original Issue Date and shall be payable

semi-annually on each Dividend Payment Date.

b)

Payment of Dividends.

Dividends shall be payable in cash; provided, however, that the Company may, at its sole option, elect to pay any dividend

in kind by issuing to the Holder additional shares of Preferred Stock having an aggregate Stated Value equal to the amount of the

dividend then due (each such payment, a “PIK Dividend”). The Company shall provide the Holder with written notice

of its election to pay a PIK Dividend at least ten (10) Business Days prior to the applicable Dividend Payment Date. If the Company

elects to pay a PIK Dividend, the Stated Value of the Holder’s Preferred Stock shall be increased by the amount of such PIK

Dividend, or the Company shall issue additional shares of Preferred Stock to the Holder reflecting such PIK Dividend. Notwithstanding

the foregoing, the Company may not elect to issue a PIK Dividend if such PIK Dividend would result in Conversion Shares issuable

upon conversion of the Preferred Stock to exceed the Issuable Maximum and the requisite Stockholder Approval has not been obtained.

c)

Dividend Priority.

So long as any shares of Preferred Stock are outstanding, no dividends or other distribution of assets (or rights to acquire assets)

shall be declared or paid or set apart for payment, and no other distribution shall be made, upon the Common Stock or any class or

series of capital stock, unless and until all accrued and unpaid dividends on the Preferred Stock have been paid in full. Notwithstanding

the foregoing, dividends may be declared and paid on any class or series of capital stock ranking senior to the Preferred Stock prior

to the payment of dividends on the Preferred Stock. Dividends shall be cumulative and if, on the Dividend Payment Date, dividends

on the Preferred Stock have not been declared and paid in full, such unpaid dividends shall continue to accrue daily from and after

the initial dividend payment date and shall compound on a semi-annual basis at the applicable rate for the Preferred Stock on each

subsequent Dividend Payment Date until paid in full.

Section

5. Voting Rights. Except as expressly set forth in this Certificate of Designations or as otherwise required by law, the provisions

of the Certificate of Incorporation or Section 10 of this Certificate of Designations, the Preferred Stock shall not be entitled to any

voting rights prior to the conversion thereof into shares of Common Stock in accordance with Section 7 hereof; provided, however, that

upon any such conversion of the Preferred Stock into shares of Common Stock, the holders of such converted shares shall be entitled to

full voting rights as holders of Common Stock.

Section

6. Liquidation. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”),

the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company (the “Liquidation Funds”),

before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding,

an amount per share of Preferred Stock equal to the amount per share such Holder would receive if such Holder converted such Preferred

Share into Common Stock immediately prior to the date of such payment (disregarding for such purposes any conversion limitations hereunder),

provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders of shares of Parity Stock,

then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal to the full amount of Liquidation

Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance with their respective certificate

of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to all holders of Preferred Stock and

all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions to be taken by each of its subsidiaries

so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation to be distributed to the Holders in accordance

with this Section 6. All the preferential amounts to be paid to the Holders under this Section 6 shall be paid or set apart for payment

before the payment or setting apart for payment of any amount for, or the distribution of any Liquidation Funds of the Company to the

holders of shares of Junior Stock in connection with a Liquidation as to which this Section 6 applies. The Company shall mail written

notice of any such Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder.

Section

7. Conversion.

a)

Conversions

at Option of Holder. Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the

Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations set

forth in Section 7(e)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion Price. Holders

shall effect conversions by providing the Company with the form of conversion notice attached hereto as Annex A (a “Notice

of Conversion”). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number

of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to

the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable

Holder delivers by .pdf via email such Notice of Conversion to the Company (such date, the “Conversion Date”).

If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion

to the Company is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee

(or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth

in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred

Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Company unless

all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate

representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted

into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.

b)

Conversion Price.

The conversion price for the Preferred Stock shall equal $2.51, subject to adjustment herein (the “Conversion Price”).

c)

Mechanics of Conversion.

i.

Delivery of Conversion Shares Upon Conversion. Not later than one (1) Trading Day after each Conversion Date (the “Share

Delivery Date”), the Company shall deliver, or cause to be delivered, to the converting Holder the number of Conversion Shares

being acquired upon the conversion of the Preferred Stock. The Conversion Shares shall bear appropriate restrictive legends reflecting

that such shares are unregistered securities under the Securities Act.

ii.

Failure to Deliver Conversion Shares. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to

or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Company

at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Company shall promptly

return to the Holder any original Preferred Stock certificate delivered to the Company and the Holder shall promptly return to the Company

the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.

iii.

Obligation Absolute. The Company’s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock

in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the

same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce

the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other

Person of any obligation to the Company or any violation or alleged violation of law by such Holder or any other Person, and irrespective

of any other circumstance which might otherwise limit such obligation of the Company to such Holder in connection with the issuance of

such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Company of any such

action that the Company may have against such Holder.

iv.

Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion. In addition to any other rights available

to the Holder, if the Company fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date

pursuant to Section 7(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open

market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction

of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating to such Share

Delivery Date (a “Buy-In”), then the Company shall (A) pay in cash to such Holder (in addition to any other remedies

available to or elected by such Holder) the amount, if any, by which (x) such Holder’s total purchase price (including any brokerage

commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock that such

Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise

to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such Holder, either reissue (if

surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case,

such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued

if the Company had timely complied with its delivery requirements under Section 7(c)(i). For example, if a Holder purchases shares of

Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred

Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such

purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Company shall be required to pay

such Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to such Holder in respect of the

Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue

any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or

injunctive relief with respect to the Company’s failure to timely deliver the Conversion Shares upon conversion of the shares of

Preferred Stock as required pursuant to the terms hereof.

v.

Reservation of Shares Issuable Upon Conversion. The Company covenants that it will at all times reserve and keep available out

of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock, free from

preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred

Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and

restrictions of Section 8) upon the conversion of the then outstanding shares of Preferred Stock. The Company covenants that all shares

of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.

vi.

Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred

Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Company shall

at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the

Conversion Price or round up to the next whole share.

vii.

Transfer Taxes and Expenses. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge

to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,

provided that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance

and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock

and the Company shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the

issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that

such tax has been paid. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion and

all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day

electronic delivery of the Conversion Shares.

d)

[Reserved].

e) Exchange

Cap. Notwithstanding anything herein to the contrary, if the Company has not obtained Stockholder Approval or obtained a written

opinion from outside counsel to the Company that such approval is not required, which opinion shall be reasonably satisfactory to

the Required Holders, then the Company may not issue, upon conversion of the Preferred Stock, a number of shares of Common Stock

which, when aggregated with any shares of Common Stock issued on or after the Original Issue Date and prior to such Conversion Date

in connection with any conversion of Preferred Stock issued pursuant to the Joint Development Agreement, would exceed 291,049 shares

of Common Stock (subject to adjustment for forward and reverse stock splits, recapitalizations and the like) (such number of shares,

the “Issuable Maximum”). Holder shall be entitled to a portion of the Issuable Maximum equal to the quotient

obtained by dividing (x) the original Stated Value of Holder’s Preferred Stock by (y) the aggregate Stated Value of all

Preferred Stock issued on the Original Issue Date to Holder. In addition, Holder may allocate its pro-rata portion of the Issuable

Maximum among Preferred Stock held by it in its sole discretion. Such portion shall be adjusted upward ratably in the event Holder

no longer holds any Preferred Stock and the amount of shares issued to Holder pursuant to Holder’s Preferred Stock was less

than Holder’s pro-rata share of the Issuable Maximum. For any reason at any time, upon the written or oral request of a

Holder, the Company shall within one (1) Business Day confirm orally and in writing to such Holder the number of shares of Common

Stock then outstanding, including by virtue of any prior conversion or exercise of convertible or exercisable securities into Common

Stock, including, without limitation, pursuant to this Certificate of Designations or securities issued pursuant to the other

Transaction Documents.

Section

8. Certain Adjustments.

a) Stock

Dividends and Stock Splits. If the Company, at any time while this Preferred Stock is outstanding: (i) pays a stock dividend or

otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common

Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion

of, or payment of a dividend on, this Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of

shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of

shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the

Company, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common

Stock (excluding any treasury shares of the Company) outstanding immediately before such event, and of which the denominator shall

be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 8(a)

shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or

distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or

re-classification.

b) Adjustment

Upon Conversion of Existing Preferred Stock. Notwithstanding anything herein to the contrary and subject to Section 7(e), the

number of shares of Common Stock issuable upon conversion of the Preferred Stock may not exceed 291,049 (the “Maximum

Issuance”); provided, however, that upon (1) the sale and issuance, in one or more offerings, of any Common Stock or any

securities entitling any Person to acquire shares of Common Stock (each such issuance, a “Dilutive Issuance”) or

(2) the issuance of Common Stock (a “Dilutive Conversion”) in connection with any conversions or exercises of any

Common Stock Equivalents that are (x) outstanding as of April 27, 2026 or (y) approved for grant by the Board of Directors on April

27, 2026, and not yet issued or outstanding as of such date (the “Existing Common Stock Equivalents”), the

Maximum Issuance shall be increased to equal the sum of (i) the Maximum Issuance immediately prior to the date of such Dilutive

Issuance or Dilutive Conversion, plus (ii) 0.1999 shares of Common Stock for each share of Common Stock issued in connection with

such Dilutive Issuance or Dilutive Conversion, as the case may be. Notwithstanding anything to the contrary contained herein, once

an adjustment to the Maximum Issuance has been made in respect of (A) Dilutive Issuances, and (B) any exercises for cash of Existing

Common Stock Equivalents, in an aggregate amount equal to $50 million, no further adjustments shall be made for any subsequent

Dilutive Conversions or Dilutive Issuances and this Section shall have no further force and effect. The Company shall provide prompt

written notice within one Trading Day following an adjustment to the Maximum Issuance via electronic mail to each Holder. For the

avoidance of doubt, no adjustment to the Maximum Issuance shall be made with respect to a Dilutive Issuance or Dilutive Conversion

to the extent that the shares of Common Stock issued in connection therewith previously resulted in an adjustment to the Maximum

Issuance. In addition, from and after the date on which all the Existing Common Stock Equivalents have been fully exercised or

converted, as applicable, no further adjustments to the Maximum Issuance shall be made pursuant to this Section 8(b).

c) Pro

Rata Distributions. During such time as this Preferred Stock is outstanding, if the Company declares or makes any dividend or

other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital

or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a

dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a

“Distribution”), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder

shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the

Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Preferred Stock (without regard to

any limitations on conversion hereof) immediately before the date of which a record is taken for such Distribution, or, if no such

record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in

such Distribution.

d) Fundamental

Transaction. If, at any time while this Preferred Stock is outstanding, (i) the Company, directly or indirectly, in one or more

related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of

its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or

other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or

indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which

holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been

accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more

related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share

exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or

(v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or

other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement)

with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (each a

“Fundamental Transaction”), then, upon any subsequent conversion of this Preferred Stock, the Holder shall have

the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the

occurrence of such Fundamental Transaction (without regard to any limitation in Section 7(e) on the conversion of this Preferred

Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving

corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such

Fundamental Transaction by a holder of the number of shares of Common Stock for which this Preferred Stock is convertible

immediately prior to such Fundamental Transaction (without regard to any limitation in Section 7(e) on the conversion of this

Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to

apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common

Stock in such Fundamental Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a

reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common

Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall

be given the same choice as to the Alternate Consideration it receives upon any conversion of this Preferred Stock following such

Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the

survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this

Certificate of Designations and the other Transaction Documents in accordance with the provisions of this Section 8(d) pursuant to

written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable

delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Preferred Stock, deliver to the Holder

in exchange for this Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in

form and substance to this Preferred Stock which is convertible for a corresponding number of shares of capital stock of such

Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this

Preferred Stock (without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction,

and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account

the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital

stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of

this Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in

form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to,

and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of

Designations and the other Transaction Documents referring to the “Company” shall refer instead to the Successor

Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this

Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity had been named as

the Company herein.

e) Calculations.

All calculations under this Section 8 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For

purposes of this Section 8, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the

sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.

f) Notice

to the Holders.

i. Adjustment

to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 8, the Company shall

promptly deliver to each Holder by .pdf via email a notice setting forth the Conversion Price after such adjustment and setting

forth a brief statement of the facts requiring such adjustment.

ii. Notice

to Allow Conversion by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the

Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the

Company shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any

shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in

connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or

transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is

converted into other securities, cash or property or (E) the Company shall authorize the voluntary or involuntary dissolution,

liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be filed at each office or

agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered by .pdf via email to each

Holder at its last .pdf via email number or email address as it shall appear upon the stock books of the Company, at least twenty

(20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a

record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be

taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,

rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or

share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of

record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such

reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any

defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such

notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the

Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current

Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof)

during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except

as may otherwise be expressly set forth herein.

Section

9. Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation,

bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of

securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Certificate

of Designations, and will at all times in good faith carry out all the provisions of this Certificate of Designations and take all action

as may be required to protect the rights of the Holders hereunder. Without limiting the generality of the foregoing or any other provision

of this Certificate of Designations or the other Transaction Documents, the Company (a) shall not increase the par value of any shares

of Common Stock receivable upon the conversion of any Preferred Stock above the Conversion Price then in effect, (b) shall take all such

actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares

of Common Stock upon the conversion of Preferred Stock and (c) shall, so long as any Preferred Stock are outstanding, take all action

necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting

the conversion of the Preferred Stock, the maximum number of shares of Common Stock as shall from time to time be necessary to effect

the conversion of the Preferred Stock then outstanding (without regard to any limitations on conversion contained herein). Notwithstanding

anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Original Issue Date of any Preferred Stock,

each Holder is not permitted to convert such Holder’s Preferred Stock in full for any reason (other than pursuant to restrictions

set forth in Section 7(e) hereof), the Company shall use its best efforts to promptly remedy such failure, including, without limitation,

obtaining such consents or approvals as necessary to effect such conversion into shares of Common Stock.

Section

10. Vote to Change the Terms of or Issue Preferred Shares. In addition to any other rights provided by law, except where the

vote or written consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of

Incorporation, without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without

a meeting of the Required Holders, voting together as a single class, the Company shall not (in any case, whether by amendment, modification,

recapitalization, merger, consolidation or otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate

of Incorporation or Bylaws, or file any certificate of designations or articles of amendment of any series of shares of preferred stock,

if such action would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions provided

for the benefit of the Preferred Stock hereunder, regardless of whether any such action shall be by means of amendment to the Certificate

of Incorporation or by merger, consolidation or otherwise; (b) increase or decrease (other than by conversion) the authorized number

of Preferred Stock; (c) without limiting any provision of Section 3, create or authorize (by reclassification or otherwise) any new class

or series of Senior Preferred Stock or Parity Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant

to the terms of the Company’s equity incentive plans and options and other equity awards granted under such plans (that have in

good faith been approved by the Board)); (e) without limiting any provision of Section 3, pay dividends or make any other distribution

on any shares of any Junior Stock; (f) issue any Preferred Stock other than as contemplated hereby; or (g) without limiting any provision

of Section 9, whether or not prohibited by the terms of the Preferred Stock, circumvent a right of the Preferred Stock hereunder.

Section

11. Miscellaneous.

a) Notices.

Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any

Notice of Conversion, shall be in writing and delivered personally, by .pdf via email, or sent by a nationally recognized overnight

courier service, addressed to the Company, at the address set forth above Attention: Chief Executive Officer, at such .pdf via email

number or address as the Company may specify for such purposes by notice to the Holders delivered in accordance with this Section 11

from time to time. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in

writing and delivered personally, by .pdf via email, or sent by a nationally recognized overnight courier service addressed to each

Holder at the .pdf via email number or address of such Holder appearing on the books of the Company, or if no such .pdf via email

number or address appears on the books of the Company, at the principal place of business of such Holder, as set forth in the Joint

Development Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest

of (i) the date of transmission, if such notice or communication is delivered via .pdf via email at the .pdf via email number set

forth in this Section 11 prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of

transmission, if such notice or communication is delivered via .pdf via email at the .pdf via email number set forth in this Section

11 on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day

following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the

party to whom such notice is required to be given.

b) Stockholder

Approval. The Company shall provide each stockholder entitled to vote at a special or annual meeting of stockholders of the

Company (the “Stockholder Meeting”), which shall be held no later than July 26, 2026 (the “Stockholder

Meeting Deadline”), to seek approval of resolutions (“Stockholder Resolutions”) providing for the

Stockholder Approval and the Company shall use its reasonable best efforts to solicit its stockholders’ approval of such

Stockholder Resolutions and to cause the board of directors of the Company to recommend to the stockholders that they approve such

Stockholder Resolutions. The Company shall be obligated to seek to obtain the Stockholder Approval by the Stockholder Meeting

Deadline. If, despite the Company’s reasonable best efforts the Stockholder Approval is not obtained on or prior to the

Stockholder Meeting Deadline, the Company shall cause an additional Stockholder Meeting to be held within 90 days later. If, despite

the Company’s reasonable best efforts the Stockholder Approval is not obtained after such subsequent stockholder meetings, the

Company shall cause an additional Stockholder Meeting to be held semi-annually thereafter until such Stockholder Approval is

obtained. Notwithstanding the above, the Company shall not be required to hold a Stockholder Meeting or seek Stockholder Approval

any time following the time when the shares of Preferred Stock are no longer outstanding if upon full conversion of the shares of

Preferred Stock, the shares of Common Stock issued pursuant to the shares of Preferred Stock would not exceed the Issuable

Maximum.

c) Absolute

Obligation. Except as expressly provided herein, no provision of this Certificate of Designations shall alter or impair the

obligation of the Company, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest,

as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein

prescribed.

d) Lost

or Mutilated Preferred Stock Certificate. If a Holder’s Preferred Stock certificate shall be mutilated, lost, stolen or

destroyed, the Company shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate,

or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so

mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and

of the ownership hereof reasonably satisfactory to the Company.

e) Governing

Law. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designations

shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the

principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and

defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its

respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts

sitting in the City of New York, Borough of Manhattan (the “New York Courts”). Each party hereto hereby

irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in

connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of

any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any

claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or

inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process

being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery

(with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designations and

agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall

be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby

irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding

arising out of or relating to this Certificate of Designations or the transactions contemplated hereby. If any party shall commence

an action or proceeding to enforce any provisions of this Certificate of Designations, then the prevailing party in such action or

proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the

investigation, preparation and prosecution of such action or proceeding.

f) Waiver.

Any waiver by the Company or a Holder of a breach of any provision of this Certificate of Designations shall not operate as or be

construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of

Designations or a waiver by any other Holders. The failure of the Company or a Holder to insist upon strict adherence to any term of

this Certificate of Designations on one or more occasions shall not be considered a waiver or deprive that party (or any other

Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designations

on any other occasion. Any waiver by the Company or a Holder must be in writing.

g) Severability.

If any provision of this Certificate of Designations is invalid, illegal or unenforceable, the balance of this Certificate of

Designations shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless

remain applicable to all other Persons and circumstances.

h) Next

Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment

shall be made on the next succeeding Business Day.

i) Headings.

The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designations and shall not

be deemed to limit or affect any of the provisions hereof.

j) Status

of Converted or Redeemed Preferred Stock. Shares of Preferred Stock may only be issued pursuant to the Joint Development

Agreement. If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Company, such shares shall resume the

status of authorized but unissued shares of preferred stock and shall no longer be designated as Series J Convertible Preferred

Stock.

RESOLVED,

FURTHER, that the Executive Chairman, Chief Executive Officer, the President or any Vice-President, of the Company be and they hereby

are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and Limitations in accordance

with the foregoing resolution and the provisions of Delaware law.

IN

WITNESS WHEREOF, the undersigned have executed this Certificate this 27th day of April, 2026.

/s/ Joshua Silverman

Name:

Joshua Silverman

Title:

Chief Executive Officer

ANNEX

A

NOTICE

OF CONVERSION

(TO

BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES

OF

PREFERRED STOCK)

The

undersigned hereby elects to convert the number of shares of Series J Convertible Preferred Stock indicated below into shares of common

stock, par value $0.0001 per share (the “Common Stock”), of StableX Technologies, Inc., a Delaware corporation (the

“Company”), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be

issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and

is delivering herewith such certificates and opinions as may be required by the Company. No fee will be charged to the Holders for any

conversion, except for any such transfer taxes.

Conversion

calculations:

Date

to Effect Conversion: _____________________________________________

Number

of shares of Preferred Stock owned prior to Conversion: ________________

Number

of shares of Preferred Stock to be Converted: ________________________

Stated

Value of shares of Preferred Stock to be Converted: ____________________

Number

of shares of Common Stock to be Issued: ___________________________

Applicable

Conversion Price:___________________________________________

Number

of shares of Preferred Stock subsequent to Conversion: ________________

Address

for Delivery: ______________________

[HOLDER]

By:

Name:

Title:

EX-3.2

EX-3.2

Filename: ex3-2.htm · Sequence: 3

Exhibit 3.2

CERTIFICATE

OF DESIGNATIONS OF

SERIES

K CONVERTIBLE PREFERRED STOCK OF

STABLEX

TECHNOLOGIES, INC.

I,

Joshua Silverman, hereby certify that I am the Chief Executive Officer of StableX Technologies, Inc. (the “Company”),

a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), and further do hereby

certify:

That

pursuant to the authority expressly conferred upon the Board of Directors of the Company (the “Board”) by the Company’s

Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”), and Section 151(g)

of the DGCL, on April 27, 2026, the Board adopted the following resolution determining it desirable and in the best interests of the

Company and its stockholders for the Company to create a series of 21,500 shares of preferred stock designated as “Series K

Convertible Preferred Stock”, none of which shares have been issued:

RESOLVED,

that pursuant to the authority vested in the Board, in accordance with the provisions of the Certificate of Incorporation, a series of

preferred stock, par value $0.0001 per share, of the Company be and hereby is created pursuant to this certificate of designations (this

“Certificate of Designations”), and that the designation and number of shares thereof and the voting and other powers,

preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and

restrictions thereof are as follows:

TERMS

OF SERIES K CONVERTIBLE PREFERRED STOCK

1. Designation

and Number of Shares. There shall hereby be created and established a series of preferred stock of the Company designated as “Series

K Convertible Preferred Stock” (the “Preferred Shares”). The authorized number of Preferred Shares shall be

21,500. Each Preferred Share shall have a par value of $0.0001. Capitalized terms not defined herein shall have the meaning as set forth

in Section 33 below.

2. Ranking.

Except to the extent that the holders of at least a majority of the outstanding Preferred Shares (provided that such holders shall include

each of Iroquois Master Fund Ltd. and Iroquois Capital Investment Group, LLC (collectively, the “Iroquois Funds”),

provided that the Iroquois Funds collectively hold an aggregate of at least 20% of the Preferred Shares issued to the Iroquois Funds

on the Issuance Date (as defined herein) ) (the “Required Holders”) expressly consent to the creation of Parity Stock

(as defined below) or Senior Preferred Stock (as defined below) in accordance with Section 18, all shares of capital stock

of the Company shall be junior in rank to all Preferred Shares with respect to the preferences as to dividends, distributions and payments

upon the liquidation, dissolution and winding up of the Company (such junior stock is referred to herein collectively as “Junior

Stock”). The rights of all such shares of capital stock of the Company shall be subject to the rights, powers, preferences

and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Designations, without the prior express

consent of the Required Holders, voting separately as a single class, the Company shall not hereafter authorize or issue any additional

or other shares of capital stock that are (i) of senior rank to the Preferred Shares in respect of the preferences as to dividends,

distributions and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Senior Preferred

Stock”), (ii) of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions

and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Parity Stock”) or

(iii) any Junior Stock having a maturity date or any other date requiring redemption or repayment of such shares of Junior Stock.

In the event of the merger or consolidation of the Company with or into another corporation, the Preferred Shares shall maintain their

relative rights, powers, designations, privileges and preferences provided for herein and no such merger or consolidation shall be consummated

if it would result in the Preferred Shares being treated in any manner inconsistently with the foregoing.

3. Dividends

and Payments.

(a) From

and after the first date of issuance of any Preferred Shares (the “Initial Issuance Date”), each holder of a Preferred

Share (each, a “Holder” and collectively, the “Holders”) shall be entitled to receive dividends

on the Stated Value of the Preferred Shares (“Dividends”) payable, subject to the conditions and other terms hereof,

in cash out of funds legally available therefor at the Dividend Rate computed on the basis of a 360-day year and twelve 30-day months

and shall compound each calendar quarter; provided that a Holder and the Company may mutually agree to convert any Dividends into shares

of Common Stock at a price to be mutually determined by the Company and such Holder, which shall not be less than the Floor Price.

(b) Dividends

shall be payable in arrears on (i) each Dividend Date, and (ii) upon any redemption in accordance with Section 12 or any required

payment upon any Triggering Event. From and after the occurrence and during the continuance of any Triggering Event and ending on the

date on which such Triggering Event is subsequently cured (and no other Triggering Event then exists), Dividends shall accrue on the

Stated Value of each Preferred Share at fifteen percent (15.0%) per annum (the “Default Rate”) and shall be computed

on the basis of a 360-day year and twelve 30-day months.

4. Conversion.

At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully paid and non-assessable

shares of Common Stock (as defined below), on the terms and conditions set forth in this Section 4.

(a) Holder’s

Conversion Right. Subject to the provisions of Section 4(d), at any time or times on or after the Initial Issuance Date, each Holder

shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued, fully paid and

non-assessable shares of Common Stock in accordance with Section 4(c) at the Conversion Rate (as defined below). The Company shall not

issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share

of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company shall pay

any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the

Transfer Agent (as defined below)) that may be payable with respect to the issuance and delivery of Common Stock upon conversion of any

Preferred Shares.

2

(b) Conversion

Rate. The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section 4(a) shall be determined

by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the “Conversion Rate”):

(i) “Conversion

Amount” means, with respect to each Preferred Share, as of the applicable date of determination, the sum of (1) the Stated

Value thereof, plus (2) the Additional Amount thereon, plus (3) the Make-Whole Amount, plus (4) and any accrued and unpaid Late Charges

(as defined below in Section 26(c)) with respect to such Stated Value and Additional Amount as of such date of determination.

(ii) “Conversion

Price” means, with respect to each Preferred Share, as of any Conversion Date or other date of determination, $2.51, subject

to adjustment as provided herein.

(c) Mechanics

of Conversion. The conversion of each Preferred Share shall be conducted in the following manner:

(i) Optional

Conversion. To convert a Preferred Share into shares of Common Stock on any date (a “Conversion Date”), a Holder

shall deliver (whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date, a copy

of an executed notice of conversion of the share(s) of Preferred Shares subject to such conversion in the form attached hereto as Exhibit

I (the “Conversion Notice”) to the Company. If required by Section 4(c)(iii), within two (2) Trading Days

following a conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally recognized overnight delivery

service for delivery to the Company the original certificates, if any, representing the Preferred Shares (the “Preferred Share

Certificates”) so converted as aforesaid (or an indemnification undertaking with respect to the Preferred Shares in the case

of its loss, theft or destruction as contemplated by Section 20(b)). On or before the first (1st) Trading Day following the date of receipt

of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation and representation as to whether

such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration statement, in the form

attached hereto as Exhibit II, of receipt of such Conversion Notice to such Holder and the Company’s transfer agent

(the “Transfer Agent”), which confirmation shall constitute an instruction to the Transfer Agent to process such Conversion

Notice in accordance with the terms herein. On or before the first (1st) Trading Day following each date on which the Company has received

a Conversion Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement

of a trade initiated on the applicable Conversion Date of such shares of Common Stock issuable pursuant to such Conversion Notice) (the

“Share Delivery Deadline”), the Company shall (1) provided that the Transfer Agent is participating in the Depository

Trust Company’s (“DTC”) Fast Automated Securities Transfer Program (“FAST”), credit such

aggregate number of shares of Common Stock to which such Holder shall be entitled pursuant to such conversion to such Holder’s

or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is

not participating in FAST, upon the request of such Holder, issue and deliver (via reputable overnight courier) to the address as specified

in such Conversion Notice, a certificate, registered in the name of such Holder or its designee, for the number of shares of Common Stock

to which such Holder shall be entitled. If the number of Preferred Shares represented by the Preferred Share Certificate(s) submitted

for conversion pursuant to Section 4(c)(iii) is greater than the number of Preferred Shares being converted, then the Company shall,

as soon as practicable and in no event later than two (2) Trading Days after receipt of the Preferred Share Certificate(s) and at its

own expense, issue and deliver to such Holder (or its designee) a new Preferred Share Certificate or a new Book-Entry (in either case,

in accordance with Section 20(d)) representing the number of Preferred Shares not converted. The Person or Persons entitled to receive

the shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated for all purposes as the record holder or holders

of such shares of Common Stock on the Conversion Date. Notwithstanding the foregoing, with respect to any Conversion Notice delivered

by a Buyer (as defined in the Securities Purchase Agreement) to the Company on or prior to 4:00 p.m. (New York City time) on the Trading

Day immediately prior to the date of initial issuance of such applicable Preferred Shares to be converted pursuant to such Conversion

Notice (each, an “Issuance Date”), which may be delivered at any time after the time of execution of the Securities

Purchase Agreement, the Company agrees to deliver the shares of Common Stock issuable upon conversion of such Preferred Shares to be

issued on such date subject to such notice(s) by 4:00 p.m. (New York City time) on such applicable Issuance Date and such Issuance Date

shall be the Share Delivery Deadline for purposes hereunder with respect to such Conversion Notice.

3

(ii) Company’s

Failure to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery

Deadline, if the Transfer Agent is not participating in FAST, to issue and deliver to such Holder (or its designee) a certificate for

the number of shares of Common Stock to which such Holder is entitled and register such shares of Common Stock on the Company’s

share register or, if the Transfer Agent is participating in FAST, to credit such Holder’s or its designee’s balance account

with DTC for such number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion of any Conversion

Amount (as the case may be) (a “Conversion Failure”), then, in addition to all other remedies available to such Holder,

(X) the Company shall pay in cash from funds legally available therefor to such Holder on each day after the Share Delivery Deadline

that the issuance of such shares of Common Stock is not timely effected an amount equal to 1% of the product of (A) the sum of the number

of shares of Common Stock not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder is entitled,

multiplied by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time during the period

beginning on the applicable Conversion Date and ending on the applicable Share Delivery Deadline, and (Y) such Holder, upon written notice

to the Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all, or any portion,

of such Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice

shall not affect the Company’s obligations to make any payments which have accrued prior to the date of such notice pursuant to

this Section 4(c)(ii) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Deadline the Transfer Agent is

not participating in FAST, the Company shall fail to issue and deliver to such Holder (or its designee) a certificate and register such

shares of Common Stock on the Company’s share register or, if the Transfer Agent is participating in FAST, the Transfer Agent shall

fail to credit the balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number of shares of

Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder or pursuant to the Company’s obligation

pursuant to clause (ii) below, and if on or after such Share Delivery Deadline such Holder acquires (in an open market transaction, stock

loan or otherwise) shares of Common Stock corresponding to all or any portion of the number of shares of Common Stock issuable upon such

conversion that such Holder is entitled to receive from the Company and has not received from the Company in connection with such Conversion

Failure (a “Buy-In”), then, in addition to all other remedies available to such Holder, the Company shall, within

two (2) Business Days after receipt of such Holder’s request and in such Holder’s discretion, either: (I) pay cash from funds

legally available therefor to such Holder in an amount equal to such Holder’s total purchase price (including brokerage commissions,

stock loan costs and other out-of-pocket expenses, if any) for the shares of Common Stock so acquired (including, without limitation,

by any other Person in respect, or on behalf, of such Holder) (the “Buy-In Price”), at which point the Company’s

obligation to so issue and deliver such certificate (and to issue such shares of Common Stock) or credit to the balance account of such

Holder or such Holder’s designee, as applicable, with DTC for the number of shares of Common Stock to which such Holder is entitled

upon such Holder’s conversion hereunder (as the case may be) (and to issue such shares of Common Stock) shall terminate, or (II)

promptly honor its obligation to so issue and deliver to such Holder a certificate or certificates representing such shares of Common

Stock or credit the balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number of shares

of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder (as the case may be) and pay cash from

funds legally available therefor to such Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (x)

such number of shares of Common Stock multiplied by (y) the lowest Closing Sale Price of the Common Stock on any Trading Day during the

period commencing on the date of the applicable Conversion Notice and ending on the date of such issuance and payment under this clause

(II). Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity,

including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure

to timely deliver certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock) upon the

conversion of the Preferred Shares as required pursuant to the terms hereof. Notwithstanding anything herein to the contrary, with respect

to any given Conversion Failure, this Section 4(c)(ii) shall not apply to a Holder to the extent the Company has already paid such amounts

in full to such Holder with respect to such Conversion Failure, as applicable, pursuant to the analogous sections of the Securities Purchase

Agreement.

4

(iii) Registration;

Book-Entry. At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request (including by

electronic-mail) to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates or in

Book-Entry form. The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the “Register”)

for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and

whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the “Registered

Preferred Shares”). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The

Company and each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred

Share for all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice

to the contrary. A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on

the Register. Upon its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder

thereof, the Company shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares

in the same aggregate Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee

pursuant to Section 19, provided that if the Company does not so record an assignment, transfer or sale (as the case may be) of such

Registered Preferred Shares within two (2) Business Days of such a request, then the Register shall be automatically deemed updated to

reflect such assignment, transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this Section 4,

following conversion of any Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be required to physically

surrender such Preferred Shares held in the form of a Preferred Share Certificate to the Company unless (A) the full or remaining number

of Preferred Shares represented by the applicable Preferred Share Certificate are being converted (in which event such certificate(s)

shall be delivered to the Company as contemplated by this Section 4(c)(iii)) or (B) such Holder has provided the Company with prior written

notice (which notice may be included in a Conversion Notice) requesting reissuance of Preferred Shares upon physical surrender of the

applicable Preferred Share Certificate. Each Holder and the Company shall maintain records showing the Stated Value, Dividends and Late

Charges converted and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case may be) or shall use

such other method, reasonably satisfactory to such Holder and the Company, so as not to require physical surrender of a Preferred Share

Certificate upon conversion. If the Company does not update the Register to record such Stated Value, Dividends and Late Charges converted

and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case may be) within two (2) Business Days

of such occurrence, then the Register shall be automatically deemed updated to reflect such occurrence. In the event of any dispute or

discrepancy, such records of such Holder establishing the number of Preferred Shares to which the record holder is entitled shall be

controlling and determinative in the absence of manifest error. A Holder and any transferee or assignee, by acceptance of a certificate,

acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of any Preferred Shares, the number of

Preferred Shares represented by such certificate may be less than the number of Preferred Shares stated on the face thereof. Each Preferred

Share Certificate shall bear the following legend:

ANY

TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD CAREFULLY REVIEW THE TERMS OF THE COMPANY’S CERTIFICATE OF DESIGNATIONS RELATING

TO THE SHARES OF SERIES K PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER OF SHARES

OF SERIES K PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES K PREFERRED STOCK STATED

ON THE FACE HEREOF PURSUANT TO SECTION 4(c)(iii) OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES K PREFERRED STOCK

REPRESENTED BY THIS CERTIFICATE.

(iv) Pro

Rata Conversion; Disputes. In the event that the Company receives a Conversion Notice from more than one Holder for the same Conversion

Date and the Company can convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert from

each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder’s Preferred Shares submitted

for conversion on such date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to

the aggregate number of Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of shares

of Common Stock issuable to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the

number of shares of Common Stock not in dispute and resolve such dispute in accordance with Section 25.

5

(d) Limitation

on Beneficial Ownership.

(i) Beneficial

Ownership. The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder shall not

have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate of

Designations and any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to such

conversion, such Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the “Maximum

Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such conversion. For purposes of

the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Holder and the other Attribution Parties

shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of

Common Stock issuable upon conversion of the Preferred Shares with respect to which the determination of such sentence is being made,

but shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted Preferred Shares

beneficially owned by such Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or nonconverted

portion of any other securities of the Company (including, without limitation, any convertible notes, convertible preferred stock or

warrants, including the Preferred Shares and the Warrants) beneficially owned by such Holder or any other Attribution Party subject to

a limitation on conversion or exercise analogous to the limitation contained in this Section 4(d)(i). For purposes of this Section 4(d)(i),

beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. In addition, a determination as to any group

status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated

thereunder. For purposes of determining the number of outstanding shares of Common Stock a Holder may acquire upon the conversion of

such Preferred Shares without exceeding the Maximum Percentage, such Holder may rely on the number of outstanding shares of Common Stock

as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form

8-K or other public filing with the SEC, as the case may be, (y) a more recent public announcement by the Company or (z) any other written

notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding (the “Reported

Outstanding Share Number”). If the Company receives a Conversion Notice from a Holder at a time when the actual number of outstanding

shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall notify such Holder in writing of the number

of shares of Common Stock then outstanding and, to the extent that such Conversion Notice would otherwise cause such Holder’s beneficial

ownership, as determined pursuant to this Section 4(d)(i), to exceed the Maximum Percentage, such Holder must notify the Company of a

reduced number of shares of Common Stock to be purchased pursuant to such Conversion Notice. For any reason at any time, upon the written

or oral request of any Holder, the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to such

Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be

determined after giving effect to the conversion or exercise of securities of the Company, including such Preferred Shares, by such Holder

and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the

issuance of shares of Common Stock to a Holder upon conversion of such Preferred Shares results in such Holder and the other Attribution

Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common

Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which such Holder’s and the other

Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall

be deemed null and void and shall be cancelled ab initio, and such Holder shall not have the power to vote or to transfer the Excess

Shares. Upon delivery of a written notice to the Company, any Holder may from time to time increase (with such increase not effective

until the sixty-first (61st) day after delivery of such notice) or decrease the Maximum Percentage of such Holder to any other

percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not

be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or

decrease will apply only to such Holder and the other Attribution Parties and not to any other Holder that is not an Attribution Party

of such Holder. For purposes of clarity, the shares of Common Stock issuable to a Holder pursuant to the terms of this Certificate of

Designations in excess of the Maximum Percentage shall not be deemed to be beneficially owned by such Holder for any purpose including

for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to convert such Preferred Shares pursuant to this

paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination

of convertibility. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity

with the terms of this Section 4(d)(i) to the extent necessary to correct this paragraph (or any portion of this paragraph) which may

be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 4(d)(i) or to make changes or

supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be

waived and shall apply to a successor holder of such Preferred Shares.

(ii) Principal

Market Regulation. The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares or otherwise pursuant

to the terms of this Certificate of Designations if the issuance of such shares of Common Stock (taken together with the issuance of

all other shares of Common Stock upon exercise of the Warrants and Placement Agent Warrants) would exceed the aggregate number of shares

of Common Stock which the Company may issue upon exercise or conversion (as the case may be) of the Preferred Shares, the Warrants and

Placement Agent Warrants without breaching the Company’s obligations under the rules and regulations of the Principal Market (the

number of shares which may be issued without violating such rules and regulations, including, but not limited to, rules related to the

aggregate offerings under Nasdaq Listing Rule 5635(d), the “Exchange Cap”), except that such limitation shall not

apply in the event that the Company (A) obtains the approval of its stockholders as required by the applicable rules and regulations

of the Principal Market for issuances of shares of Common Stock in excess of such amount (“Stockholder Approval”)

or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall be reasonably

satisfactory to the Required Holders. Until such approval or such written opinion is obtained, no Holder shall be issued in the aggregate,

upon conversion or exercise (as the case may be) of any Preferred Shares or any Warrant, shares of Common Stock in an amount greater

than the product of (i) the Exchange Cap as of the Initial Issuance Date multiplied by (ii) the quotient of (1) the aggregate number

of Preferred Shares issued to such Holder on the Initial Issuance Date divided by (2) the aggregate number of Preferred Shares issued

to the Holders on the Initial Issuance Date (with respect to each Holder, the “Exchange Cap Allocation”). In the event

that any Holder shall sell or otherwise transfer any of such Holder’s Preferred Shares, the transferee shall be allocated a pro

rata portion of such Holder’s Exchange Cap Allocation with respect to such portion of such Preferred Shares so transferred, and

the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation so allocated

to such transferee. Upon conversion in full of a holder’s Preferred Shares, the difference (if any) between such holder’s

Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon such holder’s conversion in

full of such Preferred Shares shall be allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares

and/or related Warrants on a pro rata basis in proportion to the shares of Common Stock underlying the Preferred Shares and/or related

Warrants then held by each such holder of Preferred Shares and/or related Warrants.

6

(e) Right

of Alternate Conversion.

(i) Alternate

Conversion Upon a Triggering Event. Subject to Section 4(d), at any time during a Triggering Event Redemption Right Period (as

defined herein), such Holder may, at such Holder’s option, by delivery of a Conversion Notice to the Company (the date of any such

Conversion Notice, each an “Alternate Conversion Date”), convert all, or any number of Preferred Shares (such Conversion

Amount of the Preferred Shares to be converted pursuant to this Section 4(e)(ii), each, an “Alternate Conversion Amount”)

held by such Holder into shares of Common Stock at the Alternate Conversion Price (each an “Alternate Conversion”).

(ii) Mechanics

of Alternate Conversion. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion Amount of Preferred

Shares pursuant to Section 4(c) (with “Alternate Conversion Price” replacing “Conversion Price”

for all purposes hereunder with respect to such Alternate Conversion and with “Alternate Conversion Amount” replacing

“Conversion Amount” in clause (x) of the definition of Conversion Rate above with respect to such Alternate Conversion)

by designating in the Conversion Notice delivered pursuant to this Section 4(e) of this Certificate of Designations that such

Holder is electing to use the Alternate Conversion Price for such conversion; provided that in the event of the Conversion Floor

Price Condition, on the applicable Alternate Conversion Date the Company shall also deliver to the Holder the applicable Alternate Conversion

Floor Amount. Notwithstanding anything to the contrary in this Section 4(e), but subject to Section 4(d), until the Company

delivers shares of Common Stock representing the applicable Alternate Conversion Amount of Preferred Shares to such Holder, such Preferred

Shares may be converted by such Holder into shares of Common Stock pursuant to Section 4(c) without regard to this Section

4(e).

5. Triggering

Event Redemptions.

(a) Triggering

Event. Each of the following events shall constitute a “Triggering Event” and each of the events in clauses (viii),

(ix), and (x) shall constitute a “Bankruptcy Triggering Event”:

7

(i) the

suspension from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period

of five (5) consecutive Trading Days;

(ii) the

Company’s (A) failure to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required

number of shares of Common Stock within five (5) Trading Days after the applicable Conversion Date or exercise date (as the case may

be) or (B) written notice to any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement

or through any of its agents, at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for

Warrant Shares in accordance with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common

Stock that is requested in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d) hereof;

(iii) except

to the extent the Company is in compliance with Section 11(b) below, at any time following the tenth (10th) consecutive

day that a Holder’s Authorized Share Allocation (as defined in Section 11(a) below) is less than the sum of (A) 200% of the number

of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred Shares then

held by such Holder (assuming a conversion at the Floor Price then in effect and without regard to any limitations on conversion set

forth in this Certificate of Designations) and (B) 200% of the number of shares of Common Stock that such Holder would then be entitled

to receive upon exercise in full of such Holder’s Warrants (without regard to any limitations on exercise set forth in the Warrants);

(iv) subject

to the provisions of Section 170 of the DGCL, the Board fails to declare any Dividend to be paid on the applicable Dividend Date in accordance

with Section 3 hereof;

(v) the

Company’s failure to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or any other amount

when and as due under this Certificate of Designations (including, without limitation, the Company’s failure to pay any redemption

payments or other amounts hereunder), the Securities Purchase Agreement or any other Transaction Document or any other agreement, document,

certificate or other instrument delivered in connection with the transactions contemplated hereby and thereby (in each case, whether

or not permitted pursuant to the DGCL), except, solely with respect to the failure to pay Dividends and Late Charges when and as due

hereunder, only if such failure remains uncured for a period of at least five (5) Trading Days;

(vi) the

Company fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon

conversion or exercise (as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder

under the Transaction Documents as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise

then prohibited by applicable federal securities laws, and any such failure remains uncured for at least five (5) Trading Days;

8

(vii) the

occurrence of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $250,000 of Indebtedness

(as defined in the Securities Purchase Agreement) of the Company or any of its Subsidiaries;

(viii) bankruptcy,

insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted by or against

the Company or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed within

thirty (30) days of their initiation;

(ix) the

commencement by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy,

insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the

consent by it to the entry of a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary

case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the

commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking

reorganization or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to

the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official

of the Company or any Subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit of

creditors, or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or

the admission by it in writing of its inability to pay its debts generally as they become due, the taking of corporate action by the

Company or any Subsidiary in furtherance of any such action or the taking of any action by any Person to commence a Uniform Commercial

Code foreclosure sale or any other similar action under federal, state or foreign law;

(x) the

entry by a court of (i) a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary

or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar

law or (ii) a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or

approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of

the Company or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar

document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any

Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance

of any such decree, order, judgment or other similar document or any such other decree, order, judgment or other similar document unstayed

and in effect for a period of thirty (30) consecutive days;

(xi) a

final judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company and/or any of

its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed

pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any judgment which

is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount set forth

above so long as the Company provides each Holder a written statement from such insurer or indemnity provider (which written statement

shall be reasonably satisfactory to each Holder) to the effect that such judgment is covered by insurance or an indemnity and the Company

or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance

of such judgment;

9

(xii) the

Company and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace period,

any payment with respect to any Indebtedness in excess of $250,000 due to any third party (other than, with respect to unsecured Indebtedness

only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect

to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation

of any agreement for monies owed or owing in an amount in excess of $250,000, which breach or violation permits the other party thereto

to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would,

with or without the passage of time or the giving of notice, result in a default or event of default under any agreement binding the

Company or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the business, assets,

operations (including results thereof), liabilities, properties, condition (including financial condition) or prospects of the Company

or any of its Subsidiaries, individually or in the aggregate, but only if such failure or occurrence remains uncured for a period of

at least five (5) days;

(xiii) other

than as specifically set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation

or warranty in any material respect (other than representations or warranties subject to material adverse effect or materiality, which

may not be breached in any respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a

breach of a covenant or other term or condition that is curable, only if such breach remains uncured for a period of five (5) consecutive

Trading Days;

(xiv) a

false or inaccurate certification (including a false or inaccurate deemed certification) by the Company as to whether any Triggering

Event has occurred;

(xv) any

breach or failure in any respect by the Company or any Subsidiary to comply with any provision of Section 15(l) of this Certificate of

Designations;

(xvi) any

Material Adverse Effect (as defined in the Securities Purchase Agreement) occurs that has not been cured, if capable of curing, within

five (5) Trading Days of the occurrence; or

(xvii) any

provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be

valid and binding on or enforceable against the Company, or the validity or enforceability thereof shall be contested, directly or indirectly,

by the Company or any Subsidiary, or a proceeding shall be commenced by the Company or any Subsidiary or any governmental authority having

jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof or the Company or any of its Subsidiaries

shall deny in writing that it has any liability or obligation purported to be created under one or more Transaction Documents.

10

(b) Notice

of a Triggering Event; Redemption Right. Upon the occurrence of a Triggering Event with respect to the Preferred Shares, the Company

shall within one (1) Business Day deliver written notice thereof via electronic mail and overnight courier (with next day delivery

specified) (a “Triggering Event Notice”) to each Holder. At any time after the earlier of a Holder’s receipt

of a Triggering Event Notice and such Holder becoming aware of a Triggering Event (such earlier date, the “Triggering Event

Right Commencement Date”) and ending (such ending date, the “Triggering Event Right Expiration Date”, and

each such period, a “Triggering Event Redemption Right Period”) on the fifteenth (15th) Trading Day after the later

of (x) the later of (1) the date such Triggering Event is cured and (2) the date the Company delivers written notice to

the Holders that such Triggering Event has been cured and (y) such Holder’s receipt of a Triggering Event Notice that includes

(I) a reasonable description of the applicable Triggering Event, (II) a certification as to whether, in the opinion of the Company, such

Triggering Event is capable of being cured and, if applicable, a reasonable description of any existing plans of the Company to cure

such Triggering Event and (III) a certification as to the date the Triggering Event occurred and, if cured on or prior to the date of

such Triggering Event Notice, the applicable Triggering Event Right Expiration Date, such Holder may require the Company to redeem (regardless

of whether such Triggering Event has been cured on or prior to the Triggering Event Right Expiration Date) all or any of the Preferred

Shares by delivering written notice thereof (the “Triggering Event Redemption Notice”) to the Company, which Triggering

Event Redemption Notice shall indicate the number of the Preferred Shares such Holder is electing to redeem. Each of the Preferred Shares

subject to redemption by the Company pursuant to this Section 5(b) shall be redeemed by the Company at a price equal to the greater of

(i) the product of (A) the Conversion Amount to be redeemed multiplied by (B) the Redemption Premium and (ii) the product of (X) the

Conversion Rate with respect to the Conversion Amount in effect at such time as such Holder delivers a Triggering Event Redemption Notice

multiplied by (Y) the product of (1) the Redemption Premium multiplied by (2) the greatest Closing Sale Price of the Common Stock on

any Trading Day during the period commencing on the date immediately preceding such Triggering Event and ending on the date the Company

makes the entire payment required to be made under this Section 5(b) (the “Triggering Event Redemption Price”). Redemptions

required by this Section 5(b) shall be made in accordance with the provisions of Section 12. To the extent redemptions required by this

Section 5(b) are deemed or determined by a court of competent jurisdiction to be prepayments of the Preferred Shares by the Company,

such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this Section 5(b), but

subject to Section 4(d), until the Triggering Event Redemption Price (together with any Late Charges thereon) is paid in full, the Conversion

Amount submitted for redemption under this Section 5(b) (together with any Late Charges thereon) may be converted, in whole or in part,

by such Holder into Common Stock pursuant to the terms of this Certificate of Designations. In the event of the Company’s redemption

of any of the Preferred Shares under this Section 5(b), a Holder’s damages would be uncertain and difficult to estimate because

of the parties’ inability to predict future interest rates and the uncertainty of the availability of a suitable substitute investment

opportunity for such Holder. Accordingly, any redemption premium due under this Section 5(b) is intended by the parties to be, and shall

be deemed, a reasonable estimate of such Holder’s actual loss of its investment opportunity and not as a penalty. Any redemption

upon a Triggering Event shall not constitute an election of remedies by the applicable Holder or any other Holder, and all other rights

and remedies of each Holder shall be preserved.

(c) Mandatory

Redemption upon Bankruptcy Triggering Event. Notwithstanding anything to the contrary herein, and notwithstanding any conversion

that is then required or in process, upon any Bankruptcy Triggering Event, the Company shall immediately redeem, out of funds legally

available therefor, each of the Preferred Shares then outstanding at a redemption price equal to the applicable Triggering Event Redemption

Price (calculated as if such Holder shall have delivered the Triggering Event Redemption Notice immediately prior to the occurrence of

such Bankruptcy Triggering Event), without the requirement for any notice or demand or other action by any Holder or any other person

or entity, provided that a Holder may, in its sole discretion, waive such right to receive payment upon a Bankruptcy Triggering Event,

in whole or in part, and any such waiver shall not affect any other rights of such Holder or any other Holder hereunder, including any

other rights in respect of such Bankruptcy Triggering Event, any right to conversion, and any right to payment of such Triggering Event

Redemption Price or any other Redemption Price, as applicable.

6. Rights

Upon Fundamental Transactions.

(a) Assumption.

The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (if the Successor Entity is

not the Company) assumes in writing all of the obligations of the Company under this Certificate of Designations and the other Transaction

Documents in accordance with the provisions of this Section 6(a) pursuant to written agreements in form and substance satisfactory to

the Required Holders and approved by the Required Holders prior to such Fundamental Transaction, including agreements to deliver to each

holder of Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced by a written instrument

substantially similar in form and substance to this Certificate of Designations, including, without limitation, having a stated value

and dividend rate equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having similar ranking

to the Preferred Shares, and satisfactory to the Required Holders and (ii) the Successor Entity (including its Parent Entity) is a publicly

traded corporation whose shares of common stock are quoted on or listed for trading on an Eligible Market. Upon the occurrence of any

Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental

Transaction, the provisions of this Certificate of Designations and the other Transaction Documents referring to the “Company”

shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations

of the Company under this Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity

had been named as the Company herein and therein. In addition to the foregoing, upon consummation of a Fundamental Transaction, the Successor

Entity (if the Successor Entity is not the Company) shall deliver to each Holder confirmation that there shall be issued upon conversion

or redemption of the Preferred Shares at any time after the consummation of such Fundamental Transaction, in lieu of the shares of Common

Stock (or other securities, cash, assets or other property (except such items still issuable under Sections 7 and 17, which shall continue

to be receivable thereafter)) issuable upon the conversion or redemption of the Preferred Shares prior to such Fundamental Transaction,

such shares of the publicly traded common stock (or their equivalent) of the Successor Entity (including its Parent Entity) which each

Holder would have been entitled to receive upon the happening of such Fundamental Transaction had all the Preferred Shares held by each

Holder been converted immediately prior to such Fundamental Transaction (without regard to any limitations on the conversion of the Preferred

Shares contained in this Certificate of Designations), as adjusted in accordance with the provisions of this Certificate of Designations.

Notwithstanding the foregoing, such Holder may elect, at its sole option, by delivery of written notice to the Company to waive this

Section 6(a) to permit the Fundamental Transaction without the assumption of the Preferred Shares. The provisions of this Section 6 shall

apply similarly and equally to successive Fundamental Transactions and shall be applied without regard to any limitations on the conversion

or redemption of the Preferred Shares.

11

(b) Notice

of a Change of Control Redemption Right. No sooner than twenty (20) Trading Days nor later than ten (10) Trading Days prior to the

consummation of a Change of Control (the “Change of Control Date”), but not prior to the public announcement of such

Change of Control, the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder (a “Change

of Control Notice”). At any time during the period beginning after a Holder’s receipt of a Change of Control Notice or

such Holder becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder in accordance with the

immediately preceding sentence (as applicable) and ending on the later of (A) the date of consummation of such Change of Control or (B)

twenty (20) Trading Days after the date of receipt of such Change of Control Notice or (C) twenty (20) Trading Days after the date of

the announcement of such Change of Control, such Holder may require the Company to redeem all or any portion of such Holder’s Preferred

Shares by delivering written notice thereof (“Change of Control Redemption Notice”) to the Company, which Change of

Control Redemption Notice shall indicate the number of Preferred Shares such Holder is electing to have the Company redeem. Each Preferred

Share subject to redemption pursuant to this Section 6(b) shall be redeemed by the Company in funds legally available therefor at a price

equal to the greatest of (i) the product of (x) the Change of Control Redemption Premium multiplied by (y) the Conversion Amount of the

Preferred Shares being redeemed, (ii) the product of (x) the Change of Control Redemption Premium multiplied by (y) the product of (A)

the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the quotient determined by dividing (I) the greatest Closing

Sale Price of the shares of Common Stock during the period beginning on the date immediately preceding the earlier to occur of (1) the

consummation of the applicable Change of Control and (2) the public announcement of such Change of Control and ending on the date such

Holder delivers the Change of Control Redemption Notice by (II) the Conversion Price then in effect and (iii) the product of (y) the

Change of Control Redemption Premium multiplied by (z) the product of (A) the Conversion Amount of the Preferred Shares being redeemed

multiplied by (B) the quotient of (I) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per

share of Common Stock to be paid to such holders of the shares of Common Stock upon consummation of such Change of Control (any such

non-cash consideration constituting publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities

as of the Trading Day immediately prior to the consummation of such Change of Control, the Closing Sale Price of such securities on the

Trading Day immediately following the public announcement of such proposed Change of Control and the Closing Sale Price of such securities

on the Trading Day immediately prior to the public announcement of such proposed Change of Control) divided by (II) the Conversion Price

then in effect (the “Change of Control Redemption Price”). Redemptions required by this Section 6(b) shall have priority

to payments to all other stockholders of the Company in connection with such Change of Control. To the extent redemptions required by

this Section 6(b) are deemed or determined by a court of competent jurisdiction to be prepayments of the Preferred Shares by the Company,

such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this Section 6(b), but

subject to Section 4(d), until the applicable Change of Control Redemption Price (together with any Late Charges thereon) is paid in

full to the applicable Holder, the Preferred Shares submitted by such Holder for redemption under this Section 6(b) may be converted,

in whole or in part, by such Holder into Common Stock pursuant to Section 4 or in the event the Conversion Date is after the consummation

of such Change of Control, stock or equity interests of the Successor Entity substantially equivalent to the Company’s shares of

Common Stock pursuant to Section 4. In the event of the Company’s redemption of any of the Preferred Shares under this Section

6(b), such Holder’s damages would be uncertain and difficult to estimate because of the parties’ inability to predict future

interest rates and the uncertainty of the availability of a suitable substitute investment opportunity for a Holder. Accordingly, any

redemption premium due under this Section 6(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s

actual loss of its investment opportunity and not as a penalty. The Company shall make payment of the applicable Change of Control Redemption

Price concurrently with the consummation of such Change of Control if a Change of Control Redemption Notice is received prior to the

consummation of such Change of Control and within two (2) Trading Days after the Company’s receipt of such notice otherwise (the

“Change of Control Redemption Date”). Redemptions required by this Section 6 shall be made in accordance with the

provisions of Section 12.

7. Rights

Upon Issuance of Purchase Rights and Other Corporate Events.

(a) Purchase

Rights. In addition to any adjustments pursuant to Section 8 below, if at any time the Company grants, issues or sells any Options,

Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially all of the

record holders of any class of Common Stock (the “Purchase Rights”), then each Holder will be entitled to acquire,

upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder

had held the number of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking into account

any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the Preferred Shares

were converted at the Floor Price as of the applicable record date) held by such Holder immediately prior to the date on which a record

is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders

of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent

that such Holder’s right to participate in any such Purchase Right would result in such Holder and the other Attribution Parties

exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase Right to such extent of the

Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase Right

(and beneficial ownership) to such extent of any such excess) and such Purchase Right to such extent shall be held in abeyance (and,

if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be extended by such number of

days held in abeyance, if applicable) for the benefit of such Holder until such time or times, if ever, as its right thereto would not

result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times such Holder shall be

granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right

held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall

be extended by such number of days held in abeyance, if applicable)) to the same extent as if there had been no such limitation).

12

(b) Other

Corporate Events. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental

Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or

in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to ensure

that each Holder will thereafter have the right, at such Holder’s option, to receive upon a conversion of all the Preferred Shares

held by such Holder (i) in addition to the shares of Common Stock receivable upon such conversion, such securities or other assets to

which such Holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by such

Holder upon the consummation of such Corporate Event (without taking into account any limitations or restrictions on the convertibility

of the Preferred Shares set forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable

upon such conversion, such securities or other assets received by the holders of shares of Common Stock in connection with the consummation

of such Corporate Event in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder

initially been issued with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion

rate for such consideration commensurate with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form

and substance satisfactory to the Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive

Corporate Events and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares set forth

in this Certificate of Designations.

8. Rights

Upon Issuance of Other Securities.

(a) Adjustment

of Conversion Price upon Issuance of Common Stock. If and whenever on or after the Subscription Date the Company grants, issues or

sells (or enters into any agreement or publicly announces its intention to grant, issue or sell), or in accordance with this Section

8(a) is deemed to have granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of shares of Common

Stock owned or held by or for the account of the Company, but excluding any Excluded Securities granted, issued or sold or deemed to

have been granted, issued or sold) for a consideration per share (the “New Issuance Price”) less than a price equal

to the Conversion Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such Conversion

Price then in effect is referred to herein as the “Applicable Price”) (the foregoing a “Dilutive Issuance”),

then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance

Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance

Price under this Section 8(a)), the following shall be applicable:

(i) Issuance

of Options. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options

and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon

conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the

terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued

and sold by the Company at the time of the granting, issuance or sale of such Option for such price per share. For purposes of this Section

8(a)(i), the “lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such

Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise

pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received

or receivable by the Company with respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise

of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise

pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share of Common Stock is issuable

(or may become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or

exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof, minus (2)

the sum of all amounts paid or payable to the holder of such Option (or any other Person) with respect to any one share of Common Stock

upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible

Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the value of any other consideration received

or receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further

adjustment of the Conversion Price shall be made upon the actual issuance of such share of Common Stock or of such Convertible Securities

upon the exercise of such Options or otherwise pursuant to the terms thereof or upon the actual issuance of such shares of Common Stock

upon conversion, exercise or exchange of such Convertible Securities.

(ii) Issuance

of Convertible Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible

Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or

exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall

be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution

of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this

Section 8(a)(ii), the “lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,

exercise or exchange thereof or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the

lowest amounts of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance

or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange

of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible

Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion,

exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder

of such Convertible Security (or any other Person) with respect to any one share of Common Stock upon the issuance or sale (or the agreement

to issue or sell, as applicable) of such Convertible Security plus the value of any other consideration received or receivable by, or

benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment

of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of

such Convertible Securities or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities

is made upon exercise of any Options for which adjustment of the Conversion Price has been or is to be made pursuant to other provisions

of this Section 8(a), except as contemplated below, no further adjustment of the Conversion Price shall be made by reason of such issuance

or sale.

13

(iii) Change

in Option Price or Rate of Conversion. If the purchase or exercise price provided for in any Options, the additional consideration,

if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible

Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than

proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(b) below),

the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been

in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional

consideration or increased or decreased conversion rate (as the case may be) at the time initially granted, issued or sold. For purposes

of this Section 8(a)(iii), if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible

Security that was outstanding as of the Subscription Date) are increased or decreased in the manner described in the immediately preceding

sentence, then such Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange

thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(a)

shall be made if such adjustment would result in an increase of the Conversion Price then in effect.

(iv) Calculation

of Consideration Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance

or sale or deemed issuance or sale of any other securities of the Company (as determined by the Required Holders, the “Primary

Security”, and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities”

and together with the Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate

consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price

of such Unit, (y) if such Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of

Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section 8(a)(i) or 8(a)(ii)

above and (z) the lowest VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period (the “Adjustment

Period”) immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public

announcement is released prior to the opening of the Principal Market on a Trading Day, such Trading Day shall be the first Trading Day

in such five (5) Trading Day period and if any Preferred Shares are converted, on any given Conversion Date during any such Adjustment

Period, solely with respect to such Preferred Shares converted on such applicable Conversion Date, such applicable Adjustment Period

shall be deemed to have ended on, and included, the Trading Day immediately prior to such Conversion Date). If any shares of Common Stock,

Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor

will be deemed to be the net amount of consideration received by the Company therefor. If any shares of Common Stock, Options or Convertible

Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the

fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of

consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the

five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible Securities are

issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount

of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity

as is attributable to such shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration

other than cash or publicly traded securities will be determined jointly by the Company and the Required Holders. If such parties are

unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “Valuation Event”),

the fair value of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following

such Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination

of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall

be borne by the Company.

(v) Record

Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive a dividend

or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase shares

of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the

shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution

or the date of the granting of such right of subscription or purchase (as the case may be).

(b) Adjustment

of Conversion Price upon Subdivision or Combination of Common Stock. Without limiting any provision of Sections 7, 17 or 8(a), if

the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend, stock combination, recapitalization

or other similar transaction) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Conversion

Price in effect immediately prior to such subdivision will be proportionately reduced. Without limiting any provision of Sections 7,

17 or 8(a), if the Company at any time on or after the Subscription Date combines (by any stock split, stock dividend, stock combination,

recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock into a smaller number of

shares, the Conversion Price in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant

to this Section 8(b) shall become effective immediately after the effective date of such subdivision or combination. If any event requiring

an adjustment under this Section 8(b) occurs during the period that a Conversion Price is calculated hereunder, then the calculation

of such Conversion Price shall be adjusted appropriately to reflect such event.

14

(c) Holder’s

Right of Adjusted Conversion Price. In addition to and not in limitation of the other provisions of this Section 8(b), if the Company

in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible Securities (any

such securities, “Variable Price Securities”) after the Subscription Date that are issuable pursuant to such agreement

or convertible into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with the market price

of the shares of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting

customary anti-dilution provisions (such as share splits, share combinations, share dividends and similar transactions) (each of the

formulations for such variable price being herein referred to as, the “Variable Price”), the Company shall provide

written notice thereof via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance of

such shares of Common Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into such agreement

or issues any such Variable Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion to substitute

the Variable Price for the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice delivered

upon any conversion of Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable Price rather

than the Conversion Price then in effect. A Holder’s election to rely on a Variable Price for a particular conversion of Preferred

Shares shall not obligate such Holder to rely on a Variable Price for any future conversions of Preferred Shares.

(d) Stock

Combination Event Adjustments. If at any time and from time to time on or after the Subscription Date there occurs any stock split,

stock dividend, stock combination, reverse stock split, recapitalization or other similar transaction involving the Common Stock (each,

a “Stock Combination Event”, and such date thereof, the “Stock Combination Event Date”) and the

Event Market Price is less than the Conversion Price then in effect (after giving effect to the adjustment in Section 8(b) above), then

on the fifth (5th) Trading Day immediately following such Stock Combination Event Date, the Conversion Price then in effect on such fifth

(5th) Trading Day following the Stock Combination Event (after giving effect to the adjustment in Section 8(b) above) shall be reduced

(but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence

would otherwise result in an increase in the Conversion Price hereunder, no adjustment shall be made.

(e) Other

Events. In the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly applicable,

or, if applicable, would not operate to protect any Holder from dilution (other than with respect to Excluded Securities) or if any event

occurs of the type contemplated by the provisions of this Section 8 but not expressly provided for by such provisions (including, without

limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the Board shall

in good faith determine and implement an appropriate adjustment in the Conversion Price so as to protect the rights of such Holder, provided

that no such adjustment pursuant to this Section 8(e) will increase the Conversion Price as otherwise determined pursuant to this Section

8, provided further that if such Holder does not accept such adjustments as appropriately protecting its interests hereunder against

such dilution, then the Board and such Holder shall agree, in good faith, upon an independent investment bank of nationally recognized

standing to make such appropriate adjustments, whose determination shall be final and binding absent manifest error and whose fees and

expenses shall be borne by the Company.

15

(f) Calculations.

All calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100th of a share, as

applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account

of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.

(g) Voluntary

Adjustment by Company. Subject to the rules and regulations of the Principal Market, the Company may at any time any Preferred Shares

remain outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price to any amount and

for any period of time deemed appropriate by the Board; provided that such price shall not be less than the Floor Price.

9. Reserved.

10. Noncircumvention.

The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws (as defined

in the Securities Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement,

dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any

of the terms of this Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate

of Designations and take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality

of the foregoing or any other provision of this Certificate of Designations or the other Transaction Documents, the Company (a) shall

not increase the par value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion

Price then in effect, (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and

legally issue fully paid and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c) shall, so long

as any Preferred Shares are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares

of Common Stock, solely for the purpose of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock

as shall from time to time be necessary to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations

on conversion contained herein). Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of

the Initial Issuance Date, each Holder is not permitted to convert such Holder’s Preferred Shares in full for any reason (other

than pursuant to restrictions set forth in Section 4(d)(i) hereof), the Company shall use its best efforts to promptly remedy

such failure, including, without limitation, obtaining such consents or approvals as necessary to effect such conversion into shares

of Common Stock.

16

11. Authorized

Shares.

(a) Reservation.

So long as any Preferred Shares remain outstanding, the Company shall at all times reserve out of its authorized and unissued shares

of Common Stock a number of shares of Common Stock equal to at least 200% of the aggregate number of shares of Common Stock as shall

from time to time be necessary to effect the conversion, including without limitation, of all of the Preferred Shares then outstanding

at the Floor Price then in effect (without regard to any limitations on conversions, and, for the avoidance of doubt, shall not include

Dividends with respect to such Preferred Shares or any accrued and unpaid Late Charges thereon, and assuming the Preferred Shares remain

outstanding until the expiration date of the Warrants) (the “Required Reserve Amount”). The Required Reserve Amount

(including, without limitation, each increase in the number of shares so reserved) shall be allocated pro rata among the Holders based

on the number of the Preferred Shares held by each Holder on the Initial Issuance Date or increase in the number of reserved shares,

as the case may be (the “Authorized Share Allocation”). In the event that a Holder shall sell or otherwise transfer

any of such Holder’s Preferred Shares, each transferee shall be allocated a pro rata portion of such Holder’s Authorized

Share Allocation. Any shares of Common Stock reserved and allocated to any Person which ceases to hold any Preferred Shares shall be

allocated to the remaining Holders of Preferred Shares, pro rata based on the number of the Preferred Shares then held by the Holders.

(b) Insufficient

Authorized Shares. If, notwithstanding Section 11(a) and not in limitation thereof, at any time while any of the Preferred Shares

remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation

to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common Stock equal to the Required Reserve

Amount (an “Authorized Share Failure”), then the Company shall immediately take all action necessary to increase the

Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount

for the Preferred Shares then outstanding (or deemed outstanding pursuant to Section 11(a) above). Without limiting the generality of

the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later

than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for

the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide

each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders’ approval of such increase in

authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal

(or, if a majority of the voting power then in effect of the capital stock of the Company consents to such increase, in lieu of such

proxy statement, deliver to the stockholders of the Company an information statement that has been filed with (and either approved by

or not subject to comments from) the SEC with respect thereto). In the event that the Company is prohibited from issuing shares of Common

Stock to a Holder upon any conversion due to the failure by the Company to have sufficient shares of Common Stock available out of the

authorized but unissued shares of Common Stock (such unavailable number of shares of Common Stock, the “Authorized Failure Shares”),

in lieu of delivering such Authorized Failure Shares to such Holder, the Company shall pay legally available funds in exchange for the

redemption of such portion of the Conversion Amount of the Preferred Shares convertible into such Authorized Failure Shares at a price

equal to the sum of (i) the product of (x) such number of Authorized Failure Shares and (y) the greatest Closing Sale Price of the Common

Stock on any Trading Day during the period commencing on the date such Holder delivers the applicable Conversion Notice with respect

to such Authorized Failure Shares to the Company and ending on the date of such issuance and payment under this Section 11(b); and (ii)

to the extent such Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of

a sale by such Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket expenses, if any, of such Holder

incurred in connection therewith. Nothing contained in Section 11(a) or this Section 11(b) shall limit any obligations of the Company

under any provision of the Securities Purchase Agreement.

17

12. Redemptions.

(a) General.

If a Holder has submitted a Triggering Event Redemption Notice in accordance with Section 5(b), the Company shall deliver the applicable

Triggering Event Redemption Price to such Holder in legally available funds within five (5) Business Days after the Company’s receipt

of such Holder’s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control Redemption Notice in accordance

with Section 6(b), the Company shall deliver the applicable Change of Control Redemption Price to such Holder in legally available funds

concurrently with the consummation of such Change of Control if such notice is received prior to the consummation of such Change of Control

and within five (5) Business Days after the Company’s receipt of such notice otherwise. Notwithstanding anything herein to the

contrary, in connection with any redemption hereunder at a time a Holder is entitled to receive a cash payment under any of the other

Transaction Documents, at the option of such Holder delivered in writing to the Company, the applicable Redemption Price hereunder shall

be increased by the amount of such cash payment owed to such Holder under such other Transaction Document and, upon payment in full or

conversion in accordance herewith, shall satisfy the Company’s payment obligation under such other Transaction Document. In the

event of a redemption of less than all of the Preferred Shares, the Company shall promptly cause to be issued and delivered to such Holder

a new Preferred Share Certificate (in accordance with Section 20) (or evidence of the creation of a new Book-Entry) representing the

number of Preferred Shares which have not been redeemed. In the event that the Company does not pay the applicable Redemption Price to

a Holder within the time period required for any reason (including, without limitation, to the extent such payment is prohibited pursuant

to the DGCL), at any time thereafter and until the Company pays such unpaid Redemption Price in full, such Holder shall have the option,

in lieu of redemption, to require the Company to promptly return to such Holder all or any of the Preferred Shares that were submitted

for redemption and for which the applicable Redemption Price (together with any Late Charges thereon) has not been paid. Upon the Company’s

receipt of such notice, (x) the applicable Redemption Notice shall be null and void with respect to such Preferred Shares, (y) the Company

shall immediately return the applicable Preferred Share Certificate, or issue a new Preferred Share Certificate (in accordance with Section 20(d)),

to such Holder (unless the Preferred Shares are held in Book-Entry form, in which case the Company shall deliver evidence to such Holder

that a Book-Entry for such Preferred Shares then exists), and in each case the Additional Amount of such Preferred Shares shall be increased

by an amount equal to the difference between (1) the applicable Redemption Price (as the case may be, and as adjusted pursuant to

this Section 12, if applicable) minus (2) the Stated Value portion of the Conversion Amount submitted for redemption

and (z) the Conversion Price of such Preferred Shares shall be automatically adjusted with respect to each conversion effected thereafter

by such Holder to the lowest of (A) the Conversion Price as in effect on the date on which the applicable Redemption Notice is voided,

(B) the greater of (x) the Floor Price and (y) 75% of the lowest Closing Bid Price of the Common Stock during the period

beginning on and including the date on which the applicable Redemption Notice is delivered to the Company and ending on and including

the date on which the applicable Redemption Notice is voided and (C) the greater of (x) the Floor Price and (y) 75% of

the quotient of (I) the sum of the five (5) lowest VWAPs of the Common Stock during the twenty (20) consecutive Trading Day

period ending and including the Trading Day immediately preceding the applicable Conversion Date divided by (II) five (5) (it being

understood and agreed that all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination

or other similar transaction during such period). A Holder’s delivery of a notice voiding a Redemption Notice and exercise of its

rights following such notice shall not affect the Company’s obligations to make any payments of Late Charges which have accrued

prior to the date of such notice with respect to the Preferred Shares subject to such notice.

(b) Redemption

by Multiple Holders. Upon the Company’s receipt of a Redemption Notice from any Holder for redemption or repayment as a result

of an event or occurrence substantially similar to the events or occurrences described in Section 5(b) or Section 6(b), the Company

shall immediately, but no later than one (1) Business Day of its receipt thereof, forward to each other Holder by electronic mail a copy

of such notice. If the Company receives one or more Redemption Notices, during the seven (7) Business Day period beginning on and including

the date which is two (2) Business Days prior to the Company’s receipt of the initial Redemption Notice and ending on and including

the date which is two (2) Business Days after the Company’s receipt of the initial Redemption Notice and the Company is unable

to redeem all of the Conversion Amount of such Preferred Shares designated in such initial Redemption Notice and such other Redemption

Notices received during such seven (7) Business Day period, then the Company shall redeem a pro rata amount from each Holder based on

the Stated Value of the Preferred Shares submitted for redemption pursuant to such Redemption Notices received by the Company during

such seven (7) Business Day period.

13. [Reserved.]

14. Voting

Rights. Except as otherwise provided herein or as required by applicable law and subject to the provisions of Section 4(d) hereof,

Holders of Preferred Shares shall be entitled to vote with the holders of Common Stock on all matters that such holders of Common Stock

are entitled to vote upon, in the same manner and with the same effect as the holders of Common Stock, voting together with the holders

of Common Stock as a single class. Subject to the provisions of Section 4(d) hereof, each Preferred Share shall entitle the Holder thereof

to cast that number of votes per Preferred Share as is equal to the Stated Value of such Preferred Share divided by the then applicable

Conversion Price; provided, however that in no event shall the then applicable Conversion Price for purposes of this Section

14 be less than the “Minimum Price” (as defined in Nasdaq Listing Rule 5635(d)) on the date immediately preceding

the Subscription Date (or $2.51 per share, as of the date of this Certificate of Designations, and subject to adjustments for any stock

splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the date hereof). For purposes

of clarity, this Nasdaq Minimum Price shall apply only for purposes of this Section 14 of the Certificate of Designations and not apply

to any other section of the Certificate of Designations or any Transaction Document. Notwithstanding the foregoing, to the extent that

under the DGCL the vote of the holders of the Preferred Shares, voting separately as a class or series, as applicable, is required to

authorize a given action of the Company, the affirmative vote or consent of the Required Holders of the shares of the Preferred Shares,

voting together in the aggregate and not in separate series unless required under the DGCL, represented at a duly held meeting at which

a quorum is present or by written consent of the Required Holders (except as otherwise may be required under the DGCL), voting together

in the aggregate and not in separate series unless required under the DGCL, shall constitute the approval of such action by both the

class or the series, as applicable. For the avoidance of doubt, for purposes of determining the presence of a quorum at any meeting of

the stockholders of the Company at which the Preferred Shares are entitled to vote, the number of Preferred Shares and votes represented

by such shares shall be counted on an as converted to Common Stock basis, subject to any limitations on conversion set forth herein.

Holders of the Preferred Shares shall be entitled to written notice of all stockholder meetings or written consents (and copies of proxy

materials and other information sent to stockholders) with respect to which they would be entitled to vote, which notice would be provided

pursuant to the Company’s bylaws and the DGCL.

18

15. Covenants.

For so long as any Preferred Shares are outstanding, without the prior written consent of the Required Holders:

(a) Incurrence

of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur

or guarantee, assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).

(b) Existence

of Liens. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, allow or suffer

to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts

and contract rights) owned by the Company or any of its Subsidiaries (collectively, “Liens”) other than Permitted

Liens.

(c) Restricted

Payments and Investments. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,

redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part,

whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other

pursuant to this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if any) or interest on,

such Indebtedness or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness and/or Investment,

as applicable, is due or is otherwise made or, after giving effect to such payment, (i) an event constituting a Triggering Event has

occurred and is continuing or (ii) an event that with the passage of time and without being cured would constitute a Triggering Event

has occurred and is continuing.

(d) Restriction

on Redemption and Cash Dividends. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or

indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than pursuant to

this Certificate of Designations, the Series A Certificate of Designations, the Series H-7 Certificate of Designations, the Series I

Certificate of Designations and Series J Certificate of Designations).

(e) Restriction

on Transfer of Assets. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,

sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights of the Company

or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions, other than (i) sales,

leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Company and its Subsidiaries

in the ordinary course of business consistent with its past practice, or (ii) sales of inventory and product in the ordinary course of

business.

19

(f) Maturity

of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, permit

any Indebtedness of the Company or any of its Subsidiaries to mature or accelerate prior to the conversion of all the Preferred Shares

other than as set forth in the definitive documentation governing such Indebtedness as in effect on the Initial Issuance Date.

(g) Change

in Nature of Business. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, engage

in any material line of business substantially different from those lines of business conducted by or publicly contemplated to be conducted

by the Company and/or its Subsidiaries on the Subscription Date or any business reasonably related or incidental thereto. The Company

shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, modify its or their corporate structure

or purpose in any material respect.

(h) Preservation

of Existence, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence,

rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and in good standing

in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes

such qualification necessary; provided, however, that the Company shall have the right to merge or combine wholly-owned Subsidiaries

hereunder, or eliminate or dissolve foreign Subsidiaries, in each case where such restructuring does not have a material impact on the

Company’s assets or ability to comply with the provisions hereof.

(i) Maintenance

of Properties, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, all of

its properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear

and tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which

it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.

(j) Maintenance

of Intellectual Property. The Company will, and will cause each of its Subsidiaries to, take all action necessary or advisable to

maintain all of the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or material to the

conduct of its business in full force and effect.

(k) Maintenance

of Insurance. The Company shall use reasonable best efforts to maintain, and cause each of its Subsidiaries to maintain, insurance

with responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard,

rent and business interruption insurance) with respect to its properties (including all real properties leased or owned by it) and business,

in such amounts and covering such risks as are generally consistent with the coverage held by the Company on the Initial Issuance Date.

20

(l) Transactions

with Affiliates. The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend or be a party to,

any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of

property or assets of any kind or the rendering of services of any kind) with any affiliate, except transactions in the ordinary course

of business in a manner and to an extent, if applicable, consistent with past practice and necessary or desirable for the prudent operation

of its business, for fair consideration and on terms no less favorable to it or its Subsidiaries than would be reasonably expected to

be obtained in a comparable arm’s length transaction with a Person that is not an affiliate thereof.

(m) Restricted

Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any

Preferred Shares (other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations), or (ii) issue

any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.

(n) Stay,

Extension and Usury Laws. To the extent that it may lawfully do so, the Company (A) agrees that it will not at any time insist upon,

plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever

enacted or in force) that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly waives all

benefits or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution

of any power granted to the Holders by this Certificate of Designations, but will suffer and permit the execution of every such power

as though no such law has been enacted.

(o) Taxes.

The Company and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together with any related

interest or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective assets or upon

their ownership, possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom (except

where the failure to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries).

The Company and its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure

to file would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding

the foregoing, the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain

adequate reserves therefor in accordance with GAAP.

(p) Cash

Minimum. From the Closing Date until the date on which less than 1,050 shares of the Series I Preferred Stock are outstanding, the

Company shall, at all times, maintain unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 20% of

the aggregate stated value of the Series I Preferred Stock then outstanding. Such cash shall be maintained in one or more domestic deposit

accounts, money market accounts or certificates of deposit (with a maturity of no more than three months) with one or more Eligible Banks.

For purposes hereof, an “Eligible Bank” is a U.S. chartered commercial bank with total assets in excess of $300 billion.

21

(q) Independent

Investigation. At the request of any Holder either (x) at any time when a Triggering Event has occurred and is continuing, (y) upon

the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering Event or (z) at any time such

Holder reasonably believes a Triggering Event may have occurred or be continuing, the Company shall hire an independent, reputable investment

bank selected by the Company and approved by such Holder to investigate as to whether any breach of the Certificate of Designations has

occurred (the “Independent Investigator”). If the Independent Investigator determines that such breach of the Certificate

of Designations has occurred, the Independent Investigator shall notify the Company of such breach and the Company shall deliver written

notice to each Holder of such breach. In connection with such investigation, the Independent Investigator may, during normal business

hours, inspect all contracts, books, records, personnel, offices and other facilities and properties of the Company and its Subsidiaries

and, to the extent available to the Company after the Company uses reasonable efforts to obtain them, the records of its legal advisors

and accountants (including the accountants’ work papers) and any books of account, records, reports and other papers not contractually

required of the Company to be confidential or secret, or subject to attorney-client or other evidentiary privilege, and the Independent

Investigator may make such copies and inspections thereof as the Independent Investigator may reasonably request. The Company shall furnish

the Independent Investigator with such financial and operating data and other information with respect to the business and properties

of the Company as the Independent Investigator may reasonably request. The Company shall permit the Independent Investigator to discuss

the affairs, finances and accounts of the Company with, and to make proposals and furnish advice with respect thereto to, the Company’s

officers, directors, key employees and independent public accountants or any of them (and by this provision the Company authorizes said

accountants to discuss with such Independent Investigator the finances and affairs of the Company and any Subsidiaries), all at such

reasonable times, upon reasonable notice, and as often as may be reasonably requested.

16. Liquidation,

Dissolution, Winding-Up. In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out of the assets

of the Company, whether from capital or from earnings available for distribution to its stockholders (the “Liquidation Funds”),

before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding,

an amount per Preferred Share equal to the greater of (A) 125% of the Conversion Amount of such Preferred Share on the date of such payment

and (B) the amount per share such Holder would receive if such Holder converted such Preferred Share into Common Stock immediately prior

to the date of such payment, provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders

of shares of Parity Stock, then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal

to the full amount of Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance

with their respective certificate of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to

all holders of Preferred Shares and all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions

to be taken by each of its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event

to be distributed to the Holders in accordance with this Section 16. All the preferential amounts to be paid to the Holders under this

Section 16 shall be paid or set apart for payment before the payment or setting apart for payment of any amount for, or the distribution

of any Liquidation Funds of the Company to the holders of shares of Junior Stock in connection with a Liquidation Event as to which this

Section 16 applies.

17. Distribution

of Assets. In addition to any adjustments pursuant to Section 7(a) and Section 8, if the Company shall declare or make any dividend

or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return

of capital or otherwise (including without limitation, any distribution of cash, stock or other securities, property or options by way

of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the “Distributions”),

then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as if such Holder had held the number of shares

of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking into account any limitations or restrictions

on the convertibility of the Preferred Shares and assuming for such purpose that the Preferred Share was converted at the Floor Price

as of the applicable record date) immediately prior to the date on which a record is taken for such Distribution or, if no such record

is taken, the date as of which the record holders of Common Stock are to be determined for such Distributions (provided, however, that

to the extent that such Holder’s right to participate in any such Distribution would result in such Holder and the other Attribution

Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Distribution to such extent of

the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution

(and beneficial ownership) to such extent of any such excess) and the portion of such Distribution shall be held in abeyance for the

benefit of such Holder until such time or times as its right thereto would not result in such Holder and the other Attribution Parties

exceeding the Maximum Percentage, at which time or times, if any, such Holder shall be granted such Distribution (and any Distributions

declared or made on such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if

there had been no such limitation).

18. Vote

to Change the Terms of or Issue Preferred Shares. In addition to any other rights provided by law, except where the vote or written

consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of Incorporation,

without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the

Required Holders, voting together as a single class, the Company shall not (in any case, whether by amendment, modification, recapitalization,

merger, consolidation or otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate of Incorporation

or bylaws, or file any certificate of designations or articles of amendment of any series of shares of preferred stock, if such action

would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit

of the Preferred Shares hereunder, regardless of whether any such action shall be by means of amendment to the Certificate of Incorporation

or by merger, consolidation or otherwise; provided that the affirmative vote of the Required Holders shall not be required for changes

to the Series A Preferred Stock, Series H-7 Preferred Stock, Series I Preferred Stock or Series J Preferred Stock; (b) increase or decrease

(other than by conversion) the authorized number of Preferred Shares; (c) without limiting any provision of Section 2, create or authorize

(by reclassification or otherwise) any new class or series of Senior Preferred Stock or Parity Stock, other than the Series J Preferred

Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the terms of the Company’s equity

incentive plans and options and other equity awards granted under such plans (that have in good faith been approved by the Board)); (e)

without limiting any provision of Section 2, pay dividends or make any other distribution on any shares of any Junior Stock, other than

the Series A Preferred Stock; (f) issue any Preferred Shares other than as contemplated hereby or pursuant to the Securities Purchase

Agreement; or (g) without limiting any provision of Section 10, whether or not prohibited by the terms of the Preferred Shares, circumvent

a right of the Preferred Shares hereunder.

22

19. Transfer

of Preferred Shares. A Holder may transfer some or all of its Preferred Shares without the consent of the Company, but any such transfer

shall be in compliance with all applicable securities laws.

20. Reissuance

of Preferred Share Certificates and Book Entries.

(a) Transfer.

If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share Certificate to the

Company (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon the Company

will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section 20(d)) (or

evidence of the transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number of Preferred

Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred, a new

Preferred Share Certificate (in accordance with Section 20(d)) to such Holder representing the outstanding number of Preferred Shares

not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee,

by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason

of the provisions of Section 4(c)(i) following conversion or redemption of any of the Preferred Shares, the outstanding number of Preferred

Shares represented by the Preferred Shares may be less than the number of Preferred Shares stated on the face of the Preferred Shares.

(b) Lost,

Stolen or Mutilated Preferred Share Certificate. Upon receipt by the Company of evidence reasonably satisfactory to the Company of

the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification

contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking

by the applicable Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation

of such Preferred Share Certificate, the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance

with Section 20(d)) representing the applicable outstanding number of Preferred Shares.

(c) Preferred

Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms. Each Preferred Share Certificate is exchangeable,

upon the surrender hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share Certificate or Preferred

Share Certificate(s) or new Book-Entry (in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the

Preferred Shares in the original Preferred Share Certificate, and each such new Preferred Share Certificate and/or new Book-Entry, as

applicable, will represent such portion of such outstanding number of Preferred Shares from the original Preferred Share Certificate

as is designated in writing by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one or more new Preferred

Share Certificates or split by the applicable Holder by delivery of a written notice to the Company into two or more new Book-Entries

(in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in the original Book-Entry,

and each such new Book-Entry and/or new Preferred Share Certificate, as applicable, will represent such portion of such outstanding number

of Preferred Shares from the original Book-Entry as is designated in writing by such Holder at the time of such surrender.

23

(d) Issuance

of New Preferred Share Certificate or Book-Entry. Whenever the Company is required to issue a new Preferred Share Certificate or

a new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry (i)

shall represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of Preferred

Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to Section

20(a) or Section 20(c), the number of Preferred Shares designated by such Holder) which, when added to the number of Preferred Shares

represented by the other new Preferred Share Certificates or other new Book-Entry, as applicable, issued in connection with such issuance,

does not exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate or original Book-Entry,

as applicable, immediately prior to such issuance of new Preferred Share Certificate or new Book-Entry, as applicable, and (ii) shall

have an issuance date, as indicated on the face of such new Preferred Share Certificate or in such new Book-Entry, as applicable, which

is the same as the issuance date of the original Preferred Share Certificate or in such original Book-Entry, as applicable.

21. Remedies,

Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Certificate of Designations shall

be cumulative and in addition to all other remedies available under this Certificate of Designations and any of the other Transaction

Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall

limit any Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of

this Certificate of Designations. No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy

hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude

any other or further exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or

remedy of a Holder at law or equity or under this Certificate of Designations or any of the documents shall not be deemed to be an election

of such Holder’s rights or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall

be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with

respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall

not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company

acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holders and that the remedy at law for

any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, each Holder

shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive

or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and

without posting a bond or other security. The Company shall provide all information and documentation to a Holder that is requested by

such Holder to enable such Holder to confirm the Company’s compliance with the terms and conditions of this Certificate of Designations.

24

22. Payment

of Collection, Enforcement and Other Costs. If (a) any Preferred Shares are placed in the hands of an attorney for collection or

enforcement or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under

this Certificate of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations

or (b) there occurs any bankruptcy, reorganization, receivership of the Company or other proceedings affecting Company creditors’

rights and involving a claim under this Certificate of Designations, then the Company shall pay the costs incurred by such Holder for

such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including,

without limitation, attorneys’ fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under

this Certificate of Designations with respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price

paid for each Preferred Share was less than the original Stated Value thereof.

23. Construction;

Headings. This Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders and shall not be

construed against any such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience of reference

and shall not form part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly indicates otherwise,

each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,”

“includes,” “include” and words of like import shall be construed broadly as if followed by the words “without

limitation.” The terms “herein,” “hereunder,” “hereof” and words of like import refer to this

entire Certificate of Designations instead of just the provision in which they are found. Unless expressly indicated otherwise, all section

references are to sections of this Certificate of Designations. Terms used in this Certificate of Designations and not otherwise defined

herein, but defined in the other Transaction Documents, shall have the meanings ascribed to such terms on the Initial Issuance Date in

such other Transaction Documents unless otherwise consented to in writing by the Required Holders.

24. Failure

or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder

shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further

exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and signed by an authorized

representative of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by the Company and all Holders

and shall not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained in this Section

24 shall permit any waiver of any provision of Section 4(d).

25. Dispute

Resolution.

(a) Submission

to Dispute Resolution.

(i) In

the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a VWAP

or a fair market value or the arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be) (including,

without limitation, a dispute relating to the determination of any of the foregoing), the Company or the applicable Holder (as the case

may be) shall submit the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days after the

occurrence of the circumstances giving rise to such dispute or (B) if by such Holder at any time after such Holder learned of the circumstances

giving rise to such dispute. If such Holder and the Company are unable to promptly resolve such dispute relating to such Closing Bid

Price, such Closing Sale Price, such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market value, or the arithmetic

calculation of such Conversion Rate or such applicable Redemption Price (as the case may be), at any time after the second (2nd) Business

Day following such initial notice by the Company or such Holder (as the case may be) of such dispute to the Company or such Holder (as

the case may be), then such Holder may, at its sole option, select an independent, reputable investment bank to resolve such dispute.

25

(ii) Such

Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance

with the first sentence of this Section 25 and (B) written documentation supporting its position with respect to such dispute, in each

case, no later than 5:00 p.m. (New York time) by the fifth (5th) Business Day immediately following the date on which such

Holder selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in the immediately

preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute Documentation”) (it being

understood and agreed that if either such Holder or the Company fails to so deliver all of the Required Dispute Documentation by the

Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled

to (and hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with respect

to such dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered

to such investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and such

Holder or otherwise requested by such investment bank, neither the Company nor such Holder shall be entitled to deliver or submit any

written documentation or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).

(iii) The

Company and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and such

Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses

of such investment bank shall be borne solely by the Company, and such investment bank’s resolution of such dispute shall be final

and binding upon all parties absent manifest error.

(b) Miscellaneous.

The Company expressly acknowledges and agrees that (i) this Section 25 constitutes an agreement to arbitrate between the Company and

each Holder (and constitutes an arbitration agreement) under § 7501, et seq. of the New York Civil Practice Law and Rules (“CPLR”)

and that any Holder is authorized to apply for an order to compel arbitration pursuant to CPLR § 7503(a) in order to compel compliance

with this Section 25, (ii) a dispute relating to a Conversion Price includes, without limitation, disputes as to (A) whether an issuance

or sale or deemed issuance or sale of Common Stock occurred under Section 8(a), (B) the consideration per share at which an issuance

or deemed issuance of Common Stock occurred, (C) whether any issuance or sale or deemed issuance or sale of Common Stock was an issuance

or sale or deemed issuance or sale of Excluded Securities, (D) whether an agreement, instrument, security or the like constitutes an

Option or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the terms of this Certificate of Designations and

each other applicable Transaction Document shall serve as the basis for the selected investment bank’s resolution of the applicable

dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like

that such investment bank determines are required to be made by such investment bank in connection with its resolution of such dispute

and in resolving such dispute such investment bank shall apply such findings, determinations and the like to the terms of this Certificate

of Designations and any other applicable Transaction Documents, (iv) the applicable Holder (and only such Holder with respect to disputes

solely relating to such Holder), in its sole discretion, shall have the right to submit any dispute described in this Section 25 to any

state or federal court sitting in The City of New York, Borough of Manhattan, New York, in lieu of utilizing the procedures set forth

in this Section 25 and (v) nothing in this Section 25 shall limit such Holder from obtaining any injunctive relief or other equitable

remedies (including, without limitation, with respect to any matters described in this Section 25).

26

26. Notices;

Currency; Payments.

(a) Notices.

The Company shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to the terms of this

Certificate of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever notice is

required to be given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing and shall

be given in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall provide each Holder with prompt written

notice of all actions taken pursuant to this Certificate of Designations, including in reasonable detail a description of such action

and the reason therefore. Without limiting the generality of the foregoing, the Company shall give written notice to each Holder (i)

immediately upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such

adjustment and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect

to any dividend or distribution upon the Common Stock, (B) with respect to any grant, issuances, or sales of any Options, Convertible

Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C) for determining

rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall

be made known to the public prior to or in conjunction with such notice being provided to such Holder.

(b) Currency.

All dollar amounts referred to in this Certificate of Designations are in United States Dollars (“U.S. Dollars”),

and all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies

(if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange

Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,

the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed

that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such

period of time).

(c) Payments.

Whenever any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations, unless otherwise

expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer of immediately

available funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to time. Whenever

any amount expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business Day, the same

shall instead be due on the next succeeding day which is a Business Day. Any amount due under the Transaction Documents which is not

paid when due (except to the extent such amount is simultaneously accruing Dividends at the Default Rate hereunder) shall result in a

late charge being incurred and payable by the Company in an amount equal to interest on such amount at the rate of fifteen percent (15%)

per annum from the date such amount was due until the same is paid in full (“Late Charge”).

27

27. Waiver

of Notice. To the extent permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and all other

demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate of Designations

and the Securities Purchase Agreement.

28. Governing

Law. This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning the construction,

validity, interpretation and performance of this Certificate of Designations shall be governed by, the internal laws of the State of

Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other

jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. Except as otherwise

required by Section 25 above, the Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting

in The City of New York, Borough of Manhattan, New York, for the adjudication of any dispute hereunder or in connection herewith or with

any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action

or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding

is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall

be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein (i) shall be deemed

or operate to preclude any Holder from bringing suit or taking other legal action against the Company in any other jurisdiction to collect

on the Company’s obligations to such Holder, to realize on any collateral or any other security for such obligations, or to enforce

a judgment or other court ruling in favor of such Holder or (ii) shall limit, or shall be deemed or construed to limit, any provision

of Section 25 above. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE

ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION CONTEMPLATED

HEREBY.

29. Judgment

Currency.

(a) If

for the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert

into any other currency (such other currency being hereinafter in this Section 29 referred to as the “Judgment Currency”)

an amount due in U.S. dollars under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on

the Trading Day immediately preceding:

(i) the

date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction

that will give effect to such conversion being made on such date: or

28

(ii) the

date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which

such conversion is made pursuant to this Section 29(a)(ii) being hereinafter referred to as the “Judgment Conversion Date”).

(b) If

in the case of any proceeding in the court of any jurisdiction referred to in Section 29(a)(ii) above, there is a change in the Exchange

Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall pay

such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate

prevailing on the date of payment, will produce the amount of US dollars which could have been purchased with the amount of Judgment

Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.

(c) Any

amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained

for any other amounts due under or in respect of this Certificate of Designations.

30. Severability.

If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid or unenforceable by a

court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to

apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not

affect the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of Designations as so

modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the

prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations

or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.

The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),

the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

31. Maximum

Payments. Without limiting Section 9(c) of the Securities Purchase Agreement, nothing contained herein shall be deemed to establish

or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that

the rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess

of such maximum shall be credited against amounts owed by the Company to the applicable Holder and thus refunded to the Company.

32. Stockholder

Matters; Amendment.

(a) Stockholder

Matters. Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant to the DGCL, the

Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred Shares may be effected

by written consent of the Company’s stockholders or at a duly called meeting of the Company’s stockholders, all in accordance

with the applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections of the DGCL

permitting stockholder action, approval and consent affected by written consent in lieu of a meeting.

29

(b) Amendment.

Except for Section 4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or any provision hereof may

be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without a meeting in accordance

with the DGCL, of the Required Holders, voting separately as a single class, and with such other stockholder approval, if any, as may

then be required pursuant to the DGCL and the Certificate of Incorporation.

33. Certain

Defined Terms. For purposes of this Certificate of Designations, the following terms shall have the following meanings:

(a) “1934

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

(b) “Additional

Amount” means, as of the applicable date of determination, with respect to each Preferred Share, all accrued and unpaid Dividends

on such Preferred Share.

(c) “Adjustment

Right” means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or

sale (or deemed issuance or sale in accordance with Section 8(a)) of shares of Common Stock (other than rights of the type described

in Section 7(a) hereof) that could result in a decrease in the net consideration received by the Company in connection with, or with

respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).

(d) “Affiliate”

or “Affiliated” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled

by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a

Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of

directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.

(e) “Alternate

Conversion Floor Amount” means an amount in cash, to be delivered by wire transfer of immediately available funds pursuant

to wire instructions delivered to the Company by the Holder in writing, equal to the product obtained by multiplying (A) the higher of

(I) the highest price that the Common Stock trades at on the Trading Day immediately preceding the relevant Alternate Conversion Date

and (II) the applicable Alternate Conversion Price and (B) the difference obtained by subtracting (I) the number of shares of Common

Stock delivered (or to be delivered) to the Holder on the applicable Share Delivery Deadline with respect to such Alternate Conversion

from (II) the quotient obtained by dividing (x) the applicable Conversion Amount that the Holder has elected to be the subject of the

applicable Alternate Conversion, by (y) the applicable Alternate Conversion Price without giving effect to clause (x) of such definition.

30

(f)  “Alternate

Conversion Price” means, with respect to any Alternate Conversion that price which shall be the lowest of (i) the applicable

Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii) the greater of (x) the

Floor Price and (y) 80% of the lowest VWAP of the Common Stock of any Trading Day during the twenty (20) consecutive Trading Day period

ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice (such

period, the “Alternate Conversion Measuring Period”). All such determinations to be appropriately adjusted for any

stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the

Common Stock during such Alternate Conversion Measuring Period.

(g) “Approved

Stock Plan” means any employee benefit plan or agreement which has been approved by the Board prior to or subsequent to the

Subscription Date pursuant to which shares of Common Stock and standard options to purchase Common Stock or other awards convertible,

exercisable for or exchangeable for shares of Common Stock may be issued to any employee, officer, consultant or director for services

provided to the Company in their capacity as such.

(h) “Attribution

Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder

funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly or indirectly managed or advised

by a Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of such Holder

or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with such Holder or any of the

foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated with

such Holder’s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the

foregoing is to subject collectively such Holder and all other Attribution Parties to the Maximum Percentage.

(i) “Bloomberg”

means Bloomberg, L.P.

(j) “Book-Entry”

means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of a Preferred Share Certificate issuable

hereunder.

(k) “Business

Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized

or required by law to remain closed; provided, however, for clarification, commercial

banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,

“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the

direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial

banks in The City of New York generally are open for use by customers on such day.

31

(l) “Change

of Control” means (a) any Fundamental Transaction other than (i) any merger of the Company or any of its, direct or indirect,

wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or reclassification of

the Common Stock in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization or reclassification

continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly,

are, in all material respects, the holders of the voting power of the surviving entity (or entities with the authority or voting power

to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such

reorganization, recapitalization or reclassification, (iii) pursuant to a migratory merger effected solely for the purpose of changing

the jurisdiction of incorporation of the Company or any of its Subsidiaries or (iv) bona fide arm’s length sales or acquisitions

by the Company with one or more third parties as long as holders of the Company’s voting power as of the Issuance Date continue

after such sale or acquisition to hold publicly traded securities and, directly or indirectly, are, in all material respects, the holders

of at least 51% of the voting power of the surviving entity (or entities with the authority or voting power to elect the members of the

board of directors (or their equivalent if other than a corporation) of such entity or entities) after such sale or acquisition (in each

of clauses (i) through (iv), a “Change of Control Exception”), or (b) individuals who constitute the Continuing Directors,

taken together, ceasing for any reason to constitute at least a majority of the Board, other than in connection with a Change of Control

Exception.

(m) “Change

of Control Redemption Premium” means the greater of (i) 125% or (ii) the Black-Scholes Value of the remaining unconverted shares

of Preferred Stock on the date of the consummation of such Change of Control. For purposes of this definition “Black Scholes

Value” means the value of the unconverted shares of Preferred Stock based on the Black-Scholes Option Pricing Model obtained

from the “OV” function on Bloomberg determined as of the date in question for pricing purposes and reflecting (A)

a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of such Option, Convertible

Security or Adjustment Right (as the case may be) as of the date of issuance of such Option, Convertible Security or Adjustment Right

(as the case may be), (B) an expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined

utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated

Change of Control, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share

being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Change of Control and (ii)

the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated

Change of Control (or the consummation of the applicable Change of Control, if earlier) and ending on the Trading Day of the Holder’s

request pursuant to this section, (D) a remaining option time equal to the remaining term of such Option, Convertible Security or Adjustment

Right (as the case may be), and (E) a zero cost of borrow.

(n) “Closing

Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price and

last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market

begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price (as the case may

be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by

Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing

bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security

is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively,

of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no

closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the

ask prices, respectively, of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency

succeeding to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security

on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security

on such date shall be the fair market value as mutually determined by the Company and the Required Holder. If the Company and the Required

Holders are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures

in Section 25. All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations

or other similar transactions during such period.

32

(o) “Closing

Date” shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company initially issued

the Preferred Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.

(p) “Common

Stock” means (i) the Company’s shares of common stock, par value $0.0001 per share, and (ii) any capital stock into which

such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.

(q) “Contingent

Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect

to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such

liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or

discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in

whole or in part) against loss with respect thereto.

(r) “Continuing

Directors” means the directors of the Company on the date hereof and each other director, if, in each case, such other director

is nominated for election by the Board a majority of whom are directors on the date hereof or whose election or nomination for election

was approved by one or more of such directors.

(s) “Conversion

Floor Price Condition” means that the relevant Alternate Conversion Price is being determined based on clause (x) of such definition.

(t) “Convertible

Securities” means any stock or other security (other than Options) that is at any time and under any circumstances, directly

or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares

of Common Stock.

(u) “Dividend

Date” means the first Trading Day of each calendar quarter with the first Dividend Date being July 1, 2026.

(v) “Dividend

Rate” means seven percent (7.0%) per annum, as may be adjusted from time to time in accordance with Section 3.

(w) “Eligible

Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the

OTCQX, the OTCQB or the Principal Market.

33

(x) “Event

Market Price” means, with respect to any Stock Combination Event Date, the lower of (i) the Conversion Price in effect

immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination Event

Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven (11) consecutive Trading

Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and ending on the fifth (5th)

Trading Day immediately following the Stock Combination Event Date.

(y) [Reserved.]

(z) “Floor

Price” means the lower of (x) $0.502 and (y) 20% of the “Minimum Price” (as defined in Rule 5635 of the Nasdaq

Stock Market) on the Stockholder Approval Date (as defined in the Securities Purchase Agreement), in each case, subject to adjustment

for stock splits, stock dividends, stock combinations, recapitalizations or other similar events, or, in any case, such lower amount

as permitted, from time to time, by the Principal Market.

(aa) “Fundamental

Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise,

in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation)

another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or

assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation S-X) to one or more

Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its voting

stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders

of at least either (x) more than 50% of the outstanding voting power of the Company, (y) more than 50% of the outstanding voting power

of the Company calculated as if any shares of voting stock held by all Subject Entities making or party to, or Affiliated with any Subject

Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of voting stock

such that all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or

exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding

voting power of the Company, or (iv) consummate a stock or share purchase agreement or other business combination (including, without

limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all such

Subject Entities, individually or in the aggregate, acquire, either (x) more than 50% of the outstanding voting power of the Company

(y) more than 50% of the outstanding voting power of the Company calculated as if any shares of voting stock held by all the Subject

Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock purchase agreement or other business

combination were not outstanding; or (z) such number of shares of voting stock of the Company such that the Subject Entities become collectively

the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding voting power of the Company,

or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall, directly or indirectly, including through

subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject Entity individually or the Subject Entities

in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly,

whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding shares of voting

stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization,

recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) more than 50% of the aggregate ordinary voting

power represented by issued and outstanding shares of voting stock of the Company, (y) more than 50% of the aggregate ordinary voting

power represented by issued and outstanding shares of voting stock of the Company not held by all such Subject Entities as of the date

of this Certificate of Designations calculated as if any shares of voting stock of the Company held by all such Subject Entities were

not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock

of the Company or other equity securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger

or other transaction requiring other stockholders of the Company to surrender their shares of voting stock of the Company without approval

of the stockholders of the Company or (C) directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or

more related transactions, the issuance of or the entering into any other instrument or transaction structured in a manner to circumvent,

or that circumvents, the intent of this definition in which case this definition shall be construed and implemented in a manner otherwise

than in strict conformity with the terms of this definition to the extent necessary to correct this definition or any portion of this

definition which may be defective or inconsistent with the intended treatment of such instrument or transaction.

34

(bb) “GAAP”

means United States generally accepted accounting principles, consistently applied.

(cc) “Group”

means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.

(dd) [Reserved.]

(ee) “Indebtedness”

of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed as

the deferred purchase price of property or services, including, without limitation, “capital leases” in accordance with United

States generally accepted accounting principles consistently applied for the periods covered thereby (other than trade payables entered

into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment obligations with respect to

letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments,

including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all indebtedness

created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect

to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank

under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations under

any leasing or similar arrangement which, in connection with United States generally accepted accounting principles, consistently applied

for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above

secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage,

deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in or upon any property or assets

(including accounts and contract rights) with respect to any asset or property owned by any Person, even though the Person which owns

such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in

respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.

35

(ff) “Intellectual

Property Rights” means, with respect to the Company and its Subsidiaries, all of their rights or licenses to use all trademarks,

trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights,

inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications

and registrations therefor.

(gg) “Investment”

means any beneficial ownership (including stock, partnership or limited liability company interests) of or in any Person, or any loan,

advance or capital contribution to any Person or the acquisition of all, or substantially all, of the assets of another Person or the

purchase of any assets of another Person for greater than the fair market value of such assets.

(hh) “Liquidation

Event” means, whether in a single transaction or series of transactions, the voluntary or involuntary liquidation, dissolution

or winding up of the Company or such Subsidiaries the assets of which constitute all or substantially all of the assets of the business

of the Company and its Subsidiaries, taken as a whole.

(ii)

“Make-Whole Amount” means, as of any given date and as applicable, in connection with any conversion, redemption or

other repayment hereunder, an amount equal to the amount of additional Dividends that would accrue under this Certificate of Designations

at the Dividend Rate then in effect assuming for calculation purposes that the Stated Value of this Certificate of Designations as of

the Closing Date remained outstanding through and including the one year anniversary of the applicable date of conversion of the Preferred

Shares.

(jj) [Reserved.]

(kk) “Options”

means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

(ll) “Parent

Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or

equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the

Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

(mm) “Permitted

Indebtedness” means (i) Indebtedness existing on December 31, 2025 and reflected on the Company’s balance sheet included

in the Company’s Annual Report on Form 10-K filed with the SEC on March 30, 2026, (ii) Indebtedness secured by Permitted Liens

or unsecured but as described in clauses (iv) and (v) of the definition of Permitted Liens, and (iii) if less than 9,200 Preferred Shares

remain outstanding, the Permitted Senior Indebtedness.

36

(nn) “Permitted

Liens” means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for

which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business

by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as

materialmen’s liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to

a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (A) upon

or in any equipment acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment or Indebtedness

incurred solely for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment at the time

of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds

of such equipment, in either case, with respect to Indebtedness in an aggregate amount not to exceed $150,000, (v) Liens incurred in

connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above,

provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal

amount of the Indebtedness being extended, renewed or refinanced does not increase, (vi) Liens in favor of customs and revenue authorities

arising as a matter of law to secure payments of custom duties in connection with the importation of goods, (vii) Liens arising from

judgments, decrees or attachments in circumstances not constituting a Triggering Event under Section 5(a)(xi) and (viii) Liens with respect

to the Permitted Senior Indebtedness.

(oo) “Permitted

Senior Indebtedness” means non-convertible Indebtedness issued pursuant to a credit facility with a bank or similar financial

institution with no principal payments required prior to the 91st calendar day after the Initial Issuance Date, provided, however,

that the aggregate outstanding principal amount of such Indebtedness permitted hereunder does not at any time exceed $10 million; provided,

further, however, no Permitted Senior Indebtedness shall permit the lender to accelerate such Permitted Senior Indebtedness

as a result of the occurrence of any Triggering Event hereunder or the Holder’s delivery of a Triggering Event Redemption Notice.

(pp) “Person”

means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,

any other entity or a government or any department or agency thereof.

(qq) “Principal

Market” means the Nasdaq Capital Market.

(rr) “Redemption

Notices” means, collectively, the Triggering Event Redemption Notices and the Change of Control Redemption Notices, and each

of the foregoing, individually, a “Redemption Notice.”

(ss) “Redemption

Premium” means 130%.

(tt) “Redemption

Prices” means, collectively, any Triggering Event Redemption Price and Change of Control Redemption Price, and each of the

foregoing, individually, a “Redemption Price.”

37

(uu) “SEC”

means the United States Securities and Exchange Commission or the successor thereto.

(vv) “Securities

Purchase Agreement” means that certain securities purchase agreement by and among the Company and the initial holders of Preferred

Shares, dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.

(ww) “Stated

Value” shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations,

reclassifications, combinations, subdivisions or other similar events occurring after the Initial Issuance Date with respect to the Preferred

Shares.

(xx) “Subscription

Date” means April 27, 2026.

(yy) “Subject

Entity” means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.

(zz) “Subsidiaries”

shall have the meaning as set forth in the Securities Purchase Agreement.

(aaa) “Successor

Entity” means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving

any Fundamental Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental

Transaction shall have been entered into.

(bbb) “Trading

Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock, any

day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for

the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that

“Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less

than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market

(or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the

hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the applicable Holder

or (y) with respect to all determinations other than price determinations relating to the Common Stock, any day on which The New York

Stock Exchange (or any successor thereto) is open for trading of securities.

(ccc) “Transaction

Documents” means the Securities Purchase Agreement, this Certificate of Designations, the Warrants and each of the other agreements

and instruments entered into or delivered by the Company or any of the Holders in connection with the transactions contemplated by the

Securities Purchase Agreement, all as may be amended from time to time in accordance with the terms thereof.

38

(ddd) “VWAP”

means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the

Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market

on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,

as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time) or, if the foregoing does

not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board

for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg,

or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest

closing bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market

(or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security

on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined

by the Company and the Required Holders. If the Company and the Required Holders are unable to agree upon the fair market value of such

security, then such dispute shall be resolved in accordance with the procedures in Section 25. All such determinations shall be appropriately

adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.

(eee) “Warrants”

has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants issued in exchange therefor

or replacement thereof.

(fff) “Warrant

Shares” means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.

34. Disclosure.

Upon receipt or delivery by the Company of any notice in accordance with the terms of this Certificate of Designations, unless the Company

has in good faith determined that the matters relating to such notice do not constitute material, non-public information relating to

the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business Day immediately

following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form 8-K or otherwise.

In the event that the Company believes that a notice contains material, non-public information relating to the Company or any of its

Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt of notice

from such Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the Company

immediately upon receipt of notice from such Holder), such Holder shall be entitled to presume that information contained in the notice

does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing contained in this Section

34 shall limit any obligations of the Company, or any rights of any Holder, under Section 4(l) of the Securities Purchase Agreement.

35. Absence

of Trading and Disclosure Restrictions. The Company acknowledges and agrees that no Holder is a fiduciary or agent of the Company

and that each Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain

from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an

officer of such Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,

written non-disclosure agreement, the Company acknowledges that each Holder may freely trade in any securities issued by the Company,

may possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information

to any third party.

*

* * * *

39

IN

WITNESS WHEREOF, the Company has caused this Certificate of Designations of Series K Convertible Preferred Stock of StableX Technologies,

Inc. to be signed by its Chief Executive Officer on this 27th day of April, 2026.

STABLEX

TECHNOLOGIES, INC.

By:

/s/

Joshua Silverman

Name:

Joshua

Silverman

Title:

Chief

Executive Officer

Signature

Page to Certificate of Designations

EXHIBIT

I

STABLEX

TECHNOLOGIES, INC.

CONVERSION

NOTICE

Reference

is made to the Certificate of Designations, Preferences and Rights of the Series K Convertible Preferred Stock of StableX Technologies,

Inc. (the “Certificate of Designations”). In accordance with and pursuant to the Certificate of Designations, the

undersigned hereby elects to convert the number of shares of Series K Convertible Preferred Stock, par value $0.0001 per share (the “Preferred

Shares”), of StableX Technologies, Inc., a Delaware corporation (the “Company”), indicated below into shares

of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, as of the date specified below.

Date

of Conversion:

Aggregate

number of Preferred Shares to be converted:

Aggregate

Stated Value of such Preferred Shares to be converted:

Aggregate

accrued and unpaid Dividends and accrued and

unpaid Late

Charges with respect to such Preferred Shares

and such

Aggregate Dividends to be converted:

AGGREGATE

CONVERSION AMOUNT TO BE

CONVERTED:

Please confirm

the following information:

Conversion

Price:

Number of

shares of Common Stock to be issued:

Please

issue the Common Stock into which the applicable Preferred Shares are being converted to Holder, or for its benefit, as follows:

☐ Check

here if requesting delivery as a certificate to the following name and to the following address:

Issue

to:

☐ Check

here if requesting delivery by Deposit/Withdrawal at Custodian as follows:

DTC

Participant:

DTC

Number:

Exhibit I

Account

Number:

Date:

_____________ __, ____

Name

of Registered Holder

By:

Name:

Title:

Tax

ID: _______________________

E-mail

Address: ________________

Exhibit I

EXHIBIT

II

ACKNOWLEDGMENT

The

Company hereby (a) acknowledges this Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock are eligible

to be resold by the Holder without restriction or any legend and (c) hereby directs _________________ to issue the above indicated number

of shares of Common Stock in accordance with the Transfer Agent Instructions dated [____] from the Company and acknowledged and agreed

to by ________________________.

STABLEX

TECHNOLOGIES, INC.

By:

Name:

Title:

Exhibit II

EX-3.3

EX-3.3

Filename: ex3-3.htm · Sequence: 4

Exhibit 3.3

AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF PREFERENCES

AND RIGHTS OF

SERIES H-7 CONVERTIBLE PREFERRED STOCK

OF

STABLEX TECHNOLOGIES, INC.

a Delaware corporation

This Amended and Restated Certificate

of Designations of Series H-7 Convertible Preferred Stock (this “Certificate of Designations”) is dated as of April

27, 2026 (the “Effective Date”);

WHEREAS, the board of directors (the “Board”)

of StableX Technologies, Inc. (the “Company”) pursuant to the authority expressly conferred upon the Board by the Company’s

Certificate of Incorporation (the “Certificate of Incorporation”), and Section 151 of the Delaware General Corporation

Law (“DGCL”), has previously fixed the rights, preferences, restrictions and other matters relating to a series of

the Company’s preferred stock, consisting of 22,000 authorized shares of preferred stock, classified as Series H-7 Convertible Preferred

Stock (the “Preferred Stock”), and the Certificate of Designations of the Preferred Stock (the “Original Certificate

of Designations”) evidencing such terms was filed with the Secretary of State of the State of Delaware on August 7, 2023;

WHEREAS, pursuant to the authority conferred

upon the Board in accordance with the Certificate of Incorporation and the Bylaws of the Company, the Board has duly adopted a resolution

amending and restating the rights of the Preferred Stock, declaring said amendment and restatement to be advisable and desirable; and

WHEREAS, this Certificate of Designations

has been duly adopted in accordance with Section 151 of the DGCL.

NOW, THEREFORE, be it resolved, that the

Board does hereby provide that the rights set forth in the Original Certificate of Designations are hereby amended and restated as follows:

SERIES H-7 PREFERRED STOCK

1. Designation and Number of Shares.

There shall hereby be created and established a series of preferred stock of the Company designated as “Series H-7 Convertible Preferred

Stock” (the “Preferred Shares”). The authorized number of Preferred Shares shall be 22,000. Each Preferred Share

shall have a par value of $0.0001. Capitalized terms not defined herein shall have the meaning as set forth in Section 33 below.

2. Ranking. Except to the extent

that the holders of at least a majority of the outstanding Preferred Shares (the “Required Holders”) expressly consent

to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below) in accordance with Section 18, all shares

of capital stock of the Company shall be junior in rank to all Preferred Shares with respect to the preferences as to dividends, distributions

and payments upon the liquidation, dissolution and winding up of the Company (such junior stock is referred to herein collectively as

“Junior Stock”). The rights of all such shares of capital stock of the Company shall be subject to the rights, powers,

preferences and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Designations, without

the prior express consent of the Required Holders, voting separately as a single class, the Company shall not hereafter authorize or issue

any additional or other shares of capital stock that are (i) of senior rank to the Preferred Shares in respect of the preferences as to

dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Senior

Preferred Stock”), (ii) of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions

and payments upon the liquidation, dissolution and winding up of the Company (collectively, the “Parity Stock”) or

(iii) any Junior Stock having a maturity date or any other date requiring redemption or repayment of such shares of Junior Stock that

is prior to the Maturity Date. In the event of the merger or consolidation of the Company with or into another corporation, the Preferred

Shares shall maintain their relative rights, powers, designations, privileges and preferences provided for herein and no such merger or

consolidation shall be consummated if it would result in the Preferred Shares being treated in any manner inconsistently with the foregoing.

3. Dividends and Payments.

(a) From and after the first date of

issuance of any Preferred Shares (the “Initial Issuance Date”), each holder of a Preferred Share (each, a “Holder”

and collectively, the “Holders”) shall be entitled to receive dividends on the Stated Value of the Preferred Shares

(“Dividends”) payable, subject to the conditions and other terms hereof, in cash out of funds legally available therefor

at the Dividend Rate computed on the basis of a 360-day year and twelve 30-day months and shall compound each calendar quarter; provided

that a Holder and the Company may mutually agree to convert any Dividends into shares of Common Stock at a price to be mutually determined

by the Company and such Holder, which shall not be less than the Floor Price.

(b) Dividends shall be payable in arrears

on (i) each Dividend Date, and (ii) upon any redemption in accordance with Section 12 or any required payment upon any Triggering Event.

From and after the occurrence and during the continuance of any Triggering Event and ending on the date on which such Triggering Event

is subsequently cured (and no other Triggering Event then exists), Dividends shall accrue on the Stated Value of each Preferred Share

at fifteen percent (15.0%) per annum (the “Default Rate”) and shall be computed on the basis of a 360-day year and

twelve 30-day months.

(c) On the Maturity Date, the Company

shall pay to the Holder an amount in funds legally available therefor equal to the sum of (i) 107% of the Stated Value of the Preferred

Shares held by such Holder, (ii) accrued and unpaid Dividends and (iii) unpaid Late Charges. Other than as specifically permitted hereunder,

the Company may not prepay any portion of the aggregate Stated Value underlying outstanding Preferred Shares, accrued and unpaid Dividends

or accrued and unpaid Late Charges.

4. Conversion. At any time after

the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully paid and non-assessable shares of Common

Stock (as defined below), on the terms and conditions set forth in this Section 4.

(a) Holder’s Conversion

Right. Subject to the provisions of Section 4(d), at any time or times on or after the Initial Issuance Date, each Holder shall be

entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued, fully paid and non-assessable

shares of Common Stock in accordance with Section 4(c) at the Conversion Rate (as defined below). The Company shall not issue any fraction

of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share of Common Stock,

the Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company shall pay any and all transfer,

stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the Transfer Agent (as defined

below)) that may be payable with respect to the issuance and delivery of Common Stock upon conversion of any Preferred Shares.

(b) Conversion Rate.

The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section 4(a) shall be determined by dividing

(x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the “Conversion Rate”):

(i) “Conversion Amount”

means, with respect to each Preferred Share, as of the applicable date of determination, the sum of (1) the Stated Value thereof plus

(2) the Make Whole Amount, (3) the Additional Amount thereon and any accrued and unpaid Late Charges (as defined below in Section 26(c))

with respect to such Stated Value and Additional Amount as of such date of determination.

(ii) “Conversion Price”

means, with respect to each Preferred Share, as of any Conversion Date or other date of determination, $6.1933, as of the Effective Date,

subject to adjustment as provided herein following the Effective Date.

(c) Mechanics of Conversion.

The conversion of each Preferred Share shall be conducted in the following manner:

(i) Optional Conversion.

To convert a Preferred Share into shares of Common Stock on any date (a “Conversion Date”), a Holder shall deliver

(whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date, a copy of an executed

notice of conversion of the share(s) of Preferred Shares subject to such conversion in the form attached hereto as Exhibit I

(the “Conversion Notice”) to the Company. If required by Section 4(c)(iii), within two (2) Trading Days following a

conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally recognized overnight delivery service

for delivery to the Company the original certificates, if any, representing the Preferred Shares (the “Preferred Share Certificates”)

so converted as aforesaid (or an indemnification undertaking with respect to the Preferred Shares in the case of its loss, theft or destruction

as contemplated by Section 20(b)). On or before the first (1st) Trading Day following

the date of receipt of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation and representation

as to whether such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration statement,

in the form attached hereto as Exhibit II, of receipt of such Conversion Notice to such Holder and the Company’s transfer

agent (the “Transfer Agent”), which confirmation shall constitute an instruction to the Transfer Agent to process such

Conversion Notice in accordance with the terms herein. On or before the second (2nd) Trading Day following each date on which the Company

has received a Conversion Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation

for the settlement of a trade initiated on the applicable Conversion Date of such shares of Common Stock issuable pursuant to such Conversion

Notice) (the “Share Delivery Deadline”), the Company shall (1) provided that the Transfer Agent is participating in

The Depository Trust Company’s (“DTC”) Fast Automated Securities Transfer Program (“FAST”),

credit such aggregate number of shares of Common Stock to which such Holder shall be entitled pursuant to such conversion to such Holder’s

or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is not

participating in FAST, upon the request of such Holder, issue and deliver (via reputable overnight courier) to the address as specified

in such Conversion Notice, a certificate, registered in the name of such Holder or its designee, for the number of shares of Common Stock

to which such Holder shall be entitled. If the number of Preferred Shares represented by the Preferred Share Certificate(s) submitted

for conversion pursuant to Section 4(c)(iii) is greater than the number of Preferred Shares being converted, then the Company shall, as

soon as practicable and in no event later than two (2) Trading Days after receipt of the Preferred Share Certificate(s) and at its own

expense, issue and deliver to such Holder (or its designee) a new Preferred Share Certificate or a new Book-Entry (in either case, in

accordance with Section 20(d)) representing the number of Preferred Shares not converted. The Person or Persons entitled to receive the

shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated for all purposes as the record holder or holders

of such shares of Common Stock on the Conversion Date. Notwithstanding the foregoing, with respect to any Conversion Notice delivered

by a Buyer (as defined in the Securities Purchase Agreement) to the Company on or prior to 4:00 p.m. (New York City time) on the Trading

Day immediately prior to the date of initial issuance of such applicable Preferred Shares to be converted pursuant to such Conversion

Notice (each, an “Issuance Date”), which may be delivered at any time after the time of execution of the Securities

Purchase Agreement, the Company agrees to deliver the shares of Common Stock issuable upon conversion of such Preferred Shares to be issued

on such date subject to such notice(s) by 4:00 p.m. (New York City time) on such applicable Issuance Date and such Issuance Date shall

be the Share Delivery Deadline for purposes hereunder with respect to such Conversion Notice.

(ii) Company’s Failure

to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery Deadline,

if the Transfer Agent is not participating in FAST, to issue and deliver to such Holder (or its designee) a certificate for the number

of shares of Common Stock to which such Holder is entitled and register such shares of Common Stock on the Company’s share register

or, if the Transfer Agent is participating in FAST, to credit such Holder’s or its designee’s balance account with DTC for

such number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion of any Conversion Amount (as

the case may be) (a “Conversion Failure”), then, in addition to all other remedies available to such Holder, (X) the

Company shall pay in cash from funds legally available therefor to such Holder on each day after the Share Delivery Deadline that the

issuance of such shares of Common Stock is not timely effected an amount equal to 1% of the product of (A) the sum of the number of shares

of Common Stock not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder is entitled, multiplied

by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time during the period beginning on

the applicable Conversion Date and ending on the applicable Share Delivery Deadline, and (Y) such Holder, upon written notice to the Company,

may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all, or any portion, of such Preferred

Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice shall not affect

the Company’s obligations to make any payments which have accrued prior to the date of such notice pursuant to this Section 4(c)(ii)

or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Deadline the Transfer Agent is not participating in FAST,

the Company shall fail to issue and deliver to such Holder (or its designee) a certificate and register such shares of Common Stock on

the Company’s share register or, if the Transfer Agent is participating in FAST, the Transfer Agent shall fail to credit the balance

account of such Holder or such Holder’s designee, as applicable, with DTC for the number of shares of Common Stock to which such

Holder is entitled upon such Holder’s conversion hereunder or pursuant to the Company’s obligation pursuant to clause (ii)

below, and if on or after such Share Delivery Deadline such Holder acquires (in an open market transaction, stock loan or otherwise) shares

of Common Stock corresponding to all or any portion of the number of shares of Common Stock issuable upon such conversion that such Holder

is entitled to receive from the Company and has not received from the Company in connection with such Conversion Failure (a “Buy-In”),

then, in addition to all other remedies available to such Holder, the Company shall, within two (2) Business Days after receipt of such

Holder’s request and in such Holder’s discretion, either: (I) pay cash from funds legally available therefor to such Holder

in an amount equal to such Holder’s total purchase price (including brokerage commission, stock loan costs and other out-of-pocket

expenses, if any) for the shares of Common Stock so acquired (including, without limitation, by any other Person in respect, or on behalf,

of such Holder) (the “Buy-In Price”), at which point the Company’s obligation to so issue and deliver such certificate

(and to issue such shares of Common Stock) or credit to the balance account of such Holder or such Holder’s designee, as applicable,

with DTC for the number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder (as the

case may be) (and to issue such shares of Common Stock) shall terminate, or (II) promptly honor its obligation to so issue and deliver

to such Holder a certificate or certificates representing such shares of Common Stock or credit the balance account of such Holder or

such Holder’s designee, as applicable, with DTC for the number of shares of Common Stock to which such Holder is entitled upon such

Holder’s conversion hereunder (as the case may be) and pay cash from funds legally available therefor to such Holder in an amount

equal to the excess (if any) of the Buy-In Price over the product of (x) such number of shares of Common Stock multiplied by (y) the lowest

Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Conversion Notice

and ending on the date of such issuance and payment under this clause (II). Nothing herein shall limit a Holder’s right to pursue

any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or

injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock (or to

electronically deliver such shares of Common Stock) upon the conversion of the Preferred Shares as required pursuant to the terms hereof.

Notwithstanding anything herein to the contrary, with respect to any given Conversion Failure, this Section 4(c)(ii) shall not apply to

a Holder to the extent the Company has already paid such amounts in full to such Holder with respect to such Conversion Failure, as applicable,

pursuant to the analogous sections of the Securities Purchase Agreement.

(iii) Registration; Book-Entry.

At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request (including by electronic-mail)

to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates or in Book-Entry form.

The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the “Register”)

for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and

whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the “Registered Preferred

Shares”). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The Company and

each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred Share for

all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice to the contrary.

A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on the Register. Upon

its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder thereof, the Company

shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares in the same aggregate

Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee pursuant to Section

20, provided that if the Company does not so record an assignment, transfer or sale (as the case may be) of such Registered Preferred

Shares within two (2) Business Days of such a request, then the Register shall be automatically deemed updated to reflect such assignment,

transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this Section 4, following conversion of any

Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be required to physically surrender such Preferred

Shares held in the form of a Preferred Share Certificate to the Company unless (A) the full or remaining number of Preferred Shares represented

by the applicable Preferred Share Certificate are being converted (in which event such certificate(s) shall be delivered to the Company

as contemplated by this Section 4(c)(iii)) or (B) such Holder has provided the Company with prior written notice (which notice may be

included in a Conversion Notice) requesting reissuance of Preferred Shares upon physical surrender of the applicable Preferred Share Certificate.

Each Holder and the Company shall maintain records showing the Stated Value, Dividends and Late Charges converted and/or paid (as the

case may be) and the dates of such conversions and/or payments (as the case may be) or shall use such other method, reasonably satisfactory

to such Holder and the Company, so as not to require physical surrender of a Preferred Share Certificate upon conversion. If the Company

does not update the Register to record such Stated Value, Dividends and Late Charges converted and/or paid (as the case may be) and the

dates of such conversions and/or payments (as the case may be) within two (2) Business Days of such occurrence, then the Register shall

be automatically deemed updated to reflect such occurrence. In the event of any dispute or discrepancy, such records of such Holder establishing

the number of Preferred Shares to which the record holder is entitled shall be controlling and determinative in the absence of manifest

error. A Holder and any transferee or assignee, by acceptance of a certificate, acknowledge and agree that, by reason of the provisions

of this paragraph, following conversion of any Preferred Shares, the number of Preferred Shares represented by such certificate may be

less than the number of Preferred Shares stated on the face thereof. Each Preferred Share Certificate shall bear the following legend:

ANY TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD

CAREFULLY REVIEW THE TERMS OF THE COMPANY’S CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES H-7 PREFERRED STOCK REPRESENTED

BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER OF SHARES OF SERIES H-7 PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE

MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES H-7 PREFERRED STOCK STATED ON THE FACE HEREOF PURSUANT TO SECTION 4(c)(iii) OF THE CERTIFICATE

OF DESIGNATIONS RELATING TO THE SHARES OF SERIES H-7 PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE.

(iv) Pro Rata Conversion; Disputes.

In the event that the Company receives a Conversion Notice from more than one Holder for the same Conversion Date and the Company can

convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert from each Holder electing to have

Preferred Shares converted on such date a Holder Pro Rata Amount of such Holder’s Preferred Shares submitted for conversion on such

date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to the aggregate number of

Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of shares of Common Stock issuable

to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the number of shares of Common

Stock not in dispute and resolve such dispute in accordance with Section 25.

(d) Limitation on Beneficial

Ownership.

(i) Beneficial Ownership.

The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder shall not have the right

to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate of Designations and

any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to such conversion, such

Holder together with the other Attribution Parties collectively would beneficially own in excess of 9.99% (the “Maximum Percentage”)

of the shares of Common Stock outstanding immediately after giving effect to such conversion. For purposes of the foregoing sentence,

the aggregate number of shares of Common Stock beneficially owned by such Holder and the other Attribution Parties shall include the number

of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon

conversion of the Preferred Shares with respect to which the determination of such sentence is being made, but shall exclude shares of

Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted Preferred Shares beneficially owned by such Holder

or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or nonconverted portion of any other securities

of the Company (including, without limitation, any convertible notes, convertible preferred stock or warrants, including the Preferred

Shares and the Warrants) beneficially owned by such Holder or any other Attribution Party subject to a limitation on conversion or exercise

analogous to the limitation contained in this Section 4(d)(i). For purposes of this Section 4(d)(i), beneficial ownership shall be calculated

in accordance with Section 13(d) of the 1934 Act. In addition, a determination as to any group status as contemplated above shall be determined

in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder. For purposes of determining the

number of outstanding shares of Common Stock a Holder may acquire upon the conversion of such Preferred Shares without exceeding the Maximum

Percentage, such Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company’s most recent

Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case

may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company or the Transfer Agent, if

any, setting forth the number of shares of Common Stock outstanding (the “Reported Outstanding Share Number”). If the

Company receives a Conversion Notice from a Holder at a time when the actual number of outstanding shares of Common Stock is less than

the Reported Outstanding Share Number, the Company shall notify such Holder in writing of the number of shares of Common Stock then outstanding

and, to the extent that such Conversion Notice would otherwise cause such Holder’s beneficial ownership, as determined pursuant

to this Section 4(d)(i), to exceed the Maximum Percentage, such Holder must notify the Company of a reduced number of shares of Common

Stock to be purchased pursuant to such Conversion Notice. For any reason at any time, upon the written or oral request of any Holder,

the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to such Holder the number of shares

of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect

to the conversion or exercise of securities of the Company, including such Preferred Shares, by such Holder and any other Attribution

Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common

Stock to a Holder upon conversion of such Preferred Shares results in such Holder and the other Attribution Parties being deemed to beneficially

own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section

13(d) of the 1934 Act), the number of shares so issued by which such Holder’s and the other Attribution Parties’ aggregate

beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and shall be

cancelled ab initio, and such Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice

to the Company, any Holder may from time to time increase (with such increase not effective until the sixty-first (61st)

day after delivery of such notice) or decrease the Maximum Percentage of such Holder to any other percentage not in excess of 9.99% as

specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st)

day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to such Holder and the other

Attribution Parties and not to any other Holder that is not an Attribution Party of such Holder. For purposes of clarity, the shares of

Common Stock issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Maximum Percentage shall

not be deemed to be beneficially owned by such Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the

1934 Act. No prior inability to convert such Preferred Shares pursuant to this paragraph shall have any effect on the applicability of

the provisions of this paragraph with respect to any subsequent determination of convertibility. The provisions of this paragraph shall

be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d)(i) to the extent necessary

to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent with the intended beneficial ownership

limitation contained in this Section 4(d)(i) or to make changes or supplements necessary or desirable to properly give effect to such

limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of such Preferred Shares.

(ii) Principal Market Regulation.

The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares or otherwise pursuant to the terms of

this Certificate of Designations if the issuance of such shares of Common Stock (taken together with the issuance of all other shares

of Common Stock upon exercise of the Warrants) would exceed the aggregate number of shares of Common Stock which the Company may issue

upon exercise or conversion (as the case may be) of the Preferred Shares and the Warrants without breaching the Company’s obligations

under the rules and regulations of the Principal Market (the number of shares which may be issued without violating such rules and regulations,

the “Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval

of its stockholders as required by the applicable rules and regulations of the Principal Market for issuances of shares of Common Stock

in excess of such amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which

opinion shall be reasonably satisfactory to the Required Holders. Until such approval or such written opinion is obtained, no Holder

shall be issued in the aggregate, upon conversion or exercise (as the case may be) of any Preferred Shares or any Warrant, shares of

Common Stock in an amount greater than the product of (i) the Exchange Cap as of the Initial Issuance Date multiplied by (ii) the quotient

of (1) the aggregate number of Preferred Shares issued to such Holder on the Initial Issuance Date divided by (2) the aggregate number

of Preferred Shares issued to the Holders on the Initial Issuance Date (with respect to each Holder, the “Exchange Cap Allocation”).

In the event that any Holder shall sell or otherwise transfer any of such Holder’s Preferred Shares, the transferee shall be allocated

a pro rata portion of such Holder’s Exchange Cap Allocation with respect to such portion of such Preferred Shares so transferred,

and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation

so allocated to such transferee. Upon conversion in full of a holder’s Preferred Shares, the difference (if any) between such holder’s

Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon such holder’s conversion in

full of such Preferred Shares shall be allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares

and/or related Warrants on a pro rata basis in proportion to the shares of Common Stock underlying the Preferred Shares and/or related

Warrants then held by each such holder of Preferred Shares and/or related Warrants. In the event that after November 5, 2023, the Company

is prohibited from issuing any shares of Common Stock pursuant to this Section 4(d)(ii)(the “Exchange Cap Shares”)

to a Holder, the Company shall pay cash from funds legally available therefor to such Holder in exchange for the redemption of such number

of Preferred Shares held by such Holder that are not convertible into such Exchange Cap Shares at a price equal to the sum of (i) the

product of (x) such number of Exchange Cap Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during

the period commencing on the date such Holder delivers the applicable Conversion Notice with respect to such Exchange Cap Shares to the

Company and ending on the date of such issuance and payment under this Section 4(d)(ii) and (ii) to the extent such Holder purchases

(in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Holder of Exchange Cap

Shares, any brokerage commissions and other out-of-pocket expenses, if any, of such Holder incurred in connection therewith.

(e) Right of Alternate Conversion.

(i) Alternate Conversion Upon

a Triggering Event. Subject to Section 4(d), at any time during a Triggering Event Redemption Right Period (as defined below), such

Holder may, at such Holder’s option, by delivery of a Conversion Notice to the Company (the date of any such Conversion Notice,

each an “Alternate Conversion Date”), convert all, or any number of Preferred Shares (such Conversion Amount of the

Preferred Shares to be converted pursuant to this Section 4(e)(ii), each, an “Alternate Conversion Amount”) into shares

of Common Stock at the Alternate Conversion Price (each an “Alternate Conversion”).

(ii) Mechanics of Alternate

Conversion. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion Amount of Preferred Shares

pursuant to Section 4(c) (with “Alternate Conversion Price” replacing “Conversion Price” for all purposes hereunder

with respect to such Alternate Conversion and with “Alternate Conversion Amount” replacing “Conversion Amount”

in clause (x) of the definition of Conversion Rate above with respect to such Alternate Conversion) by designating in the Conversion Notice

delivered pursuant to this Section 4(e) of this Certificate of Designations that such Holder is electing to use the Alternate Conversion

Price for such conversion; provided that in the event of the Conversion Floor Price Condition, on the applicable Alternate Conversion

Date the Company shall also deliver to the Holder the applicable Alternate Conversion Floor Amount. Notwithstanding anything to the contrary

in this Section 4(e), but subject to Section 4(d), until the Company delivers shares of Common Stock representing the applicable Alternate

Conversion Amount of Preferred Shares to such Holder, such Preferred Shares may be converted by such Holder into shares of Common Stock

pursuant to Section 4(c) without regard to this Section 4(e).

5. Triggering Event Redemptions.

(a) Triggering Event.

Each of the following events shall constitute a “Triggering Event” and each of the events in clauses (viii), (ix),

and (x) shall constitute a “Bankruptcy Triggering Event”:

(i) the suspension from trading

or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period of five (5) consecutive

Trading Days;

(ii) the Company’s (A) failure

to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required number of shares of Common

Stock within five (5) Trading Days after the applicable Conversion Date or exercise date (as the case may be) or (B) written notice to

any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement or through any of its agents,

at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for Warrant Shares in accordance

with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common Stock that is requested

in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d) hereof;

(iii) except to the extent the

Company is in compliance with Section 11(b) below, at any time following the tenth (10th)

consecutive day that a Holder’s Authorized Share Allocation (as defined in Section 11(a) below) is less than the sum of (A) 150%

of the number of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred

Shares then held by such Holder (assuming a conversion at the Floor Price then in effect and without regard to any limitations on conversion

set forth in this Certificate of Designations) and (B) 150% of the number of shares of Common Stock that such Holder would then be entitled

to receive upon exercise in full of such Holder’s Warrants (without regard to any limitations on exercise set forth in the Warrants);

(iv) subject to the applicable

provisions of the DGCL, the Board fails to declare any Dividend to be paid on the applicable Dividend Date in accordance with Section

3;

(v) the Company’s failure

to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or any other amount when and as due under

this Certificate of Designations (including, without limitation, the Company’s failure to pay any redemption payments or amounts

hereunder), the Securities Purchase Agreement or any other Transaction Document or any other agreement, document, certificate or other

instrument delivered in connection with the transactions contemplated hereby and thereby (in each case, whether or not permitted pursuant

to the DGCL), except, in the case of a failure to pay Dividends and Late Charges when and as due, in each such case only if such failure

remains uncured for a period of at least five (5) Trading Days;

(vi) the Company fails to remove

any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon conversion or exercise (as

the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder under the Transaction Documents

as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise then prohibited by applicable

federal securities laws, and any such failure remains uncured for at least five (5) Trading Days;

(vii) the occurrence of any default

under, redemption of or acceleration prior to maturity of at least an aggregate of $500,000 of Indebtedness (as defined in the Securities

Purchase Agreement) of the Company or any of its Subsidiaries;

(viii) bankruptcy, insolvency,

reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted by or against the Company

or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed within thirty (30)

days of their initiation;

(ix) the commencement by the Company

or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization

or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent by it to the entry of

a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary case or proceeding under

any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the commencement of any bankruptcy

or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under

any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to the appointment of or taking possession

by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Subsidiary or of

any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the execution of a composition

of debts, or the occurrence of any other similar federal, state or foreign proceeding, or the admission by it in writing of its inability

to pay its debts generally as they become due, the taking of corporate action by the Company or any Subsidiary in furtherance of any such

action or the taking of any action by any Person to commence a Uniform Commercial Code foreclosure sale or any other similar action under

federal, state or foreign law;

(x) the entry by a court of (i)

a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary or involuntary case or

proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or (ii) a decree,

order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or approving as properly filed

a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of the Company or any Subsidiary

under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar document appointing a custodian,

receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Subsidiary or of any substantial

part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree, order, judgment

or other similar document or any such other decree, order, judgment or other similar document unstayed and in effect for a period of thirty

(30) consecutive days;

(xi) a final judgment or judgments

for the payment of money aggregating in excess of $500,000 are rendered against the Company and/or any of its Subsidiaries and which judgments

are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed pending appeal, or are not discharged

within thirty (30) days after the expiration of such stay; provided, however, any judgment which is covered by insurance or an indemnity

from a credit worthy party shall not be included in calculating the $500,000 amount set forth above so long as the Company provides each

Holder a written statement from such insurer or indemnity provider (which written statement shall be reasonably satisfactory to each Holder)

to the effect that such judgment is covered by insurance or an indemnity and the Company or such Subsidiary (as the case may be) will

receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance of such judgment;

(xii) the Company and/or any Subsidiary,

individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace period, any payment with respect to

any Indebtedness in excess of $500,000 due to any third party (other than, with respect to unsecured Indebtedness only, payments contested

by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect to which adequate reserves

have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation of any agreement for monies

owed or owing in an amount in excess of $500,000, which breach or violation permits the other party thereto to declare a default or otherwise

accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would, with or without the passage of

time or the giving of notice, result in a default or event of default under any agreement binding the Company or any Subsidiary, which

default or event of default would or is likely to have a material adverse effect on the business, assets, operations (including results

thereof), liabilities, properties, condition (including financial condition) or prospects of the Company or any of its Subsidiaries, individually

or in the aggregate, but only if such failure or occurrence remains uncured for a period of at least five (5) days;

(xiii) other than as specifically

set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation or warranty in any material

respect (other than representations or warranties subject to material adverse effect or materiality, which may not be breached in any

respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a breach of a covenant or other

term or condition that is curable, only if such breach remains uncured for a period of five (5) consecutive Trading Days;

(xiv) a false or inaccurate certification

(including a false or inaccurate deemed certification) by the Company as to whether any Triggering Event has occurred;

(xv) any breach or failure in

any respect by the Company or any Subsidiary to comply with any provision of Section 15(m) of this Certificate of Designations;

(xvi) any Material Adverse Effect

(as defined in the Securities Purchase Agreement) occurs that has not been cured, if capable of curing, within five (5) Trading Days of

the occurrence thereof; or

(xvii) any provision of any Transaction

Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be valid and binding on or enforceable

against the Company, or the validity or enforceability thereof shall be contested, directly or indirectly, by the Company or any Subsidiary,

or a proceeding shall be commenced by the Company or any Subsidiary or any governmental authority having jurisdiction over any of them,

seeking to establish the invalidity or unenforceability thereof or the Company or any of its Subsidiaries shall deny in writing that it

has any liability or obligation purported to be created under one or more Transaction Documents.

(b) Notice of a Triggering

Event; Redemption Right. Upon the occurrence of a Triggering Event with respect to the Preferred Shares, the Company shall within

one (1) Business Day deliver written notice thereof via electronic mail and overnight courier (with next day delivery specified) (a “Triggering

Event Notice”) to each Holder. At any time after the earlier of a Holder’s receipt of a Triggering Event Notice and such

Holder becoming aware of a Triggering Event (such earlier date, the “Triggering Event Right Commencement Date”) and

ending (such ending date, the “Triggering Event Right Expiration Date”, and each such period, a “Triggering

Event Redemption Right Period”) on the fifteenth (15th) Trading Day after the later of (x) the later of (1) the date such Triggering

Event is cured and (2) the date the Company delivers written notice to the Holders of the cure of such Triggering Event and (y) such Holder’s

receipt of a Triggering Event Notice that includes (I) a reasonable description of the applicable Triggering Event, (II) a certification

as to whether, in the opinion of the Company, such Triggering Event is capable of being cured and, if applicable, a reasonable description

of any existing plans of the Company to cure such Triggering Event and (III) a certification as to the date the Triggering Event occurred

and, if cured on or prior to the date of such Triggering Event Notice, the applicable Triggering Event Right Expiration Date, such Holder

may require the Company to redeem (regardless of whether such Triggering Event has been cured on or prior to the Triggering Event Right

Expiration Date) all or any of the Preferred Shares by delivering written notice thereof (the “Triggering Event Redemption Notice”)

to the Company, which Triggering Event Redemption Notice shall indicate the number of the Preferred Shares such Holder is electing to

redeem. Each of the Preferred Shares subject to redemption by the Company pursuant to this Section 5(b) shall be redeemed by the Company

at a price equal to the greater of (i) the product of (A) the Conversion Amount to be redeemed multiplied by (B) the Redemption Premium

and (ii) the product of (X) the Conversion Rate with respect to the Conversion Amount in effect at such time as such Holder delivers a

Triggering Event Redemption Notice multiplied by (Y) the product of (1) the Redemption Premium multiplied by (2) the greatest Closing

Sale Price of the Common Stock on any Trading Day during the period commencing on the date immediately preceding such Triggering Event

and ending on the date the Company makes the entire payment required to be made under this Section 5(b) (the “Triggering Event

Redemption Price”). Redemptions required by this Section 5(b) shall be made in accordance with the provisions of Section 12.

To the extent redemptions required by this Section 5(b) are deemed or determined by a court of competent jurisdiction to be prepayments

of the Preferred Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the

contrary in this Section 5(b), but subject to Section 4(d), until the Triggering Event Redemption Price (together with any Late Charges

thereon) is paid in full, the Conversion Amount submitted for redemption under this Section 5(b) (together with any Late Charges thereon)

may be converted, in whole or in part, by such Holder into Common Stock pursuant to the terms of this Certificate of Designations. In

the event of the Company’s redemption of any of the Preferred Shares under this Section 5(b), a Holder’s damages would be

uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the

availability of a suitable substitute investment opportunity for such Holder. Accordingly, any redemption premium due under this Section

5(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of its investment

opportunity and not as a penalty. Any redemption upon a Triggering Event shall not constitute an election of remedies by the applicable

Holder or any other Holder, and all other rights and remedies of each Holder shall be preserved.

(c) Mandatory Redemption

upon Bankruptcy Triggering Event. Notwithstanding anything to the contrary herein, and notwithstanding any conversion that is then

required or in process, upon any Bankruptcy Triggering Event, whether occurring prior to or following the Maturity Date, the Company shall

immediately redeem, out of funds legally available therefor, each of the Preferred Shares then outstanding at a redemption price equal

to the applicable Triggering Event Redemption Price (calculated as if such Holder shall have delivered the Triggering Event Redemption

Notice immediately prior to the occurrence of such Bankruptcy Triggering Event), without the requirement for any notice or demand or other

action by any Holder or any other person or entity, provided that a Holder may, in its sole discretion, waive such right to receive payment

upon a Bankruptcy Triggering Event, in whole or in part, and any such waiver shall not affect any other rights of such Holder or any other

Holder hereunder, including any other rights in respect of such Bankruptcy Triggering Event, any right to conversion, and any right to

payment of such Triggering Event Redemption Price or any other Redemption Price, as applicable.

6. Rights Upon Fundamental Transactions.

(a) Assumption. The Company

shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (if the Successor Entity is not the Company)

assumes in writing all of the obligations of the Company under this Certificate of Designations and the other Transaction Documents in

accordance with the provisions of this Section 6(a) pursuant to written agreements in form and substance satisfactory to the Required

Holders and approved by the Required Holders prior to such Fundamental Transaction, including agreements to deliver to each holder of

Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced by a written instrument substantially

similar in form and substance to this Certificate of Designations, including, without limitation, having a stated value and dividend rate

equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having similar ranking to the Preferred Shares,

and satisfactory to the Required Holders, and (ii) the Successor Entity (including its Parent Entity) is a publicly traded corporation

whose shares of common stock are quoted on or listed for trading on an Eligible Market. Upon the occurrence of any Fundamental Transaction,

the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions

of this Certificate of Designations and the other Transaction Documents referring to the “Company” shall refer instead to

the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under

this Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity had been named as

the Company herein and therein. In addition to the foregoing, upon consummation of a Fundamental Transaction, the Successor Entity (if

the Successor Entity is not the Company) shall deliver to each Holder confirmation that there shall be issued upon conversion or redemption

of the Preferred Shares at any time after the consummation of such Fundamental Transaction, in lieu of the shares of Common Stock (or

other securities, cash, assets or other property (except such items still issuable under Sections 7 and 17, which shall continue to be

receivable thereafter)) issuable upon the conversion or redemption of the Preferred Shares prior to such Fundamental Transaction, such

shares of the publicly traded common stock (or their equivalent) of the Successor Entity (including its Parent Entity) which each Holder

would have been entitled to receive upon the happening of such Fundamental Transaction had all the Preferred Shares held by each Holder

been converted immediately prior to such Fundamental Transaction (without regard to any limitations on the conversion of the Preferred

Shares contained in this Certificate of Designations), as adjusted in accordance with the provisions of this Certificate of Designations.

Notwithstanding the foregoing, such Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section

6(a) to permit the Fundamental Transaction without the assumption of the Preferred Shares. The provisions of this Section 6 shall apply

similarly and equally to successive Fundamental Transactions and shall be applied without regard to any limitations on the conversion

or redemption of the Preferred Shares.

(b) Notice of a Change of

Control Redemption Right. No sooner than twenty (20) Trading Days nor later than ten (10) Trading Days prior to the consummation of

a Change of Control (the “Change of Control Date”), but not prior to the public announcement of such Change of Control,

the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder (a “Change of Control

Notice”). At any time during the period beginning after a Holder’s receipt of a Change of Control Notice or such Holder

becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder in accordance with the immediately

preceding sentence (as applicable) and ending on the later of (A) the date of consummation of such Change of Control or (B) twenty (20)

Trading Days after the date of receipt of such Change of Control Notice or (C) twenty (20) Trading Days after the date of the announcement

of such Change of Control, such Holder may require the Company to redeem all or any portion of such Holder’s Preferred Shares by

delivering written notice thereof (“Change of Control Redemption Notice”) to the Company, which Change of Control Redemption

Notice shall indicate the number of Preferred Shares such Holder is electing to have the Company redeem. Each Preferred Share subject

to redemption pursuant to this Section 6(b) shall be redeemed by the Company in funds legally available therefor at a price equal to the

greatest of (i) the product of (w) the Change of Control Redemption Premium multiplied by (y) the Conversion Amount of the Preferred Shares

being redeemed, (ii) the product of (x) the Change of Control Redemption Premium multiplied by (y) the product of (A) the Conversion Amount

of the Preferred Shares being redeemed multiplied by (B) the quotient determined by dividing (I) the greatest Closing Sale Price of the

shares of Common Stock during the period beginning on the date immediately preceding the earlier to occur of (1) the consummation of the

applicable Change of Control and (2) the public announcement of such Change of Control and ending on the date such Holder delivers the

Change of Control Redemption Notice by (II) the Conversion Price then in effect and (iii) the product of (y) the Change of Control Redemption

Premium multiplied by (z) the product of (A) the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the quotient

of (I) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per share of Common Stock to be paid

to such holders of the shares of Common Stock upon consummation of such Change of Control (any such non-cash consideration constituting

publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities as of the Trading Day immediately

prior to the consummation of such Change of Control, the Closing Sale Price of such securities on the Trading Day immediately following

the public announcement of such proposed Change of Control and the Closing Sale Price of such securities on the Trading Day immediately

prior to the public announcement of such proposed Change of Control) divided by (II) the Conversion Price then in effect (the “Change

of Control Redemption Price”). Redemptions required by this Section 6(b) shall have priority to payments to all other stockholders

of the Company in connection with such Change of Control. To the extent redemptions required by this Section 6(b) are deemed or determined

by a court of competent jurisdiction to be prepayments of the Preferred Shares by the Company, such redemptions shall be deemed to be

voluntary prepayments. Notwithstanding anything to the contrary in this Section 6(b), but subject to Section 4(d), until the applicable

Change of Control Redemption Price (together with any Late Charges thereon) is paid in full to the applicable Holder, the Preferred Shares

submitted by such Holder for redemption under this Section 6(b) may be converted, in whole or in part, by such Holder into Common Stock

pursuant to Section 4 or in the event the Conversion Date is after the consummation of such Change of Control, stock or equity interests

of the Successor Entity substantially equivalent to the Company’s shares of Common Stock pursuant to Section 4. In the event of

the Company’s redemption of any of the Preferred Shares under this Section 6(b), such Holder’s damages would be uncertain

and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the availability

of a suitable substitute investment opportunity for a Holder. Accordingly, any redemption premium due under this Section 6(b) is intended

by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of its investment opportunity and

not as a penalty. The Company shall make payment of the applicable Change of Control Redemption Price concurrently with the consummation

of such Change of Control if a Change of Control Redemption Notice is received prior to the consummation of such Change of Control and

within two (2) Trading Days after the Company’s receipt of such notice otherwise (the “Change of Control Redemption Date”).

Redemptions required by this Section 6 shall be made in accordance with the provisions of Section 12.

7. Rights Upon Issuance of Purchase

Rights and Other Corporate Events.

(a) Purchase Rights.

In addition to any adjustments pursuant to Section 8 below, if at any time the Company grants, issues or sells any Options, Convertible

Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially all of the record holders

of any class of Common Stock (the “Purchase Rights”), then each Holder will be entitled to acquire, upon the terms

applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number

of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking into account any limitations

or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the Preferred Shares were converted

at the Alternate Conversion Price as of the applicable record date) held by such Holder immediately prior to the date on which a record

is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders

of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent

that such Holder’s right to participate in any such Purchase Right would result in such Holder and the other Attribution Parties

exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase Right to such extent of the Maximum

Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase Right (and beneficial

ownership) to such extent of any such excess) and such Purchase Right to such extent shall be held in abeyance (and, if such Purchase

Right has an expiration date, maturity date or other similar provision, such term shall be extended by such number of days held in abeyance,

if applicable) for the benefit of such Holder until such time or times, if ever, as its right thereto would not result in such Holder

and the other Attribution Parties exceeding the Maximum Percentage, at which time or times such Holder shall be granted such right (and

any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right held similarly in abeyance

(and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be extended by such number

of days held in abeyance, if applicable)) to the same extent as if there had been no such limitation).

(b) Other Corporate Events.

In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental Transaction pursuant

to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange for shares

of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to ensure that each Holder will

thereafter have the right, at such Holder’s option, to receive upon a conversion of all the Preferred Shares held by such Holder

(i) in addition to the shares of Common Stock receivable upon such conversion, such securities or other assets to which such Holder would

have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by such Holder upon the consummation

of such Corporate Event (without taking into account any limitations or restrictions on the convertibility of the Preferred Shares set

forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable upon such conversion, such

securities or other assets received by the holders of shares of Common Stock in connection with the consummation of such Corporate Event

in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder initially been issued

with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion rate for such consideration

commensurate with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form and substance satisfactory to

the Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive Corporate Events and shall be applied

without regard to any limitations on the conversion or redemption of the Preferred Shares set forth in this Certificate of Designations.

8. Rights Upon Issuance of Other Securities.

(a) Adjustment of Conversion

Price upon Issuance of Common Stock. If and whenever on or after the Subscription Date the Company grants, issues or sells (or enters

into any agreement or publicly announces its intention to grant, issue or sell), or in accordance with this Section 8(a) is deemed to

have granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of shares of Common Stock owned or

held by or for the account of the Company, but excluding any Excluded Securities granted, issued or sold or deemed to have been granted,

issued or sold) for a consideration per share (the “New Issuance Price”) less than a price equal to the Conversion

Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such Conversion Price then

in effect is referred to herein as the “Applicable Price”) (the foregoing a “Dilutive Issuance”),

then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance

Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance

Price under this Section 8(a)), the following shall be applicable:

(i) Issuance of Options.

If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options and the lowest

price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon conversion, exercise

or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof is less

than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company

at the time of the granting, issuance or sale of such Option for such price per share. For purposes of this Section 8(a)(i), the “lowest

price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon conversion, exercise

or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof”

shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with

respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion,

exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof and

(y) the lowest exercise price set forth in such Option for which one share of Common Stock is issuable (or may become issuable assuming

all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible Securities

issuable upon exercise of any such Option or otherwise pursuant to the terms thereof, minus (2) the sum of all amounts paid or payable

to the holder of such Option (or any other Person) with respect to any one share of Common Stock upon the granting, issuance or sale of

such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise

of such Option or otherwise pursuant to the terms thereof plus the value of any other consideration received or receivable by, or benefit

conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price

shall be made upon the actual issuance of such share of Common Stock or of such Convertible Securities upon the exercise of such Options

or otherwise pursuant to the terms thereof or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange

of such Convertible Securities.

(ii) Issuance of Convertible

Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible Securities

and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or exchange thereof

or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding

and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution of such agreement to issue

or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this Section 8(a)(ii), the “lowest

price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or exchange thereof or otherwise

pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received

or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or pursuant to the agreement to issue

or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security or otherwise

pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible Security for which one share of Common

Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion, exercise or exchange thereof or otherwise

pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Convertible Security (or any other

Person) with respect to any one share of Common Stock upon the issuance or sale (or the agreement to issue or sell, as applicable) of

such Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of

such Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price shall be

made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities or otherwise

pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for

which adjustment of the Conversion Price has been or is to be made pursuant to other provisions of this Section 8(a), except as contemplated

below, no further adjustment of the Conversion Price shall be made by reason of such issuance or sale.

(iii) Change in Option Price

or Rate of Conversion. If the purchase or exercise price provided for in any Options, the additional consideration, if any, payable

upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible

into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than proportional changes in

conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(b) below), the Conversion Price in

effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been in effect at such time

had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased

or decreased conversion rate (as the case may be) at the time initially granted, issued or sold. For purposes of this Section 8(a)(iii),

if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible Security that was outstanding

as of the Subscription Date) are increased or decreased in the manner described in the immediately preceding sentence, then such Option

or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to

have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(a) shall be made if such adjustment

would result in an increase of the Conversion Price then in effect.

(iv) Calculation of Consideration

Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance or sale or deemed

issuance or sale of any other securities of the Company (as determined by the Required Holders, the “Primary Security”,

and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities” and together with the

Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate consideration per share

of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price of such Unit, (y) if such

Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of Common Stock is at any time

issuable upon the exercise or conversion of the Primary Security in accordance with Section 8(a)(i) or 8(a)(ii) above and (z) the lowest

VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period (the “Adjustment Period”)

immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public announcement is released

prior to the opening of the Principal Market on a Trading Day, such Trading Day shall be the first Trading Day in such five Trading Day

period and if any Preferred Shares are converted, on any given Conversion Date during any such Adjustment Period, solely with respect

to such Preferred Shares converted on such applicable Conversion Date, such applicable Adjustment Period shall be deemed to have ended

on, and included, the Trading Day immediately prior to such Conversion Date). If any shares of Common Stock, Options or Convertible Securities

are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount

of consideration received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are issued or sold

for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration,

except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company

for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding

the date of receipt. If any shares of Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity

in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be

the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common

Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash or publicly traded

securities will be determined jointly by the Company and the Required Holders. If such parties are unable to reach agreement within ten

(10) days after the occurrence of an event requiring valuation (the “Valuation Event”), the fair value of such consideration

will be determined within five (5) Trading Days after the tenth (10th) day following such

Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination of

such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be

borne by the Company.

(v) Record Date. If the

Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution

payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase shares of Common Stock, Options

or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the shares of Common Stock deemed

to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting

of such right of subscription or purchase (as the case may be).

(b) Adjustment of Conversion

Price upon Subdivision or Combination of Common Stock. Without limiting any provision of Sections 7, 17 or 8(a), if the Company at

any time on or after the Subscription Date subdivides (by any stock split, stock dividend, stock combination, recapitalization or other

similar transaction) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Conversion Price

in effect immediately prior to such subdivision will be proportionately reduced. Without limiting any provision of Sections 7, 17 or 8(a),

if the Company at any time on or after the Subscription Date combines (by any stock split, stock dividend, stock combination, recapitalization

or other similar transaction) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion

Price in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant to this Section 8(b)

shall become effective immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under

this Section 8(b) occurs during the period that a Conversion Price is calculated hereunder, then the calculation of such Conversion Price

shall be adjusted appropriately to reflect such event.

(c) Holder’s Right

of Adjusted Conversion Price. In addition to and not in limitation of the other provisions of this Section 8(b), if the Company in

any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible Securities (any such

securities, “Variable Price Securities”) after the Subscription Date that are issuable pursuant to such agreement or

convertible into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with the market price of

the shares of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting customary

anti-dilution provisions (such as share splits, share combinations, share dividends and similar transactions) (each of the formulations

for such variable price being herein referred to as, the “Variable Price”), the Company shall provide written notice

thereof via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance of such shares of Common

Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into such agreement or issues any

such Variable Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion to substitute the Variable

Price for the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice delivered upon any conversion

of Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable Price rather than the Conversion

Price then in effect. A Holder’s election to rely on a Variable Price for a particular conversion of Preferred Shares shall not

obligate such Holder to rely on a Variable Price for any future conversions of Preferred Shares.

(d) Stock Combination Event

Adjustments. If at any time and from time to time on or after the Subscription Date there occurs any stock split, stock dividend,

stock combination, reverse stock split, recapitalization or other similar transaction involving the Common Stock (each, a “Stock

Combination Event”, and such date thereof, the “Stock Combination Event Date”) and the Event Market Price

is less than the Conversion Price then in effect (after giving effect to the adjustment in Section 8(b) above), then on the fifth (5th)

Trading Day immediately following such Stock Combination Event Date, the Conversion Price then in effect on such fifth (5th) Trading Day

following the Stock Combination Event (after giving effect to the adjustment in Section 8(b) above) shall be reduced (but in no event

increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence would otherwise

result in an increase in the Conversion Price hereunder, no adjustment shall be made.

(e) Other Events. In

the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly applicable, or, if

applicable, would not operate to protect any Holder from dilution or if any event occurs of the type contemplated by the provisions of

this Section 8 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights,

phantom stock rights or other rights with equity features), then the Board shall in good faith determine and implement an appropriate

adjustment in the Conversion Price so as to protect the rights of such Holder, provided that no such adjustment pursuant to this Section

8(e) will increase the Conversion Price as otherwise determined pursuant to this Section 8, provided further that if such Holder does

not accept such adjustments as appropriately protecting its interests hereunder against such dilution, then the Board and such Holder

shall agree, in good faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments,

whose determination shall be final and binding absent manifest error and whose fees and expenses shall be borne by the Company.

(f) Calculations. All

calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100th

of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned

or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.

(g) Voluntary Adjustment

by Company. Subject to the rules and regulations of the Principal Market, the Company may at any time any Preferred Shares remain

outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price to any amount and for any

period of time deemed appropriate by the Board.

9. Reserved.

10. Noncircumvention. The Company

hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws (as defined in the Securities

Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue

or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this

Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate of Designations and

take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality of the foregoing or

any other provision of this Certificate of Designations or the other Transaction Documents, the Company (a) shall not increase the par

value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion Price then in effect,

(b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid

and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c) shall, so long as any Preferred Shares are outstanding,

take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose

of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock as shall from time to time be necessary

to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations on conversion contained herein).

Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Initial Issuance Date, each Holder

is not permitted to convert such Holder’s Preferred Shares in full for any reason (other than pursuant to restrictions set forth

in Section 4(d)(i) hereof), the Company shall use its best efforts to promptly remedy such failure, including, without limitation, obtaining

such consents or approvals as necessary to effect such conversion into shares of Common Stock.

11. Authorized Shares.

(a) Reservation. So long

as any Preferred Shares remain outstanding, the Company shall at all times reserve at least 150% of the aggregate number of shares of

Common Stock as shall from time to time be necessary to effect the conversion of all of the Preferred Shares then outstanding at the Floor

Price then in effect (without regard to any limitations on conversions and assuming the Preferred Shares remain outstanding until the

Maturity Date) (the “Required Reserve Amount”). The Required Reserve Amount (including, without limitation, each increase

in the number of shares so reserved) shall be allocated pro rata among the Holders based on the number of the Preferred Shares held by

each Holder on the Initial Issuance Date or increase in the number of reserved shares, as the case may be (the “Authorized Share

Allocation”). In the event that a Holder shall sell or otherwise transfer any of such Holder’s Preferred Shares, each

transferee shall be allocated a pro rata portion of such Holder’s Authorized Share Allocation. Any shares of Common Stock reserved

and allocated to any Person which ceases to hold any Preferred Shares shall be allocated to the remaining Holders of Preferred Shares,

pro rata based on the number of the Preferred Shares then held by the Holders.

(b) Insufficient Authorized

Shares. If, notwithstanding Section 11(a) and not in limitation thereof, at any time while any of the Preferred Shares remain outstanding

the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve

for issuance upon conversion of the Preferred Shares at least a number of shares of Common Stock equal to the Required Reserve Amount

(an “Authorized Share Failure”), then the Company shall immediately take all action necessary to increase the Company’s

authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for the Preferred

Shares then outstanding (or deemed outstanding pursuant to Section 11(a) above). Without limiting the generality of the foregoing sentence,

as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after

the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase

in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide each stockholder with a

proxy statement and shall use its best efforts to solicit its stockholders’ approval of such increase in authorized shares of Common

Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal (or, if a majority of the voting

power then in effect of the capital stock of the Company consents to such increase, in lieu of such proxy statement, deliver to the stockholders

of the Company an information statement that has been filed with (and either approved by or not subject to comments from) the SEC with

respect thereto). In the event that the Company is prohibited from issuing shares of Common Stock to a Holder upon any conversion due

to the failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common

Stock (such unavailable number of shares of Common Stock, the “Authorized Failure Shares”), in lieu of delivering such

Authorized Failure Shares to such Holder, the Company shall pay legally available funds in exchange for the redemption of such portion

of the Conversion Amount of the Preferred Shares convertible into such Authorized Failure Shares at a price equal to the sum of (i) the

product of (x) such number of Authorized Failure Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day

during the period commencing on the date such Holder delivers the applicable Conversion Notice with respect to such Authorized Failure

Shares to the Company and ending on the date of such issuance and payment under this Section 11(a); and (ii) to the extent such Holder

purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Holder of Authorized

Failure Shares, any brokerage commissions and other out-of-pocket expenses, if any, of such Holder incurred in connection therewith. Nothing

contained in Section 11(a) or this Section 11(b) shall limit any obligations of the Company under any provision of the Securities Purchase

Agreement.

12. Redemptions.

(a) General. If a Holder

has submitted a Triggering Event Redemption Notice in accordance with Section 5(b), the Company shall deliver the applicable Triggering

Event Redemption Price to such Holder in legally available funds within five (5) Business Days after the Company’s receipt of such

Holder’s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control Redemption Notice in accordance with

Section 6(b), the Company shall deliver the applicable Change of Control Redemption Price to such Holder in legally available funds concurrently

with the consummation of such Change of Control if such notice is received prior to the consummation of such Change of Control and within

five (5) Business Days after the Company’s receipt of such notice otherwise. If a Holder has submitted a Maturity Redemption Notice

in accordance with Section 13 below, the Company shall deliver the applicable Maturity Redemption Price to such Holder in legally available

funds on the applicable Maturity Redemption Date. Notwithstanding anything herein to the contrary, in connection with any redemption hereunder

at a time a Holder is entitled to receive a cash payment under any of the other Transaction Documents, at the option of such Holder delivered

in writing to the Company, the applicable Redemption Price hereunder shall be increased by the amount of such cash payment owed to such

Holder under such other Transaction Document and, upon payment in full or conversion in accordance herewith, shall satisfy the Company’s

payment obligation under such other Transaction Document. In the event of a redemption of less than all of the Preferred Shares, the Company

shall promptly cause to be issued and delivered to such Holder a new Preferred Share Certificate (in accordance with Section 20) (or evidence

of the creation of a new Book-Entry) representing the number of Preferred Shares which have not been redeemed. In the event that the Company

does not pay the applicable Redemption Price to a Holder within the time period required for any reason (including, without limitation,

to the extent such payment is prohibited pursuant to the DGCL), at any time thereafter and until the Company pays such unpaid Redemption

Price in full, such Holder shall have the option, in lieu of redemption, to require the Company to promptly return to such Holder all

or any of the Preferred Shares that were submitted for redemption and for which the applicable Redemption Price (together with any Late

Charges thereon) has not been paid. Upon the Company’s receipt of such notice, (x) the applicable Redemption Notice shall be null

and void with respect to such Preferred Shares, (y) the Company shall immediately return the applicable Preferred Share Certificate, or

issue a new Preferred Share Certificate (in accordance with Section 20(d)), to such Holder (unless the Preferred Shares are held in Book-Entry

form, in which case the Company shall deliver evidence to such Holder that a Book-Entry for such Preferred Shares then exists), and in

each case the Additional Amount of such Preferred Shares shall be increased by an amount equal to the difference between (1) the applicable

Redemption Price (as the case may be, and as adjusted pursuant to this Section 12, if applicable) minus (2) the Stated Value portion of

the Conversion Amount submitted for redemption and (z) the Conversion Price of such Preferred Shares shall be automatically adjusted with

respect to each conversion effected thereafter by such Holder to the lowest of (A) the Conversion Price as in effect on the date on which

the applicable Redemption Notice is voided, (B) the greater of (x) the Floor Price and (y) 75% of the lowest Closing Bid Price of the

Common Stock during the period beginning on and including the date on which the applicable Redemption Notice is delivered to the Company

and ending on and including the date on which the applicable Redemption Notice is voided and (C) the greater of (x) the Floor Price and

(y) 75% of the quotient of (I) the sum of the five (5) lowest VWAPs of the Common Stock during the twenty (20) consecutive Trading Day

period ending and including the Trading Day immediately preceding the applicable Conversion Date divided by (II) five (5) (it being understood

and agreed that all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other

similar transaction during such period). A Holder’s delivery of a notice voiding a Redemption Notice and exercise of its rights

following such notice shall not affect the Company’s obligations to make any payments of Late Charges which have accrued prior to

the date of such notice with respect to the Preferred Shares subject to such notice.

(b) Redemption by Multiple

Holders. Upon the Company’s receipt of a Redemption Notice from any Holder for redemption or repayment as a result of an event

or occurrence substantially similar to the events or occurrences described in Section 5(b) or Section 6(b), the Company shall immediately,

but no later than one (1) Business Day of its receipt thereof, forward to each other Holder by electronic mail a copy of such notice.

If the Company receives one or more Redemption Notices, during the seven (7) Business Day period beginning on and including the date which

is two (2) Business Days prior to the Company’s receipt of the initial Redemption Notice and ending on and including the date which

is two (2) Business Days after the Company’s receipt of the initial Redemption Notice and the Company is unable to redeem all of

the Conversion Amount of such Preferred Shares designated in such initial Redemption Notice and such other Redemption Notices received

during such seven (7) Business Day period, then the Company shall redeem a pro rata amount from each Holder based on the Stated Value

of the Preferred Shares submitted for redemption pursuant to such Redemption Notices received by the Company during such seven (7) Business

Day period.

13. Reserved.

14. Voting Rights. Except as otherwise

provided herein or as required by applicable law, Holders of Preferred Shares shall be entitled to vote with holders of the Common Stock

on all matters that such holders of Common Stock are entitled to vote upon, in the same manner and with the same effect as the holders

of Common Stock, voting together with the holders of Common Stock as a single class. Each Preferred Share shall entitle the Holder thereof

to cast that number of votes per Preferred Share equal to the number of Conversion Shares underlying the Preferred Shares determined by

dividing the Stated Value by the NASDAQ Minimum Price (as defined in Nasdaq Listing Rule 5635(d)) immediately preceding the execution

and delivery of the Securities Purchase Agreement (or $92.16 per share, as of the Effective Date, and subject to adjustments for any stock

splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the Effective Date). For purposes

of clarity, NASDAQ Minimum Price shall apply only for purposes of this Section 14 of the Certificate of Designations and not apply to

any other section of the Certificate of Designations or any Transaction Document. Notwithstanding the foregoing, to the extent that under

the DGCL the vote of the holders of the Preferred Shares, voting separately as a class or series, as applicable, is required to authorize

a given action of the Company, the affirmative vote or consent of the Required Holders of the shares of the Preferred Shares, voting together

in the aggregate and not in separate series unless required under the DGCL, represented at a duly held meeting at which a quorum is present

or by written consent of the Required Holders (except as otherwise may be required under the DGCL), voting together in the aggregate and

not in separate series unless required under the DGCL, shall constitute the approval of such action by both the class or the series, as

applicable. Solely for purposes of determining the presence of a quorum at any meeting of the stockholders of the Company at which the

Preferred Shares are entitled to vote, the number of Preferred Shares and votes represented by such shares shall be counted on an as converted

to Common Stock basis, disregarding, for such purposes, any limitations on conversion set forth herein. Holders of the Preferred Shares

shall be entitled to written notice of all stockholder meetings or written consents (and copies of proxy materials and other information

sent to stockholders) with respect to which they would be entitled to vote, which notice would be provided pursuant to the Bylaws and

the DGCL.

15. Covenants. For so long as any

Preferred Shares are outstanding, without the prior written consent of the Required Holders:

(a) Incurrence of Indebtedness.

The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur or guarantee, assume

or suffer to exist any Indebtedness (other than Permitted Indebtedness).

(b) Existence of Liens.

The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, allow or suffer to exist any

mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts and contract

rights) owned by the Company or any of its Subsidiaries (collectively, “Liens”) other than Permitted Liens.

(c) Restricted Payments and

Investments. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, redeem, defease,

repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether by way

of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other pursuant to

this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if any) or interest on, such Indebtedness

or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness and/or Investment, as applicable,

is due or is otherwise made or, after giving effect to such payment, (i) an event constituting a Triggering Event has occurred and is

continuing or (ii) an event that with the passage of time and without being cured would constitute a Triggering Event has occurred and

is continuing.

(d) Restriction on Redemption

and Cash Dividends. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, redeem,

repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than as required by this Certificate

of Designations, the Series A Certificate of Designations, the Series I Certificate of Designations, the Series J Certificate of Designations

or the certificate of designations for the Series K Convertible Preferred Stock, par value $0.0001 per share (“Series K Preferred

Stock”), of the Company).

(e) Restriction on Transfer

of Assets. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, sell, lease,

license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights of the Company or any Subsidiary

owned or hereafter acquired whether in a single transaction or a series of related transactions, other than (i) sales, leases, licenses,

assignments, transfers, conveyances and other dispositions of such assets or rights by the Company and its Subsidiaries in the ordinary

course of business consistent with its past practice, or (ii) sales of inventory and product in the ordinary course of business.

(f) Maturity of Indebtedness.

The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, permit any Indebtedness of

the Company or any of its Subsidiaries to mature or accelerate prior to the Maturity Date.

(g) Change in Nature of Business.

The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, engage in any material line

of business substantially different from those lines of business conducted by or publicly contemplated to be conducted by the Company

and/or its Subsidiaries on the Subscription Date or any business reasonably related or incidental thereto. The Company shall not, and

the Company shall cause each of its Subsidiaries to not, directly or indirectly, modify its or their corporate structure or purpose in

any material respect.

(h) Preservation of Existence,

Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence, rights and

privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and in good standing in each

jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes such qualification

necessary; provided, however, that the Company shall have the right to merge or combine wholly-owned Subsidiaries hereunder, or eliminate

or dissolve foreign Subsidiaries, in each case where such restructuring does not have a material impact on the Company’s assets

or ability to comply with the provisions hereof.

(i) Maintenance of Properties,

Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, all of its properties which

are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear and tear excepted, and

comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which it is a party as lessee

or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.

(j) Maintenance of Intellectual

Property. The Company will, and will cause each of its Subsidiaries to, take all action necessary or advisable to maintain all of

the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or material to the conduct of its business

in full force and effect.

(k) Maintenance of Insurance.

The Company shall use reasonable best efforts to maintain, and cause each of its Subsidiaries to maintain, insurance with responsible

and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard, rent and business

interruption insurance) with respect to its properties (including all real properties leased or owned by it) and business, in such amounts

and covering such risks as are generally consistent with the coverage held by the Company on the Initial Issuance Date.

(l) Transactions with Affiliates.

The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend or be a party to, any transaction or

series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of property or assets of

any kind or the rendering of services of any kind) with any affiliate, except transactions in the ordinary course of business in a manner

and to an extent, if applicable, consistent with past practice and necessary or desirable for the prudent operation of its business, for

fair consideration and on terms no less favorable to it or its Subsidiaries than would be reasonably expected to be obtained in a comparable

arm’s length transaction with a Person that is not an affiliate thereof.

(m) Restricted Issuances.

The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any Preferred Shares

(other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations) or (ii) issue any other securities

that would cause a breach or default under this Certificate of Designations or the Warrants.

(n) Stay, Extension and Usury

Laws. To the extent that it may lawfully do so, the Company (A) agrees that it will not at any time insist upon, plead, or in any

manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever enacted or in force)

that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly waives all benefits or advantages

of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution of any power granted to

the Holders by this Certificate of Designations, but will suffer and permit the execution of every such power as though no such law has

been enacted.

(o) Taxes. The Company

and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together with any related interest

or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective assets or upon their ownership,

possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom (except where the failure

to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). The Company and

its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure to file would

not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding the foregoing,

the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain adequate reserves

therefor in accordance with GAAP.

(p) Cash Minimum .

From January 1, 2025, and until no Preferred Shares are outstanding, the Company shall, at all times, maintain unencumbered, unrestricted

cash and cash equivalents on hand in amount equal to at least 120% of the aggregate Stated Value of the Preferred Shares then outstanding.

Such cash shall be maintained in one or more domestic deposit accounts, money market accounts or certificates of deposit (with a maturity

of no more than three months) with one or more Eligible Banks. For purposes hereof, an “Eligible Bank” is a U.S. chartered

commercial bank with total assets in excess of $300 billion.

(q) Reserved.

(r) Independent Investigation.

At the request of any Holder either (x) at any time when a Triggering Event has occurred and is continuing, (y) upon the occurrence of

an event that with the passage of time or giving of notice would constitute a Triggering Event or (z) at any time such Holder reasonably

believes a Triggering Event may have occurred or be continuing, the Company shall hire an independent, reputable investment bank selected

by the Company and approved by such Holder to investigate as to whether any breach of the Certificate of Designations has occurred (the

“Independent Investigator”). If the Independent Investigator determines that such breach of the Certificate of Designations

has occurred, the Independent Investigator shall notify the Company of such breach and the Company shall deliver written notice to each

Holder of such breach. In connection with such investigation, the Independent Investigator may, during normal business hours, inspect

all contracts, books, records, personnel, offices and other facilities and properties of the Company and its Subsidiaries and, to the

extent available to the Company after the Company uses reasonable efforts to obtain them, the records of its legal advisors and accountants

(including the accountants’ work papers) and any books of account, records, reports and other papers not contractually required

of the Company to be confidential or secret, or subject to attorney-client or other evidentiary privilege, and the Independent Investigator

may make such copies and inspections thereof as the Independent Investigator may reasonably request. The Company shall furnish the Independent

Investigator with such financial and operating data and other information with respect to the business and properties of the Company as

the Independent Investigator may reasonably request. The Company shall permit the Independent Investigator to discuss the affairs, finances

and accounts of the Company with, and to make proposals and furnish advice with respect thereto to, the Company’s officers, directors,

key employees and independent public accountants or any of them (and by this provision the Company authorizes said accountants to discuss

with such Independent Investigator the finances and affairs of the Company and any Subsidiaries), all at such reasonable times, upon reasonable

notice, and as often as may be reasonably requested.

16. Liquidation, Dissolution, Winding-Up.

In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out of the assets of the Company, whether from capital

or from earnings available for distribution to its stockholders (the “Liquidation Funds”), before any amount shall

be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding, an amount per Preferred

Share equal to the greater of (A) 125% of the Conversion Amount of such Preferred Share on the date of such payment and (B) the amount

per share such Holder would receive if such Holder converted such Preferred Share into Common Stock immediately prior to the date of such

payment, provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders of shares of Parity

Stock, then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal to the full amount of

Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance with their respective

certificate of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to all holders of Preferred

Shares and all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions to be taken by each of

its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event to be distributed to the

Holders in accordance with this Section 16. All the preferential amounts to be paid to the Holders under this Section 16 shall be paid

or set apart for payment before the payment or setting apart for payment of any amount for, or the distribution of any Liquidation Funds

of the Company to the holders of shares of Junior Stock in connection with a Liquidation Event as to which this Section 16 applies.

17. Distribution of Assets. In

addition to any adjustments pursuant to Section 7(a) and Section 8, if the Company shall declare or make any dividend or other distributions

of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return of capital or otherwise

(including without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,

reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the “Distributions”),

then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as if such Holder had held the number of shares

of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking into account any limitations or restrictions

on the convertibility of the Preferred Shares and assuming for such purpose that the Preferred Share was converted at the Alternate Conversion

Price as of the applicable record date)immediately prior to the date on which a record is taken for such Distribution or, if no such record

is taken, the date as of which the record holders of Common Stock are to be determined for such Distributions (provided, however, that

to the extent that such Holder’s right to participate in any such Distribution would result in such Holder and the other Attribution

Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Distribution to such extent of

the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution

(and beneficial ownership) to such extent of any such excess) and the portion of such Distribution shall be held in abeyance for the benefit

of such Holder until such time or times as its right thereto would not result in such Holder and the other Attribution Parties exceeding

the Maximum Percentage, at which time or times, if any, such Holder shall be granted such Distribution (and any Distributions declared

or made on such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had

been no such limitation).

18. Vote to Change the Terms of or

Issue Preferred Shares. In addition to any other rights provided by law, except where the vote or written consent of the holders of

a greater number of shares is required by law or by another provision of the Certificate of Incorporation, without first obtaining the

affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the Required Holders, voting together

as a single class, the Company shall not (in any case, whether by amendment, modification, recapitalization, merger, consolidation or

otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate of Incorporation or Bylaws, or file any certificate

of designations or articles of amendment of any series of shares of preferred stock, if such action would adversely alter or change in

any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit of the Preferred Shares hereunder,

regardless of whether any such action shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation or

otherwise; provided that the affirmative vote of the Required Holders shall not be required for changes to the Series A Preferred Stock,

Series K Preferred Stock, Series I Preferred Stock or Series J Preferred Stock; (b) increase or decrease (other than by conversion) the

authorized number of Preferred Shares; (c) without limiting any provision of Section 2, create or authorize (by reclassification or otherwise)

any new class or series of Senior Preferred Stock or Parity Stock, other than the Series J Preferred Stock and Series K Preferred Stock;

(d) purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the terms of the Company’s equity incentive

plans and options and other equity awards granted under such plans (that have in good faith been approved by the Board)); (e) without

limiting any provision of Section 2, pay dividends or make any other distribution on any shares of any Junior Stock; (f) issue any Preferred

Shares other than as contemplated hereby or pursuant to the Securities Purchase Agreement; or (g) without limiting any provision of Section

10, whether or not prohibited by the terms of the Preferred Shares, circumvent a right of the Preferred Shares hereunder.

19. Transfer of Preferred Shares.

A Holder may transfer some or all of its Preferred Shares without the consent of the Company, but any such transfer shall be in compliance

with all applicable securities laws.

20. Reissuance of Preferred Share Certificates

and Book Entries.

(a) Transfer. If any

Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share Certificate to the Company

(or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon the Company will forthwith

issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section 20(d)) (or evidence of the

transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number of Preferred Shares being transferred

by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred, a new Preferred Share Certificate

(in accordance with Section 20(d)) to such Holder representing the outstanding number of Preferred Shares not being transferred (or evidence

of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee, by acceptance of the Preferred Share

Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason of the provisions of Section 4(c)(i)

following conversion or redemption of any of the Preferred Shares, the outstanding number of Preferred Shares represented by the Preferred

Shares may be less than the number of Preferred Shares stated on the face of the Preferred Shares.

(b) Lost, Stolen or Mutilated

Preferred Share Certificate. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction

or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification contemplated below shall suffice

as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the applicable Holder to the

Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of such Preferred Share Certificate,

the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance with Section 20(d)) representing

the applicable outstanding number of Preferred Shares.

(c) Preferred Share Certificate

and Book-Entries Exchangeable for Different Denominations and Forms. Each Preferred Share Certificate is exchangeable, upon the surrender

hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share Certificate or Preferred Share Certificate(s)

or new Book-Entry (in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in

the original Preferred Share Certificate, and each such new Preferred Share Certificate and/or new Book-Entry, as applicable, will represent

such portion of such outstanding number of Preferred Shares from the original Preferred Share Certificate as is designated in writing

by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one or more new Preferred Share Certificates or split

by the applicable Holder by delivery of a written notice to the Company into two or more new Book-Entries (in accordance with Section

20(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in the original Book-Entry, and each such new Book-Entry

and/or new Preferred Share Certificate, as applicable, will represent such portion of such outstanding number of Preferred Shares from

the original Book-Entry as is designated in writing by such Holder at the time of such surrender.

(d) Issuance of New Preferred

Share Certificate or Book-Entry. Whenever the Company is required to issue a new Preferred Share Certificate or a new Book-Entry pursuant

to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry (i) shall represent, as indicated

on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of Preferred Shares remaining outstanding

(or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to Section 20(a) or Section 20(c), the number

of Preferred Shares designated by such Holder) which, when added to the number of Preferred Shares represented by the other new Preferred

Share Certificates or other new Book-Entry, as applicable, issued in connection with such issuance, does not exceed the number of Preferred

Shares remaining outstanding under the original Preferred Share Certificate or original Book-Entry, as applicable, immediately prior to

such issuance of new Preferred Share Certificate or new Book-Entry, as applicable, and (ii) shall have an issuance date, as indicated

on the face of such new Preferred Share Certificate or in such new Book-Entry, as applicable, which is the same as the issuance date of

the original Preferred Share Certificate or in such original Book-Entry, as applicable.

21. Remedies, Characterizations, Other

Obligations, Breaches and Injunctive Relief. The remedies provided in this Certificate of Designations shall be cumulative and in

addition to all other remedies available under this Certificate of Designations and any of the other Transaction Documents, at law or

in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit any Holder’s

right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Certificate of Designations.

No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver

thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other or further exercise

thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy of a Holder at law or equity

or under this Certificate of Designations or any of the documents shall not be deemed to be an election of such Holder’s rights

or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall be no characterization concerning

this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion

and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall not, except as expressly provided

herein, be subject to any other obligation of the Company (or the performance thereof). No failure on the part of a Holder to exercise,

and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise

by such Holder of any right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power

or remedy. In addition, the exercise of any right or remedy of any Holder at law or equity or under Preferred Shares or any of the documents

shall not be deemed to be an election of such Holder’s rights or remedies under such documents or at law or equity. The Company

acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holders and that the remedy at law for

any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, each Holder

shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive

or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and

without posting a bond or other security. The Company shall provide all information and documentation to a Holder that is requested by

such Holder to enable such Holder to confirm the Company’s compliance with the terms and conditions of this Certificate of Designations.

22. Payment of Collection, Enforcement

and Other Costs. If (a) any Preferred Shares are placed in the hands of an attorney for collection or enforcement or is collected

or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under this Certificate of Designations

with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations or (b) there occurs any bankruptcy,

reorganization, receivership of the Company or other proceedings affecting Company creditors’ rights and involving a claim under

this Certificate of Designations, then the Company shall pay the costs incurred by such Holder for such collection, enforcement or action

or in connection with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation, attorneys’

fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under this Certificate of Designations with

respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price paid for each Preferred Share was less

than the original Stated Value thereof.

23. Construction; Headings. This

Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders and shall not be construed against any

such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience of reference and shall not form

part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly indicates otherwise, each pronoun

herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,”

“includes,” “include” and words of like import shall be construed broadly as if followed by the words “without

limitation.” The terms “herein,” “hereunder,” “hereof” and words of like import refer to this

entire Certificate of Designations instead of just the provision in which they are found. Unless expressly indicated otherwise, all section

references are to sections of this Certificate of Designations. Terms used in this Certificate of Designations and not otherwise defined

herein, but defined in the other Transaction Documents, shall have the meanings ascribed to such terms on the Initial Issuance Date in

such other Transaction Documents unless otherwise consented to in writing by the Required Holders.

24. Failure or Indulgence Not Waiver.

No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof,

nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other

right, power or privilege. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving

party. This Certificate of Designations shall be deemed to be jointly drafted by the Company and all Holders and shall not be construed

against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained in this Section 24 shall permit any waiver

of any provision of Section 4(d).

25. Dispute Resolution.

(a) Submission to Dispute

Resolution.

(i) In the case of a dispute relating

to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a VWAP or a fair market value or the

arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be) (including, without limitation, a

dispute relating to the determination of any of the foregoing), the Company or the applicable Holder (as the case may be) shall submit

the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days after the occurrence of the circumstances

giving rise to such dispute or (B) if by such Holder at any time after such Holder learned of the circumstances giving rise to such dispute.

If such Holder and the Company are unable to promptly resolve such dispute relating to such Closing Bid Price, such Closing Sale Price,

such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market value, or the arithmetic calculation of such Conversion

Rate or such applicable Redemption Price (as the case may be), at any time after the second (2nd)

Business Day following such initial notice by the Company or such Holder (as the case may be) of such dispute to the Company or such Holder

(as the case may be), then such Holder may, at its sole option, select an independent, reputable investment bank to resolve such dispute.

(ii) Such Holder and the Company

shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance with the first sentence

of this Section 25 and (B) written documentation supporting its position with respect to such dispute, in each case, no later than 5:00

p.m. (New York time) by the fifth (5th) Business Day immediately following the date on

which such Holder selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in the

immediately preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute Documentation”)

(it being understood and agreed that if either such Holder or the Company fails to so deliver all of the Required Dispute Documentation

by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be

entitled to (and hereby waives its right to) deliver or submit any written documentation or other support to such investment bank with

respect to such dispute and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was

delivered to such investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company

and such Holder or otherwise requested by such investment bank, neither the Company nor such Holder shall be entitled to deliver or submit

any written documentation or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).

(iii) The Company and such Holder

shall cause such investment bank to determine the resolution of such dispute and notify the Company and such Holder of such resolution

no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses of such investment bank

shall be borne solely by the Company, and such investment bank’s resolution of such dispute shall be final and binding upon all

parties absent manifest error.

(b) Miscellaneous. The

Company expressly acknowledges and agrees that (i) this Section 25 constitutes an agreement to arbitrate between the Company and each

Holder (and constitutes an arbitration agreement) under § 7501, et seq. of the New York Civil Practice Law and Rules (“CPLR”)

and that any Holder is authorized to apply for an order to compel arbitration pursuant to CPLR § 7503(a) in order to compel compliance

with this Section 25, (ii) a dispute relating to a Conversion Price includes, without limitation, disputes as to (A) whether an issuance

or sale or deemed issuance or sale of Common Stock occurred under Section 8(a), (B) the consideration per share at which an issuance or

deemed issuance of Common Stock occurred, (C) whether any issuance or sale or deemed issuance or sale of Common Stock was an issuance

or sale or deemed issuance or sale of Excluded Securities, (D) whether an agreement, instrument, security or the like constitutes an Option

or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the terms of this Certificate of Designations and each other

applicable Transaction Document shall serve as the basis for the selected investment bank’s resolution of the applicable dispute,

such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such

investment bank determines are required to be made by such investment bank in connection with its resolution of such dispute and in resolving

such dispute such investment bank shall apply such findings, determinations and the like to the terms of this Certificate of Designations

and any other applicable Transaction Documents, (iv) the applicable Holder (and only such Holder with respect to disputes solely relating

to such Holder), in its sole discretion, shall have the right to submit any dispute described in this Section 25 to any state or federal

court sitting in The City of New York, Borough of Manhattan in lieu of utilizing the procedures set forth in this Section 25 and (v) nothing

in this Section 25 shall limit such Holder from obtaining any injunctive relief or other equitable remedies (including, without limitation,

with respect to any matters described in this Section 25).

26. Notices; Currency; Payments.

(a) Notices. The Company

shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to the terms of this Certificate

of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever notice is required to be

given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing and shall be given in accordance

with Section 9(f) of the Securities Purchase Agreement. The Company shall provide each Holder with prompt written notice of all actions

taken pursuant to this Certificate of Designations, including in reasonable detail a description of such action and the reason therefore.

Without limiting the generality of the foregoing, the Company shall give written notice to each Holder (i) immediately upon any adjustment

of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (ii) at least fifteen

(15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon

the Common Stock, (B) with respect to any grant, issuances, or sales of any Options, Convertible Securities or rights to purchase stock,

warrants, securities or other property to holders of shares of Common Stock or (C) for determining rights to vote with respect to any

Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public prior

to or in conjunction with such notice being provided to such Holder.

(b) Currency. All dollar

amounts referred to in this Certificate of Designations are in United States Dollars (“U.S. Dollars”), and all amounts

owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall

be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange

Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,

the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed

that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such

period of time).

(c) Payments. Whenever

any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations, unless otherwise expressly

set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer of immediately available

funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to time. Whenever any amount

expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business Day, the same shall instead

be due on the next succeeding day which is a Business Day. Any amount due under the Transaction Documents which is not paid when due (except

to the extent such amount is simultaneously accruing Dividends at the Default Rate hereunder) shall result in a late charge being incurred

and payable by the Company in an amount equal to interest on such amount at the rate of fifteen percent (15%) per annum from the date

such amount was due until the same is paid in full (“Late Charge”).

27. Waiver of Notice. To the extent

permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and all other demands and notices in connection

with the delivery, acceptance, performance, default or enforcement of this Certificate of Designations and the Securities Purchase Agreement.

28. Governing Law. This Certificate

of Designations shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation

and performance of this Certificate of Designations shall be governed by, the internal laws of the State of Delaware, without giving effect

to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause

the application of the laws of any jurisdictions other than the State of Delaware. Except as otherwise required by Section 25 above, the

Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough

of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed

herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally

subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue

of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process

in any manner permitted by law. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner

permitted by law. Nothing contained herein (i) shall be deemed or operate to preclude any Holder from bringing suit or taking other legal

action against the Company in any other jurisdiction to collect on the Company’s obligations to such Holder, to realize on any collateral

or any other security for such obligations, or to enforce a judgment or other court ruling in favor of such Holder or (ii) shall limit,

or shall be deemed or construed to limit, any provision of Section 25 above. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY

HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF

THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION CONTEMPLATED HEREBY.

29. Judgment Currency.

(a) If for the purpose of obtaining

or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert into any other currency (such

other currency being hereinafter in this Section 29 referred to as the “Judgment Currency”) an amount due in U.S. dollars

under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on the Trading Day immediately preceding:

(i) the date actual payment of

the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction that will give effect

to such conversion being made on such date: or

(ii) the date on which the foreign

court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which such conversion is made

pursuant to this Section 29(a)(ii) being hereinafter referred to as the “Judgment Conversion Date”).

(b) If in the case of any proceeding

in the court of any jurisdiction referred to in Section 29(a)(ii) above, there is a change in the Exchange Rate prevailing between the

Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall pay such adjusted amount as may

be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate prevailing on the date of payment,

will produce the amount of US dollars which could have been purchased with the amount of Judgment Currency stipulated in the judgment

or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.

(c) Any amount due from the

Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained for any other amounts

due under or in respect of this Certificate of Designations.

30. Severability. If any provision

of this Certificate of Designations is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent

jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest

extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity

of the remaining provisions of this Certificate of Designations so long as this Certificate of Designations as so modified continues to

express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity

or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations

of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor

in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which

comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

31. Maximum Payments. Without limiting

Section 9(d) of the Securities Purchase Agreement, nothing contained herein shall be deemed to establish or require the payment of a rate

of interest or other charges in excess of the maximum permitted by applicable law. In the event that the rate of interest required to

be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess of such maximum shall be credited

against amounts owed by the Company to the applicable Holder and thus refunded to the Company.

32. Stockholder Matters; Amendment.

(a) Stockholder Matters.

Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant to the DGCL, the Certificate

of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred Shares may be effected by written

consent of the Company’s stockholders or at a duly called meeting of the Company’s stockholders, all in accordance with the

applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections of the DGCL permitting

stockholder action, approval and consent affected by written consent in lieu of a meeting.

(b) Amendment. Except

for Section 4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or any provision hereof may be amended

by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without a meeting in accordance with the

DGCL, of the Required Holders, voting separate as a single class, and with such other stockholder approval, if any, as may then be required

pursuant to the DGCL and the Certificate of Incorporation.

33. Certain Defined Terms. For

purposes of this Certificate of Designations, the following terms shall have the following meanings:

(a) “1934 Act”

means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

(b) [Reserved.]

(c) “Additional Amount”

means, as of the applicable date of determination, with respect to each Preferred Share, all accrued and unpaid Dividends on such Preferred

Share.

(d) “Adjustment Right”

means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or sale (or deemed

issuance or sale in accordance with Section 8(a)) of shares of Common Stock (other than rights of the type described in Section 7(a) hereof)

that could result in a decrease in the net consideration received by the Company in connection with, or with respect to, such securities

(including, without limitation, any cash settlement rights, cash adjustment or other similar rights).

(e) “Affiliate”

or “Affiliated” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled

by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a

Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of

directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.

(f) “Alternate Conversion

Floor Amount” means an amount in cash, to be delivered by wire transfer of immediately available funds pursuant to wire instructions

delivered to the Company by the Holder in writing, equal to the product obtained by multiplying (A) the applicable Conversion Amount by

(B) 25%.

(g) “Alternate Conversion

Price” means, with respect to any Alternate Conversion that price which shall be the lowest of (i) the applicable Conversion

Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii) the greater of (x) the Floor Price

and (y) seventy-five percent (75%) of the lowest VWAP of the Common Stock of any Trading Day during the twenty (20) consecutive Trading

Day period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice

(such period, the “Alternate Conversion Measuring Period”). All such determinations to be appropriately adjusted for

any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases

the Common Stock during such Alternate Conversion Measuring Period.

(h) “Approved Stock

Plan” means any employee benefit plan or agreement which has been approved by the Board prior to or subsequent to the Subscription

Date pursuant to which shares of Common Stock and standard options to purchase Common Stock may be issued to any employee, officer, consultant

or director for services provided to the Company in their capacity as such.

(i) “Attribution Parties”

means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds or managed accounts,

currently, or from time to time after the Initial Issuance Date, directly or indirectly managed or advised by a Holder’s investment

manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of such Holder or any of the foregoing, (iii) any

Person acting or who could be deemed to be acting as a Group together with such Holder or any of the foregoing and (iv) any other Persons

whose beneficial ownership of the Company’s Common Stock would or could be aggregated with such Holder’s and the other Attribution

Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing is to subject collectively such Holder

and all other Attribution Parties to the Maximum Percentage.

(j) “Bloomberg”

means Bloomberg, L.P.

(k) “Book-Entry”

means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of a Preferred Share Certificate issuable

hereunder.

(l) “Business Day”

means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by

law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required

by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any

other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so

long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are

open for use by customers on such day.

(m) Reserved.

(n) “Change of Control”

means (1) any Fundamental Transaction other than (i) any merger of the Company or any of its, direct or indirect, wholly-owned Subsidiaries

with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or reclassification of the Common Stock in which

holders of the Company’s voting power immediately prior to such reorganization, recapitalization or reclassification continue after

such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly, are, in all

material respects, the holders of the voting power of the surviving entity (or entities with the authority or voting power to elect the

members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such reorganization,

recapitalization or reclassification, (iii) pursuant to a migratory merger effected solely for the purpose of changing the jurisdiction

of incorporation of the Company or any of its Subsidiaries or (iv) bone fide arm’s length sales or acquisitions by the Company with

one or more third parties as long as holders of the Company’s voting power as of the Issuance Date continue after such sale or acquisition

to hold publicly traded securities and, directly or indirectly, are, in all material respects, the holders of at least 51% of the voting

power of the surviving entity (or entities with the authority or voting power to elect the members of the board of directors (or their

equivalent if other than a corporation) of such entity or entities) after such sale or acquisition; or (2) a reconstitution of the board

of directors of the Company whereby three or more members of such board of directors resign or are replaced.

(o) “Change of Control

Redemption Premium” means 150%.

(p) “Closing Bid Price”

and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing trade

price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate

on an extended hours basis and does not designate the closing bid price or the closing trade price (as the case may be) then the last

bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the

Principal Market is not the principal securities exchange or trading market for such security, the last closing bid price or last trade

price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as

reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of such security

in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price

or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively,

of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding to its functions

of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any

of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date shall be the

fair market value as mutually determined by the Company and the Required Holder. If the Company and the Required Holders are unable to

agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 25.

All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or

other similar transactions during such period.

(q) “Closing Date”

shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company initially issued the Preferred

Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.

(r) “Common Stock”

means (i) the Company’s shares of common stock, $0.0001 par value per share, and (ii) any capital stock into which such common stock

shall have been changed or any share capital resulting from a reclassification of such common stock.

(s) “Contingent Obligation”

means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any Indebtedness, lease,

dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary

effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements

relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with

respect thereto.

(t) “Conversion Floor

Price Condition” means that the relevant Alternate Conversion Price, is being determined based on clause (x) of such definitions.

(u) Reserved.

(v) “Convertible Securities”

means any stock or other security (other than Options) that is at any time and under any circumstances, directly or indirectly, convertible

into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares of Common Stock.

(w) “Dividend Date”

means the first Trading Day of each calendar quarter.

(x) “Dividend Rate”

means eight percent (8.0%) per annum, as may be adjusted from time to time in accordance with Section 2.

(y) “Eligible Market”

means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the Principal Market.

(z) Reserved.

(aa) Reserved.

(bb) “Event Market

Price”  means, with respect to any Stock Combination Event Date, the lower of (i)

the Conversion Price in effect immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following

such Stock Combination Event Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven

(11) consecutive Trading Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and

ending on the fifth (5th) Trading Day immediately following the Stock Combination Event Date.

(cc) “Excluded Securities”

means (i) shares of Common Stock or standard options to purchase Common Stock issued or issuable to directors, officers, employees or

other service providers of the Company for services rendered to the Company in their capacity as such pursuant to an Approved Stock Plan

(as defined above), provided that (A) all such issuances (taking into account the shares of Common Stock issuable upon exercise of such

options) after the Subscription Date pursuant to this clause (i) do not, in the aggregate, exceed more than 2% of the Common Stock issued

and outstanding immediately prior to the Subscription Date and (B) the exercise price of any such options is not lowered, none of such

options are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such options are

otherwise materially changed in any manner that adversely affects any of the Buyers (as defined in the Securities Purchase Agreement;

provided further that the foregoing clause (i)(A)(i) shall not apply from August 4, 2025, until November 4, 2025; (ii) shares of Common

Stock issued or issuable upon the conversion or exercise of Convertible Securities (other than standard options to purchase Common Stock

issued or issuable pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription Date, provided

that the conversion price of any such Convertible Securities (other than standard options to purchase shares of Common Stock issued pursuant

to an Approved Stock Plan that are covered by clause (i) above) is not lowered (other than in accordance with the terms thereof in effect

as of the Subscription Date) from the conversion price in effect as of the Subscription Date (whether pursuant to the terms of such Convertible

Securities or otherwise), none of such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to

an Approved Stock Plan that are covered by clause (i) above) are amended to increase the number of shares issuable thereunder and none

of the terms or conditions of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to

an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed in any manner that adversely affects any

of the Buyers; (iii) the Conversion Shares issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of this

Certificate of Designations; provided, that the terms of this Certificate of Designations are not amended, modified or changed on or

after the Subscription Date (other than in accordance with the terms thereof, including antidilution adjustments pursuant to the terms

thereof in effect as of the Subscription Date), (iv) the Warrant Shares; provided, that the terms of the Warrants are not amended, modified

or changed on or after the Subscription Date (other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription

Date), (v) securities issued as consideration for the acquisition of another entity by the Company by merger, purchase of substantially

all of the assets or other reorganization or bona fide joint venture agreement, provided that such issuance is approved by the majority

of the disinterested directors of the Company and provided that such securities are issued as “restricted securities” (as

defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith

during the Restricted Period and such issuance does not, in the aggregate, exceed more than 5% of the shares of Common Stock issued and

outstanding immediately prior to the date hereof and (vi) securities issued pursuant to those certain Restricted Stock and Cash-Settled

Restricted Stock Unit Award Agreements, dated as of December 2, 2024, by and between the Company and each director of the Company, which

includes the issuance of (i) fully vested restricted shares of the Company’s Common Stock issued under the StableX, Inc. Long-Term

Incentive Plan, as amended and (ii) fully vested cash-settled restricted stock units of the Company (the “RSUs”),

representing shares of Common Stock and shares of Common Stock underlying the RSUs in an aggregate amount equal to the quotient of (i)

$713,125 divided by (ii) the Closing Sale Price of the Company’s Common Stock on December 2, 2024.

(dd) “Floor Price”

means $11.904, as of the Effective Date (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations

or other similar events following the Effective Date) which was 20% of the “Minimum Price” (as defined in Rule 5635 of the

Nasdaq Stock Market) on the Stockholder Approval Date (as defined in the Purchase Agreement) (as adjusted for stock splits, stock dividends,

stock combinations, recapitalizations or other similar events subsequent to the Stockholder Approval Date and prior to the Effective Date)

or, in any case, such lower amount as permitted, from time to time, by the Principal Market.

(ee) “Fundamental Transaction”

means (A) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related

transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Subject Entity,

or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company or

any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation S-X) to one or more Subject Entities, or (iii)

make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its voting stock be subject to or party

to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at least either (x) more

than 50% of the outstanding voting power of the Company, (y) more than 50% of the outstanding voting power of the Company calculated as

if any shares of voting stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities making or party

to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of voting stock such that all Subject Entities

making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively

the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of the outstanding voting power of the Company, or

(iv) consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,

spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate,

acquire, either (x) more than 50% of the outstanding voting power of the Company (y) more than 50% of the outstanding voting power of

the Company calculated as if any shares of voting stock held by all the Subject Entities making or party to, or Affiliated with any Subject

Entity making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number of shares

of voting stock of the Company such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under

the 1934 Act) of more than 50% of the outstanding voting power of the Company, or (v) reorganize, recapitalize or reclassify its Common

Stock, (B) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related

transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner”

(as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance,

tender, tender offer, exchange, reduction in outstanding shares of voting stock, merger, consolidation, business combination, reorganization,

recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever,

of either (x) more than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the

Company, (y) more than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the

Company not held by all such Subject Entities as of the date of this Certificate of Designations calculated as if any shares of voting

stock of the Company held by all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power

represented by issued and outstanding shares of voting stock of the Company or other equity securities of the Company sufficient to allow

such Subject Entities to effect a statutory short form merger or other transaction requiring other stockholders of the Company to surrender

their shares of voting stock of the Company without approval of the stockholders of the Company or (C) directly or indirectly, including

through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument

or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition

shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary

to correct this definition or any portion of this definition which may be defective or inconsistent with the intended treatment of such

instrument or transaction.

(ff) “GAAP”

means United States generally accepted accounting principles, consistently applied.

(gg) “Group”

means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.

(hh) Reserved.

(ii) “Indebtedness”

means of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed

as the deferred purchase price of property or services, including, without limitation, “capital leases” in accordance with

United States generally accepted accounting principles consistently applied for the periods covered thereby (other than trade payables

entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment obligations with respect

to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar

instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all

indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case

with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller

or bank under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations

under any leasing or similar arrangement which, in connection with United States generally accepted accounting principles, consistently

applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F)

above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage,

deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in or upon any property or assets

(including accounts and contract rights) with respect to any asset or property owned by any Person, even though the Person which owns

such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect

of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.

(jj) Reserved.

(kk) Reserved.

(ll) Reserved.

(mm) Reserved.

(nn) “Intellectual

Property Rights” means, with respect to the Company and its Subsidiaries, all of their rights or licenses to use all trademarks,

trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights,

inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications

and registrations therefor.

(oo) “Investment”

means any beneficial ownership (including stock, partnership or limited liability company interests) of or in any Person, or any loan,

advance or capital contribution to any Person or the acquisition of all, or substantially all, of the assets of another Person or the

purchase of any assets of another Person for greater than the fair market value of such assets.

(pp) “Liquidation Event”

means, whether in a single transaction or series of transactions, the voluntary or involuntary liquidation, dissolution or winding up

of the Company or such Subsidiaries the assets of which constitute all or substantially all of the assets of the business of the Company

and its Subsidiaries, taken as a whole.

(qq) “Make-Whole Amount”

means, as of any given date and as applicable, in connection with any conversion, redemption or other repayment hereunder, an amount equal

to the amount of additional Dividends that would accrue under this Certificate of Designations at the Dividend Rate then in effect assuming

for calculation purposes that the Stated Value of this Certificate of Designations as of the Closing Date remained outstanding through

and including the twelve (12) month anniversary of the Subscription Date.

(rr) “Material Adverse

Effect” means any material adverse effect on the business, properties, assets, liabilities, operations, results of operations,

condition (financial or otherwise) or prospects of the Company and its Subsidiaries, if any, individually or taken as a whole, or on the

transactions contemplated hereby or on the other Transaction Documents (as defined below), or by the agreements and instruments to be

entered into in connection therewith or on the authority or ability of the Company to perform its obligations under the Transaction Documents.

(ss) “Maturity Date”

shall mean October 27, 2027; provided, however, the Maturity Date may be extended at the option of a Holder (i) in the event that, and

for so long as, a Triggering Event shall have occurred and be continuing or any event shall have occurred and be continuing that with

the passage of time and the failure to cure would result in a Triggering Event or (ii) through the date that is twenty (20) Business Days

after the consummation of a Fundamental Transaction in the event that a Fundamental Transaction is publicly announced or a Change of Control

Notice is delivered prior to the Maturity Date, provided further that if a Holder elects to convert some or all of its Preferred Shares

pursuant to Section 4 hereof, and the Conversion Amount would be limited pursuant to Section 4(d) hereunder, the Maturity Date shall automatically

be extended until such time as such provision shall not limit the conversion of such Preferred Shares.

(tt) “Options”

means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

(uu) “Parent Entity”

of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security

is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with

the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

(vv) “Permitted Indebtedness”

means (i) Indebtedness existing on January 31, 2023, and reflected on the Company’s balance sheet included in the Company’s

Quarterly Report on Form 10-Q filed with the SEC on May 9, 2023, (ii) Indebtedness secured by Permitted Liens or unsecured but as described

in clauses (iv) and (v) of the definition of Permitted Liens and (iii) if (x) the Stockholder Approval Date has occurred, and (y) less

than 4,400 Preferred Shares remain outstanding, the Permitted Senior Indebtedness.

(ww) “Permitted Liens”

means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for which adequate

reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business by operation

of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as materialmen’s

liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to a liability that is

not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (A) upon or in any equipment

acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment or Indebtedness incurred solely

for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment at the time of its acquisition,

provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds of such equipment, in

either case, with respect to Indebtedness in an aggregate amount not to exceed $150,000, (v) Liens incurred in connection with the extension,

renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above, provided that any extension, renewal

or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness being

extended, renewed or refinanced does not increase, (vi) Liens in favor of customs and revenue authorities arising as a matter of law to

secure payments of custom duties in connection with the importation of goods, (vii) Liens arising from judgments, decrees or attachments

in circumstances not constituting a Triggering Event under Section 5(a)(vii) and (viii) Liens with respect to the Permitted Senior Indebtedness.

(xx) “Permitted Senior

Indebtedness” means non-convertible Indebtedness issued pursuant to a credit facility with a bank or similar financial institution

with no principal payments required prior to the 91st calendar day after the Maturity

Date and otherwise on terms and conditions acceptable to the Eligible Buyers (as defined in the Securities Purchase Agreement) in their

sole and absolute discretion, provided, however, that the aggregate outstanding principal amount of such Indebtedness permitted

hereunder does not at any time exceed $10 million; provided, further, however, no Permitted Senior Indebtedness shall permit the lender

to accelerate such Permitted Senior Indebtedness as a result of the occurrence of any Triggering Event hereunder or the Holder’s

delivery of a Triggering Event Redemption Notice.

(yy) “Person”

means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,

any other entity or a government or any department or agency thereof.

(zz) Reserved.

(aaa) “Principal Market”

means the Nasdaq Capital Market.

(bbb) “Redemption Notices”

means, collectively, the Triggering Event Redemption Notices, the Maturity Redemption Notice and the Change of Control Redemption Notices,

and each of the foregoing, individually, a “Redemption Notice.”

(ccc) “Redemption Premium”

means 130%.

(ddd) “Redemption Prices”

means, collectively, any Triggering Event Redemption Price, Change of Control Redemption Price and Maturity Redemption Price (including

in each case, any interest, damages and Make Whole Amount thereon), and each of the foregoing, individually, a “Redemption Price.”

(eee) “SEC”

means the United States Securities and Exchange Commission or the successor thereto.

(fff) “Securities Purchase

Agreement” means that certain securities purchase agreement by and among the Company and the initial holders of Preferred Shares,

dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.

(ggg) “Stated Value”

shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications,

combinations, subdivisions or other similar events occurring after the Initial Issuance Date with respect to the Preferred Shares.

(hhh) “Subscription

Date” means August 7, 2023.

(iii) “Subject Entity”

means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.

(jjj) “Subsidiaries”

shall have the meaning as set forth in the Securities Purchase Agreement.

(kkk) “Successor Entity”

means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving any Fundamental

Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental Transaction shall

have been entered into.

(lll) “Trading Day”

means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock, any day on which the

Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock,

then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that “Trading

Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours

or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange

or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00

p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the applicable Holder or (y) with respect

to all determinations other than price determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any

successor thereto) is open for trading of securities.

(mmm) “Transaction

Documents” means the Securities Purchase Agreement, this Certificate of Designations, the Warrants and each of the other agreements

and instruments entered into or delivered by the Company or any of the Holders in connection with the transactions contemplated by the

Securities Purchase Agreement, all as may be amended from time to time in accordance with the terms thereof.

(nnn) Reserved.

(ooo) “VWAP”

means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the

Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market

on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,

as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time) or, if the foregoing does

not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for

such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg,

or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing

bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market (or a similar

organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security on such date

on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company

and the Required Holders. If the Company and the Required Holders are unable to agree upon the fair market value of such security, then

such dispute shall be resolved in accordance with the procedures in Section 25. All such determinations shall be appropriately adjusted

for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.

(ppp) “Warrants”

has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants issued in exchange therefor

or replacement thereof.

(qqq) “Warrant Shares”

means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.

34. Disclosure. Upon receipt or

delivery by the Company of any notice in accordance with the terms of this Certificate of Designations, unless the Company has in good

faith determined that the matters relating to such notice do not constitute material, non-public information relating to the Company or

any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business Day immediately following such notice

delivery date, publicly disclose such material, non-public information on a Current Report on Form 8-K or otherwise. In the event that

the Company believes that a notice contains material, non-public information relating to the Company or any of its Subsidiaries, the Company

so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt of notice from such Holder, as applicable),

and in the absence of any such written indication in such notice (or notification from the Company immediately upon receipt of notice

from such Holder), such Holder shall be entitled to presume that information contained in the notice does not constitute material, non-public

information relating to the Company or any of its Subsidiaries. Nothing contained in this Section 34 shall limit any obligations of the

Company, or any rights of any Holder, under Section 4(l) of the Securities Purchase Agreement.

35. Absence of Trading and Disclosure

Restrictions. The Company acknowledges and agrees that no Holder is a fiduciary or agent of the Company and that each Holder shall

have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain from trading any securities

while in possession of such information in the absence of a written non-disclosure agreement signed by an officer of such Holder that

explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed, written non-disclosure agreement,

the Company acknowledges that each Holder may freely trade in any securities issued by the Company, may possess and use any information

provided by the Company in connection with such trading activity, and may disclose any such information to any third party.

* * * * *

IN WITNESS WHEREOF, the Company has caused

this Amended and Restated Certificate of Designations of Series H-7 Convertible Preferred Stock of StableX Technologies, Inc. to be signed

by its Chief Executive Officer on this 27th day of April, 2026.

STABLEX TECHNOLOGIES, INC.

By:

/s/ Joshua Silverman

Name:

Joshua Silverman

Title:

Chief Executive Officer

EXHIBIT I

STABLEX TECHNOLOGIES, INC.

CONVERSION NOTICE

Reference is made to the Amended and Restated

Certificate of Designations, Preferences and Rights of the Series H-7 Convertible Preferred Stock of StableX Technologies, Inc. (the “Certificate

of Designations”). In accordance with and pursuant to the Certificate of Designations, the undersigned hereby elects to convert

the number of shares of Series H-7 Convertible Preferred Stock, $0.0001 par value per share (the “Preferred Shares”),

of StableX Technologies, Inc., a Delaware corporation (the “Company”), indicated below into shares of common stock,

$0.0001 value per share (the “Common Stock”), of the Company, as of the date specified below.

Date of Conversion:

Aggregate number of Preferred Shares to be converted

Aggregate Stated Value of such Preferred Shares to be

converted:

Aggregate accrued and unpaid Dividends, Make-Whole Amount and accrued and unpaid Late Charges with respect to such Preferred Shares, such Aggregate Make-Whole

Amount and such Aggregate Dividends to be converted:

AGGREGATE CONVERSION AMOUNT TO BE CONVERTED:

Please confirm the following information:

Conversion Price:

Number of shares of Common Stock to be issued:

If this Conversion Notice is being delivered with respect to an Alternate Conversion, check here if Holder is electing to use the following Alternate Conversion Price:____________

Please issue the Common Stock into which the applicable Preferred

Shares are being converted to Holder, or for its benefit, as follows:

Check here if requesting delivery as a certificate to the following name and to the following address:

Issue to:

☐ Check here

if requesting delivery by Deposit/Withdrawal at Custodian as follows:

DTC Participant:

DTC Number:

Account Number:

Date: _____________ __, ____

Name of Registered Holder

By:

Name:

Title:

Tax

ID:

E-mail

Address:

EXHIBIT II

ACKNOWLEDGMENT

The Company hereby (a) acknowledges this

Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock are eligible to be resold by the Holder without

restriction or any legend and (c) hereby directs _________________ to issue the above indicated number of shares of Common Stock in accordance

with the Transfer Agent Instructions dated [ ]___, from the Company and acknowledged and agreed to by ________________________.

STABLEX TECHNOLOGIES, INC.

By:

Name:

Title:

EX-3.4

EX-3.4

Filename: ex3-4.htm · Sequence: 5

Exhibit 3.4

AMENDED

AND RESTATED CERTIFICATE OF DESIGNATIONS OF

SERIES

I CONVERTIBLE PREFERRED STOCK OF

STABLEX

TECHNOLOGIES, INC.

This

Amended and Restated Certificate of Designations of Series I Convertible Preferred Stock (this “Certificate of Designations”)

is dated as of April 27, 2026 (the “Effective Date”);

WHEREAS,

the board of directors (the “Board”) of StableX Technologies, Inc. (the “Company”) pursuant to

the authority expressly conferred upon the Board by the Company’s Certificate of Incorporation (the “Certificate of Incorporation”),

and Section 151 of the Delaware General Corporation Law (“DGCL”), has previously fixed the rights, preferences, restrictions

and other matters relating to a series of the Company’s preferred stock, consisting of 7,000 authorized shares of preferred stock,

classified as Series I Convertible Preferred Stock (the “Preferred Stock”), and the Certificate of Designations of

the Preferred Stock (the “Original Certificate of Designations”) evidencing such terms was filed with the Secretary

of State of the State of Delaware on August 6, 2025;

WHEREAS,

pursuant to the authority conferred upon the Board in accordance with the Certificate of Incorporation and the Bylaws of the Company,

the Board has duly adopted a resolution amending and restating the rights of the Preferred Stock, declaring said amendment and restatement

to be advisable and desirable; and

WHEREAS,

this Certificate of Designations has been duly adopted in accordance with Section 151 of the DGCL.

NOW,

THEREFORE, be it resolved, that the Board does hereby provide that the rights set forth in the Original Certificate of Designations are

hereby amended and restated as follows:

TERMS

OF SERIES I CONVERTIBLE PREFERRED STOCK

1.

Designation and Number of Shares. There shall hereby be created and established a series of preferred stock of the Company designated

as “Series I Convertible Preferred Stock” (the “Preferred Shares”). The authorized number of Preferred

Shares shall be seven thousand (7,000) shares. Each Preferred Share shall have a par value of $0.0001. Capitalized terms not defined

herein shall have the meaning as set forth in Section 33 below.

2.

Ranking. Except to the extent that the holders of at least a majority of the outstanding Preferred Shares (the “Required

Holders”) expressly consent to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below)

in accordance with Section 18, all shares of capital stock of the Company shall be junior in rank to all Preferred Shares with

respect to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company

(such junior stock is referred to herein collectively as “Junior Stock”). The rights of all such shares of capital

stock of the Company shall be subject to the rights, powers, preferences and privileges of the Preferred Shares. Without limiting any

other provision of this Certificate of Designations, without the prior express consent of the Required Holders, voting separately as

a single class, the Company shall not hereafter authorize or issue any additional or other shares of capital stock that are (i) of senior

rank to the Preferred Shares in respect of the preferences as to dividends, distributions and payments upon the liquidation, dissolution

and winding up of the Company (collectively, the “Senior Preferred Stock”), (ii) of pari passu rank to the Preferred

Shares in respect of the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of

the Company (collectively, the “Parity Stock”) or (iii) any Junior Stock having a maturity date or any other date

requiring redemption or repayment of such shares of Junior Stock that is prior to the Maturity Date. In the event of the merger or consolidation

of the Company with or into another corporation, the Preferred Shares shall maintain their relative rights, powers, designations, privileges

and preferences provided for herein and no such merger or consolidation shall be consummated if it would result in the Preferred Shares

being treated in any manner inconsistently with the foregoing. Further to the foregoing, the Preferred Shares shall rank junior to shares

of Series H-7 Convertible Preferred Stock, par value $0.0001 per share (“Series H-7 Preferred Stock”), of the Company

issued and outstanding pursuant to that certain Certificate of Designations establishing the rights, preferences, restrictions and other

matters relating to the Series H-7 Preferred Stock (as may be amended from time to time, the “Series H-7 Certificate of Designations”)

with respect to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company.

3.

Dividends and Payments.

(a)

From and after the first date of issuance of any Preferred Shares (the “Initial Issuance Date”), each holder of a

Preferred Share (each, a “Holder” and collectively, the “Holders”) shall be entitled to receive

dividends on the Stated Value of the Preferred Shares (“Dividends”) payable, subject to the conditions and other terms

hereof, in cash out of funds legally available therefor at the Dividend Rate computed on the basis of a 360-day year and twelve 30-day

months and shall compound each calendar quarter; provided that a Holder and the Company may mutually agree to convert any Dividends into

shares of Common Stock at a price to be mutually determined by the Company and such Holder, which shall not be less than the Floor Price.

(b)

Dividends shall be payable in arrears on (i) each Dividend Date, and (ii) upon any redemption in accordance with Section 12 or

any required payment upon any Triggering Event. From and after the occurrence and during the continuance of any Triggering Event and

ending on the date on which such Triggering Event is subsequently cured (and no other Triggering Event then exists), Dividends shall

accrue on the Stated Value of each Preferred Share at fifteen percent (15.0%) per annum (the “Default Rate”) and shall

be computed on the basis of a 360-day year and twelve 30-day months.

(c)

On the Maturity Date, the Company shall pay to the Holder an amount in funds legally available therefor equal to the sum of (i) 107%

of the Stated Value of the Preferred Shares held by such Holder, (ii) accrued and unpaid Dividends and (iii) unpaid Late Charges. Other

than as specifically permitted hereunder, the Company may not prepay any portion of the aggregate Stated Value underlying outstanding

Preferred Shares, accrued and unpaid Dividends or accrued and unpaid Late Charges.

4.

Conversion. At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully

paid and non-assessable shares of Common Stock (as defined below), on the terms and conditions set forth in this Section 4.

(a)

Holder’s Conversion Right. Subject to the provisions of Section 4(d), at any time or times on or after the Initial Issuance

Date, each Holder shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued,

fully paid and non-assessable shares of Common Stock in accordance with Section 4(c) at the Conversion Rate (as defined below).

The Company shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance

of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole share.

The Company shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees

and expenses of the Transfer Agent (as defined below)) that may be payable with respect to the issuance and delivery of Common Stock

upon conversion of any Preferred Shares.

(b)

Conversion Rate. The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section 4(a)

shall be determined by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (the “Conversion

Rate”):

(i)

“Conversion Amount” means, with respect to each Preferred Share, as of the applicable date of determination, the sum

of (1) the Stated Value thereof, plus (2) the Additional Amount thereon and any accrued and unpaid Late Charges (as defined below in

Section 26(c)) with respect to such Stated Value and Additional Amount as of such date of determination.

(ii)

“Conversion Price” means, with respect to each Preferred Share, as of any Conversion Date or other date of determination,

$8.00, as of the date of the Original Certificate of Designations and subject to adjustment as provided herein.

(c)

Mechanics of Conversion. The conversion of each Preferred Share shall be conducted in the following manner:

(i)

Optional Conversion. To convert a Preferred Share into shares of Common Stock on any date (a “Conversion Date”), a

Holder shall deliver (whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date,

a copy of an executed notice of conversion of the share(s) of Preferred Shares subject to such conversion in the form attached hereto

as Exhibit I (the “Conversion Notice”) to the Company. If required by Section 4(c)(iii), within

two (2) Trading Days following a conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally recognized

overnight delivery service for delivery to the Company the original certificates, if any, representing the Preferred Shares (the “Preferred

Share Certificates”) so converted as aforesaid (or an indemnification undertaking with respect to the Preferred Shares in the

case of its loss, theft or destruction as contemplated by Section 20(b)). On or before the first (1st) Trading Day following the

date of receipt of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation and representation

as to whether such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration statement,

in the form attached hereto as Exhibit II, of receipt of such Conversion Notice to such Holder and the Company’s

transfer agent (the “Transfer Agent”), which confirmation shall constitute an instruction to the Transfer Agent to

process such Conversion Notice in accordance with the terms herein. On or before the first (1st) Trading Day following each date on which

the Company has received a Conversion Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule

or regulation for the settlement of a trade initiated on the applicable Conversion Date of such shares of Common Stock issuable pursuant

to such Conversion Notice) (the “Share Delivery Deadline”), the Company shall (1) provided that the Transfer Agent

is participating in the Depository Trust Company’s (“DTC”) Fast Automated Securities Transfer Program (“FAST”),

credit such aggregate number of shares of Common Stock to which such Holder shall be entitled pursuant to such conversion to such Holder’s

or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (2) if the Transfer Agent is

not participating in FAST, upon the request of such Holder, issue and deliver (via reputable overnight courier) to the address as specified

in such Conversion Notice, a certificate, registered in the name of such Holder or its designee, for the number of shares of Common Stock

to which such Holder shall be entitled. If the number of Preferred Shares represented by the Preferred Share Certificate(s) submitted

for conversion pursuant to Section 4(c)(iii) is greater than the number of Preferred Shares being converted, then the Company

shall, as soon as practicable and in no event later than two (2) Trading Days after receipt of the Preferred Share Certificate(s) and

at its own expense, issue and deliver to such Holder (or its designee) a new Preferred Share Certificate or a new Book-Entry (in either

case, in accordance with Section 20(d)) representing the number of Preferred Shares not converted. The Person or Persons entitled

to receive the shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated for all purposes as the record

holder or holders of such shares of Common Stock on the Conversion Date. Notwithstanding the foregoing, with respect to any Conversion

Notice delivered by a Buyer (as defined in the Securities Purchase Agreement) to the Company on or prior to 4:00 p.m. (New York City

time) on the Trading Day immediately prior to the date of initial issuance of such applicable Preferred Shares to be converted pursuant

to such Conversion Notice (each, an “Issuance Date”), which may be delivered at any time after the time of execution

of the Securities Purchase Agreement, the Company agrees to deliver the shares of Common Stock issuable upon conversion of such Preferred

Shares to be issued on such date subject to such notice(s) by 4:00 p.m. (New York City time) on such applicable Issuance Date and such

Issuance Date shall be the Share Delivery Deadline for purposes hereunder with respect to such Conversion Notice.

(ii)

Company’s Failure to Timely Convert. If the Company shall fail, for any reason or for no reason, on or prior to the applicable

Share Delivery Deadline, if the Transfer Agent is not participating in FAST, to issue and deliver to such Holder (or its designee) a

certificate for the number of shares of Common Stock to which such Holder is entitled and register such shares of Common Stock on the

Company’s share register or, if the Transfer Agent is participating in FAST, to credit such Holder’s or its designee’s

balance account with DTC for such number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion

of any Conversion Amount (as the case may be) (a “Conversion Failure”), then, in addition to all other remedies available

to such Holder, (X) the Company shall pay in cash from funds legally available therefor to such Holder on each day after the Share Delivery

Deadline that the issuance of such shares of Common Stock is not timely effected an amount equal to 1% of the product of (A) the sum

of the number of shares of Common Stock not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder

is entitled, multiplied by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time during

the period beginning on the applicable Conversion Date and ending on the applicable Share Delivery Deadline, and (Y) such Holder, upon

written notice to the Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all,

or any portion, of such Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding

of a Conversion Notice shall not affect the Company’s obligations to make any payments which have accrued prior to the date of

such notice pursuant to this Section 4(c)(ii) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery

Deadline the Transfer Agent is not participating in FAST, the Company shall fail to issue and deliver to such Holder (or its designee)

a certificate and register such shares of Common Stock on the Company’s share register or, if the Transfer Agent is participating

in FAST, the Transfer Agent shall fail to credit the balance account of such Holder or such Holder’s designee, as applicable, with

DTC for the number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder or pursuant

to the Company’s obligation pursuant to clause (ii) below, and if on or after such Share Delivery Deadline such Holder acquires

(in an open market transaction, stock loan or otherwise) shares of Common Stock corresponding to all or any portion of the number of

shares of Common Stock issuable upon such conversion that such Holder is entitled to receive from the Company and has not received from

the Company in connection with such Conversion Failure (a “Buy-In”), then, in addition to all other remedies available

to such Holder, the Company shall, within two (2) Business Days after receipt of such Holder’s request and in such Holder’s

discretion, either: (I) pay cash from funds legally available therefor to such Holder in an amount equal to such Holder’s total

purchase price (including brokerage commissions, stock loan costs and other out-of-pocket expenses, if any) for the shares of Common

Stock so acquired (including, without limitation, by any other Person in respect, or on behalf, of such Holder) (the “Buy-In

Price”), at which point the Company’s obligation to so issue and deliver such certificate (and to issue such shares of

Common Stock) or credit to the balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number

of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion hereunder (as the case may be) (and to

issue such shares of Common Stock) shall terminate, or (II) promptly honor its obligation to so issue and deliver to such Holder a certificate

or certificates representing such shares of Common Stock or credit the balance account of such Holder or such Holder’s designee,

as applicable, with DTC for the number of shares of Common Stock to which such Holder is entitled upon such Holder’s conversion

hereunder (as the case may be) and pay cash from funds legally available therefor to such Holder in an amount equal to the excess (if

any) of the Buy-In Price over the product of (x) such number of shares of Common Stock multiplied by (y) the lowest Closing Sale Price

of the Common Stock on any Trading Day during the period commencing on the date of the applicable Conversion Notice and ending on the

date of such issuance and payment under this clause (II). Nothing herein shall limit a Holder’s right to pursue any other remedies

available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief

with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock (or to electronically

deliver such shares of Common Stock) upon the conversion of the Preferred Shares as required pursuant to the terms hereof. Notwithstanding

anything herein to the contrary, with respect to any given Conversion Failure, this Section 4(c)(ii) shall not apply to a Holder

to the extent the Company has already paid such amounts in full to such Holder with respect to such Conversion Failure, as applicable,

pursuant to the analogous sections of the Securities Purchase Agreement.

(iii)

Registration; Book-Entry. At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request

(including by electronic-mail) to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates

or in Book-Entry form. The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the “Register”)

for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and

whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the “Registered

Preferred Shares”). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The

Company and each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred

Share for all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice

to the contrary. A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on

the Register. Upon its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder

thereof, the Company shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares

in the same aggregate Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee

pursuant to Section 19, provided that if the Company does not so record an assignment, transfer or sale (as the case may

be) of such Registered Preferred Shares within two (2) Business Days of such a request, then the Register shall be automatically deemed

updated to reflect such assignment, transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this

Section 4, following conversion of any Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be

required to physically surrender such Preferred Shares held in the form of a Preferred Share Certificate to the Company unless (A) the

full or remaining number of Preferred Shares represented by the applicable Preferred Share Certificate are being converted (in which

event such certificate(s) shall be delivered to the Company as contemplated by this Section 4(c)(iii)) or (B) such Holder has

provided the Company with prior written notice (which notice may be included in a Conversion Notice) requesting reissuance of Preferred

Shares upon physical surrender of the applicable Preferred Share Certificate. Each Holder and the Company shall maintain records showing

the Stated Value, Dividends and Late Charges converted and/or paid (as the case may be) and the dates of such conversions and/or payments

(as the case may be) or shall use such other method, reasonably satisfactory to such Holder and the Company, so as not to require physical

surrender of a Preferred Share Certificate upon conversion. If the Company does not update the Register to record such Stated Value,

Dividends and Late Charges converted and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case

may be) within two (2) Business Days of such occurrence, then the Register shall be automatically deemed updated to reflect such occurrence.

In the event of any dispute or discrepancy, such records of such Holder establishing the number of Preferred Shares to which the record

holder is entitled shall be controlling and determinative in the absence of manifest error. A Holder and any transferee or assignee,

by acceptance of a certificate, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of any

Preferred Shares, the number of Preferred Shares represented by such certificate may be less than the number of Preferred Shares stated

on the face thereof. Each Preferred Share Certificate shall bear the following legend:

ANY

TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD CAREFULLY REVIEW THE TERMS OF THE COMPANY’S CERTIFICATE OF DESIGNATIONS RELATING

TO THE SHARES OF SERIES I PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER OF

SHARES OF SERIES I PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES I PREFERRED STOCK

STATED ON THE FACE HEREOF PURSUANT TO SECTION 4(C)(III) OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES I

PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE.

(iv)

Pro Rata Conversion; Disputes. In the event that the Company receives a Conversion Notice from more than one Holder for the same

Conversion Date and the Company can convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert

from each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder’s Preferred Shares submitted

for conversion on such date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to

the aggregate number of Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of shares

of Common Stock issuable to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the

number of shares of Common Stock not in dispute and resolve such dispute in accordance with Section 25.

(d)

Limitation on Beneficial Ownership.

(i)

Beneficial Ownership. The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder

shall not have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate

of Designations and any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to

such conversion, such Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the

“Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such conversion.

For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Holder and the other

Attribution Parties shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the

number of shares of Common Stock issuable upon conversion of the Preferred Shares with respect to which the determination of such sentence

is being made, but shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted Preferred

Shares beneficially owned by such Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or

nonconverted portion of any other securities of the Company (including, without limitation, any convertible notes, convertible preferred

stock or warrants, including the Preferred Shares and the Warrants) beneficially owned by such Holder or any other Attribution Party

subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 4(d)(i). For purposes

of this Section 4(d)(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. In addition,

a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and

the rules and regulations promulgated thereunder. For purposes of determining the number of outstanding shares of Common Stock a Holder

may acquire upon the conversion of such Preferred Shares without exceeding the Maximum Percentage, such Holder may rely on the number

of outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report

on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be, (y) a more recent public announcement

by the Company or (z) any other written notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common

Stock outstanding (the “Reported Outstanding Share Number”). If the Company receives a Conversion Notice from a Holder

at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company

shall notify such Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Conversion

Notice would otherwise cause such Holder’s beneficial ownership, as determined pursuant to this Section 4(d)(i), to exceed

the Maximum Percentage, such Holder must notify the Company of a reduced number of shares of Common Stock to be purchased pursuant to

such Conversion Notice. For any reason at any time, upon the written or oral request of any Holder, the Company shall within one (1)

Business Day confirm orally and in writing or by electronic mail to such Holder the number of shares of Common Stock then outstanding.

In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of

securities of the Company, including such Preferred Shares, by such Holder and any other Attribution Party since the date as of which

the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common Stock to a Holder upon conversion

of such Preferred Shares results in such Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate,

more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the

1934 Act), the number of shares so issued by which such Holder’s and the other Attribution Parties’ aggregate beneficial

ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and shall be cancelled

ab initio, and such Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice to the

Company, any Holder may from time to time increase (with such increase not effective until the sixty-first (61st) day after delivery

of such notice) or decrease the Maximum Percentage of such Holder to any other percentage not in excess of 9.99% as specified in such

notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after

such notice is delivered to the Company and (ii) any such increase or decrease will apply only to such Holder and the other Attribution

Parties and not to any other Holder that is not an Attribution Party of such Holder. For purposes of clarity, the shares of Common Stock

issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Maximum Percentage shall not be deemed

to be beneficially owned by such Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act.

No prior inability to convert such Preferred Shares pursuant to this paragraph shall have any effect on the applicability of the provisions

of this paragraph with respect to any subsequent determination of convertibility. The provisions of this paragraph shall be construed

and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d)(i) to the extent necessary

to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent with the intended beneficial ownership

limitation contained in this Section 4(d)(i) or to make changes or supplements necessary or desirable to properly give effect

to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of such Preferred

Shares.

(ii)

Principal Market Regulation. The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares or

otherwise pursuant to the terms of this Certificate of Designations if the issuance of such shares of Common Stock (taken together with

the issuance of all other shares of Common Stock upon exercise of the Warrants) would exceed the aggregate number of shares of Common

Stock which the Company may issue upon exercise or conversion (as the case may be) of the Preferred Shares and the Warrants without breaching

the Company’s obligations under the rules and regulations of the Principal Market (the number of shares which may be issued without

violating such rules and regulations, including, but not limited to, rules related to the aggregate offerings under Nasdaq Listing Rule

5635(d), the “Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains

the approval of its stockholders as required by the applicable rules and regulations of the Principal Market for issuances of shares

of Common Stock in excess of such amount (“Stockholder Approval”) or (B) obtains a written opinion from outside counsel

to the Company that such approval is not required, which opinion shall be reasonably satisfactory to the Required Holders. Until such

approval or such written opinion is obtained, no Holder shall be issued in the aggregate, upon conversion or exercise (as the case may

be) of any Preferred Shares or any Warrant, shares of Common Stock in an amount greater than the product of (i) the Exchange Cap as of

the Initial Issuance Date multiplied by (ii) the quotient of (1) the aggregate number of Preferred Shares issued to such Holder on the

Initial Issuance Date divided by (2) the aggregate number of Preferred Shares issued to the Holders on the Initial Issuance Date (with

respect to each Holder, the “Exchange Cap Allocation”). In the event that any Holder shall sell or otherwise transfer

any of such Holder’s Preferred Shares, the transferee shall be allocated a pro rata portion of such Holder’s Exchange Cap

Allocation with respect to such portion of such Preferred Shares so transferred, and the restrictions of the prior sentence shall apply

to such transferee with respect to the portion of the Exchange Cap Allocation so allocated to such transferee. Upon conversion in full

of a holder’s Preferred Shares, the difference (if any) between such holder’s Exchange Cap Allocation and the number of shares

of Common Stock actually issued to such holder upon such holder’s conversion in full of such Preferred Shares shall be allocated,

to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares and/or related Warrants on a pro rata basis in

proportion to the shares of Common Stock underlying the Preferred Shares and/or related Warrants then held by each such holder of Preferred

Shares and/or related Warrants.

(e)

Right of Alternate Conversion.

(i)

Alternate Conversion Upon a Triggering Event. Subject to Section 4(d), at any time during a Triggering Event Redemption Right

Period (as defined herein), such Holder may, at such Holder’s option, by delivery of a Conversion Notice to the Company (the date

of any such Conversion Notice, each an “Alternate Conversion Date”), convert all, or any number of Preferred Shares

(such Conversion Amount of the Preferred Shares to be converted pursuant to this Section 4(e)(ii), each, an “Alternate

Conversion Amount”) held by such Holder into shares of Common Stock at the Alternate Conversion Price (each an “Alternate

Conversion”).

(ii)

Mechanics of Alternate Conversion. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion

Amount of Preferred Shares pursuant to Section 4(c) (with “Alternate Conversion Price” replacing “Conversion

Price” for all purposes hereunder with respect to such Alternate Conversion and with “Alternate Conversion Amount”

replacing “Conversion Amount” in clause (x) of the definition of Conversion Rate above with respect to such Alternate

Conversion) by designating in the Conversion Notice delivered pursuant to this Section 4(e) of this Certificate of Designations

that such Holder is electing to use the Alternate Conversion Price for such conversion; provided that in the event of the Conversion

Floor Price Condition, on the applicable Alternate Conversion Date the Company shall also deliver to the Holder the applicable Alternate

Conversion Floor Amount. Notwithstanding anything to the contrary in this Section 4(e), but subject to Section 4(d), until

the Company delivers shares of Common Stock representing the applicable Alternate Conversion Amount of Preferred Shares to such Holder,

such Preferred Shares may be converted by such Holder into shares of Common Stock pursuant to Section 4(c) without regard to this

Section 4(e).

5.

Triggering Event Redemptions.

(a)

Triggering Event. Each of the following events shall constitute a “Triggering Event” and each of the events in clauses

(viii), (ix), and (x) shall constitute a “Bankruptcy Triggering Event”:

(i)

the suspension from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period

of five (5) consecutive Trading Days;

(ii)

the Company’s (A) failure to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required

number of shares of Common Stock within five (5) Trading Days after the applicable Conversion Date or exercise date (as the case may

be) or (B) written notice to any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement

or through any of its agents, at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for

Warrant Shares in accordance with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common

Stock that is requested in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d)

hereof;

(iii)

except to the extent the Company is in compliance with Section 11(b) below, at any time following the tenth (10th) consecutive

day that a Holder’s Authorized Share Allocation (as defined in Section 11(a) below) is less than the sum of (A) 200% of

the number of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred

Shares then held by such Holder (assuming a conversion at the Floor Price then in effect and without regard to any limitations on conversion

set forth in this Certificate of Designations) and (B) 200% of the number of shares of Common Stock that such Holder would then be entitled

to receive upon exercise in full of such Holder’s Warrants (without regard to any limitations on exercise set forth in the Warrants);

(iv)

subject to the provisions of Section 170 of the DGCL, the Board fails to declare any Dividend to be paid on the applicable Dividend Date

in accordance with Section 3 hereof;

(v)

the Company’s failure to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or any other

amount when and as due under this Certificate of Designations (including, without limitation, the Company’s failure to pay any

redemption payments or other amounts hereunder), the Securities Purchase Agreement or any other Transaction Document or any other agreement,

document, certificate or other instrument delivered in connection with the transactions contemplated hereby and thereby (in each case,

whether or not permitted pursuant to the DGCL), except, solely with respect to the failure to pay Dividends and Late Charges when and

as due hereunder, only if such failure remains uncured for a period of at least five (5) Trading Days;

(vi)

the Company fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon

conversion or exercise (as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder

under the Transaction Documents as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise

then prohibited by applicable federal securities laws, and any such failure remains uncured for at least five (5) Trading Days;

(vii)

the occurrence of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $250,000 of Indebtedness

(as defined in the Securities Purchase Agreement) of the Company or any of its Subsidiaries;

(viii)

bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted

by or against the Company or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed

within thirty (30) days of their initiation;

(ix)

the commencement by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy,

insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the

consent by it to the entry of a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary

case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the

commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking

reorganization or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to

the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official

of the Company or any Subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit of

creditors, or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or

the admission by it in writing of its inability to pay its debts generally as they become due, the taking of corporate action by the

Company or any Subsidiary in furtherance of any such action or the taking of any action by any Person to commence a Uniform Commercial

Code foreclosure sale or any other similar action under federal, state or foreign law;

(x)

the entry by a court of (i) a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary

or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar

law or (ii) a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or

approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of

the Company or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar

document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any

Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance

of any such decree, order, judgment or other similar document or any such other decree, order, judgment or other similar document unstayed

and in effect for a period of thirty (30) consecutive days;

(xi)

a final judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company and/or any

of its Subsidiaries and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed

pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any

judgment which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount

set forth above so long as the Company provides each Holder a written statement from such insurer or indemnity provider (which written

statement shall be reasonably satisfactory to each Holder) to the effect that such judgment is covered by insurance or an indemnity and

the Company or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within thirty (30) days

of the issuance of such judgment;

(xii)

the Company and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace

period, any payment with respect to any Indebtedness in excess of $250,000 due to any third party (other than, with respect to unsecured

Indebtedness only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings

and with respect to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach

or violation of any agreement for monies owed or owing in an amount in excess of $250,000, which breach or violation permits the other

party thereto to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or

event that would, with or without the passage of time or the giving of notice, result in a default or event of default under any agreement

binding the Company or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the

business, assets, operations (including results thereof), liabilities, properties, condition (including financial condition) or prospects

of the Company or any of its Subsidiaries, individually or in the aggregate, but only if such failure or occurrence remains uncured for

a period of at least five (5) days;

(xiii)

other than as specifically set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation

or warranty in any material respect (other than representations or warranties subject to material adverse effect or materiality, which

may not be breached in any respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a

breach of a covenant or other term or condition that is curable, only if such breach remains uncured for a period of five (5) consecutive

Trading Days;

(xiv)

a false or inaccurate certification (including a false or inaccurate deemed certification) by the Company as to whether any Triggering

Event has occurred;

(xv)

any breach or failure in any respect by the Company or any Subsidiary to comply with any provision of Section 15(m) of this Certificate

of Designations;

(xvi)

any Material Adverse Effect (as defined in the Securities Purchase Agreement) occurs that has not been cured, if capable of curing, within

five (5) Trading Days of the occurrence; or

(xvii)

any provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to

be valid and binding on or enforceable against the Company, or the validity or enforceability thereof shall be contested, directly or

indirectly, by the Company or any Subsidiary, or a proceeding shall be commenced by the Company or any Subsidiary or any governmental

authority having jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof or the Company or any

of its Subsidiaries shall deny in writing that it has any liability or obligation purported to be created under one or more Transaction

Documents.

(b)

Notice of a Triggering Event; Redemption Right. Upon the occurrence of a Triggering Event with respect to the Preferred Shares,

the Company shall within one (1) Business Day deliver written notice thereof via electronic mail and overnight courier (with next day

delivery specified) (a “Triggering Event Notice”) to each Holder. At any time after the earlier of a Holder’s

receipt of a Triggering Event Notice and such Holder becoming aware of a Triggering Event (such earlier date, the “Triggering

Event Right Commencement Date”) and ending (such ending date, the “Triggering Event Right Expiration Date”,

and each such period, a “Triggering Event Redemption Right Period”) on the fifteenth (15th) Trading Day after the

later of (x) the later of (1) the date such Triggering Event is cured and (2) the date the Company delivers written notice to the Holders

that such Triggering Event has been cured and (y) such Holder’s receipt of a Triggering Event Notice that includes (I) a reasonable

description of the applicable Triggering Event, (II) a certification as to whether, in the opinion of the Company, such Triggering Event

is capable of being cured and, if applicable, a reasonable description of any existing plans of the Company to cure such Triggering Event

and (III) a certification as to the date the Triggering Event occurred and, if cured on or prior to the date of such Triggering Event

Notice, the applicable Triggering Event Right Expiration Date, such Holder may require the Company to redeem (regardless of whether such

Triggering Event has been cured on or prior to the Triggering Event Right Expiration Date) all or any of the Preferred Shares by delivering

written notice thereof (the “Triggering Event Redemption Notice”) to the Company, which Triggering Event Redemption

Notice shall indicate the number of the Preferred Shares such Holder is electing to redeem. Each of the Preferred Shares subject to redemption

by the Company pursuant to this Section 5(b) shall be redeemed by the Company at a price equal to the greater of (i) the product

of (A) the Conversion Amount to be redeemed multiplied by (B) the Redemption Premium and (ii) the product of (X) the Conversion Rate

with respect to the Conversion Amount in effect at such time as such Holder delivers a Triggering Event Redemption Notice multiplied

by (Y) the product of (1) the Redemption Premium multiplied by (2) the greatest Closing Sale Price of the Common Stock on any Trading

Day during the period commencing on the date immediately preceding such Triggering Event and ending on the date the Company makes the

entire payment required to be made under this Section 5(b) (the “Triggering Event Redemption Price”). Redemptions

required by this Section 5(b) shall be made in accordance with the provisions of Section 12. To the extent redemptions

required by this Section 5(b) are deemed or determined by a court of competent jurisdiction to be prepayments of the Preferred

Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this

Section 5(b), but subject to Section 4(d), until the Triggering Event Redemption Price (together with any Late Charges

thereon) is paid in full, the Conversion Amount submitted for redemption under this Section 5(b) (together with any Late Charges

thereon) may be converted, in whole or in part, by such Holder into Common Stock pursuant to the terms of this Certificate of Designations.

In the event of the Company’s redemption of any of the Preferred Shares under this Section 5(b), a Holder’s damages

would be uncertain and difficult to estimate because of the parties’ inability to predict future interest rates and the uncertainty

of the availability of a suitable substitute investment opportunity for such Holder. Accordingly, any redemption premium due under this

Section 5(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of

its investment opportunity and not as a penalty. Any redemption upon a Triggering Event shall not constitute an election of remedies

by the applicable Holder or any other Holder, and all other rights and remedies of each Holder shall be preserved.

(c)

Mandatory Redemption upon Bankruptcy Triggering Event. Notwithstanding anything to the contrary herein, and notwithstanding any

conversion that is then required or in process, upon any Bankruptcy Triggering Event, whether occurring prior to or following the Maturity

Date, the Company shall immediately redeem, out of funds legally available therefor, each of the Preferred Shares then outstanding at

a redemption price equal to the applicable Triggering Event Redemption Price (calculated as if such Holder shall have delivered the Triggering

Event Redemption Notice immediately prior to the occurrence of such Bankruptcy Triggering Event), without the requirement for any notice

or demand or other action by any Holder or any other person or entity, provided that a Holder may, in its sole discretion, waive

such right to receive payment upon a Bankruptcy Triggering Event, in whole or in part, and any such waiver shall not affect any other

rights of such Holder or any other Holder hereunder, including any other rights in respect of such Bankruptcy Triggering Event, any right

to conversion, and any right to payment of such Triggering Event Redemption Price or any other Redemption Price, as applicable.

6.

Rights Upon Fundamental Transactions.

(a)

Assumption. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity (if the

Successor Entity is not the Company) assumes in writing all of the obligations of the Company under this Certificate of Designations

and the other Transaction Documents in accordance with the provisions of this Section 6(a) pursuant to written agreements in form

and substance satisfactory to the Required Holders and approved by the Required Holders prior to such Fundamental Transaction, including

agreements to deliver to each holder of Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced

by a written instrument substantially similar in form and substance to this Certificate of Designations, including, without limitation,

having a stated value and dividend rate equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having

similar ranking to the Preferred Shares, and satisfactory to the Required Holders and (ii) the Successor Entity (including its Parent

Entity) is a publicly traded corporation whose shares of common stock are quoted on or listed for trading on an Eligible Market. Upon

the occurrence of any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after

the date of such Fundamental Transaction, the provisions of this Certificate of Designations and the other Transaction Documents referring

to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company

and shall assume all of the obligations of the Company under this Certificate of Designations and the other Transaction Documents with

the same effect as if such Successor Entity had been named as the Company herein and therein. In addition to the foregoing, upon consummation

of a Fundamental Transaction, the Successor Entity (if the Successor Entity is not the Company) shall deliver to each Holder confirmation

that there shall be issued upon conversion or redemption of the Preferred Shares at any time after the consummation of such Fundamental

Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such items still issuable

under Sections 7 and 17, which shall continue to be receivable thereafter)) issuable upon the conversion or redemption

of the Preferred Shares prior to such Fundamental Transaction, such shares of the publicly traded common stock (or their equivalent)

of the Successor Entity (including its Parent Entity) which each Holder would have been entitled to receive upon the happening of such

Fundamental Transaction had all the Preferred Shares held by each Holder been converted immediately prior to such Fundamental Transaction

(without regard to any limitations on the conversion of the Preferred Shares contained in this Certificate of Designations), as adjusted

in accordance with the provisions of this Certificate of Designations. Notwithstanding the foregoing, such Holder may elect, at its sole

option, by delivery of written notice to the Company to waive this Section 6(a) to permit the Fundamental Transaction without

the assumption of the Preferred Shares. The provisions of this Section 6 shall apply similarly and equally to successive Fundamental

Transactions and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares.

(b)

Notice of a Change of Control Redemption Right. No sooner than twenty (20) Trading Days nor later than ten (10) Trading Days prior

to the consummation of a Change of Control (the “Change of Control Date”), but not prior to the public announcement

of such Change of Control, the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder

(a “Change of Control Notice”). At any time during the period beginning after a Holder’s receipt of a Change

of Control Notice or such Holder becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder

in accordance with the immediately preceding sentence (as applicable) and ending on the later of (A) the date of consummation of such

Change of Control or (B) twenty (20) Trading Days after the date of receipt of such Change of Control Notice or (C) twenty (20) Trading

Days after the date of the announcement of such Change of Control, such Holder may require the Company to redeem all or any portion of

such Holder’s Preferred Shares by delivering written notice thereof (“Change of Control Redemption Notice”)

to the Company, which Change of Control Redemption Notice shall indicate the number of Preferred Shares such Holder is electing to have

the Company redeem. Each Preferred Share subject to redemption pursuant to this Section 6(b) shall be redeemed by the Company

in funds legally available therefor at a price equal to the greatest of (i) the product of (x) the Change of Control Redemption Premium

multiplied by (y) the Conversion Amount of the Preferred Shares being redeemed, (ii) the product of (x) the Change of Control Redemption

Premium multiplied by (y) the product of (A) the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the quotient

determined by dividing (I) the greatest Closing Sale Price of the shares of Common Stock during the period beginning on the date immediately

preceding the earlier to occur of (1) the consummation of the applicable Change of Control and (2) the public announcement of such Change

of Control and ending on the date such Holder delivers the Change of Control Redemption Notice by (II) the Conversion Price then in effect

and (iii) the product of (y) the Change of Control Redemption Premium multiplied by (z) the product of (A) the Conversion Amount of the

Preferred Shares being redeemed multiplied by (B) the quotient of (I) the aggregate cash consideration and the aggregate cash value of

any non-cash consideration per share of Common Stock to be paid to such holders of the shares of Common Stock upon consummation of such

Change of Control (any such non-cash consideration constituting publicly-traded securities shall be valued at the highest of the Closing

Sale Price of such securities as of the Trading Day immediately prior to the consummation of such Change of Control, the Closing Sale

Price of such securities on the Trading Day immediately following the public announcement of such proposed Change of Control and the

Closing Sale Price of such securities on the Trading Day immediately prior to the public announcement of such proposed Change of Control)

divided by (II) the Conversion Price then in effect (the “Change of Control Redemption Price”). Redemptions required

by this Section 6(b) shall have priority to payments to all other stockholders of the Company in connection with such Change of

Control. To the extent redemptions required by this Section 6(b) are deemed or determined by a court of competent jurisdiction

to be prepayments of the Preferred Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding

anything to the contrary in this Section 6(b), but subject to Section 4(d), until the applicable Change of Control Redemption

Price (together with any Late Charges thereon) is paid in full to the applicable Holder, the Preferred Shares submitted by such Holder

for redemption under this Section 6(b) may be converted, in whole or in part, by such Holder into Common Stock pursuant to Section

4 or in the event the Conversion Date is after the consummation of such Change of Control, stock or equity interests of the Successor

Entity substantially equivalent to the Company’s shares of Common Stock pursuant to Section 4. In the event of the Company’s

redemption of any of the Preferred Shares under this Section 6(b), such Holder’s damages would be uncertain and difficult

to estimate because of the parties’ inability to predict future interest rates and the uncertainty of the availability of a suitable

substitute investment opportunity for a Holder. Accordingly, any redemption premium due under this Section 6(b) is intended by

the parties to be, and shall be deemed, a reasonable estimate of such Holder’s actual loss of its investment opportunity and not

as a penalty. The Company shall make payment of the applicable Change of Control Redemption Price concurrently with the consummation

of such Change of Control if a Change of Control Redemption Notice is received prior to the consummation of such Change of Control and

within two (2) Trading Days after the Company’s receipt of such notice otherwise (the “Change of Control Redemption Date”).

Redemptions required by this Section 6 shall be made in accordance with the provisions of Section 12.

7.

Rights Upon Issuance of Purchase Rights and Other Corporate Events.

(a)

Purchase Rights. In addition to any adjustments pursuant to Section 8 below, if at any time the Company grants, issues

or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially

all of the record holders of any class of Common Stock (the “Purchase Rights”), then each Holder will be entitled

to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if

such Holder had held the number of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking

into account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the

Preferred Shares were converted at the Floor Price as of the applicable record date) held by such Holder immediately prior to the date

on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which

the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,

however, to the extent that such Holder’s right to participate in any such Purchase Right would result in such Holder and

the other Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase

Right to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a

result of such Purchase Right (and beneficial ownership) to such extent of any such excess) and such Purchase Right to such extent shall

be held in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be

extended by such number of days held in abeyance, if applicable) for the benefit of such Holder until such time or times, if ever, as

its right thereto would not result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or

times such Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any

subsequent Purchase Right held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar

provision, such term shall be extended by such number of days held in abeyance, if applicable)) to the same extent as if there had been

no such limitation).

(b)

Other Corporate Events. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any

Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect

to or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to

ensure that each Holder will thereafter have the right, at such Holder’s option, to receive upon a conversion of all the Preferred

Shares held by such Holder (i) in addition to the shares of Common Stock receivable upon such conversion, such securities or other assets

to which such Holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by

such Holder upon the consummation of such Corporate Event (without taking into account any limitations or restrictions on the convertibility

of the Preferred Shares set forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable

upon such conversion, such securities or other assets received by the holders of shares of Common Stock in connection with the consummation

of such Corporate Event in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder

initially been issued with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion

rate for such consideration commensurate with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form

and substance satisfactory to the Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive

Corporate Events and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares set forth

in this Certificate of Designations.

8.

Rights Upon Issuance of Other Securities.

(a)

Adjustment of Conversion Price upon Issuance of Common Stock. If and whenever on or after the Subscription Date the Company grants,

issues or sells (or enters into any agreement or publicly announces its intention to grant, issue or sell), or in accordance with this

Section 8(a) is deemed to have granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of

shares of Common Stock owned or held by or for the account of the Company, but excluding any Excluded Securities granted, issued or sold

or deemed to have been granted, issued or sold) for a consideration per share (the “New Issuance Price”) less than

a price equal to the Conversion Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or

sale (such Conversion Price then in effect is referred to herein as the “Applicable Price”) (the foregoing a “Dilutive

Issuance”), then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount

equal to the New Issuance Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion

Price and the New Issuance Price under this Section 8(a)), the following shall be applicable:

(i)

Issuance of Options. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell)

any Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such

Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise

pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and

to have been issued and sold by the Company at the time of the granting, issuance or sale of such Option for such price per share. For

purposes of this Section 8(a)(i), the “lowest price per share for which one share of Common Stock is at any time issuable

upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of

any such Option or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the lowest amounts

of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the granting, issuance

or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon

exercise of such Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which

one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any such

Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise

pursuant to the terms thereof, minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) with

respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion,

exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus

the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other Person).

Except as contemplated below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such share of Common

Stock or of such Convertible Securities upon the exercise of such Options or otherwise pursuant to the terms thereof or upon the actual

issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.

(ii)

Issuance of Convertible Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell)

any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,

exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common

Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time

of execution of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes

of this Section 8(a)(ii), the “lowest price per share for which one share of Common Stock is at any time issuable upon the

conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the

sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon

the issuance or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion,

exercise or exchange of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set

forth in such Convertible Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market

conditions) upon conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts

paid or payable to the holder of such Convertible Security (or any other Person) with respect to any one share of Common Stock upon the

issuance or sale (or the agreement to issue or sell, as applicable) of such Convertible Security plus the value of any other consideration

received or receivable by, or benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated

below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion,

exercise or exchange of such Convertible Securities or otherwise pursuant to the terms thereof, and if any such issuance or sale of such

Convertible Securities is made upon exercise of any Options for which adjustment of the Conversion Price has been or is to be made pursuant

to other provisions of this Section 8(a), except as contemplated below, no further adjustment of the Conversion Price shall be

made by reason of such issuance or sale.

(iii)

Change in Option Price or Rate of Conversion. If the purchase or exercise price provided for in any Options, the additional consideration,

if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible

Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than

proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(b)

below), the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would

have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price,

additional consideration or increased or decreased conversion rate (as the case may be) at the time initially granted, issued or sold.

For purposes of this Section 8(a)(iii), if the terms of any Option or Convertible Security (including, without limitation, any

Option or Convertible Security that was outstanding as of the Subscription Date) are increased or decreased in the manner described in

the immediately preceding sentence, then such Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise,

conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant

to this Section 8(a) shall be made if such adjustment would result in an increase of the Conversion Price then in effect.

(iv)

Calculation of Consideration Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection

with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Required Holders, the

“Primary Security”, and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities”

and together with the Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate

consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price

of such Unit, (y) if such Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of

Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section 8(a)(i)

or 8(a)(ii) above and (z) the lowest VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period

(the “Adjustment Period”) immediately following the public announcement of such Dilutive Issuance (for the avoidance

of doubt, if such public announcement is released prior to the opening of the Principal Market on a Trading Day, such Trading Day shall

be the first Trading Day in such five (5) Trading Day period and if any Preferred Shares are converted, on any given Conversion Date

during any such Adjustment Period, solely with respect to such Preferred Shares converted on such applicable Conversion Date, such applicable

Adjustment Period shall be deemed to have ended on, and included, the Trading Day immediately prior to such Conversion Date). If any

shares of Common Stock, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration

received therefor will be deemed to be the net amount of consideration received by the Company therefor. If any shares of Common Stock,

Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received by

the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in

which case the amount of consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such

security for each of the five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible

Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity,

the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving

entity as is attributable to such shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any

consideration other than cash or publicly traded securities will be determined jointly by the Company and the Required Holders. If such

parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “Valuation

Event”), the fair value of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following

such Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination

of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall

be borne by the Company.

(v)

Record Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive

a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase

shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale

of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution

or the date of the granting of such right of subscription or purchase (as the case may be).

(b)

Adjustment of Conversion Price upon Subdivision or Combination of Common Stock. Without limiting any provision of Sections

7, 17 or 8(a), if the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend,

stock combination, recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock into

a greater number of shares, the Conversion Price in effect immediately prior to such subdivision will be proportionately reduced. Without

limiting any provision of Sections 7, 17 or 8(a), if the Company at any time on or after the Subscription Date combines

(by any stock split, stock dividend, stock combination, recapitalization or other similar transaction) one or more classes of its outstanding

shares of Common Stock into a smaller number of shares, the Conversion Price in effect immediately prior to such combination will be

proportionately increased. Any adjustment pursuant to this Section 8(b) shall become effective immediately after the effective

date of such subdivision or combination. If any event requiring an adjustment under this Section 8(b) occurs during the period

that a Conversion Price is calculated hereunder, then the calculation of such Conversion Price shall be adjusted appropriately to reflect

such event.

(c)

Holder’s Right of Adjusted Conversion Price. In addition to and not in limitation of the other provisions of this Section

8(b), if the Company in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible

Securities (any such securities, “Variable Price Securities”) after the Subscription Date that are issuable pursuant

to such agreement or convertible into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with

the market price of the shares of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations

reflecting customary anti-dilution provisions (such as share splits, share combinations, share dividends and similar transactions) (each

of the formulations for such variable price being herein referred to as, the “Variable Price”), the Company shall

provide written notice thereof via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance

of such shares of Common Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into such

agreement or issues any such Variable Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion

to substitute the Variable Price for the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice

delivered upon any conversion of Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable

Price rather than the Conversion Price then in effect. A Holder’s election to rely on a Variable Price for a particular conversion

of Preferred Shares shall not obligate such Holder to rely on a Variable Price for any future conversions of Preferred Shares.

(d)

Stock Combination Event Adjustments. If at any time and from time to time on or after the Subscription Date there occurs any stock

split, stock dividend, stock combination, recapitalization or other similar transaction involving the Common Stock (each, a “Stock

Combination Event”, and such date thereof, the “Stock Combination Event Date”) and the Event Market Price

is less than the Conversion Price then in effect (after giving effect to the adjustment in Section 8(b) above), then on the fifth

(5th) Trading Day immediately following such Stock Combination Event Date, the Conversion Price then in effect on such fifth (5th) Trading

Day following the Stock Combination Event (after giving effect to the adjustment in Section 8(b) above) shall be reduced (but

in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding  sentence

would otherwise result in an increase in the Conversion Price hereunder, no adjustment shall be made.

(e)

Other Events. In the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly

applicable, or, if applicable, would not operate to protect any Holder from dilution (other than with respect to Excluded Securities)

or if any event occurs of the type contemplated by the provisions of this Section 8 but not expressly provided for by such provisions

(including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features),

then the Board shall in good faith determine and implement an appropriate adjustment in the Conversion Price so as to protect the rights

of such Holder, provided that no such adjustment pursuant to this Section 8(e) will increase the Conversion Price as otherwise

determined pursuant to this Section 8, provided further that if such Holder does not accept such adjustments as appropriately

protecting its interests hereunder against such dilution, then the Board and such Holder shall agree, in good faith, upon an independent

investment bank of nationally recognized standing to make such appropriate adjustments, whose determination shall be final and binding

absent manifest error and whose fees and expenses shall be borne by the Company.

(f)

Calculations. All calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100th

of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held

by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.

(g)

Voluntary Adjustment by Company. Subject to the rules and regulations of the Principal Market, the Company may at any time any

Preferred Shares remain outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price

to any amount and for any period of time deemed appropriate by the Board.

9.

Reserved.

10.

Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation,

Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger, scheme

of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance

of any of the terms of this Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate

of Designations and take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality

of the foregoing or any other provision of this Certificate of Designations or the other Transaction Documents, the Company (a) shall

not increase the par value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion

Price then in effect, (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally

issue fully paid and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c) shall, so long as any Preferred

Shares are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock,

solely for the purpose of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock as shall from

time to time be necessary to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations on conversion

contained herein). Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Initial Issuance

Date, each Holder is not permitted to convert such Holder’s Preferred Shares in full for any reason (other than pursuant to restrictions

set forth in Section 4(d)(i) hereof), the Company shall use its best efforts to promptly remedy such failure, including, without

limitation, obtaining such consents or approvals as necessary to effect such conversion into shares of Common Stock.

11.

Authorized Shares.

(a)

Reservation. So long as any Preferred Shares remain outstanding, the Company shall at all times reserve out of its authorized

and unissued shares of Common Stock a number of shares of Common Stock equal to at least 200% of the aggregate number of shares of Common

Stock as shall from time to time be necessary to effect the conversion, including without limitation, of all of the Preferred Shares

then outstanding at the Floor Price then in effect (without regard to any limitations on conversions, and, for the avoidance of doubt,

shall not include Dividends with respect to such Preferred Shares or any accrued and unpaid Late Charges thereon, and assuming the Preferred

Shares remain outstanding until the Maturity Date) (the “Required Reserve Amount”). The Required Reserve Amount (including,

without limitation, each increase in the number of shares so reserved) shall be allocated pro rata among the Holders based on the number

of the Preferred Shares held by each Holder on the Initial Issuance Date or increase in the number of reserved shares, as the case may

be (the “Authorized Share Allocation”). In the event that a Holder shall sell or otherwise transfer any of such Holder’s

Preferred Shares, each transferee shall be allocated a pro rata portion of such Holder’s Authorized Share Allocation. Any shares

of Common Stock reserved and allocated to any Person which ceases to hold any Preferred Shares shall be allocated to the remaining Holders

of Preferred Shares, pro rata based on the number of the Preferred Shares then held by the Holders.

(b)

Insufficient Authorized Shares. If, notwithstanding Section 11(a) and not in limitation thereof, at any time while any

of the Preferred Shares remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common

Stock to satisfy its obligation to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common

Stock equal to the Required Reserve Amount (an “Authorized Share Failure”), then the Company shall immediately take

all action necessary to increase the Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to

reserve the Required Reserve Amount for the Preferred Shares then outstanding (or deemed outstanding pursuant to Section 11(a)

above). Without limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized

Share Failure, but in no event later than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold

a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection with

such meeting, the Company shall provide each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders’

approval of such increase in authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that

they approve such proposal (or, if a majority of the voting power then in effect of the capital stock of the Company consents to such

increase, in lieu of such proxy statement, deliver to the stockholders of the Company an information statement that has been filed with

(and either approved by or not subject to comments from) the SEC with respect thereto). In the event that the Company is prohibited from

issuing shares of Common Stock to a Holder upon any conversion due to the failure by the Company to have sufficient shares of Common

Stock available out of the authorized but unissued shares of Common Stock (such unavailable number of shares of Common Stock, the “Authorized

Failure Shares”), in lieu of delivering such Authorized Failure Shares to such Holder, the Company shall pay legally available

funds in exchange for the redemption of such portion of the Conversion Amount of the Preferred Shares convertible into such Authorized

Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorized Failure Shares and (y) the greatest Closing

Sale Price of the Common Stock on any Trading Day during the period commencing on the date such Holder delivers the applicable Conversion

Notice with respect to such Authorized Failure Shares to the Company and ending on the date of such issuance and payment under this Section

11(b); and (ii) to the extent such Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver

in satisfaction of a sale by such Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket expenses, if

any, of such Holder incurred in connection therewith. Nothing contained in Section 11(a) or this Section 11(b) shall limit

any obligations of the Company under any provision of the Securities Purchase Agreement.

12.

Redemptions.

(a)

General. If a Holder has submitted a Triggering Event Redemption Notice in accordance with Section 5(b), the Company shall

deliver the applicable Triggering Event Redemption Price to such Holder in legally available funds within five (5) Business Days after

the Company’s receipt of such Holder’s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control

Redemption Notice in accordance with Section 6(b), the Company shall deliver the applicable Change of Control Redemption Price

to such Holder in legally available funds concurrently with the consummation of such Change of Control if such notice is received prior

to the consummation of such Change of Control and within five (5) Business Days after the Company’s receipt of such notice otherwise.

Notwithstanding anything herein to the contrary, in connection with any redemption hereunder at a time a Holder is entitled to receive

a cash payment under any of the other Transaction Documents, at the option of such Holder delivered in writing to the Company, the applicable

Redemption Price hereunder shall be increased by the amount of such cash payment owed to such Holder under such other Transaction Document

and, upon payment in full or conversion in accordance herewith, shall satisfy the Company’s payment obligation under such other

Transaction Document. In the event of a redemption of less than all of the Preferred Shares, the Company shall promptly cause to be issued

and delivered to such Holder a new Preferred Share Certificate (in accordance with Section 20) (or evidence of the creation of

a new Book-Entry) representing the number of Preferred Shares which have not been redeemed. In the event that the Company does not pay

the applicable Redemption Price to a Holder within the time period required for any reason (including, without limitation, to the extent

such payment is prohibited pursuant to the DGCL), at any time thereafter and until the Company pays such unpaid Redemption Price in full,

such Holder shall have the option, in lieu of redemption, to require the Company to promptly return to such Holder all or any of the

Preferred Shares that were submitted for redemption and for which the applicable Redemption Price (together with any Late Charges thereon)

has not been paid. Upon the Company’s receipt of such notice, (x) the applicable Redemption Notice shall be null and void with

respect to such Preferred Shares, (y) the Company shall immediately return the applicable Preferred Share Certificate, or issue a new

Preferred Share Certificate (in accordance with Section 20(d)), to such Holder (unless the Preferred Shares are held in Book-Entry

form, in which case the Company shall deliver evidence to such Holder that a Book-Entry for such Preferred Shares then exists), and in

each case the Additional Amount of such Preferred Shares shall be increased by an amount equal to the difference between (1) the applicable

Redemption Price (as the case may be, and as adjusted pursuant to this Section 12, if applicable) minus (2) the Stated

Value portion of the Conversion Amount submitted for redemption and (z) the Conversion Price of such Preferred Shares shall be automatically

adjusted with respect to each conversion effected thereafter by such Holder to the lowest of (A) the Conversion Price as in effect on

the date on which the applicable Redemption Notice is voided, (B) the greater of (x) the Floor Price and (y) 75% of the lowest Closing

Bid Price of the Common Stock during the period beginning on and including the date on which the applicable Redemption Notice is delivered

to the Company and ending on and including the date on which the applicable Redemption Notice is voided and (C) the greater of (x) the

Floor Price and (y) 75% of the quotient of (I) the sum of the five (5) lowest VWAPs of the Common Stock during the twenty (20) consecutive

Trading Day period ending and including the Trading Day immediately preceding the applicable Conversion Date divided by (II) five (5)

(it being understood and agreed that all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock

combination or other similar transaction during such period). A Holder’s delivery of a notice voiding a Redemption Notice and exercise

of its rights following such notice shall not affect the Company’s obligations to make any payments of Late Charges which have

accrued prior to the date of such notice with respect to the Preferred Shares subject to such notice.

(b)

Redemption by Multiple Holders. Upon the Company’s receipt of a Redemption Notice from any Holder for redemption or repayment

as a result of an event or occurrence substantially similar to the events or occurrences described in Section 5(b) or Section

6(b), the Company shall immediately, but no later than one (1) Business Day of its receipt thereof, forward to each other Holder

by electronic mail a copy of such notice. If the Company receives one or more Redemption Notices, during the seven (7) Business Day period

beginning on and including the date which is two (2) Business Days prior to the Company’s receipt of the initial Redemption Notice

and ending on and including the date which is two (2) Business Days after the Company’s receipt of the initial Redemption Notice

and the Company is unable to redeem all of the Conversion Amount of such Preferred Shares designated in such initial Redemption Notice

and such other Redemption Notices received during such seven (7) Business Day period, then the Company shall redeem a pro rata amount

from each Holder based on the Stated Value of the Preferred Shares submitted for redemption pursuant to such Redemption Notices received

by the Company during such seven (7) Business Day period.

13.

[Reserved].

14.

Voting Rights. Except as otherwise provided herein or as required by applicable law and subject to the provisions of Section

4(d) hereof, Holders of Preferred Shares shall be entitled to vote with the holders of Common Stock on all matters that such holders

of Common Stock are entitled to vote upon, in the same manner and with the same effect as the holders of Common Stock, voting together

with the holders of Common Stock as a single class. Subject to the provisions of Section 4(d) hereof, each Preferred Share shall

entitle the Holder thereof to cast that number of votes per Preferred Share as is equal to the Stated Value of such Preferred Share divided

by the then applicable Conversion Price; provided, however that in no event shall the then applicable Conversion Price

for purposes of this Section 14 be less than the “Minimum Price” (as defined in Nasdaq Listing Rule 5635(d))

on the date immediately preceding the Subscription Date (or $7.628 per share, as of the date of the Effective Date, and subject to adjustments

for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the Effective Date).

For purposes of clarity, this Nasdaq Minimum Price shall apply only for purposes of this Section 14 of the Certificate of Designations

and not apply to any other section of the Certificate of Designations or any Transaction Document. Notwithstanding the foregoing, to

the extent that under the DGCL the vote of the holders of the Preferred Shares, voting separately as a class or series, as applicable,

is required to authorize a given action of the Company, the affirmative vote or consent of the Required Holders of the shares of the

Preferred Shares, voting together in the aggregate and not in separate series unless required under the DGCL, represented at a duly held

meeting at which a quorum is present or by written consent of the Required Holders (except as otherwise may be required under the DGCL),

voting together in the aggregate and not in separate series unless required under the DGCL, shall constitute the approval of such action

by both the class or the series, as applicable. For the avoidance of doubt, for purposes of determining the presence of a quorum at any

meeting of the stockholders of the Company at which the Preferred Shares are entitled to vote, the number of Preferred Shares and votes

represented by such shares shall be counted on an as converted to Common Stock basis, subject to any limitations on conversion set forth

herein. Holders of the Preferred Shares shall be entitled to written notice of all stockholder meetings or written consents (and copies

of proxy materials and other information sent to stockholders) with respect to which they would be entitled to vote, which notice would

be provided pursuant to the Company’s bylaws and the DGCL.

15.

Covenants. For so long as any Preferred Shares are outstanding, without the prior written consent of the Required Holders:

(a)

Incurrence of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,

incur or guarantee, assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).

(b)

Existence of Liens. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,

allow or suffer to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets

(including accounts and contract rights) owned by the Company or any of its Subsidiaries (collectively, “Liens”) other

than Permitted Liens.

(c)

Restricted Payments and Investments. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly

or indirectly, redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in

whole or in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any

Indebtedness (other pursuant to this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if

any) or interest on, such Indebtedness or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness

and/or Investment, as applicable, is due or is otherwise made or, after giving effect to such payment, (i) an event constituting a Triggering

Event has occurred and is continuing or (ii) an event that with the passage of time and without being cured would constitute a Triggering

Event has occurred and is continuing.

(d)

Restriction on Redemption and Cash Dividends. The Company shall not, and the Company shall cause each of its Subsidiaries to not,

directly or indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than

as required by this Certificate of Designations, the Series A Certificate of Designations, the Series H-7 Certificate of Designations,

the Series J Certificate of Designations or the certificate of designations for the Series K Convertible Preferred Stock, par value $0.0001

per share (“Series K Preferred Stock”), of the Company).

(e)

Restriction on Transfer of Assets. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly

or indirectly, sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights

of the Company or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions, other

than (i) sales, leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Company

and its Subsidiaries in the ordinary course of business consistent with its past practice, or (ii) sales of inventory and product in

the ordinary course of business.

(f)

Maturity of Indebtedness. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,

permit any Indebtedness of the Company or any of its Subsidiaries to mature or accelerate prior to the Maturity Date.

(g)

Change in Nature of Business. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or

indirectly, engage in any material line of business substantially different from those lines of business conducted by or publicly contemplated

to be conducted by the Company and/or its Subsidiaries on the Subscription Date or any business reasonably related or incidental thereto.

The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, modify its or their corporate

structure or purpose in any material respect.

(h)

Preservation of Existence, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve,

its existence, rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and

in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its

business makes such qualification necessary; provided, however, that the Company shall have the right to merge or combine

wholly-owned Subsidiaries hereunder, or eliminate or dissolve foreign Subsidiaries, in each case where such restructuring does not have

a material impact on the Company’s assets or ability to comply with the provisions hereof.

(i)

Maintenance of Properties, Etc. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve,

all of its properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary

wear and tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which

it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.

(j)

Maintenance of Intellectual Property. The Company will, and will cause each of its Subsidiaries to, take all action necessary

or advisable to maintain all of the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or

material to the conduct of its business in full force and effect.

(k)

Maintenance of Insurance. The Company shall use reasonable best efforts to maintain, and cause each of its Subsidiaries to maintain,

insurance with responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability,

hazard, rent and business interruption insurance) with respect to its properties (including all real properties leased or owned by it)

and business, in such amounts and covering such risks as are generally consistent with the coverage held by the Company on the Initial

Issuance Date.

(l)

Transactions with Affiliates. The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend

or be a party to, any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer

or exchange of property or assets of any kind or the rendering of services of any kind) with any affiliate, except transactions in the

ordinary course of business in a manner and to an extent, if applicable, consistent with past practice and necessary or desirable for

the prudent operation of its business, for fair consideration and on terms no less favorable to it or its Subsidiaries than would be

reasonably expected to be obtained in a comparable arm’s length transaction with a Person that is not an affiliate thereof.

(m)

Restricted Issuances. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders,

(i) issue any Preferred Shares (other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations)

or (ii) issue any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.

(n)

Stay, Extension and Usury Laws. To the extent that it may lawfully do so, the Company (A) agrees that it will not at any time

insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever

or whenever enacted or in force) that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly

waives all benefits or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the

execution of any power granted to the Holders by this Certificate of Designations, but will suffer and permit the execution of every

such power as though no such law has been enacted.

(o)

Taxes. The Company and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together

with any related interest or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective

assets or upon their ownership, possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom

(except where the failure to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries).

The Company and its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure

to file would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding

the foregoing, the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain

adequate reserves therefor in accordance with GAAP.

(p)

Cash Minimum. From the Closing Date until no shares of Preferred Shares are outstanding, the Company shall, at all times, maintain

unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 50% of the aggregate Stated Value of the Preferred

Shares then outstanding. Such cash shall be maintained in one or more domestic deposit accounts, money market accounts or certificates

of deposit (with a maturity of no more than three months) with one or more Eligible Banks. For purposes hereof, an “Eligible

Bank” is a U.S. chartered commercial bank with total assets in excess of $300 billion.

(q)

Independent Investigation. At the request of any Holder either (x) at any time when a Triggering Event has occurred and is continuing,

(y) upon the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering Event or (z) at any

time such Holder reasonably believes a Triggering Event may have occurred or be continuing, the Company shall hire an independent, reputable

investment bank selected by the Company and approved by such Holder to investigate as to whether any breach of the Certificate of Designations

has occurred (the “Independent Investigator”). If the Independent Investigator determines that such breach of the

Certificate of Designations has occurred, the Independent Investigator shall notify the Company of such breach and the Company shall

deliver written notice to each Holder of such breach. In connection with such investigation, the Independent Investigator may, during

normal business hours, inspect all contracts, books, records, personnel, offices and other facilities and properties of the Company and

its Subsidiaries and, to the extent available to the Company after the Company uses reasonable efforts to obtain them, the records of

its legal advisors and accountants (including the accountants’ work papers) and any books of account, records, reports and other

papers not contractually required of the Company to be confidential or secret, or subject to attorney-client or other evidentiary privilege,

and the Independent Investigator may make such copies and inspections thereof as the Independent Investigator may reasonably request.

The Company shall furnish the Independent Investigator with such financial and operating data and other information with respect to the

business and properties of the Company as the Independent Investigator may reasonably request. The Company shall permit the Independent

Investigator to discuss the affairs, finances and accounts of the Company with, and to make proposals and furnish advice with respect

thereto to, the Company’s officers, directors, key employees and independent public accountants or any of them (and by this provision

the Company authorizes said accountants to discuss with such Independent Investigator the finances and affairs of the Company and any

Subsidiaries), all at such reasonable times, upon reasonable notice, and as often as may be reasonably requested.

16.

Liquidation, Dissolution, Winding-Up. In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out

of the assets of the Company, whether from capital or from earnings available for distribution to its stockholders (the “Liquidation

Funds”), before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock

then outstanding, an amount per Preferred Share equal to the greater of (A) 125% of the Conversion Amount of such Preferred Share on

the date of such payment and (B) the amount per share such Holder would receive if such Holder converted such Preferred Share into Common

Stock immediately prior to the date of such payment, provided that if the Liquidation Funds are insufficient to pay the full amount

due to the Holders and holders of shares of Parity Stock, then each Holder and each holder of Parity Stock shall receive a percentage

of the Liquidation Funds equal to the full amount of Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation

preference, in accordance with their respective certificate of designations (or equivalent), as a percentage of the full amount of Liquidation

Funds payable to all holders of Preferred Shares and all holders of shares of Parity Stock. To the extent necessary, the Company shall

cause such actions to be taken by each of its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a

Liquidation Event to be distributed to the Holders in accordance with this Section 16. All the preferential amounts to be paid

to the Holders under this Section 16 shall be paid or set apart for payment before the payment or setting apart for payment of

any amount for, or the distribution of any Liquidation Funds of the Company to the holders of shares of Junior Stock in connection with

a Liquidation Event as to which this Section 16 applies.

17.

Distribution of Assets. In addition to any adjustments pursuant to Section 7(a) and Section 8, if the Company shall

declare or make any dividend or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of

Common Stock, by way of return of capital or otherwise (including without limitation, any distribution of cash, stock or other securities,

property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar

transaction) (the “Distributions”), then each Holder, as holders of Preferred Shares, will be entitled to such Distributions

as if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of the Preferred Shares (without

taking into account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that

the Preferred Share was converted at the Floor Price as of the applicable record date)immediately prior to the date on which a record

is taken for such Distribution or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined

for such Distributions (provided, however, that to the extent that such Holder’s right to participate in any such

Distribution would result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, then such Holder shall not

be entitled to participate in such Distribution to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership

of such shares of Common Stock as a result of such Distribution (and beneficial ownership) to such extent of any such excess) and the

portion of such Distribution shall be held in abeyance for the benefit of such Holder until such time or times as its right thereto would

not result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times, if any, such Holder

shall be granted such Distribution (and any Distributions declared or made on such initial Distribution or on any subsequent Distribution

held similarly in abeyance) to the same extent as if there had been no such limitation).

18.

Vote to Change the Terms of or Issue Preferred Shares. In addition to any other rights provided by law, except where the vote

or written consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of Incorporation,

without first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the

Required Holders, voting together as a single class, the Company shall not (in any case, whether by amendment, modification, recapitalization,

merger, consolidation or otherwise): (a) amend or repeal any provision of, or add any provision to, its Certificate of Incorporation

or bylaws, or file any certificate of designations or articles of amendment of any series of shares of preferred stock, if such action

would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit

of the Preferred Shares hereunder, regardless of whether any such action shall be by means of amendment to the Certificate of Incorporation

or by merger, consolidation or otherwise; provided that the affirmative vote of the Required Holders shall not be required for

changes to the Series A Preferred Stock, Series H-7 Preferred Stock, Series J Preferred Stock or Series K Preferred Stock; (b) increase

or decrease (other than by conversion) the authorized number of Preferred Shares; (c) without limiting any provision of Section 2,

create or authorize (by reclassification or otherwise) any new class or series of Senior Preferred Stock or Parity Stock, other than

the Series J Preferred Stock and Series K Preferred Stock; (d) purchase, repurchase or redeem any shares of Junior Stock (other than

pursuant to the terms of the Company’s equity incentive plans and options and other equity awards granted under such plans (that

have in good faith been approved by the Board)); (e) without limiting any provision of Section 2, pay dividends or make any other

distribution on any shares of any Junior Stock, other than the Series A Junior Participating Preferred Stock, par value $0.0001 per share

(the “Series A Preferred Stock”), of the Company; (f) issue any Preferred Shares other than as contemplated hereby

or pursuant to the Securities Purchase Agreement; or (g) without limiting any provision of Section 10, whether or not prohibited

by the terms of the Preferred Shares, circumvent a right of the Preferred Shares hereunder.

19.

Transfer of Preferred Shares. A Holder may transfer some or all of its Preferred Shares without the consent of the Company, but

any such transfer shall be in compliance with all applicable securities laws.

20.

Reissuance of Preferred Share Certificates and Book Entries.

(a)

Transfer. If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share

Certificate to the Company (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon

the Company will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section

20(d)) (or evidence of the transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number

of Preferred Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred,

a new Preferred Share Certificate (in accordance with Section 20(d)) to such Holder representing the outstanding number of Preferred

Shares not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee,

by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason

of the provisions of Section 4(c)(i) following conversion or redemption of any of the Preferred Shares, the outstanding number

of Preferred Shares represented by the Preferred Shares may be less than the number of Preferred Shares stated on the face of the Preferred

Shares.

(b)

Lost, Stolen or Mutilated Preferred Share Certificate. Upon receipt by the Company of evidence reasonably satisfactory to the

Company of the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification

contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking

by the applicable Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation

of such Preferred Share Certificate, the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance

with Section 20(d)) representing the applicable outstanding number of Preferred Shares.

(c)

Preferred Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms. Each Preferred Share Certificate

is exchangeable, upon the surrender hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share

Certificate or Preferred Share Certificate(s) or new Book-Entry (in accordance with Section 20(d)) representing, in the aggregate,

the outstanding number of the Preferred Shares in the original Preferred Share Certificate, and each such new Preferred Share Certificate

and/or new Book-Entry, as applicable, will represent such portion of such outstanding number of Preferred Shares from the original Preferred

Share Certificate as is designated in writing by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one

or more new Preferred Share Certificates or split by the applicable Holder by delivery of a written notice to the Company into two or

more new Book-Entries (in accordance with Section 20(d)) representing, in the aggregate, the outstanding number of the Preferred

Shares in the original Book-Entry, and each such new Book-Entry and/or new Preferred Share Certificate, as applicable, will represent

such portion of such outstanding number of Preferred Shares from the original Book-Entry as is designated in writing by such Holder at

the time of such surrender.

(d)

Issuance of New Preferred Share Certificate or Book-Entry. Whenever the Company is required to issue a new Preferred Share Certificate

or a new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry

(i) shall represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of

Preferred Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to

Section 20(a) or Section 20(c), the number of Preferred Shares designated by such Holder) which, when added to the number

of Preferred Shares represented by the other new Preferred Share Certificates or other new Book-Entry, as applicable, issued in connection

with such issuance, does not exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate

or original Book-Entry, as applicable, immediately prior to such issuance of new Preferred Share Certificate or new Book-Entry, as applicable,

and (ii) shall have an issuance date, as indicated on the face of such new Preferred Share Certificate or in such new Book-Entry, as

applicable, which is the same as the issuance date of the original Preferred Share Certificate or in such original Book-Entry, as applicable.

21.

Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Certificate of Designations

shall be cumulative and in addition to all other remedies available under this Certificate of Designations and any of the other Transaction

Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall

limit any Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of

this Certificate of Designations. No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy

hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude

any other or further exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or

remedy of a Holder at law or equity or under this Certificate of Designations or any of the documents shall not be deemed to be an election

of such Holder’s rights or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall

be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with

respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall

not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). No failure

on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof;

nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other or further exercise thereof

or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy of any Holder at law or equity

or under Preferred Shares or any of the documents shall not be deemed to be an election of such Holder’s rights or remedies under

such documents or at law or equity. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable

harm to the Holders and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event

of any such breach or threatened breach, each Holder shall be entitled, in addition to all other available remedies, to specific performance

and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such

case without the necessity of proving actual damages and without posting a bond or other security. The Company shall provide all information

and documentation to a Holder that is requested by such Holder to enable such Holder to confirm the Company’s compliance with the

terms and conditions of this Certificate of Designations.

22.

Payment of Collection, Enforcement and Other Costs. If (a) any Preferred Shares are placed in the hands of an attorney for collection

or enforcement or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under

this Certificate of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations

or (b) there occurs any bankruptcy, reorganization, receivership of the Company or other proceedings affecting Company creditors’

rights and involving a claim under this Certificate of Designations, then the Company shall pay the costs incurred by such Holder for

such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including,

without limitation, attorneys’ fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under

this Certificate of Designations with respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price

paid for each Preferred Share was less than the original Stated Value thereof.

23.

Construction; Headings. This Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders

and shall not be construed against any such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience

of reference and shall not form part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly

indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof.

The terms “including,” “includes,” “include” and words of like import shall

be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”

“hereof” and words of like import refer to this entire Certificate of Designations instead of just the provision in

which they are found. Unless expressly indicated otherwise, all section references are to sections of this Certificate of Designations.

Terms used in this Certificate of Designations and not otherwise defined herein, but defined in the other Transaction Documents, shall

have the meanings ascribed to such terms on the Initial Issuance Date in such other Transaction Documents unless otherwise consented

to in writing by the Required Holders.

24.

Failure or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege

hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude

other or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and

signed by an authorized representative of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by

the Company and all Holders and shall not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing

contained in this Section 24 shall permit any waiver of any provision of Section 4(d).

25.

Dispute Resolution.

(a)

Submission to Dispute Resolution.

(i)

In the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a

VWAP or a fair market value or the arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be)

(including, without limitation, a dispute relating to the determination of any of the foregoing), the Company or the applicable Holder

(as the case may be) shall submit the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days

after the occurrence of the circumstances giving rise to such dispute or (B) if by such Holder at any time after such Holder learned

of the circumstances giving rise to such dispute. If such Holder and the Company are unable to promptly resolve such dispute relating

to such Closing Bid Price, such Closing Sale Price, such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market

value, or the arithmetic calculation of such Conversion Rate or such applicable Redemption Price (as the case may be), at any time after

the second (2nd) Business Day following such initial notice by the Company or such Holder (as the case may be) of such dispute to the

Company or such Holder (as the case may be), then such Holder may, at its sole option, select an independent, reputable investment bank

to resolve such dispute.

(ii)

Such Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance

with the first sentence of this Section 25 and (B) written documentation supporting its position with respect to such dispute,

in each case, no later than 5:00 p.m. (New York time) by the fifth (5th) Business Day immediately following the date on which such Holder

selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in the immediately preceding

clauses (A) and (B) are collectively referred to herein as the “Required Dispute Documentation”) (it being understood

and agreed that if either such Holder or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute Submission

Deadline, then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and hereby

waives its right to) deliver or submit any written documentation or other support to such investment bank with respect to such dispute

and such investment bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered to such investment

bank prior to the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and such Holder or otherwise

requested by such investment bank, neither the Company nor such Holder shall be entitled to deliver or submit any written documentation

or other support to such investment bank in connection with such dispute (other than the Required Dispute Documentation).

(iii)

The Company and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and such

Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses

of such investment bank shall be borne solely by the Company, and such investment bank’s resolution of such dispute shall be final

and binding upon all parties absent manifest error.

(b)

Miscellaneous. The Company expressly acknowledges and agrees that (i) this Section 25 constitutes an agreement to arbitrate

between the Company and each Holder (and constitutes an arbitration agreement) under § 7501, et seq. of the New York Civil Practice

Law and Rules (“CPLR”) and that any Holder is authorized to apply for an order to compel arbitration pursuant to CPLR

§ 7503(a) in order to compel compliance with this Section 25, (ii) a dispute relating to a Conversion Price includes, without

limitation, disputes as to (A) whether an issuance or sale or deemed issuance or sale of Common Stock occurred under Section 8(a),

(B) the consideration per share at which an issuance or deemed issuance of Common Stock occurred, (C) whether any issuance or sale or

deemed issuance or sale of Common Stock was an issuance or sale or deemed issuance or sale of Excluded Securities, (D) whether an agreement,

instrument, security or the like constitutes an Option or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the

terms of this Certificate of Designations and each other applicable Transaction Document shall serve as the basis for the selected investment

bank’s resolution of the applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make

all findings, determinations and the like that such investment bank determines are required to be made by such investment bank in connection

with its resolution of such dispute and in resolving such dispute such investment bank shall apply such findings, determinations and

the like to the terms of this Certificate of Designations and any other applicable Transaction Documents, (iv) the applicable Holder

(and only such Holder with respect to disputes solely relating to such Holder), in its sole discretion, shall have the right to submit

any dispute described in this Section 25 to any state or federal court sitting in The City of New York, Borough of Manhattan,

New York, in lieu of utilizing the procedures set forth in this Section 25 and (v) nothing in this Section 25 shall limit

such Holder from obtaining any injunctive relief or other equitable remedies (including, without limitation, with respect to any matters

described in this Section 25).

26.

Notices; Currency; Payments.

(a)

Notices. The Company shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to

the terms of this Certificate of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever

notice is required to be given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing

and shall be given in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall provide each Holder

with prompt written notice of all actions taken pursuant to this Certificate of Designations, including in reasonable detail a description

of such action and the reason therefore. Without limiting the generality of the foregoing, the Company shall give written notice to each

Holder (i) immediately upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation

of such adjustment and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A)

with respect to any dividend or distribution upon the Common Stock, (B) with respect to any grant, issuances, or sales of any Options,

Convertible Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C)

for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such

information shall be made known to the public prior to or in conjunction with such notice being provided to such Holder.

(b)

Currency. All dollar amounts referred to in this Certificate of Designations are in United States Dollars (“U.S. Dollars”),

and all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies

(if any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange

Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,

the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed

that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such

period of time).

(c)

Payments. Whenever any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations,

unless otherwise expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer

of immediately available funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to

time. Whenever any amount expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business

Day, the same shall instead be due on the next succeeding day which is a Business Day. Any amount due under the Transaction Documents

which is not paid when due (except to the extent such amount is simultaneously accruing Dividends at the Default Rate hereunder) shall

result in a late charge being incurred and payable by the Company in an amount equal to interest on such amount at the rate of fifteen

percent (15%) per annum from the date such amount was due until the same is paid in full (“Late Charge”).

27.

Waiver of Notice. To the extent permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and

all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate of

Designations and the Securities Purchase Agreement.

28.

Governing Law. This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning

the construction, validity, interpretation and performance of this Certificate of Designations shall be governed by, the internal laws

of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware

or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. Except

as otherwise required by Section 25 above, the Company hereby irrevocably submits to the exclusive jurisdiction of the state and

federal courts sitting in The City of New York, Borough of Manhattan, New York, for the adjudication of any dispute hereunder or in connection

herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in

any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action

or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained

herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall

be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein (i) shall be deemed

or operate to preclude any Holder from bringing suit or taking other legal action against the Company in any other jurisdiction to collect

on the Company’s obligations to such Holder, to realize on any collateral or any other security for such obligations, or to enforce

a judgment or other court ruling in favor of such Holder or (ii) shall limit, or shall be deemed or construed to limit, any provision

of Section 25 above. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR

THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION

CONTEMPLATED HEREBY.

29.

Judgment Currency.

(a)

If for the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert

into any other currency (such other currency being hereinafter in this Section 29 referred to as the “Judgment Currency”)

an amount due in U.S. dollars under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on

the Trading Day immediately preceding:

(i)

the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction

that will give effect to such conversion being made on such date: or

(ii)

the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of

which such conversion is made pursuant to this Section 29(a)(ii) being hereinafter referred to as the “Judgment Conversion

Date”).

(b)

If in the case of any proceeding in the court of any jurisdiction referred to in Section 29(a)(ii) above, there is a change in

the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party

shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange

Rate prevailing on the date of payment, will produce the amount of US dollars which could have been purchased with the amount of Judgment

Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.

(c)

Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained

for any other amounts due under or in respect of this Certificate of Designations.

30.

Severability. If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid

or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall

be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such

provision shall not affect the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of

Designations as so modified continues to express, without material change, the original intentions of the parties as to the subject matter

hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective

expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred

upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)

with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

31.

Maximum Payments. Without limiting Section 9(c) of the Securities Purchase Agreement, nothing contained herein shall be deemed

to establish or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the

event that the rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments

in excess of such maximum shall be credited against amounts owed by the Company to the applicable Holder and thus refunded to the Company.

32.

Stockholder Matters; Amendment.

(a)

Stockholder Matters. Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant

to the DGCL, the Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred

Shares may be effected by written consent of the Company’s stockholders or at a duly called meeting of the Company’s stockholders,

all in accordance with the applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections

of the DGCL permitting stockholder action, approval and consent affected by written consent in lieu of a meeting.

(b)

Amendment. Except for Section 4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or

any provision hereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without

a meeting in accordance with the DGCL, of the Required Holders, voting separately as a single class, and with such other stockholder

approval, if any, as may then be required pursuant to the DGCL and the Certificate of Incorporation.

33.

Certain Defined Terms. For purposes of this Certificate of Designations, the following terms shall have the following meanings:

(a)

“1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

(b)

“Additional Amount” means, as of the applicable date of determination, with respect to each Preferred Share, all accrued

and unpaid Dividends on such Preferred Share.

(c)

”Adjustment Right” means any right granted with respect to any securities issued in connection with,

or with respect to, any issuance or sale (or deemed issuance or sale in accordance with Section 8(a)) of shares of Common Stock

(other than rights of the type described in Section 7(a) hereof) that could result in a decrease in the net consideration received

by the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash

adjustment or other similar rights).

(d)

”Affiliate” or “Affiliated” means, with respect to any Person, any other Person that directly

or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this definition

that “control” of a Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary

voting power for the election of directors of such Person or direct or cause the direction of the management and policies of such Person

whether by contract or otherwise.

(e)

”Alternate Conversion Floor Amount” means an amount in cash, to be delivered by wire transfer

of immediately available funds pursuant to wire instructions delivered to the Company by the Holder in writing, equal to the product

obtained by multiplying (A) the higher of (I) the highest price that the Common Stock trades at on the Trading Day immediately preceding

the relevant Alternate Conversion Date and (II) the applicable Alternate Conversion Price and (B) the difference obtained by subtracting

(I) the number of shares of Common Stock delivered (or to be delivered) to the Holder on the applicable Share Delivery Deadline with

respect to such Alternate Conversion from (II) the quotient obtained by dividing (x) the applicable Conversion Amount that the Holder

has elected to be the subject of the applicable Alternate Conversion, by (y) the applicable Alternate Conversion Price without giving

effect to clause (x) of such definition.

(f)

”Alternate Conversion Price” means, with respect to any Alternate Conversion that price which shall

be the lowest of (i) the applicable Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion,

and (ii) the greater of (x) the Floor Price and (y) 80% of the lowest VWAP of the Common Stock of any Trading Day during the twenty (20)

consecutive Trading Day period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable

Conversion Notice (such period, the “Alternate Conversion Measuring Period”). All such determinations to be appropriately

adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases

or increases the Common Stock during such Alternate Conversion Measuring Period.

(g)

“Approved Stock Plan” means any employee benefit plan or agreement which has been approved by the Board prior to or

subsequent to the Subscription Date pursuant to which shares of Common Stock and standard options to purchase Common Stock or other awards

convertible, exercisable for or exchangeable for shares of Common Stock may be issued to any employee, officer, consultant or director

for services provided to the Company in their capacity as such.

(h)

“Attribution Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including,

any funds, feeder funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly or indirectly

managed or advised by a Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates

of such Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with such Holder

or any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated

with such Holder’s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of

the foregoing is to subject collectively such Holder and all other Attribution Parties to the Maximum Percentage.

(i)

“Bloomberg” means Bloomberg, L.P.

(j)

“Book-Entry” means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of

a Preferred Share Certificate issuable hereunder.

(k)

“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New

York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not

be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential

employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental

authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York

generally are open for use by customers on such day.

(l)

“Change of Control” means (a) any Fundamental Transaction other than (i) any merger of the Company or any of its,

direct or indirect, wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or

reclassification of the Common Stock in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization

or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and,

directly or indirectly, are, in all material respects, the holders of the voting power of the surviving entity (or entities with the

authority or voting power to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity

or entities) after such reorganization, recapitalization or reclassification, (iii) pursuant to a migratory merger effected solely for

the purpose of changing the jurisdiction of incorporation of the Company or any of its Subsidiaries or (iv) bona fide arm’s length

sales or acquisitions by the Company with one or more third parties as long as holders of the Company’s voting power as of the

Issuance Date continue after such sale or acquisition to hold publicly traded securities and, directly or indirectly, are, in all material

respects, the holders of at least 51% of the voting power of the surviving entity (or entities with the authority or voting power to

elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such

sale or acquisition (in each of clauses (i) through (iv), a “Change of Control Exception”), or (b) individuals who

constitute the Continuing Directors, taken together, ceasing for any reason to constitute at least a majority of the Board, other than

in connection with a Change of Control Exception.

(m)

“Change of Control Redemption Premium” means the greater of (i) 125% or (ii) the Black-Scholes Value of the remaining

unconverted shares of Preferred Stock on the date of the consummation of such Change of Control. For purposes of this definition “Black

Scholes Value” means the value of the unconverted shares of Preferred Stock based on the Black-Scholes Option Pricing Model

obtained from the “OV” function on Bloomberg determined as of the date in question for pricing purposes and reflecting

(A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement

of the applicable Change of Control and the Maturity Date, (B) an expected volatility equal to the 100 day volatility obtained from the

HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public

announcement of the applicable contemplated Change of Control, (C) the underlying price per share used in such calculation shall be the

greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being

offered in such Change of Control and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the

public announcement of the applicable contemplated Change of Control (or the consummation of the applicable Change of Control, if earlier)

and ending on the Trading Day of the Holder’s request pursuant to this section, (D) a remaining option time equal to the time between

the date of the public announcement of the applicable contemplated Change of Control and the Maturity Date, and (E) a zero cost of borrow.

(n)

“Closing Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing

bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the

Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price

(as the case may be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time,

as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the

last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where

such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade

price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by

Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of

the bid prices, or the ask prices, respectively, of any market makers for such security as reported in The Pink Open Market (or a similar

organization or agency succeeding to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be

calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the

case may be) of such security on such date shall be the fair market value as mutually determined by the Company and the Required Holder.

If the Company and the Required Holders are unable to agree upon the fair market value of such security, then such dispute shall be resolved

in accordance with the procedures in Section 25. All such determinations shall be appropriately adjusted for any stock splits,

stock dividends, stock combinations, recapitalizations or other similar transactions during such period.

(o)

“Closing Date” shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company

initially issued the Preferred Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.

(p)

“Common Stock” means (i) the Company’s shares of common stock, par value $0.0001 per share, and (ii) any capital

stock into which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.

(q)

“Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that

Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the

Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability

will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will

be protected (in whole or in part) against loss with respect thereto.

(r)

“Continuing Directors” means the directors of the Company on the date hereof and each other director, if, in each

case, such other director is nominated for election by the Board a majority of whom are directors on the date hereof or whose election

or nomination for election was approved by one or more of such directors.

(s)

“Conversion Floor Price Condition” means that the relevant Alternate Conversion Price is being determined based on

clause (x) of such definition.

(t)

“Convertible Securities” means any stock or other security (other than Options) that is at any time and under any

circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof

to acquire, any shares of Common Stock.

(u)

“Dividend Date” means the first Trading Day of each calendar quarter.

(v)

“Dividend Rate” means seven percent (7.0%) per annum, as may be adjusted from time to time in accordance with Section

3.

(w)

“Eligible Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq

Global Market, the OTCQX, the OTCQB or the Principal Market.

(x)

“Event Market Price” means, with respect to any Stock Combination Event Date, the lower of (i) the Conversion Price

in effect immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination

Event Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven (11) consecutive

Trading Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and ending on the

fifth (5th) Trading Day immediately following the Stock Combination Event Date.

(y)

”Excluded Securities” means (i) shares of Common Stock or standard options to purchase Common Stock issued

to directors, officers or employees of the Company for services rendered to the Company in their capacity as such pursuant to an Approved

Stock Plan (as defined above), provided that (A) following November 4, 2025 (the “Equity Award Restriction Date”),

all such issuances (taking into account the shares of Common Stock issuable upon exercise of such options) after the Equity Award Restriction

Date pursuant to this clause (i) do not, in the aggregate, exceed more than 10.0% of the Common Stock issued and outstanding immediately

prior to the Equity Award Restriction Date and (B) the exercise price of any such options is not lowered, none of such options are amended

to increase the number of shares issuable thereunder and none of the terms or conditions of any such options are otherwise materially

changed in any manner that adversely affects any of the Buyers (as defined in the Securities Purchase Agreement); (ii) shares of Common

Stock issued upon the conversion or exercise of Convertible Securities (other than standard options to purchase Common Stock issued pursuant

to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription Date, provided that the conversion

price of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan

that are covered by clause (i) above) is not lowered (other than in accordance with the terms thereof in effect as of the Subscription

Date) from the conversion price in effect as of the Subscription Date (whether pursuant to the terms of such Convertible Securities or

otherwise), none of such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved

Stock Plan that are covered by clause (i) above) are amended to increase the number of shares issuable thereunder and none of the terms

or conditions of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved

Stock Plan that are covered by clause (i) above) are otherwise materially changed in any manner that adversely affects any of the Buyers;

(iii) the shares of Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of this Certificate

of Designations; provided, that the terms of this Certificate of Designations are not amended, modified or changed on or after

the Subscription Date (other than in accordance with the terms thereof, including antidilution adjustments pursuant to the terms thereof

in effect as of the Subscription Date), (iv) the shares of Common Stock issuable upon exercise of the Warrants; provided, that

the terms of the Warrants are not amended, modified or changed on or after the Subscription Date (other than antidilution adjustments

pursuant to the terms thereof in effect as of the Subscription Date), (v) the issuance of the payment of dividends of preferred share

purchase rights (the “Rights”), with each such Right entitling the holder to purchase from the Company one one-thousandth

of a share of Series A Junior Participating Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”),

of the Company, declared by the board of directors of the Company on July 31, 2025, to stockholders of record at the close of business

on August 11, 2025, (vi) the Series A Preferred Stock, pursuant to that certain Certificate of Designations establishing the rights,

preferences, restrictions and other matters relating to the Series A Preferred Stock (the “Series A Certificate of Designations”),

and (vii) shares of Common Stock as payment of dividends on the Series A Preferred Stock in accordance with the Series A Certificate

of Designations.

(z)

“Floor Price” means $1.5256, as of the Effective Date (subject to adjustment for stock splits, stock dividends, stock

combinations, recapitalizations or other similar events following the Effective Date), which was 20% of the “Minimum Price”

(as defined in Rule 5635 of the Nasdaq Stock Market) on the Stockholder Approval Date (as defined in the Purchase Agreement) (as adjusted

for stock splits, stock dividends, stock combinations, recapitalizations or other similar events subsequent to the Stockholder Approval

Date and prior to the Effective Date) or, in any case, such lower amount as permitted, from time to time, by the Principal Market.

(aa)

“Fundamental Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries,

Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the

surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all

of the properties or assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation

S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject

to or have its voting stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that

is accepted by the holders of at least either (x) more than 50% of the outstanding voting power of the Company, (y) more than 50% of

the outstanding voting power of the Company calculated as if any shares of voting stock held by all Subject Entities making or party

to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z)

such number of shares of voting stock such that all Subject Entities making or party to, or Affiliated with any Subject Entity making

or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934

Act) of more than 50% of the outstanding voting power of the Company, or (iv) consummate a stock or share purchase agreement or other

business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one

or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire, either (x) more than 50% of the

outstanding voting power of the Company (y) more than 50% of the outstanding voting power of the Company calculated as if any shares

of voting stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock

purchase agreement or other business combination were not outstanding; or (z) such number of shares of voting stock of the Company such

that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of

the outstanding voting power of the Company, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall,

directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject

Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3

under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange,

reduction in outstanding shares of voting stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off,

scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) more

than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company, (y) more

than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company not held

by all such Subject Entities as of the date of this Certificate of Designations calculated as if any shares of voting stock of the Company

held by all such Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued

and outstanding shares of voting stock of the Company or other equity securities of the Company sufficient to allow such Subject Entities

to effect a statutory short form merger or other transaction requiring other stockholders of the Company to surrender their shares of

voting stock of the Company without approval of the stockholders of the Company or (C) directly or indirectly, including through subsidiaries,

Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction

structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed

and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary to correct

this definition or any portion of this definition which may be defective or inconsistent with the intended treatment of such instrument

or transaction.

(bb)

“GAAP” means United States generally accepted accounting principles, consistently applied.

(cc)

“Group” means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in

Rule 13d-5 thereunder.

(dd)

“Indebtedness” means of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations

issued, undertaken or assumed as the deferred purchase price of property or services, including, without limitation, “capital leases”

in accordance with United States generally accepted accounting principles consistently applied for the periods covered thereby (other

than trade payables entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment

obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds,

debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets

or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as

financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights

and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property),

(F) all monetary obligations under any leasing or similar arrangement which, in connection with United States generally accepted accounting

principles, consistently applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to

in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise,

to be secured by) any mortgage, deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever

in or upon any property or assets (including accounts and contract rights) with respect to any asset or property owned by any Person,

even though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and

(H) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G)

above.

(ee)

Reserved.

(ff)

Reserved.

(gg)

Reserved.

(hh)

“Intellectual Property Rights” means, with respect to the Company and its Subsidiaries, all of their rights or licenses

to use all trademarks, trade names, service marks, service mark registrations, service names, original works of authorship, patents,

patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property

rights and all applications and registrations therefor.

(ii)

“Investment” means any beneficial ownership (including stock, partnership or limited liability company interests)

of or in any Person, or any loan, advance or capital contribution to any Person or the acquisition of all, or substantially all, of the

assets of another Person or the purchase of any assets of another Person for greater than the fair market value of such assets.

(jj)

“Liquidation Event” means, whether in a single transaction or series of transactions, the voluntary or involuntary

liquidation, dissolution or winding up of the Company or such Subsidiaries the assets of which constitute all or substantially all of

the assets of the business of the Company and its Subsidiaries, taken as a whole.

(kk)

“Maturity Date” shall mean October 27, 2027; provided, however, the Maturity Date may be extended upon

the mutual consent of a Holder and the Company with respect to such Holder; and provided further, however, the Maturity

Date may be extended at the option of a Holder with respect to such Holder (i) in the event that, and for so long as, a Triggering Event

shall have occurred and be continuing or any event shall have occurred and be continuing that with the passage of time and the failure

to cure would result in a Triggering Event or (ii) through the date that is twenty (20) Business Days after the consummation of a Fundamental

Transaction in the event that a Fundamental Transaction is publicly announced or a Change of Control Notice is delivered prior to the

Maturity Date, provided further that if a Holder elects to convert some or all of its Preferred Shares pursuant to Section

4 hereof, and the Conversion Amount would be limited pursuant to Section 4(d) hereunder, the Maturity Date shall automatically

be extended until such time as such provision shall not limit the conversion of such Preferred Shares.

(ll)

“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible

Securities.

(mm)

“Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose

common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent

Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

(nn)

“Permitted Indebtedness” means (i) Indebtedness existing on June 30, 2025, and reflected on the Company’s balance

sheet included in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 14, 2025, (ii) Indebtedness secured by

Permitted Liens or unsecured but as described in clauses (iv) and (v) of the definition of Permitted Liens and (iii) if (x) the Stockholder

Approval Date has occurred, and (y) less than 3,000 Preferred Shares remain outstanding, the Permitted Senior Indebtedness.

(oo)

“Permitted Liens” means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate

proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary

course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation

of law, such as materialmen’s liens, mechanics’ liens and other similar liens, arising in the ordinary course of business

with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv)

Liens (A) upon or in any equipment acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment

or Indebtedness incurred solely for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment

at the time of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon,

and the proceeds of such equipment, in either case, with respect to Indebtedness in an aggregate amount not to exceed $150,000, (v) Liens

incurred in connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause

(iv) above, provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing

Lien and the principal amount of the Indebtedness being extended, renewed or refinanced does not increase, (vi) Liens in favor of customs

and revenue authorities arising as a matter of law to secure payments of custom duties in connection with the importation of goods, (vii)

Liens arising from judgments, decrees or attachments in circumstances not constituting a Triggering Event under Section 5(a)(vii)

and (viii) Liens with respect to the Permitted Senior Indebtedness.

(pp)

“Permitted Senior Indebtedness” means non-convertible Indebtedness issued pursuant to a credit facility with a bank

or similar financial institution with no principal payments required prior to the 91st calendar day after the Maturity Date, provided,

however, that the aggregate outstanding principal amount of such Indebtedness permitted hereunder does not at any time exceed

$10 million; provided, further, however, no Permitted Senior Indebtedness shall permit the lender to accelerate

such Permitted Senior Indebtedness as a result of the occurrence of any Triggering Event hereunder or the Holder’s delivery of

a Triggering Event Redemption Notice.

(qq)

“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,

an unincorporated organization, any other entity or a government or any department or agency thereof.

(rr)

“Principal Market” means the Nasdaq Capital Market.

(ss)

“Redemption Notices” means, collectively, the Triggering Event Redemption Notices and the Change of Control Redemption

Notices, and each of the foregoing, individually, a “Redemption Notice.”

(tt)

“Redemption Premium” means 130%.

(uu)

“Redemption Prices” means, collectively, any Triggering Event Redemption Price and Change of Control Redemption Price,

and each of the foregoing, individually, a “Redemption Price.”

(vv)

“SEC” means the United States Securities and Exchange Commission or the successor thereto.

(ww)

“Securities Purchase Agreement” means that certain securities purchase agreement by and among the Company and the

initial holders of Preferred Shares, dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.

(xx)

“Stated Value” shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations,

reorganizations, reclassifications, combinations, subdivisions or other similar events occurring after the Initial Issuance Date with

respect to the Preferred Shares.

(yy)

“Subscription Date” means August 4, 2025.

(zz)

“Subject Entity” means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.

(aaa)

“Subsidiaries” shall have the meaning as set forth in the Securities Purchase Agreement.

(bbb) “Successor

Entity” means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving

any Fundamental Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental

Transaction shall have been entered into.

(ccc)

“Trading Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the

Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading

market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded,

provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such

exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading

on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange

or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing

by the applicable Holder or (y) with respect to all determinations other than price determinations relating to the Common Stock, any

day on which The New York Stock Exchange (or any successor thereto) is open for trading of securities.

(ddd)

“Transaction Documents” means the Securities Purchase Agreement, this Certificate of Designations, the Warrants and

each of the other agreements and instruments entered into or delivered by the Company or any of the Holders in connection with the transactions

contemplated by the Securities Purchase Agreement, all as may be amended from time to time in accordance with the terms thereof.

(eee)

“VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal

Market (or, if the Principal Market is not the principal trading market for such security, then on the principal securities exchange

or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00

p.m., New York time, as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time)

or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the

electronic bulletin board for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York

time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours,

the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported

in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be

calculated for such security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market

value as mutually determined by the Company and the Required Holders. If the Company and the Required Holders are unable to agree upon

the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 25. All

such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other

similar transaction during such period.

(fff)

“Warrants” has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants

issued in exchange therefor or replacement thereof.

(ggg)

“Warrant Shares” means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.

34.

Disclosure. Upon receipt or delivery by the Company of any notice in accordance with the terms of this Certificate of Designations,

unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public information

relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business Day

immediately following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form

8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information relating to the Company

or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt

of notice from such Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the

Company immediately upon receipt of notice from such Holder), such Holder shall be entitled to presume that information contained in

the notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing contained

in this Section 34 shall limit any obligations of the Company, or any rights of any Holder, under Section 4(l) of the Securities

Purchase Agreement.

35.

Absence of Trading and Disclosure Restrictions. The Company acknowledges and agrees that no Holder is a fiduciary or agent of

the Company and that each Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company

or (b) refrain from trading any securities while in possession of such information in the absence of a written non-disclosure agreement

signed by an officer of such Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such

an executed, written non-disclosure agreement, the Company acknowledges that each Holder may freely trade in any securities issued by

the Company, may possess and use any information provided by the Company in connection with such trading activity, and may disclose any

such information to any third party.

*

* * * *

IN

WITNESS WHEREOF, the Company has caused this Amended and Restated Certificate of Designations of Series I Convertible Preferred Stock

of StableX Technologies, Inc. to be signed by its Chief Executive Officer on this 27th day of April, 2026.

STABLEX

TECHNOLOGIES, INC.

By:

/s/

Josuha Silverman

Name:

Joshua

Silverman

Title:

Chief

Executive Officer

EXHIBIT

I

STABLEX

TECHNOLOGIES, INC.

CONVERSION

NOTICE

Reference

is made to the Amended and Restated Certificate of Designations, Preferences and Rights of the Series I Convertible Preferred Stock of

StableX Technologies, Inc. (the “Certificate of Designations”). In accordance with and pursuant to the Certificate

of Designations, the undersigned hereby elects to convert the number of shares of Series I Convertible Preferred Stock, $0.0001 par value

per share (the “Preferred Shares”), of StableX Technologies, Inc. a Delaware corporation (the “Company”),

indicated below into shares of common stock, $0.0001 value per share (the “Common Stock”), of the Company, as of the

date specified below.

● Date

of Conversion

Aggregate

number of Preferred Shares to be converted

Aggregate

Stated Value of such Preferred Shares to be converted:

Aggregate

accrued and unpaid Dividends and accrued and unpaid Late Charges with respect to such Preferred Shares and such aggregate Dividends

to be converted:

AGGREGATE

CONVERSION AMOUNT TO BE CONVERTED:

Please

confirm the following information:

Conversion

Price:

Number

of shares of Common Stock to be issued:

☐ If

this Conversion Notice is being delivered with respect to an Alternate Conversion, check here if Holder is electing to use the following

Alternate Conversion Price: ____________

Please

issue the Common Stock into which the applicable Preferred Shares are being converted to Holder, or for its benefit, as follows:

☐ Check

here if requesting delivery as a certificate to the following name and to the following address:

Issue

to:

Check

here if requesting delivery by Deposit/Withdrawal at Custodian as follows:

DTC

Participant:

DTC

Number:

Account

Number:

Date:

______________________________

Name

of Registered Holder

By:

Name:

Title:

Tax

ID: _____________________________

Email

Address:________________________

EXHIBIT

II

ACKNOWLEDGMENT

The

Company hereby (a) acknowledges this Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock are eligible

to be resold by the Holder without restriction or any legend and (c) hereby directs _________________ to issue the above indicated number

of shares of Common Stock in accordance with the Transfer Agent Instructions dated __________, 2025 from the Company and acknowledged

and agreed to by ________________________.

STABLEX

TECHNOLOGIES, INC.

By:

Name:

Title:

EX-3.5

EX-3.5

Filename: ex3-5.htm · Sequence: 6

Exhibit 3.5

Certificate

of Amendment

of

Certificate

of Incorporation

of

StableX

Technologies, INC.

StableX

Technologies, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware

(the “Corporation”) hereby certifies:

1.

The Amended and Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of Delaware on May 28, 2020 (as amended, the “Certificate of Incorporation”).

2.

Resolutions were duly adopted by the Board of Directors of the Corporation setting forth this proposed amendment to the Certificate of Incorporation.

3.

Article I of the Certificate of Incorporation is hereby amended and restated in its entirety to read as follows:

“The

name of the corporation is Fabric.AI, Inc. (hereinafter referred to as the “Corporation”).

4.

The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

5.

The effective date of this Certificate of Amendment to the Certificate of Incorporation shall be 12:01 a.m. on April 28, 2026.

[Signature

page follows.]

IN

WITNESS WHEREOF, said corporation has caused this Certificate of Amendment to be executed this 27th day of April, 2026.

StableX

Technologies, Inc.

By:

/s/

Joshua Silverman

Name:

Joshua

Silverman

Title:

Executive

Chairman

EX-4.1

EX-4.1

Filename: ex4-1.htm · Sequence: 7

Exhibit 4.1

FORM

OF WARRANT

NEITHER

THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE

HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED

FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES

ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO

THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE

144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER

LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT

MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION 1(a) OF THIS WARRANT.

STABLEX

TECHNOLOGIES, INC.

Warrant

to Purchase Common Stock

Warrant

No.:

Date

of Issuance: [●] (“Issuance Date”)

StableX

Technologies, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration,

the receipt and sufficiency of which are hereby acknowledged, [BUYER], the registered holder hereof or its permitted assigns (the “Holder”),

is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,

upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer

or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m.,

New York time, on the Expiration Date (as defined below), _________________1 (subject to adjustment as provided herein)

fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”, and such

number of Warrant Shares, the “Warrant Number”). Except as otherwise defined herein, capitalized terms in this Warrant

shall have the meanings set forth in Section 19 or in the Securities Purchase Agreement (as defined below). This Warrant is one of the

Warrants to Purchase Common Stock (the “SPA Warrants”) issued pursuant to Section 1 of that certain Securities Purchase

Agreement, dated as of April 27, 2026 (the “Subscription Date”), by and among the Company and the investors (the “Buyers”)

referred to therein, as amended from time to time (the “Securities Purchase Agreement”).

1

100% warrant coverage (equal to number of shares of Common Stock issuable upon conversion of Preferred Shares)

1. EXERCISE

OF WARRANT.

(a) Mechanics

of Exercise. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section

1(f)), this Warrant may be exercised by the Holder on any day on or after the Issuance Date (an “Exercise Date”),

in whole or in part, by delivery (whether via electronic mail or otherwise) of a written notice, in the form attached hereto as Exhibit

A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. Within one (1)

Trading Day (or any other settlement cycle as may be in effect pursuant to Rule 15c6-1 under the Exchange Act from time to time)

following an exercise of this Warrant as aforesaid, the Holder shall deliver payment to the Company of an amount equal to the

Exercise Price in effect on the date of such exercise multiplied by the number of Warrant Shares as to which this Warrant was so

exercised (the “Aggregate Exercise Price”) in cash or via wire transfer of immediately available funds if the

Holder did not notify the Company in such Exercise Notice that such exercise was made pursuant to a Cashless Exercise (as defined in

Section 1(d)). The Holder shall not be required to deliver the original of this Warrant in order to effect an exercise hereunder.

Execution and delivery of an Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as

cancellation of the original of this Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of

Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining Warrant Shares shall have the same effect

as cancellation of the original of this Warrant after delivery of the Warrant Shares in accordance with the terms hereof. On or

before the first (1st) Trading Day following the date on which the Company has received an Exercise Notice, the Company shall

transmit by facsimile or electronic mail an acknowledgment of confirmation of receipt of such Exercise Notice, in the form attached

hereto as Exhibit B, to the Holder and the Company’s transfer agent (the “Transfer Agent”),

which confirmation shall constitute an instruction to the Transfer Agent to process such Exercise Notice in accordance with the

terms herein. On or before the first (1st) Trading Day following the date on which the Company has received such Exercise Notice (or

such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade of

such Warrant Shares initiated on the applicable Exercise Date), the Company shall (X) provided that the Transfer Agent is

participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program

(“FAST”), upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the

Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC through its

Deposit/Withdrawal at Custodian system, or (Y) if the Transfer Agent is not participating in the DTC FAST, upon the request of the

Holder, issue and deliver (via reputable overnight courier) to the address as specified in the Exercise Notice, a certificate,

registered in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder shall be entitled

pursuant to such exercise. Upon delivery of an Exercise Notice, the Holder shall be deemed for all corporate purposes to have become

the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such

Warrant Shares are credited to the Holder’s DTC account or the date of delivery of the certificates evidencing such Warrant

Shares (as the case may be). If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the

number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being

acquired upon an exercise and upon surrender of this Warrant to the Company by the Holder, then, at the request of the Holder, the

Company shall as soon as practicable and in no event later than two (2) Business Days after any exercise and at its own expense,

issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section 7(d)) representing the right to purchase

the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares

with respect to which this Warrant is exercised. No fractional shares of Common Stock are to be issued upon the exercise of this

Warrant, but rather the number of shares of Common Stock to be issued shall be rounded up to the nearest whole number. The Company

shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and

expenses of the Transfer Agent) that may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of

this Warrant. Notwithstanding the foregoing, except in the case where an exercise of this Warrant is validly made pursuant to a

Cashless Exercise, the Company’s failure to deliver Warrant Shares to the Holder on or prior to the later of (i) two (2)

Trading Days after receipt of the applicable Exercise Notice (or such earlier date as required pursuant to the 1934 Act or other

applicable law, rule or regulation for the settlement of a trade of such Warrant Shares initiated on the applicable Exercise Date)

and (ii) one (1) Trading Day after the Company’s receipt of the Aggregate Exercise Price (or valid notice of a Cashless

Exercise if permissible) (such later date, the “Share Delivery Date”) shall not be deemed to be a breach of this

Warrant. Notwithstanding anything to the contrary contained in this Warrant or the Registration Rights Agreement, after the

effective date of the Registration Statement (as defined in the Registration Rights Agreement) and prior to the Holder’s

receipt of the notice of a Grace Period (as defined in the Registration Rights Agreement), the Company shall cause the Transfer

Agent to deliver unlegended shares of Common Stock to the Holder (or its designee) in connection with any sale of Registrable

Securities (as defined in the Registration Rights Agreement) with respect to which the Holder has entered into a contract for sale,

and delivered a copy of the prospectus included as part of the particular Registration Statement to the extent applicable, and for

which the Holder has not yet settled. From the Issuance Date through and including the Expiration Date, the Company shall maintain a

transfer agent that participates in FAST.

(b) Exercise

Price. For purposes of this Warrant, “Exercise Price” means $2.51, subject to adjustment as provided

herein.

(c) Company’s

Failure to Timely Deliver Securities. If the Company shall fail, for any reason or for no reason, on or prior to the Share

Delivery Date, either (I) if the Transfer Agent is not participating in FAST, to issue and deliver to the Holder (or its designee) a

certificate for the number of Warrant Shares to which the Holder is entitled and register such Warrant Shares on the Company’s

share register or, if the Transfer Agent is participating in FAST, to credit the balance account of the Holder or the Holder’s

designee with DTC for such number of Warrant Shares to which the Holder is entitled upon the Holder’s exercise of this Warrant

(as the case may be) or (II) if a Registration Statement covering the resale of the Warrant Shares that are the subject of the

Exercise Notice (the “Unavailable Warrant Shares”) is not available for the resale of such Unavailable Warrant

Shares and the Company fails to promptly, but in no event later than as required pursuant to the Registration Rights Agreement (x)

so notify the Holder and (y) deliver the Warrant Shares electronically without any restrictive legend by crediting such aggregate

number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s

balance account with DTC through its Deposit/Withdrawal At Custodian system (the event described in the immediately foregoing clause

(II) is hereinafter referred as a “Notice Failure” and together with the event described in clause (I) above, a

“Delivery Failure”), then, in addition to all other remedies available to the Holder, (X) the Company shall pay

in cash to the Holder on each day after the Share Delivery Date and during such Delivery Failure an amount equal to 2% of the

product of (A) the sum of the number of shares of Common Stock not issued to the Holder on or prior to the Share Delivery Date and

to which the Holder is entitled, multiplied by (B) any trading price of the Common Stock selected by the Holder in writing as in

effect at any time during the period beginning on the applicable Exercise Date and ending on the applicable Share Delivery Date, and

(Y) the Holder, upon written notice to the Company, may void its Exercise Notice with respect to, and retain or have returned, as

the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the voiding

of an Exercise Notice shall not affect the Company’s obligations to make any payments which have accrued prior to the date of

such notice pursuant to this Section 1(c) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Date

either (I) the Transfer Agent is not participating in the DTC FAST, the Company shall fail to issue and deliver to the Holder (or

its designee) a certificate and register such shares of Common Stock on the Company’s share register or, if the Transfer Agent

is participating in the DTC FAST, the Transfer Agent shall fail to credit the balance account of the Holder or the Holder’s

designee with DTC for the number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise

hereunder or pursuant to the Company’s obligation pursuant to clause (ii) below or (II) a Notice Failure occurs, and if on or

after such Share Delivery Date the Holder acquires (in an open market transaction, stock loan or otherwise) shares of Common Stock

corresponding to all or any portion of the number of shares of Common Stock issuable upon such exercise that the Holder is entitled

to receive from the Company and has not received from the Company in connection with such Delivery Failure or Notice Failure, as

applicable (a “Buy-In”), then, in addition to all other remedies available to the Holder, the Company shall,

within two (2) Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the

Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions, stock loan costs and other

out-of-pocket expenses, if any) for the shares of Common Stock so acquired (including, without limitation, by any other Person in

respect, or on behalf, of the Holder) (the “Buy-In Price”), at which point the Company’s obligation to so

issue and deliver such certificate (and to issue such shares of Common Stock) or credit the balance account of such Holder or such

Holder’s designee, as applicable, with DTC for the number of Warrant Shares to which the Holder is entitled upon the

Holder’s exercise hereunder (as the case may be) (and to issue such Warrant Shares) shall terminate, or (ii) promptly honor

its obligation to so issue and deliver to the Holder a certificate or certificates representing such Warrant Shares or credit the

balance account of such Holder or such Holder’s designee, as applicable, with DTC for the number of Warrant Shares to which

the Holder is entitled upon the Holder’s exercise hereunder (as the case may be) and pay cash to the Holder in an amount equal

to the excess (if any) of the Buy-In Price over the product of (A) such number of Warrant Shares multiplied by (B) the lowest

Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the applicable Exercise Notice

and ending on the date of such issuance and payment under this clause (ii) (the “Buy-In Payment Amount”). Nothing

shall limit the Holder’s right to pursue any other remedies available to it hereunder, at law or in equity, including, without

limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver

certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock) upon the exercise of

this Warrant as required pursuant to the terms hereof. While this Warrant is outstanding, the Company shall cause its transfer agent

to participate in FAST. In addition to the foregoing rights, (i) if the Company fails to deliver the applicable number of Warrant

Shares upon an exercise pursuant to Section 1 by the applicable Share Delivery Date, then the Holder shall have the right to rescind

such exercise in whole or in part and retain and/or have the Company return, as the case may be, any portion of this Warrant that

has not been exercised pursuant to such Exercise Notice; provided that the rescission of an exercise shall not affect the

Company’s obligation to make any payments that have accrued prior to the date of such notice pursuant to this Section 1(c) or

otherwise, and (ii) if a registration statement (which may be the Registration Statement) covering the issuance or resale of the

Warrant Shares that are subject to an Exercise Notice is not available for the issuance or resale, as applicable, of such Warrant

Shares, as required by and in accordance with the terms of the Registration Rights Agreement, and the Holder has submitted an

Exercise Notice prior to receiving notice of the non-availability of such registration statement and the Company has not already

delivered the Warrant Shares underlying such Exercise Notice electronically without any restrictive legend by crediting such

aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its

designee’s balance account with DTC through its Deposit / Withdrawal At Custodian system, the Holder shall have the option, by

delivery of notice to the Company, to (x) rescind such Exercise Notice in whole or in part and retain or have returned, as the case

may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the rescission of an

Exercise Notice shall not affect the Company’s obligation to make any payments that have accrued prior to the date of such

notice pursuant to this Section 1(c) or otherwise, and/or (y) switch some or all of such Exercise Notice from a cash exercise to a

Cashless Exercise.

(d) Cashless

Exercise. Notwithstanding anything contained herein to the contrary (other than Section 1(f) below), if at the time of exercise

hereof a Registration Statement (as defined in the Registration Rights Agreement) is not effective (or the prospectus contained

therein is not available for use) for the resale by the Holder of all of the Warrant Shares, then the Holder may, in its sole

discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to

the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the

“Net Number” of Warrant Shares determined according to the following formula (a “Cashless

Exercise”):

Net Number = (A x B) - (A x C)

B

For

purposes of the foregoing formula:

A=

the total number of shares with respect to which this Warrant is then being exercised.

B

= as elected by the Holder: (i) the VWAP of the Common Stock on the Trading Day immediately preceding the date of the applicable Exercise

Notice if such Exercise Notice is (1) both executed and delivered pursuant to Section 1(a) hereof on a day that is not a Trading Day

or (2) both executed and delivered pursuant to Section 1(a) hereof on a Trading Day prior to the opening of “regular trading hours”

(as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option

of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Exercise Notice or (z) the Bid

Price of the Common Stock as of the time of the Holder’s execution of the applicable Exercise Notice if such Exercise Notice is

executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter pursuant to Section

1(a) hereof, or (iii) the Closing Sale Price of the Common Stock on the date of the applicable Exercise Notice if the date of such Exercise

Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant to Section 1(a) hereof after the close of “regular

trading hours” on such Trading Day.

C

= the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

If

the Warrant Shares are issued in a Cashless Exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the

1933 Act, the Warrant Shares take on the registered characteristics of the Warrants being exercised. For purposes of Rule 144(d) promulgated

under the 1933 Act, as in effect on the Subscription Date, it is intended that the Warrant Shares issued in a Cashless Exercise shall

be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the

date this Warrant was originally issued pursuant to the Securities Purchase Agreement.

(e) Disputes.

In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares

to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares that are not

disputed and resolve such dispute in accordance with Section 15.

(f) Limitations

on Exercises.

(i)

Beneficial Ownership. The Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have

the right to exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall

be null and void and treated as if never made, to the extent that after giving effect to such exercise, the Holder together with the

other Attribution Parties collectively would beneficially own in excess of [4.99][9.99]% (the “Maximum

Percentage”) of the Common Stock outstanding immediately after giving effect to such exercise. For purposes of the

foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution

Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of

shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being

made, but shall exclude shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised portion of

this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the

unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or

convertible preferred stock or warrants, including other SPA Warrants) beneficially owned by the Holder or any other Attribution

Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 1(f)(i). For purposes

of this Section 1(f)(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. In addition, a

determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and

the rules and regulations promulgated thereunder. For purposes of determining the number of outstanding shares of Common Stock the

Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of

outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report

on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be, (y) a more recent public

announcement by the Company or (z) any other written notice by the Company or the Transfer Agent, if any, setting forth the number

of shares of Common Stock outstanding (the “Reported Outstanding Share Number”). If the Company receives an

Exercise Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported

Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then

outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder’s beneficial ownership, as

determined pursuant to this Section 1(f)(i), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced

number of Warrant Shares to be acquired pursuant to such Exercise Notice (the number of shares by which such purchase is reduced,

the “Reduction Shares”) and (ii) as soon as reasonably practicable, the Company shall return to the Holder any

exercise price paid by the Holder for the Reduction Shares. For any reason at any time, upon the written or oral request of the

Holder, the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to the Holder the number

of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after

giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and any other

Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of

shares of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other Attribution Parties being

deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock

(as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the Holder’s and the other

Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”)

shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the

Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company

shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the

Company, the Holder may from time to time increase (with such increase not effective until the sixty-first (61st) day after delivery

of such notice) or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice;

provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such

notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution

Parties and not to any other holder of SPA Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the

shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be

beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No

prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of

this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed

and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(f)(i) to the extent necessary to

correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial

ownership limitation contained in this Section 1(f)(i) or to make changes or supplements necessary or desirable to properly give

effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of

this Warrant.

(ii)

Principal Market Regulation. The Company shall not issue any shares of Common Stock upon the exercise of this Warrant

if the issuance of such shares of Common Stock (taken together with the issuance of such shares upon the conversion of the Preferred

Shares or otherwise pursuant to the terms of the Certificate of Designations) would exceed the aggregate number of shares of Common

Stock which the Company may issue upon exercise or conversion or otherwise pursuant to the terms of the Certificate of Designations,

the SPA Warrants and Placement Agent Warrants without breaching the Company’s obligations under the rules or regulations of

the Principal Market (the number of shares which may be issued without violating such rules and regulations, the “Exchange

Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval of its

stockholders as required by the applicable rules of the Principal Market for issuances of shares of Common Stock in excess of such

amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall

be reasonably satisfactory to the Holder. Until such approval or such written opinion is obtained, no Buyer shall be issued in the

aggregate, upon conversion or exercise (as the case may be) of any Preferred Shares or any of the SPA Warrants or otherwise pursuant

to the terms of the Certificate of Designations or the SPA Warrants, shares of Common Stock in an amount greater than the product of

(i) the Exchange Cap as of the Issuance Date multiplied by (ii) the quotient of (1) the aggregate number of Preferred Shares issued

to such Buyer pursuant to the Securities Purchase Agreement on the Closing Date (as defined in the Securities Purchase Agreement)

divided by (2) the aggregate stated value of all Preferred Shares issued to the Buyers pursuant to the Securities Purchase Agreement

on the Closing Date (with respect to each Buyer, the “Exchange Cap Allocation”). In the event that any Buyer

shall sell or otherwise transfer any of such Buyer’s SPA Warrants, the transferee shall be allocated a pro rata portion of

such Buyer’s Exchange Cap Allocation with respect to such portion of such SPA Warrants so transferred, and the restrictions of

the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation so allocated to such

transferee. Upon conversion and exercise in full of a holder’s Preferred Shares and SPA Warrants, the difference (if any)

between such holder’s Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon

such holder’s conversion in full of such Preferred Shares and such holder’s exercise in full of such SPA Warrants shall

be allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares and related SPA Warrants on a

pro rata basis in proportion to the shares of Common Stock underlying the Preferred Shares and related SPA Warrants then held by

each such holder of Preferred Shares and related SPA Warrants.

(g) Reservation

of Shares.

(i)  Required

Reserve Amount. So long as this Warrant remains outstanding, the Company shall at all times keep reserved for issuance under this

Warrant a number of shares of Common Stock at least equal to 200% of the maximum number of shares of Common Stock as shall be necessary

to satisfy the Company’s obligation to issue shares of Common Stock under the SPA Warrants then outstanding (without regard to

any limitations on exercise) (the “Required Reserve Amount”); provided that at no time shall the number of shares

of Common Stock reserved pursuant to this Section 1(g)(i) be reduced other than proportionally in connection with any exercise or redemption

of SPA Warrants or such other event covered by Section 2(a) below. The Required Reserve Amount (including, without limitation, each increase

in the number of shares so reserved) shall be allocated pro rata among the holders of the SPA Warrants based on the number of shares

of Common Stock issuable upon exercise of SPA Warrants held by each holder on the Closing Date (as defined in the Securities Purchase

Agreement) (without regard to any limitations on exercise) or increase in the number of reserved shares, as the case may be (the “Authorized

Share Allocation”). In the event that a holder shall sell or otherwise transfer any of such holder’s SPA Warrants, each

transferee shall be allocated a pro rata portion of such holder’s Authorized Share Allocation. Any shares of Common Stock reserved

and allocated to any Person which ceases to hold any SPA Warrants shall be allocated to the remaining holders of SPA Warrants, pro rata

based on the number of shares of Common Stock issuable upon exercise of the SPA Warrants then held by such holders (without regard to

any limitations on exercise).

(ii)  Insufficient

Authorized Shares. If, notwithstanding Section 1(g)(i) above, and not in limitation thereof, at any time while any of the SPA Warrants

remain outstanding, the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its

obligation to reserve the Required Reserve Amount (an “Authorized Share Failure”), then the Company shall use its

best efforts to take all action necessary to increase the Company’s authorized shares of Common Stock to an amount sufficient to

allow the Company to reserve the Required Reserve Amount for all the SPA Warrants then outstanding. Without limiting the generality of

the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later

than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for

the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide

each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders’ approval of such increase in

authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal.

Notwithstanding the foregoing, if at any such time of an Authorized Share Failure, the Company is able to obtain the written consent

of a majority of the shares of its issued and outstanding shares of Common Stock to approve the increase in the number of authorized

shares of Common Stock, the Company may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information

Statement on Schedule 14C. In the event that the Company is prohibited from issuing shares of Common Stock upon an exercise of this Warrant

due to the failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common

Stock (such unavailable number of shares of Common Stock, the “Authorization Failure Shares”), in lieu of delivering

such Authorization Failure Shares to the Holder, the Company shall pay cash in exchange for the cancellation of such portion of this

Warrant exercisable into such Authorization Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorization

Failure Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date

the Holder delivers the applicable Exercise Notice with respect to such Authorization Failure Shares to the Company and ending on the

date of such issuance and payment under this Section 1(g); and (ii) to the extent the Holder purchases (in an open market transaction

or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of Authorization Failure Shares, any Buy-In Payment

Amount, brokerage commissions and other out-of-pocket expenses, if any, of the Holder incurred in connection therewith. Nothing contained

in this Section 1(g) shall limit any obligations of the Company under any provision of the Securities Purchase Agreement.

2. ADJUSTMENT

OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant

are subject to adjustment from time to time as set forth in this Section 2.

(a)

Stock Dividends and Splits. Without limiting any provision of Section 2(b), Section 3 or Section 4, if the Company, at any time

on or after the Subscription Date, (i) pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or

otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, other than Excluded Securities

(as defined in the Securities Purchase Agreement), (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise)

one or more classes of its then outstanding shares of Common Stock into a larger number of shares or (iii) combines (by combination,

reverse stock split or otherwise) one or more classes of its then outstanding shares of Common Stock into a smaller number of shares

then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common

Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding

immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the

record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause

(ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. If any

event requiring an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then the

calculation of such Exercise Price shall be adjusted appropriately to reflect such event.

(b)

Adjustment Upon Issuance of Shares of Common Stock. If and whenever on or after the Subscription Date, the Company shall sell,

enter into an agreement to sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue

(or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents (but

excluding any Excluded Securities), at an effective price per share less than the Exercise Price then in effect (such lower price, the

“Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (it being understood

and agreed that if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase

price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights

per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per

share that is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date

of the Dilutive Issuance at such effective price), then simultaneously with the consummation (or, if earlier, the announcement) of each

Dilutive Issuance the Exercise Price shall be reduced and only reduced to equal the Base Share Price. Notwithstanding the foregoing,

no adjustments shall be made, paid or issued under this Section 2(b) in respect of any issuances of Excluded Securities. The Company

shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common Stock or Common

Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price, or applicable reset price, exchange

price, conversion price and other pricing terms.

(i)

Issuance of Options. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell)

any Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such

Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise

pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and

to have been issued and sold by the Company at the time of the granting, issuance or sale (or the time of execution of such agreement

to grant, issue or sell, as applicable) of such Option for such price per share. For purposes of this Section 2(b)(i), the “lowest

price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Options or upon conversion,

exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof”

shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company

with respect to any one share of Common Stock upon the granting, issuance or sale (or pursuant to the agreement to grant, issue or sell,

as applicable) of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable

upon exercise of such Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for

which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any

such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise

pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) upon

the granting, issuance or sale (or the agreement to grant, issue or sell, as applicable) of such Option, upon exercise of such Option

and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to

the terms thereof plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option

(or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance

of such shares of Common Stock or of such Convertible Securities upon the exercise of such Options or otherwise pursuant to the terms

of or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.

(ii)

Issuance of Convertible Securities. If the Company in any manner issues or sells (or enters into any agreement to issue or sell)

any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,

exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common

Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time

of execution of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes

of this Section 2(b)(ii), the “lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,

exercise or exchange thereof or otherwise pursuant to the terms thereof” shall be equal to (1) the lower of (x) the sum of the

lowest amounts of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance

or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange

of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible

Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion,

exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder

of such Convertible Security (or any other Person) upon the issuance or sale (or the agreement to issue or sell, as applicable) of such

Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such

Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon

the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities or otherwise

pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for

which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section 2(b), except as contemplated

below, no further adjustment of the Exercise Price shall be made by reason of such issuance or sale.

(iii)

Calculation of Consideration Received. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection

with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the “Primary

Security”, and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary Securities”

and together with the Primary Security, each a “Unit”), together comprising one integrated transaction, the aggregate

consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price

of such Unit, (y) if such Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of

Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Sections 2(b)(i) or 2(b)(ii)

above and (z) the lowest VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period (the “Adjustment

Period”) immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public

announcement is released prior to the opening of the Principal Market on a Trading Day, such Trading Day shall be the first Trading Day

in such five Trading Day period and if this Warrant is exercised, on any given Exercise Date during any such Adjustment Period, solely

with respect to such portion of this Warrant exercised on such applicable Exercise Date, such applicable Adjustment Period shall be deemed

to have ended on, and included, the Trading Day immediately prior to such Exercise Date). If any shares of Common Stock, Options or Convertible

Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be

the net amount of consideration received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are

issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of

such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration

received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading

Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible Securities are issued to the owners

of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor

will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to

such shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash

or publicly traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement

within ten (10) days after the occurrence of an event requiring valuation (the “Valuation Event”), the fair value

of such consideration will be determined within five (5) Trading Days after the tenth (10th) day following such Valuation

Event by an independent, reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall

be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.

(iv)

Record Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive

a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase

shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale

of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution

or the date of the granting of such right of subscription or purchase (as the case may be).

(c)

Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to Section 2, the number of Warrant

Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such

adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the

aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained

herein).

(d) Reserved.

(e)

Stock Combination Event Adjustment. If at any time and from time to time on or after the Issuance Date there occurs

any stock split, stock dividend, stock combination, reverse stock split, recapitalization or other similar transaction involving the

outstanding Common Stock (each, a “Stock Combination Event”, and such date thereof, the “Stock

Combination Event Date”) and the Event Market Price is less than the Exercise Price then in effect (after giving effect to

the adjustment in clause 2(a) above), then on the sixteenth (16th) Trading Day immediately following such Stock Combination Event

(“Stock Combination Event Adjustment Date”), the Exercise Price then in effect on the Stock Combination Event

Adjustment Date (after giving effect to the adjustment in clause 2(a) above) shall be reduced (but in no event increased) to the

Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence would otherwise result in an

increase in the Exercise Price hereunder, no adjustment shall be made.

(f) Other

Events. In the event that the Company (or any Subsidiary (as defined in the Securities Purchase Agreement)) shall take any

action to which the provisions hereof are not strictly applicable, or, if applicable, would not operate to protect the Holder from

dilution or if any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such

provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with

equity features), then the Company’s board of directors shall in good faith determine and implement an appropriate adjustment

in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder, provided that no

such adjustment pursuant to this Section 2(f) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise

determined pursuant to this Section 2, provided further that if the Holder does not accept such adjustments as appropriately

protecting its interests hereunder against such dilution, then the Company’s board of directors and the Holder shall agree, in

good faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments, whose

determination shall be final and binding absent manifest error and whose fees and expenses shall be borne by the Company.

(g)

Calculations. All calculations under this Section 2 shall be made by rounding to the nearest cent or the nearest 1/100th of a

share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by

or for the account of the Company, and the disposition of any such shares shall be considered an issuance or sale of shares of

Common Stock.

(h) Voluntary

Adjustment By Company. Subject to the rules and regulations of the Principal Market, the Company may at any time during the term

of this Warrant, with the prior written consent of the Required Holders (as defined in the Securities Purchase Agreement), reduce

the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the

Company.

3. RIGHTS

UPON DISTRIBUTION OF ASSETS. In addition to any adjustments pursuant to Section 2 above or Section 4(a) below, if the Company shall

declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,

by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property,

options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification, corporate rearrangement, scheme

of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then,

in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated

therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard

to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before

the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of

shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that to the extent that the

Holder’s right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the

Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to the extent of the Maximum Percentage

(and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution (and beneficial ownership)

to the extent of any such excess) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until

such time or times, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum

Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial

Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).

4. PURCHASE

RIGHTS; FUNDAMENTAL TRANSACTIONS.

(a)

Purchase Rights. In addition to any adjustments pursuant to Sections 2 or 3 above, if at any time the Company grants, issues or

sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record

holders of any class of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon

the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had

held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or

restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which

a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the

record holders of shares of Common Stock are to be determined for the grant, issuance or sale of such Purchase Rights

(provided, however, that to the extent that the Holder’s right to participate in any such Purchase Right would

result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to

participate in such Purchase Right to the extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of

such shares of Common Stock as a result of such Purchase Right (and beneficial ownership) to the extent of any such excess) and such

Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times, if ever, as its

right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or

times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on

any subsequent Purchase Right held similarly in abeyance) to the same extent as if there had been no such limitation).

(b) Fundamental

Transactions. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes

in writing all of the obligations of the Company under this Warrant and the other Transaction Documents (as defined in the

Securities Purchase Agreement) in accordance with the provisions of this Section 4(b) pursuant to written agreements in form and

substance satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, including agreements to

deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument

substantially similar in form and substance to this Warrant, including, without limitation, which is exercisable for a corresponding

number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant

(without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise

price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the

shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to

the number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant

immediately prior to the consummation of such Fundamental Transaction) and (ii) the Successor Entity (including its Parent Entity)

is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. Upon the consummation

of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of

the applicable Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the

“Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall

assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such

Successor Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity shall

deliver to the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after the consummation of

the applicable Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property

(except such items still issuable under Sections 3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon

the exercise of this Warrant prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its

equivalent) of the Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the

happening of the applicable Fundamental Transaction had this Warrant been exercised immediately prior to the applicable Fundamental

Transaction (without regard to any limitations on the exercise of this Warrant), as adjusted in accordance with the provisions of

this Warrant. Notwithstanding the foregoing, and without limiting Section 1(f) hereof, the Holder may elect, at its sole option, by

delivery of written notice to the Company to waive this Section 4(b) to permit the Fundamental Transaction without the assumption of

this Warrant. In addition to and not in substitution for any other rights hereunder, prior to the consummation of each Fundamental

Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to

or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to

insure that the Holder will thereafter have the right to receive upon an exercise of this Warrant at any time after the consummation

of the applicable Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other

securities, cash, assets or other property (except such items still issuable under Sections 3 and 4(a) above, which shall continue

to be receivable thereafter)) issuable upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock,

securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the

Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction had this Warrant been

exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations on the exercise of this

Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory to the

Holder.

(c) Black

Scholes Value. Notwithstanding the foregoing and the provisions of Section 4(b) above, at the request of the Holder delivered at

any time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the consummation of

any Fundamental Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the date that is ninety

(90) days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current

Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase this Warrant from the

Holder on the date of such request by paying to the Holder cash in an amount equal to the greatest of (i) the Black Scholes Value of

the remaining unexercised portion of this Warrant, and (ii) the positive difference between (1) the product of the number of Warrant

Shares underlying the unexercised portion of the Warrant and the highest VWAP for the Common Stock during the period commencing

twenty (20) Trading Days prior to the public announcement of the Fundamental Transaction and ending on the consummation thereof and

(2) the remaining aggregate Exercise Price of this Warrant. Payment of such amounts shall be made by the Company (or at the

Company’s direction) to the Holder on or prior to the later of (x) the second (2nd) Trading Day after the date of such request

and (y) the date of consummation of such Fundamental Transaction; provided, however, that if the Fundamental Transaction is not

within the Company’s control, including in the event that such Fundamental Transaction is not approved by the board of

directors of the Company, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or

form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is

being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that

consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice

to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if

holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of

Common Stock will be deemed to have received common stock of the Successor Entity (which such Successor Entity may be the Company

following such Fundamental Transaction) in such Fundamental Transaction.

(d) Application.

The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and

shall be applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without regard to any limitations

on the exercise of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum Percentage,

applied however with respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of

this Warrant (or any such other warrant)).

5. NONCIRCUMVENTION.

The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation (as defined in the

Securities Purchase Agreement), Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization, transfer of assets,

consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary action, avoid or seek

to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions

of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing,

the Company (a) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the

Exercise Price then in effect, and (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly

and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this Warrant. Notwithstanding anything herein

to the contrary, if after the sixty (60) calendar day anniversary of the Issuance Date, the Holder is not permitted to exercise this

Warrant in full for any reason (other than pursuant to restrictions set forth in Section 1(f) hereof), the Company shall use its best

efforts to promptly remedy such failure, including, without limitation, obtaining such consents or approvals as necessary to permit such

exercise into shares of Common Stock.

6. WARRANT

HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder

of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of capital stock of the Company for any purpose,

nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,

any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any

reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,

receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled

to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities

on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such

liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the

Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with

the giving thereof to the stockholders; provided that the Company shall have no such obligation to the extent such information is filed

with the SEC through EDGAR and are available to the public through the EDGAR system.

7. REISSUANCE

OF WARRANTS.

(a) Transfer

of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will

forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may

request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total

number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder

representing the right to purchase the number of Warrant Shares not being transferred.

(b) Lost,

Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,

destruction or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall

suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the

Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the

Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase

the Warrant Shares then underlying this Warrant.

(c) Exchangeable

for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the

Company, for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the

number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion

of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional

shares of Common Stock shall be given.

(d) Issuance

of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant

(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to

purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or

Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the

other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this

Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date,

and (iv) shall have the same rights and conditions as this Warrant.

(e) Representation

by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any

exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for

distributing or reselling such Warrant Shares or any part thereof in violation of the 1933 Act or any applicable state securities

law, except pursuant to sales registered or exempted under the 1933 Act.

8. NOTICES.

Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance

with Section 9(f) of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions

taken pursuant to this Warrant (other than the issuance of shares of Common Stock upon exercise in accordance with the terms hereof),

including in reasonable detail a description of such action and the reason therefor. Without limiting the generality of the foregoing,

the Company will give written notice to the Holder (i) immediately upon each adjustment of the Exercise Price and the number of Warrant

Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s), (ii) at least fifteen (15) days prior

to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common

Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock, warrants,

securities or other property to holders of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction,

dissolution or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction

with such notice being provided to the Holder, and (iii) at least ten (10) Trading Days prior to the consummation of any Fundamental

Transaction. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the

Company or any of its Subsidiaries, the Company shall simultaneously file such notice with the SEC (as defined in the Securities Purchase

Agreement) pursuant to a Current Report on Form 8-K. If the Company or any of its Subsidiaries provides material non-public information

to the Holder that is not simultaneously filed in a Current Report on Form 8-K and the Holder has not agreed to receive such material

non-public information, the Company hereby covenants and agrees that the Holder shall not have any duty of confidentiality to the Company,

any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agents with respect to, or a duty to

any of the foregoing not to trade on the basis of, such material non-public information. It is expressly understood and agreed that the

time of execution specified by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.

9. DISCLOSURE.

Upon delivery by the Company to the Holder (or receipt by the Company from the Holder) of any notice in accordance with the terms of

this Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public

information relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York City time on the Business

Day immediately following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form

8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information relating to the Company

or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt

of notice from the Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the

Company immediately upon receipt of notice from the Holder), the Holder shall be entitled to presume that information contained in the

notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing contained in

this Section 9 shall limit any obligations of the Company, or any rights of the Holder, under Section 4(i) of the Securities Purchase

Agreement.

10. ABSENCE

OF TRADING AND DISCLOSURE RESTRICTIONS. The Company acknowledges and agrees that the Holder is not a fiduciary or agent of the Company

and that the Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain

from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an

officer of the Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,

written non-disclosure agreement, the Company acknowledges that the Holder may freely trade in any securities issued by the Company,

may possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information

to any third party.

11. AMENDMENT

AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant (other than Section 1(f)) may be amended and the

Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company

has obtained the written consent of the Required Holders (as defined in the Securities Purchase Agreement). No waiver shall be effective

unless it is in writing and signed by an authorized representative of the waiving party.

12. SEVERABILITY.

If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent

jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest

extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity

of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the

original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s)

in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization

of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the

prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of

the prohibited, invalid or unenforceable provision(s).

13. GOVERNING

LAW. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,

validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving

effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would

cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably waives personal

service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the Company

at the address set forth in Section 9(f) of the Securities Purchase Agreement and agrees that such service shall constitute good and

sufficient service of process and notice thereof. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and

federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection

herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in

any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action

or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained

herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall

be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction

to collect on the Company’s obligations to the Holder, to realize on any collateral or any other security for such obligations,

or to enforce a judgment or other court ruling in favor of the Holder. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE

TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS

WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.

14. CONSTRUCTION;

HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any

Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the

interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed

to such terms on the Closing Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents unless otherwise

consented to in writing by the Holder.

15. DISPUTE

RESOLUTION.

(a) Submission

to Dispute Resolution.

(i)

In the case of a dispute relating to the Exercise Price, the Closing Sale Price, the Bid Price, Black Scholes Value or fair market

value or the arithmetic calculation of the number of Warrant Shares (as the case may be) (including, without limitation, a dispute

relating to the determination of any of the foregoing), the Company or the Holder (as the case may be) shall submit the dispute to

the other party via facsimile (A) if by the Company, within two (2) Business Days after the occurrence of the circumstances giving

rise to such dispute or (B) if by the Holder, at any time after the Holder learned of the circumstances giving rise to such dispute.

If the Holder and the Company are unable to promptly resolve such dispute relating to such Exercise Price, such Closing Sale Price,

such Bid Price, such Black Scholes Value or such fair market value or such arithmetic calculation of the number of Warrant Shares

(as the case may be), at any time after the second (2nd) Business Day following such initial notice by the Company or the Holder (as

the case may be) of such dispute to the Company or the Holder (as the case may be), then the Holder may, at its sole option, select

an independent, reputable investment bank to resolve such dispute.

(ii)

The Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in

accordance with the first sentence of this Section 15 and (B) written documentation supporting its position with respect to such

dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5th) Business Day immediately following the date on

which the Holder selected such investment bank (the “Dispute Submission Deadline”) (the documents referred to in

the immediately preceding clauses (A) and (B) are collectively referred to herein as the “Required Dispute

Documentation”) (it being understood and agreed that if either the Holder or the Company fails to so deliver all of the

Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute

Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit any written documentation or other

support to such investment bank with respect to such dispute and such investment bank shall resolve such dispute based solely on the

Required Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission Deadline). Unless

otherwise agreed to in writing by both the Company and the Holder or otherwise requested by such investment bank, neither the

Company nor the Holder shall be entitled to deliver or submit any written documentation or other support to such investment bank in

connection with such dispute (other than the Required Dispute Documentation).

(iii)

The Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and

the Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees

and expenses of such investment bank shall be borne solely by the Company, and such investment bank’s resolution of such

dispute shall be final and binding upon all parties absent manifest error.

(b) Miscellaneous.

The Company expressly acknowledges and agrees that (i) this Section 15 constitutes an agreement to arbitrate between the Company and

the Holder (and constitutes an arbitration agreement) under the rules then in effect under § 7501, et seq. of the New York

Civil Practice Law and Rules (“CPLR”) and that the Holder is authorized to apply for an order to compel

arbitration pursuant to CPLR § 7503(a) in order to compel compliance with this Section 15, (ii) the terms of this Warrant and

each other applicable Transaction Document shall serve as the basis for the selected investment bank’s resolution of the

applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations

and the like that such investment bank determines are required to be made by such investment bank in connection with its resolution

of such dispute, (iii) the Holder (and only the Holder), in its sole discretion, shall have the right to submit any dispute

described in this Section 15 to any state or federal court sitting in The City of New York, Borough of Manhattan in lieu of

utilizing the procedures set forth in this Section 15 and (iv) nothing in this Section 15 shall limit the Holder from obtaining any

injunctive relief or other equitable remedies (including, without limitation, with respect to any matters described in this Section

15).

16. REMEDIES,

CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative

and in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity

(including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder

to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Warrant. The Company

covenants to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein.

Amounts set forth or provided for herein with respect to payments, exercises and the like (and the computation thereof) shall be the

amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the

Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause

irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that,

in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other

available remedies, to specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from

any court of competent jurisdiction in any such case without the necessity of proving actual damages and without posting a bond or

other security. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable

the Holder to confirm the Company’s compliance with the terms and conditions of this Warrant (including, without limitation,

compliance with Section 2 hereof). The issuance of shares and certificates for shares as contemplated hereby upon the exercise of

this Warrant shall be made without charge to the Holder or such shares for any issuance tax or other costs in respect thereof,

provided that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the

issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.

17.

PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER COSTS. If (a) this Warrant is placed in the hands of an attorney for

collection or enforcement or is collected or enforced through any legal proceeding or the holder otherwise takes action to collect

amounts due under this Warrant or to enforce the provisions of this Warrant or (b) there occurs any bankruptcy, reorganization,

receivership of the company or other proceedings affecting company creditors’ rights and involving a claim under this Warrant,

then the Company shall pay the costs incurred by the Holder for such collection, enforcement or action or in connection with such

bankruptcy, reorganization, receivership or other proceeding, including, without limitation, attorneys’ fees and

disbursements.

18. TRANSFER.

This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except as may otherwise be required

by Section 2(g) of the Securities Purchase Agreement and applicable securities laws.

19. CERTAIN

DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

(a)

“1933 Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder.

(b)

“1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

(c)

“Adjustment Right” means any right granted with respect to any securities issued in connection with, or with respect

to, any issuance or sale (or deemed issuance or sale in accordance with Section 2) of Common Stock (other than rights of the type described

in Section 3 and 4 hereof) that could result in a decrease in the net consideration received by the Company in connection with, or with

respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).

(d)

“Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled

by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a

Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of

directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.

(e)

“Attribution Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including,

any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed

or advised by the Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of

the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or

any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated

with the Holder’s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of

the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.

(f)

“Bid Price” means, for any security as of the particular time of determination, the bid price for such security on

the Principal Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal securities

exchange or trading market for such security, the bid price of such security on the principal securities exchange or trading market where

such security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the

bid price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg

as of such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination, the

average of the bid prices of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency

succeeding to its functions of reporting prices) as of such time of determination. If the Bid Price cannot be calculated for a security

as of the particular time of determination on any of the foregoing bases, the Bid Price of such security as of such time of determination

shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree

upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 15. All

such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction

during such period.

(g)

[Reserved.]

(h)

“Black Scholes Value” means the value of the unexercised portion of this Warrant remaining on the date of the Holder’s

request pursuant to Section 4(c)(i), which value is calculated using the Black Scholes Option Pricing Model obtained from the “OV”

function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common

Stock during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction

(or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request

pursuant to Section 4(c)(i) and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if

any) plus the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price

equal to the Exercise Price in effect on the date of the Holder’s request pursuant to Section 4(c)(i), (iii) a risk-free interest

rate corresponding to the U.S. Treasury rate for a period equal to the greater of (1) the remaining term of this Warrant as of the date

of the Holder’s request pursuant to Section 4(c)(i) and (2) the remaining term of this Warrant as of the date of consummation of

the applicable Fundamental Transaction or as of the date of the Holder’s request pursuant to Section 4(c)(i) if such request is

prior to the date of the consummation of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility

equal to the 30 day volatility obtained from the “HVT” function on Bloomberg (determined utilizing a 365 day annualization

factor) as of the Trading Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental

Transaction and (B) the date of the Holder’s request pursuant to Section 4(c)(i).

(i)

“Bloomberg” means Bloomberg, L.P.

(j)

“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New

York are authorized or required by law to remain closed; provided, however, for clarification,

commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,

“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the

direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial

banks in The City of New York generally are open for use by customers on such day.

(k)

“Closing Sale Price” means, for any security as of any date, the last closing trade price for such security on the

Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate

the closing trade price, then the last trade price of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or,

if the Principal Market is not the principal securities exchange or trading market for such security, the last trade price of such security

on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing

does not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security

as reported by Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any

market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding to its functions

of reporting prices). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases,

the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.

If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in

accordance with the procedures in Section 15. All such determinations shall be appropriately adjusted for any stock dividend, stock split,

stock combination or other similar transaction during such period.

(l)

“Common Stock” means (i) the Company’s shares of common stock, $0.0001 par value per share, and (ii) any capital

stock into which such common stock shall have been changed or any capital stock resulting from a reclassification of such common stock.

(m)

“Convertible Securities” means any stock or other security (other than Options) that is at any time and under any

circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof

to acquire, any Common Stock.

(n)

“Eligible Market” means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq

Global Market, the Nasdaq Capital Market or the Principal Market.

(o)

[Reserved]

(p)

“Event Market Price” means, with respect to any Stock Combination Event Date, the lower of (i) the Exercise Price

in effect immediately after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination

Event Date as set forth herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven (11) consecutive

Trading Day period commencing on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and ending on the

fifth (5th) Trading Day immediately following the Stock Combination Event Date.

(o)

“Expiration Date” means the date that is the fifth (5th) anniversary of the Issuance Date or, if such date falls on

a day other than a Trading Day or on which trading does not take place on the Principal Market (a “Holiday”), the

next date that is not a Holiday.

(q)

“Fundamental Transaction” means (A) that the Company shall, directly or indirectly, including through subsidiaries,

Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the

surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all

of the properties or assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation

S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject

to or have its voting stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that

is accepted by the holders of at least either (x) more than 50% of the outstanding voting power of the Company, (y) more than 50% of

the outstanding voting power of the Company calculated as if any shares of voting stock held by all Subject Entities making or party

to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z)

such number of shares of voting stock such that all Subject Entities making or party to, or Affiliated with any Subject Entity making

or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934

Act) of more than 50% of the outstanding voting power of the Company, or (iv) consummate a stock or share purchase agreement or other

business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one

or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire, either (x) more than 50% of the

outstanding voting power of the Company (y) more than 50% of the outstanding voting power of the Company calculated as if any shares

of voting stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock

purchase agreement or other business combination were not outstanding; or (z) such number of shares of voting stock of the Company such

that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of more than 50% of

the outstanding voting power of the Company, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall,

directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject

Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3

under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange,

reduction in outstanding shares of voting stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off,

scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) more

than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company, (y) more

than 50% of the aggregate ordinary voting power represented by issued and outstanding shares of voting stock of the Company not held

by all such Subject Entities as of the date of this Warrant calculated as if any shares of voting stock of the Company held by all such

Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding

shares of voting stock of the Company or other equity securities of the Company sufficient to allow such Subject Entities to effect a

statutory short form merger or other transaction requiring other stockholders of the Company to surrender their shares of voting stock

of the Company without approval of the stockholders of the Company or (C) directly or indirectly, including through subsidiaries, Affiliates

or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction structured

in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed and implemented

in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary to correct this definition

or any portion of this definition which may be defective or inconsistent with the intended treatment of such instrument or transaction.

(r)

“Group” means a “group” as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5

thereunder.

(s)

[Reserved]

(t)

[Reserved]

(u)

“Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible

Securities.

(v)

“Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose

common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent

Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

(w)

“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,

an unincorporated organization, any other entity or a government or any department or agency thereof.

(x) “Principal

Market” means the Nasdaq Capital Market.

(y) “Registration

Rights Agreement” means that certain registration rights agreement, dated as of the Closing Date, by and among the Company

and the Buyers of the Preferred Shares and SPA Warrants relating to, among other things, the registration of the resale of the shares

of Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations

and exercise of the SPA Warrants, as may be amended from time to time.

(z) “SEC”

means the United States Securities and Exchange Commission or the successor thereto.

(aa)

“Subject Entity” means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.

(ab) “Successor

Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental

Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been

entered into.

(ac)

“Trading Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the

Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading

market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded,

provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or

market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange

or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during

the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or

(y) with respect to all determinations other than price or trading volume determinations relating to the Common Stock, any day on which

The New York Stock Exchange (or any successor thereto) is open for trading of securities.

(ad)

[Reserved]

(ae)

“VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal

Market (or, if the Principal Market is not the principal trading market for such security, then on the principal securities exchange

or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00

p.m., New York time, as reported by Bloomberg through its “VAP” function (set to 09:30 start time and 16:00 end time) or,

if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic

bulletin board for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as

reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the

average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in

The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated

for such security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as

mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such

security, then such dispute shall be resolved in accordance with the procedures in Section 15. All such determinations shall be appropriately

adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.

[signature

page follows]

IN

WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out

above.

STABLEX

TECHNOLOGIES, INC.

By:

Name:

Joshua

Silverman

Title:

Chief Executive

Officer

EXHIBIT

A

EXERCISE

NOTICE

TO

BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT

TO PURCHASE COMMON STOCK

STABLEX

TECHNOLOGIES, INC.

The

undersigned holder hereby elects to exercise the Warrant to Purchase Common Stock No. _______ (the “Warrant”) of STABLEX

TECHNOLOGIES, INC., a Delaware corporation (the “Company”), as specified below. Capitalized terms used herein and

not otherwise defined shall have the respective meanings set forth in the Warrant.

1.    Form

of Exercise Price. The Holder intends that payment of the Aggregate Exercise Price shall be made as:

☐ a

“Cash Exercise” with respect to _________________ Warrant Shares; and/or

☐ a

“Cashless Exercise” with respect to _______________ Warrant Shares.

In

the event that the Holder has elected a Cashless Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto,

the Holder hereby represents and warrants that (i) this Exercise Notice was executed by the Holder at __________ [a.m.][p.m.] on the

date set forth below and (ii) if applicable, the Bid Price as of such time of execution of this Exercise Notice was $________.

2. Payment

of Exercise Price. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to

be issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance

with the terms of the Warrant.

3.  Delivery

of Warrant Shares. The Company shall deliver to Holder, or its designee or agent as specified below, __________ shares of Common

Stock in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:

☐ Check

here if requesting delivery as a certificate to the following name and to the following address:

Issue

to:

☐ Check

here if requesting delivery by Deposit/Withdrawal at Custodian as follows:

DTC

Participant:

DTC

Number:

Account

Number:

Date: ___________________________ __, __

Name

of Registered Holder

By:

Name:

Title:

Tax ID:

Facsimile:

E-mail

Address:

EXHIBIT

B

ACKNOWLEDGMENT

The

Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares of Common

Stock in accordance with the Transfer Agent Instructions dated _________, 202_, from the Company and acknowledged and agreed to by _______________.

STABLEX

TECHNOLOGIES, INC.

By:

Name:

Title:

EX-4.2

EX-4.2

Filename: ex4-2.htm · Sequence: 8

Exhibit 4.2

NEITHER

THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION

OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED

(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS

OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE

OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON

STOCK PURCHASE WARRANT

StableX

Technologies, Inc.

Warrant

Shares: _______

Initial

Exercise Date: [_______], 2026

THIS

COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the

“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set

forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m.

(New York City time) on [______________]1 (the “Termination Date”) but not thereafter, to subscribe for

and purchase from StableX Technologies, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject

to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.0001 per share (“Common

Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined

in Section 2(b).

Section

1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain

Omnibus Waiver, Consent, Notice and Amendment Agreement (the “Agreement”), dated April 27, 2026, among the Company

and the investor listed on the signature page attached thereto and as set forth below.

a) “Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

1

Insert the date that is five (5) years following the Initial Exercise Date, provided that, if such date is not a Trading Day, insert the

immediately following Trading Day.

b) “Bid

Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock

is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)

on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.

(New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB Venture Market (“OTCQB”) or the OTCQX

Best Market (“OTCQX”) is not a Trading Market, the volume weighted average price of the Common Stock for such date

(or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on

OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (“Pink Market”) operated

by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price

per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined

by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably

acceptable to the Company, the fees and expenses of which shall be paid by the Company.

c) “Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability

company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

d) “Commission”

means the United States Securities and Exchange Commission.

e) “Common

Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire

at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is

at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

f) “Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

g) “Subsidiaries”

means any Person in which the Company, directly or indirectly, (i) owns any of the outstanding capital stock or holds any equity or similar

interest of such Person or (ii) controls or operates all or any part of the business, operations or administration of such Person.

h) “Trading

Day” means a day on which the principal Trading Market is open for trading.

i) Trading

Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date

in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York

Stock Exchange (or any successors to any of the foregoing).

2

j) “Transfer

Agent” means Equiniti Trust Company LLC, and any successor transfer agent of the Company.

k) “VWAP”

means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed

or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)

on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.

(New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted average

price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not

then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market operated

by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price

per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined

by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably

acceptable to the Company, the fees and expenses of which shall be paid by the Company.

Section

2. Exercise.

a) Exercise

of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on

or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted

by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”).

Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined

in Section 2(d)(i) herein), in each case following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise

Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United

States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.

No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)

of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically

surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has

been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably

practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting

in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding

number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and

the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver

any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance

of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the

Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount

stated on the face hereof.

3

b) Exercise

Price. The exercise price per share of Common Stock under this Warrant shall be $5.00, subject to adjustment hereunder (the “Exercise

Price”).

c) Cashless

Exercise. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained

therein is not available for the resale of the Warrant Shares by the Holder, and subject to the prior written consent of the Company,

then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the

Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

(A)

=

as

applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of

Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed

and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined

in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,

either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of

the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of

the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading

hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of

“regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable

Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered

pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

(B)

=

the

Exercise Price of this Warrant, as adjusted hereunder; and

(X)

=

the

number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such

exercise were by means of a cash exercise rather than a cashless exercise.

4

If

Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the

Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.  The

Company agrees not to take any position contrary to this Section 2(c). For the avoidance of doubt, the

Holder cannot cashless exercise pursuant to this Section 2(c) if at the time of exercise hereof there is an effective registration statement

registering, or the prospectus contained therein is available for the resale of the Warrant Shares by the Holder.

d) Mechanics

of Exercise.

i. Delivery

of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares acquired hereunder to be transmitted by the Transfer

Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust

Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such

system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the

Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations

pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate or a book-entry

certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares

to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date

that is the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each

case after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon

delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the

Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided

that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one

(1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case after the delivery to the

Company of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice

of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,

for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice

of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share

Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds

such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains

outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed

in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date

of delivery of the Notice of Exercise.

5

ii. Delivery

of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and

upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing

the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other

respects be identical with this Warrant.

iii. Rescission

Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)

by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

iv. Compensation

for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if

the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section

2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by

its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares

of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon

such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)

the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds

(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection

with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)

at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise

was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock

that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the

Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares

of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately

preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating

the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing

herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without

limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares

of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

6

v. No

Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this

Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,

at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the

Exercise Price or round up to the next whole share.

vi. Charges,

Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other

incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and

such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,

however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when

surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may

require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company

shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company

(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

vii. Closing

of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,

pursuant to the terms hereof.

e) Holder’s

Exercise Limitations. The Company shall not effect any exercise of this Warrant, and

a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section

2 or otherwise, to the extent that after giving effect to such issuance after exercise as

set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s

Affiliates, and any other Persons acting as a group together with the Holder or any of the

Holder’s Affiliates (such Persons, “Attribution Parties”)), would

beneficially own in excess of the Beneficial Ownership Limitation (as defined below).

For purposes of the foregoing sentence, the number of shares of Common Stock beneficially

owned by the Holder and its Affiliates and Attribution Parties shall include the number of

shares of Common Stock issuable upon exercise of this Warrant with respect to which such

determination is being made, but shall exclude the number of shares of Common Stock which

would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant

beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)

exercise or conversion of the unexercised or nonconverted portion of any other securities

of the Company (including, without limitation, any other Common Stock Equivalents) subject

to a limitation on conversion or exercise analogous to the limitation contained herein beneficially

owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set

forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership

shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and

regulations promulgated thereunder, it being acknowledged by the Holder that the Company

is not representing to the Holder that such calculation is in compliance with Section 13(d)

of the Exchange Act and the Holder is solely responsible for any schedules required to be

filed in accordance therewith. To the extent that the limitation contained in this Section

2(e) applies, the determination of whether this Warrant is exercisable (in relation to other

securities owned by the Holder together with any Affiliates and Attribution Parties) and

of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder,

and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination

of whether this Warrant is exercisable (in relation to other securities owned by the Holder

together with any Affiliates and Attribution Parties) and of which portion of this Warrant

is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company

shall have no obligation to verify or confirm the accuracy of such determination. In addition,

a determination as to any group status as contemplated above shall be determined in accordance

with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.

For purposes of this Section 2(e), in determining the number of outstanding shares of Common

Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected

in (A) the Company’s most recent periodic or annual report filed with the Commission,

as the case may be, (B) a more recent public announcement by the Company or (C) a more recent

written notice by the Company or the Transfer Agent setting forth the number of shares of

Common Stock outstanding.  Upon the written or oral request of a Holder, the Company

shall within one (1) Trading Day confirm orally and in writing to the Holder the number of

shares of Common Stock then outstanding.  In any case, the number of outstanding shares

of Common Stock shall be determined after giving effect to the conversion or exercise of

securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution

Parties since the date as of which such number of outstanding shares of Common Stock was

reported. The “Beneficial Ownership Limitation” shall be [9.99/4.99%]

of the number of shares of the Common Stock outstanding immediately after giving effect to

the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder,

upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation

provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no

event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after

giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held

by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase

in the Beneficial Ownership Limitation will not be effective until the 61st day

after such notice is delivered to the Company. The provisions of this paragraph shall be

construed and implemented in a manner otherwise than in strict conformity with the terms

of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective

or inconsistent with the intended Beneficial Ownership Limitation herein contained or to

make changes or supplements necessary or desirable to properly give effect to such limitation.

The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

7

Section

3. Certain Adjustments.

a) Stock

Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes

a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of

Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this

Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse

stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the

Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which

the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event

and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of

shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant

shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for

the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the

effective date in the case of a subdivision, combination or re-classification.

b) Subsequent

Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells

any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any

class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms

applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number

of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including

without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance

or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are

to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that to the extent that the Holder’s

right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder

shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as

a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until

such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

c) Pro

Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution

of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,

without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,

corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after

the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent

that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete

exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership

Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as

of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,

however, that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding

the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in

the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution

shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder

exceeding the Beneficial Ownership Limitation).

d) Calculations.

All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes

of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the

number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

e) Notice

to Holder.

i. Adjustment

to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly

deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number

of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

8

ii. Notice

to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common

Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall

authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock

of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification

of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of

all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,

cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs

of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall

appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter

specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,

rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled

to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,

consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected

that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other

property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to

deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to

be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information

regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a

Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such

notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

Section

4. Transfer of Warrant.

a) Transferability.

Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any

registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or

its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the

Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender

and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,

as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a

new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything

herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned

this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date

on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance

herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

9

b) New

Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,

together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or

its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,

the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in

accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and

shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c) Warrant

Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant

Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder

of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other

purposes, absent actual notice to the contrary.

d) Representation

by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise

hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or

reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant

to sales registered or exempted under the Securities Act.

Section

5. Miscellaneous.

a) No

Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends

or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set

forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to

Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required

to net cash settle an exercise of this Warrant.

b) Loss,

Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory

to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case

of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include

the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make

and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

10

c) Saturdays,

Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted

herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.

d) Authorized

Shares.

The

Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a

sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.

The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with

the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all

such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any

applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants

that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise

of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly

issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof

(other than taxes in respect of any transfer occurring contemporaneously with such issue).

Except

and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending

its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale

of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,

but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary

or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the

foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise

immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company

may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially

reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,

as may be, necessary to enable the Company to perform its obligations under this Warrant.

Before

taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the

Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from

any public regulatory body or bodies having jurisdiction thereof.

11

e) Jurisdiction.

All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance

with the provisions of the Agreement.

f) Restrictions.

The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not

utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

g) Nonwaiver

and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as

a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that the right

to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Agreement, if

the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the

Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited

to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due

pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

h) Notices.

Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered

in accordance with the notice provisions of the Agreement.

i) Limitation

of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant

Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase

price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the

Company.

j) Remedies.

The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific

performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss

incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any

action for specific performance that a remedy at law would be adequate.

k) Successors

and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the

benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.

The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable

by the Holder or holder of Warrant Shares.

l) Amendment.

Other than Section 2(e) and this Section 5(l), which may not be modified, amended or waived, this Warrant may be modified or amended

or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this Warrant, on the other

hand.

m) Severability.

Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,

but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the

extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

n) Headings.

The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this

Warrant.

********************

(Signature

Page Follows)

12

IN

WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above

indicated.

STABLEX TECHNOLOGIES, Inc.

By:

Name:

Title:

NOTICE

OF EXERCISE

To: StableX

Technologies, Inc.

(1) The

undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised

in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2) Payment

shall take the form of (check applicable box):

☐ in

lawful money of the United States; or

☐ if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection

2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure

set forth in subsection 2(c).

(3) Please

issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

The

Warrant Shares shall be delivered to the following DWAC Account Number:

_______________________________

_______________________________

_______________________________

(4) Accredited

Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act

of 1933, as amended.

[SIGNATURE

OF HOLDER]

Name

of Investing Entity: ________________________________________________________________________

Signature

of Authorized Signatory of Investing Entity: _________________________________________________

Name

of Authorized Signatory: ___________________________________________________________________

Title

of Authorized Signatory: ____________________________________________________________________

Date:

_______________________________________________________________________________________

EXHIBIT

B

ASSIGNMENT

FORM

(To

assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase

shares.)

FOR

VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

Name:

(Please

Print)

Address:

(Please

Print)

Phone

Number:

Email

Address:

Dated:

_______________ __, ______

Holder’s

Signature: _______________________

Holder’s

Address: _______________________

EX-4.3

EX-4.3

Filename: ex4-3.htm · Sequence: 9

Exhibit

4.3

NEITHER

THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION

OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED

(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS

OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

STABLEX

TECHNOLOGIES, INC.

Warrant

To Purchase Shares Of Common Stock

Warrant

Shares: _______

Issue

Date: April __, 2026

This

WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, JD Advisors,

LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions

hereinafter set forth, at any time on or after the Exercisability Date (as defined herein) and on or prior to 5:00 p.m. (New York City

time) on _________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from StableX Technologies,

Inc., a Delaware corporation (the “Company”), up to _________ shares (as subject to adjustment hereunder, the “Warrant

Shares”) of common stock, par value $0.0001 per share (“Common Stock”). The purchase price of one share

of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(c). This Warrant is one of the Warrants

to purchase shares of Common Stock (the “Consulting Warrants”) issued pursuant to that certain Amended and Restated

Consulting Agreement (the “Consulting Agreement”), dated April 27, 2026, by and among the Company and JD Advisors,

LLC.

Section

1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Consulting Agreement

and as set forth below.

“Affiliate”

means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control

with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

“Bid

Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock

is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)

on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.

(New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted on a Trading Market and

if the Common Stock is listed or quoted for trading on the OTC Market Group’s OTCQB exchange (“OTCQB”) or OTCQX

exchange (“OTCQX”) (or any successors to either of the foregoing) , the VWAP of the Common Stock for such date (or

the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB

or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding

to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all other cases, the

fair market value of a share of the Common Stock as determined by an independent appraiser selected in good faith by the Holder reasonably

acceptable to the Company, the fees and expenses of which shall be paid by the Company.

1

“Business

Day” means any day other than a Saturday, a Sunday or any day on which commercial banks in the City of New York are authorized

or required by law or executive order to close or be closed; provided, however, for clarification, commercial banks in the City of New

York shall not be deemed to be authorized or required by law or executive order to close or be closed due to “stay at home”,

“shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of any

physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including

for wire transfers) of commercial banks in the City of New York are open for use by customers on such day.

“Common

Stock Equivalents” means any securities of the Company or its subsidiaries which would entitle the holder thereof to acquire

at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is

at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common

Stock.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“Person”

means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability

company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

“Securities

Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“Trading

Day” means a day on which the principal Trading Market is open for trading.

“Trading

Market” means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading

on the date in question: the NYSE American, the Nasdaq Stock Market LLC, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq

Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).

“VWAP”

means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then

listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding

date) on the Trading Market on which the Common Stock are then listed or quoted as reported by Bloomberg (based on a trading day from

9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the shares of Common Stock are listed or quoted on the OTCQB

or OTCQX (each as operated by OTC Markets Group, Inc., or any successor market), the volume weighted average price of the Common Stock

for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the shares of Common Stock are not then listed

or quoted for trading on the OTCQB or OTCQX Markets and if prices for the Common Stock are then reported in the OTC Pink Market published

by OTC Markets Group Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid

price per share of the shares of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock

as determined by an independent appraiser selected in good faith by the Board of Directors of the Company and reasonably acceptable to

the Holder, the fees and expenses of which shall be paid by the Company.

2

Section

2. Exercise.

a)

Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times

on or after the Exercisability Date (as defined below) and on or before the Termination Date by delivery to the Company of a duly executed

facsimile copy or PDF copy submitted by email (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice

of Exercise”). Within one (1) Trading Day following the date of exercise as aforesaid, the Holder shall deliver the aggregate

Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United

States bank unless the cashless exercise procedure specified in Section 2(d) below is specified in the applicable Notice of Exercise.

No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)

of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically

surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has

been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading

Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases

of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant

Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall

maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection

to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this

Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant

Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated

on the face hereof.

b)

Exercisability Date. The Warrant Shares shall become exercisable [________], provided there has been no breach or alleged breach

by the Holder of the terms of the Consulting Agreement. If there has been any breach or alleged breach by the Holder of the terms of

the Consulting Agreement prior to the Termination Date, this Warrant shall be forfeited and terminated immediately upon notice of such

breach by the Company to the Holder.

c)

Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $[____], subject to adjustment hereunder

(the “Exercise Price”).

d)

Cashless Exercise. Notwithstanding anything contained herein to the contrary, if, and only if, at the time of exercise hereof,

there is no effective registration statement, or the prospectus contained therein is not available for use, registering for resale by

the Holder of all of the Warrant Shares, then the Holder may, in its sole discretion, exercise this Warrant in whole or in part, in lieu

of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Exercise Price, elect

instead to receive upon such exercise the “Net Number” of Warrant Shares determined according to the following formula (a

“Cashless Exercise”):

Net

Number = (A x B) - (A x C)

B

3

For

purposes of the foregoing formula:

A

=

the

number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such

exercise were by means of a cash exercise rather than a Cashless Exercise.

B

=

as

applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of

Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed

and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined

in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the

Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid

Price of the Common Stock on the Company’s principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”)

as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during

“regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours

after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the

date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is

both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading

Day.

C =

the

Exercise Price of this Warrant, as adjusted hereunder.

If

Warrant Shares are issued in such a Cashless Exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the

Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period

of the Warrants being exercised may be tacked onto the holding period of the Warrant Shares. The Company agrees not to take any position

contrary to this Section 2(d).

Notwithstanding

anything to the contrary contained herein, the Warrant may not be exercised pursuant to a Cashless Exercise at any time during which

there is an effective registration statement registering the resale by the Holder of the Warrant Shares.

4

e)

Mechanics of Exercise.

i. Delivery

of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased

hereunder to be transmitted by the Company’s transfer agent (the “Transfer Agent”)

to the Holder by crediting the account of the Holder’s or its designee’s balance

account with The Depository Trust Company through its Deposit or Withdrawal at Custodian

system (“DWAC”) if the Company is then a participant in such system and

either (A) there is an effective registration statement permitting the issuance of the Warrant

Shares to or resale of the Warrant Shares by Holder or (B) the Warrant Shares are eligible

for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144,

and otherwise by physical delivery of a certificate, registered in the Company’s share

register in the name of the Holder or its designee, for the number of Warrant Shares to which

the Holder is entitled pursuant to such exercise to the address specified by the Holder in

the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after

the delivery to the Company by the Holder of the Notice of Exercise, (ii) one (1) Trading

Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of

Trading Days comprising the Standard Settlement Period after the delivery to the Company

of the Notice of Exercise (such date, the “Warrant Share Delivery Date”).

Notwithstanding the foregoing, the Company shall not be required to cause the applicable

Warrant Shares to be transmitted or a certificate or book-entry statement to be physically

delivered unless and until the aggregate Exercise Price is received by the Company (other

than in the case of a Cashless Exercise). Upon delivery of the Notice of Exercise, the Holder

shall be deemed for all corporate purposes to have become the holder of record of the Warrant

Shares with respect to which this Warrant has been exercised, irrespective of the date of

delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other

than in the case of a Cashless Exercise) is received within one (1) Trading Day following

delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the

Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date,

other than the Company’s failure to receive the aggregate Exercise Price, other than

in the case of a Cashless Exercise or any delays caused by the Transfer Agent, the Company

shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000

of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the

date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading

Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading

Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder

rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant

in the FAST program so long as this Warrant remains outstanding and exercisable. As used

herein, “Standard Settlement Period” means the standard settlement period,

expressed in a number of Trading Days, on the Company’s primary Trading Market with

respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

ii. Delivery

of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the

Company shall, at the request of a Holder and upon surrender of this Warrant certificate,

at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing

the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant,

which new Warrant shall in all other respects be identical with this Warrant.

iii. Rescission

Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the

Warrant Shares pursuant to Section 2(e)(i) by the Warrant Share Delivery Date, then the Holder

will have the right to rescind such exercise; provided, however, that the Holder shall

be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise

notice concurrently with the return to the Holder of the aggregate Exercise Price paid to

the Company for such Warrant Shares and the restoration of the Holder’s right to acquire

such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant

certificate evidencing such restored right).

iv. No

Fractional Shares or Scrip. No fractional shares or scrip

representing fractional shares shall be issued upon the exercise of this Warrant. As to any

fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise,

the Company shall, at its election, either pay a cash adjustment in respect of such final

fraction in an amount equal to such fraction multiplied by the Exercise Price or round up

to the next whole share.

5

v. Charges,

Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder

for any issue or transfer tax or other incidental expense in respect of the issuance of such

Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant

Shares shall be issued in the name of the Holder or in such name or names as may be directed

by the Holder; provided, however, that in the event that Warrant Shares are to be

issued in a name other than the name of the Holder, this Warrant when surrendered for exercise

shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and

the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse

it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees

required for same-day processing of any Notice of Exercise and all fees to the Depository

Trust Company (or another established clearing corporation performing similar functions)

required for same-day electronic delivery of the Warrant Shares.

vi. Closing

of Books. The Company will not close its stockholder books or records in any manner which

prevents the timely exercise of this Warrant, pursuant to the terms hereof.

f)

Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right

to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance

after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other

Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),

would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the

number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number

of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude

the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant

beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or

nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject

to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its

Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(f), beneficial ownership

shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being

acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)

of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent

that the limitation contained in this Section 2(f) applies, the determination of whether this Warrant is exercisable (in relation to

other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable

shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination

of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution

Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company

shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status

as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated

thereunder. For purposes of this Section 2(f), in determining the number of outstanding shares of Common Stock, a Holder may rely on

the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed

with the Securities and Exchange Commission (the “Commission”), as the case may be, (B) a more recent public announcement

by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common

Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing

to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall

be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or

its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The

“Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants,

9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock

issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation

provisions of this Section 2(f), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares

of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held

by the Holder and the provisions of this Section 2(f) shall continue to apply. Any increase in the Beneficial Ownership Limitation will

not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed

and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(f) to correct this paragraph (or any

portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make

changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph

shall apply to a successor holder of this Warrant

6

g)

Trading Market Regulation. The Company shall not issue any shares of Common Stock upon the exercise of this Warrant if the issuance of

such shares of Common Stock would exceed the aggregate number of shares of Common Stock which the Company may issue upon exercise or

conversion or otherwise pursuant to the terms of the Consulting Warrants without breaching the Company’s obligations under the

rules or regulations of the Trading Market (the number of shares which may be issued without violating such rules and regulations, the

“Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval

of its stockholders as required by the applicable rules of the Trading Market for issuances of shares of Common Stock in excess of the

Exchange Cap or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall

be reasonably satisfactory to the Holder.

Section

3. Certain Adjustments.

a)

Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise

makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares

of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this

Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse

stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common

Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the

numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event

and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of

shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant

shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for

the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the

effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price

of this Warrant will not be adjusted in the event that the Company or any subsidiary thereof, as applicable, sells or grants any option

to purchase, or sell or any grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option

to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise

Price then in effect.

7

b)

Fundamental Transaction. In case of any reclassification of the Common Stock (other than in a transaction to which Section 3(a) applies),

any consolidation of the Company with, or merger of the Company into, any other entity, any merger of another entity into the Company

(other than a merger that does not result in any reclassification, conversion, exchange or cancellation of outstanding Common Stock of

the Company), then lawful provision shall be made as part of the terms of such transaction whereby the Holder of this Warrant then outstanding

shall have the right thereafter, during the period this Warrant shall be exercisable, to exercise this Warrant only for the kind and

amount of securities, cash and other property receivable upon the reclassification, consolidation, merger, sale, transfer or share exchange

by a holder of the number of Common Stock of the Company into which this Warrant might have been able to exercise for immediately prior

to the reclassification, consolidation, merger, sale, transfer or share exchange assuming that such holder of Common Stock failed to

exercise rights of election, if any, as to the kind or amount of securities, cash or other property receivable upon consummation of such

transaction subject to adjustment as provided in Section 3(a) above following the date of consummation of such transaction. The provisions

of this Section 3(b) shall similarly apply to successive reclassifications, consolidations, mergers, sales, transfers or share exchanges.

c)

Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case

may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall

be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

d)

Notice to Holder.

i. Adjustment

to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision

of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email

a notice setting forth the Exercise Price after such adjustment and any resulting adjustment

to the number of Warrant Shares and setting forth a brief statement of the facts requiring

such adjustment.

ii. Notice

to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other

distribution in whatever form) on the Common Stock, (B) the Company shall declare a special

nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall

authorize the granting to all holders of the Common Stock rights or warrants to subscribe

for or purchase any shares of capital stock of any class or of any rights, (D) the approval

of any stockholders of the Company shall be required in connection with any reclassification

of the Common Stock, any consolidation or merger to which the Company (and all of its subsidiaries,

taken as a whole) is a party, any sale or transfer of all or substantially all of the assets

of the Company, or any compulsory share exchange whereby the Common Stock is converted into

other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary

dissolution, liquidation or winding up of the affairs of the Company, then, in each case,

the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile

number or email address as it shall appear upon the Warrant Register of the Company, at least

20 calendar days prior to the applicable record or effective date hereinafter specified,

a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,

distribution, redemption, rights or warrants, or if a record is not to be taken, the date

as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,

redemption, rights or warrants are to be determined or (y) the date on which such reclassification,

consolidation, merger, sale, transfer or share exchange is expected to become effective or

close, and the date as of which it is expected that holders of the Common Stock of record

shall be entitled to exchange their shares of Common Stock for securities, cash or other

property deliverable upon such reclassification, consolidation, merger, sale, transfer or

share exchange; provided that the failure to deliver such notice or any defect therein or

in the delivery thereof shall not affect the validity of the corporate action required to

be specified in such notice. To the extent that any notice provided in this Warrant constitutes,

or contains, as reasonably determined by the Company, material, non-public information regarding

the Company or any of the subsidiaries, the Company shall simultaneously file such notice

with the Commission pursuant to a Current Report on Form 8-K, The Holder shall remain entitled

to exercise this Warrant during the period commencing on the date of such notice to the effective

date of the event triggering such notice except as may otherwise be expressly set forth herein.

Notwithstanding the foregoing, no notice need be given to the Holder if the Company makes

a public announcement of the applicable event via nationally distributed press release or

via a publicly available and legally compliant filing with the Commission.

8

Section

4. Transfer of Warrant.

a)

Transferability. Prior to the vesting in full of the Warrant Shares pursuant to the terms and conditions of this Warrant, this

Warrant and all rights hereunder are non-transferable without the written consent of the Company. Upon the vesting in full of the Warrant

Shares pursuant to the terms and conditions of this Warrant and subject to compliance with any applicable securities laws and the conditions

set forth in Section 4(d), this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant

at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the

form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon

the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant

or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument

of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant

shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender

this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant

to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this

Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant

Shares without having a new Warrant issued.

b)

New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of

the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by

the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division

or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided

or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of

this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c)

Warrant Register. The Company shall register this Warrant, upon records to be maintained by or on behalf of the Company for that purpose

(the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat

the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the

Holder, and for all other purposes, absent actual notice to the contrary.

d)

Representation by Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any

exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing

or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except

pursuant to sales registered or exempted under the Securities Act.

9

Section

5. Miscellaneous.

a)

No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends

or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(e)(i), except as expressly set

forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “Cashless Exercise” pursuant to

Section 2(d), in no event shall the Company be required to net cash settle an exercise of this Warrant.

b)

Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably

satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,

and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,

shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the

Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant

or stock certificate.

c)

Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required

or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business

Day.

d)

Authorized Shares.

i.

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock

a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.

The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with

the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all

such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any

applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants

that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise

of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly

issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof

(other than taxes in respect of any transfer occurring contemporaneously with such issue).

ii.

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,

amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue

or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this

Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may

be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality

of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise

immediately prior to such increase in par value, (ii) take all such reasonable action as may be necessary or appropriate in order that

the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use

commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction

thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

10

iii.

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or

in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents therein, as may be necessary

from any public regulatory body or bodies having jurisdiction thereof.

e)

Governing Law; Venue. This Warrant shall be deemed to have been executed and delivered in New York and both this Warrant and the transactions

contemplated hereby shall be governed as to validity, interpretation, construction, effect, and in all other respects by the laws of

the State of New York applicable to agreements wholly performed within the borders of such state and without regard to the conflicts

of laws principles thereof (other than Section 5-1401 of The New York General Obligations Law). Each of the Holder and the Company: (a)

agrees that any legal suit, action or proceeding arising out of or relating to this Warrant and/or the transactions contemplated hereby

shall be instituted exclusively in the Supreme Court of the State of New York, New York County, or in the United States District Court

for the Southern District of New York, (b) waives any objection which it may have or hereafter to the venue of any such suit, action

or proceeding, and (c) irrevocably consents to the jurisdiction of Supreme Court of the State of New York, New York County, or in the

United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Holder and the

Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding

in the Supreme Court of the State of New York, New York County, or in the United States District Court for the Southern District of New

York and agrees that service of process upon the Company mailed by certified mail to the Company’s address or delivered by Federal

Express via overnight delivery shall be deemed in every respect effective service of process upon the Company, in any such suit, action

or proceeding, and service of process upon the Holder mailed by certified mail to the Holder’s address or delivered by Federal

Express via overnight delivery shall be deemed in every respect effective service process upon the Holder, in any such suit, action or

proceeding. THE HOLDER (ON BEHALF OF ITSELF, ITS SUBSIDIARIES AND, TO THE FULLEST EXTENT PERMITTED BY LAW, ON BEHALF OF ITS RESPECTIVE

EQUITY HOLDERS AND CREDITORS) HEREBY WAIVES ANY RIGHT HOLDER MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING

OUT OF OR IN CONNECTION WITH THIS WARRANT AND THE TRANSACTIONS CONTEMPLATED BY THIS WARRANT.

f)

Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and

the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

g)

Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate

as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision

of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material

damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,

but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting

any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

h)

Notices. Any and all notices or other communications or deliveries to be provided hereunder shall be made in accordance with the Consulting

Agreement.

i)

Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase

Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for

the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors

of the Company.

j)

Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including to seek recovery of damages,

will be entitled to seek specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be

adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive

and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

k) Successors

and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit

of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions

of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder

or holder of Warrant Shares.

l)

Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one

hand, and the Holder of this Warrant, on the other hand.

m)

Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under

applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be

ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions

of this Warrant.

n)

Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed

a part of this Warrant.

********************

(Signature

Page Follows)

11

IN

WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above

indicated.

STABLEX

TECHNOLOGIES, INC.

By:

Name:

Joshua

Silverman

Title:

Chief

Executive Officer

12

NOTICE

OF EXERCISE

TO:

STABLEX

TECHNOLOGIES, INC.

(1)

The undersigned hereby elects to purchase _________Warrant Shares of the Company pursuant to the terms of the attached Warrant

(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,

if any.

(2)

Payment shall take the form of (check applicable box):

in lawful money of the United States; or

if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the

formula set forth in subsection 2(d), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant

to the cashless exercise procedure set forth in subsection 2(d).

(3)

Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

The

Warrant Shares shall be delivered to the following DWAC Account Number:

[SIGNATURE

OF HOLDER]

Name

of Investing Entity:____________________________________________

_________________________________________________________________

Signature

of Authorized Signatory of Investing Entity:

______________________________________________________

Name

of Authorized Signatory:

____________________________________________________________

Title

of Authorized Signatory:

Date:___________________________________________________________

13

ASSIGNMENT

FORM

(To

assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

FOR

VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

Name:

(Please

Print)

Address:

(Please

Print)

Phone Number:

Email Address:

Dated: ____________

Holder’s Signature: _______________________________

Holder’s Address: ________________________________

14

EX-4.4

EX-4.4

Filename: ex4-4.htm · Sequence: 10

Exhibit 4.4

Amendment

to Rights Agreement

This

Amendment (this “Amendment”) to the Rights Agreement, is made as of April 27, 2026, by and between StableX Technologies,

Inc., a Delaware corporation (the “Company”), and Equiniti Trust Company, LLC (“Rights Agent”),

as rights agent, is amending that certain Rights Agreement, dated as of July 31, 2025, by and between the Company and the Rights Agent

(the “Rights Agreement”). Except as set forth herein, any defined terms contained herein have the respective meaning(s)

set forth in the Rights Agreement.

WITNESSETH

WHEREAS,

the Company and the Rights Agent desire, pursuant to and in accordance with Section 27 of the Rights Agreement, to amend the Rights Agreement

to make certain amendments to the definition of “Exempt Person” under the Rights Agreement.

NOW,

THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the Company and the Rights Agent agree as follows:

1. Amendment

to Rights Plan. The parties hereby agree that Section 1(q) of the Rights Agreement is

hereby amended and restated as follows (emphasis added):

(q) “Exempt

Person” shall mean (A) the Company or any Subsidiary of the Company, in each case

including, without limitation, in its fiduciary capacity, or any employee benefit plan of

the Company or of any Subsidiary of the Company, or any entity or trustee holding (or acting

in a fiduciary capacity in respect of) Company Stock for or pursuant to the terms of any

such plan or for the purpose of funding any such plan or funding other employee benefits

for employees of the Company or of any Subsidiary of the Company, or (B) any other Person

if the Board of Directors has determined in good faith that such Person shall be an “Exempt

Person.”

2. Counterparts;

Facsimile Execution. This Amendment may be executed in one or more counterparts (including

by electronic mail, in PDF or by DocuSign or similar electronic signature), all of which

shall be considered one and the same agreement and shall become effective when one or more

counterparts have been signed by each of the parties and delivered to the other parties.

Counterparts may be delivered via facsimile, electronic mail (including any electronic signature

covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic

Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission

method and any counterpart so delivered shall be deemed to have been duly and validly delivered

and be valid and effective for all purposes.

3. Governing

Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement

and interpretation of this Amendment shall be governed by the internal laws of the State

of New York, without giving effect to any choice of law or conflict of law provision or rule

(whether of the State of New York or any other jurisdictions) that would cause the application

of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably

submits to the exclusive jurisdiction of the state and federal courts sitting in The City

of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection

herewith or with any transaction contemplated hereby, and hereby irrevocably waives, and

agrees not to assert in any suit, action or proceeding, any claim that it is not personally

subject to the jurisdiction of any such court, that such suit, action or proceeding is brought

in an inconvenient forum or that the venue of such suit, action or proceeding is improper.

Each party hereby irrevocably waives personal service of process and consents to process

being served in any such suit, action or proceeding by mailing a copy thereof to such party

at the address for such notices to it under the Rights Agreement and agrees that such service

shall constitute good and sufficient service of process and notice thereof. Nothing contained

herein shall be deemed to limit in any way any right to serve process in any manner permitted

by law.

4. Terms

and Conditions of the Rights Agreement. Except as modified and amended herein, all of

the terms and conditions of the Rights Agreement shall remain in full force and effect.

[Signature

pages follow immediately.]

In

witness whereof, the undersigned has executed and delivered

this Amendment as of the date first above written.

Company:

STABLEX

TECHNOLOGIES, Inc.

By:

/s/

Joshua Silverman

Name:

Joshua

Silverman

Title:

Chief

Executive Officer

In

witness whereof, the undersigned has executed and delivered

this Amendment as of the date first above written.

Rights

Agent:

EQUINITI

TRUST COMPANY, LLC

By:

/s/

Krista Riley

Name

of signatory:

Krista

Riley

Title:

Manager,

Corporate Stock Transfer

EX-10.1

EX-10.1

Filename: ex10-1.htm · Sequence: 11

Exhibit 10.1

JOINT

DEVELOPMENT & LICENSE AGREEMENT

This

Joint Development & License Agreement (the “Agreement”) is entered into as of April 27, 2026 (“Effective

Date”) by and between Kopin Corporation, a Delaware corporation having a place of business at 125 North Drive, Westborough,

MA 01581 (“Kopin”), and StableX Technologies, Inc., a Delaware corporation having a place of business at 1185

Avenue of the Americas, New York, New York 10036 (“StableX”), each referred to herein as a “Party”

and together the “Parties.”

RECITALS

WHEREAS,

Kopin is in the business of developing and manufacturing advanced display and optical technologies;

WHEREAS,

StableX is in the business of acquiring and developing stablecoin assets, infrastructure, and related technologies to capitalize on the

growth of the stablecoin industry;

WHEREAS,

Kopin and StableX desire to work together to further develop and commercialize Kopin’s proprietary interface for GPU-to-GPU connectivity

on the terms set forth herein; and

WHEREAS,

Kopin and StableX have concurrently entered into various transaction agreements, including an Exclusive Supply and Distribution Agreement

(the “Supply Agreement” and together with this Agreement, the “Transaction Agreements”)

to facilitate the Project.

NOW,

THEREFORE, in consideration of the foregoing, the mutual covenants and agreements of the Parties contained herein, and other good

and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties to this Agreement agree as follows:

ARTICLE

I -DEFINITIONS

1.1

“Affiliate” means a corporation or other legal entity directly or indirectly (a) controlled by a Party, (b)

controlling the Party, or (c) controlled by the corporation, legal entity or persons which control the Party. For the purposes of this

paragraph, to “control” a corporation or an entity means to own or control, either directly or indirectly such as through

intermediary entities, (1) more than fifty percent (50%) of the shares or other securities entitled to vote for election of directors

(or other managing authority) of the corporation or entity; or (2) more than fifty percent (50%) of the equity or other ownership interest

of the corporation or entity.

1.2

“Bankruptcy Event” means, with respect to any Person, the occurrence of any of the following: (a) such Person

shall commence a voluntary case or other proceeding seeking liquidation, reorganization, or other relief with respect to itself or its

debts under any bankruptcy, insolvency, or other similar law now or hereafter in effect, or seeking the appointment of a trustee, receiver,

liquidator, custodian, or other similar official of it or any substantial part of its property; (b) such Person shall consent to any

such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against

it; (c) an involuntary case or other proceeding shall be commenced against such Person seeking liquidation, reorganization, or other

relief with respect to it or its debts under any bankruptcy, insolvency, or other similar law now or hereafter in effect, or seeking

the appointment of a trustee, receiver, liquidator, custodian, or other similar official of it or any substantial part of its property,

and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of sixty (60) consecutive days; (d)

such Person shall make a general assignment for the benefit of creditors; (e) such Person shall fail generally to pay, or shall admit

in writing its inability to pay, its debts as they become due; (f) such Person shall take any corporate or other organizational action

to authorize any of the foregoing; or (g) such Person shall cease to conduct substantially all of its business operations for a period

of ninety (90) or more consecutive days, other than as a result of a permitted transfer or assignment of this Agreement.

Page 1 of 22

1.3

“Control”, “Controls,” or “Controlled by” means the possession

by a Party (whether by ownership, license, or otherwise other than pursuant to this Agreement) of (a) with respect to any materials and

information, the legal authority or right to possession of such materials or information, with the right to provide such materials or

information to the other Party on the terms set forth herein, or (b) with respect to intellectual property and other intangible rights,

the legal authority or right to grant a license, sublicense, access, or right to use (as applicable) to the other Party under such intellectual

property and other intangible rights on the terms set forth herein, in each case (a) and (b), without breaching or otherwise violating

the terms of any arrangement or agreement with a third party or requiring consent from a third party; provided that neither Party

shall be deemed to Control any item or right of a third party if access by the other Party to such item or right requires or triggers

a payment obligation to such third party, unless the other Party agrees to bear such payment obligation.

1.4

“Development Plan” is defined in Section 2.1.

1.5

“Development Work” means all engineering, design, research, development, customization, and testing activities

performed by or on behalf of Kopin to develop the Project Technology in accordance with the applicable Development Plan.

1.6

“Field” means data communications chips expressly identified in an agreed Development Plan, including GPU-to-GPU,

Board-to-Board and Rack-to-Rack communications, and excluding any applications, use cases, architectures or technologies not expressly

set out in such Development Plan.

1.7

“HyperScaler Products” shall mean Products and Services using the Project Technology for end users in commercial

hyperscaler deployments only.

1.8

“Intellectual Property Rights” means any and all rights, title, and interest in and to intellectual property,

whether protected, created, or arising under the laws of the United States or any other jurisdiction, including: (a) patents, patent

applications, patent disclosures, and all related continuations, continuations-in-part, divisionals, reissues, re-examinations, substitutions,

and extensions thereof; (b) trademarks, service marks, trade names, trade dress, logos, corporate names, domain names, and other source

identifiers, together with all goodwill associated therewith; (c) copyrights, works of authorship, and moral rights; (d) trade secrets,

know-how, inventions, processes, techniques, methodologies, and other confidential or proprietary information; (e) mask works and semiconductor

topography rights; (f) database rights; (g) rights of publicity and privacy; (h) all registrations, applications, renewals, extensions,

and reversions of the foregoing; and (i) all other intellectual property rights and proprietary rights, however denominated, throughout

the world.

Page 2 of 22

1.9

“JSC” is identified in Section 2.1.

1.10

“Kopin Background Technology” means all Technology Controlled by Kopin on the Effective Date (including, for

clarity, the existing production version of the Monochrome MicroLED and the color MicroLED Design and production line configuration),

and any improvements and modifications to such Technology that is Controlled by Kopin at any time, excluding Project Technology.

1.11

“Military, Government and Defense Products” shall mean Products and Services using the Project Technology for

or with respect to: (a) government agencies, departments, instrumentalities or other public sector bodies, including defense, intelligence,

national security and public research bodies; (b) military, defense or government intelligence end users; and (c) defense contractors,

subcontractors, integrators and other entities primarily engaged in supplying products or services to government, military, defense or

government intelligence markets, in each case on a worldwide basis.

1.12

“Ordinary Course of Business” means, with respect to StableX, the conduct of its business in good faith and

in a manner consistent with (a) its stated business objectives and business plan as communicated to Kopin as of the Effective Date (including

as reflected in its organizational and governing documents provided to Kopin prior to the Effective Date), (b) maintaining organizational,

operational and financial resources reasonably sufficient to perform its obligations under this Agreement, and (c) using commercially

reasonable efforts to pursue active sales, marketing and commercial engagement activities in the hyperscale market, in each case subject

to temporary deviations caused by events outside StableX’s reasonable control.

1.13

“Production Plan” means the funding, development, manufacturing and commercialization plan for production deployment

of the Project Technology, as agreed in writing by the Parties pursuant to Section 2.3(e).

1.14

“Products” and “Services” used separately or together, means any equipment or services,

respectively, designed, developed or commercialized pursuant to any Development Plan and, if applicable, any agreed Production Plan under

this Agreement.

1.15

“Project Technology” means all Technology in the Field that is developed by either party in performance of

an agreed Development Plan, irrespective of inventorship, but excluding Kopin Background Technology and any next generation, follow-on

or derivative chipsets or technologies not expressly identified in such Development Plan. For the avoidance of doubt, Project Technology

shall not include any current generation IP with respect to the Monochrome and Color MicroLED developments under IBAS and SBIR developments,

next generation, follow-on or derivative chipsets, architectures or technologies, or any broader platform or system-level developments,

except to the extent expressly and specifically identified in an agreed Development Plan.

Page 3 of 22

1.16

“Successful Demo” means achievement of the prototype demonstration criteria expressly identified as such in

each applicable Development Plan.

1.17

“Technology” means any information, data, materials, discovery, invention, idea, discovery, process, protocol,

techniques, formulation, know-how, trade secret, method, development, enhancement, modification, improvement, work of authorship, computer

software (including, but not limited to, source code and object or executable code), material, or sample; and documentation of any of

the foregoing (including any records, data, concepts, information, designs, programs, formulae, or writings); in each case whether patentable

or not, or susceptible to copyright, trade secret, or any other form of legal protection under applicable law (including regulations).

ARTICLE

II -TECHNOLOGY DEVELOPMENT

2.1

General. The Parties will work together to develop a prototype and demonstration version of the Project Technology in accordance

with one or more statements of work or purchase orders (each, a “Development Plan”) agreed in writing between

the Parties from time to time, which shall set out the scope, deliverables, timelines and other relevant terms of the applicable development

activities. Following achievement of a Successful Demo, the Parties may proceed to production deployment and commercialization only pursuant

to an agreed Production Plan. The Parties acknowledge that StableX is funding the development of the prototype and demonstration version

of the Project Technology and, subject to agreement on a Production Plan, may take commercial risk associated with bringing the Project

Technology to production, while Kopin is performing the Development Work and retaining ownership of the Kopin Background Technology.

The project that is the subject of a Development Plan is a “Project”. Kopin will provide and make available

all equipment, materials, supplies and personnel reasonably required to fulfill its agreed upon development obligations as set forth

in the applicable Development Plan. In addition, Kopin will keep StableX informed on a regular basis as to the progress and results of

its work under each Development Plan. All Development Plans and Projects shall be subject to approval in accordance with Article III

and also oversight by the Joint Steering Committee (the “JSC”) as set forth in Article III; provided that Kopin

shall retain day-to-day responsibility for the conduct and execution of the Development Work and, within five (5) business days of the

Effective Date Kopin will provide a detailed staff listing of which personnel will conduct the Development Work. The Parties acknowledge

that the objective of each Development Plan is to enable production deployment of the Project Technology, subject to the funding and

commercialization framework set out in this Agreement. No Development Plan shall expand the scope of the Field without the prior written

agreement of both Parties.

2.2

Development Plan. Kopin agrees to work diligently towards completion of the goals and objectives set forth in each Development

Plan and to use commercially reasonable efforts to carry out the obligations and activities specified in each Development Plan. Any material

modification to a Development Plan shall require JSC approval.

Page 4 of 22

2.3

Budget and Costs.

(a)

StableX agrees that it will pay Kopin up to $15,000,000 in the aggregate for the development of the Project Technology through achievement

of at least one Successful Demo meeting the criteria expressly agreed in the applicable Development Plan and the funding schedule agreed

by the Parties (the “Development Funds”). As of the Effective Date, StableX shall ensure that at least $5,000,000

of funds are available in a segregated account to cover Development Plan needs and StableX shall not use such funds for any purpose inconsistent

with its payment obligations under this Agreement. StableX shall, at Kopin’s reasonable request, provide an account statement within

three (3) business days. StableX agrees not to take any action that would materially impair the availability of funds in the segregated

account or the Development Funds generally.

(b)

Each Development Plan includes a budget (“Budget”) setting forth Kopin’s budget with respect to its performance

of such Development Plan. StableX shall issue a Purchase Order (as defined below) in an initial funding amount of $5,000,000 within ten

(10) business days after the Effective Date (“Kickoff Payment”), which StableX shall pay to Kopin within ten

(10) business days of Kopin’s receipt of such Purchase Order. Following the Kickoff Payment, the remaining Development Funds shall

be paid by StableX to Kopin in installments in accordance with a time-based funding schedule agreed by the Parties as part of the applicable

Development Plan, which shall provide for the full funding of the Development Work through to Successful Demo. StableX shall issue Purchase

Orders in accordance with such funding schedule, and Kopin shall issue invoices accordingly. Each invoice shall be payable within ten

(10) business days of receipt. Each Purchase Order shall be subject to review and approval by the JSC, which approval shall not be unreasonably

withheld, conditioned or delayed and shall be based on consistency with the Budget and the applicable Development Plan. For the avoidance

of doubt, StableX’s obligation to fund any Purchase Order shall not be contingent on the achievement or verification of any technological

or development milestones. A Development Plan may include indicative milestones or workstreams for tracking and reporting purposes, but

such milestones shall not operate as a condition to payment. Except as set forth in this Section 2.3, each Party shall be solely responsible

for any costs or expenses it incurs in the performance of its obligations hereunder. For the avoidance of doubt, in no event shall StableX’s

aggregate monetary obligations hereunder exceed $15,000,000 without its express prior written consent.

(c)

Kopin shall (i) provide StableX with periodic written reports (“Development Reports”) not less than once per

month concerning all material activities undertaken in respect of the applicable Development Plan, (ii) keep StableX informed on a timely

basis concerning all material progress in the applicable Development Plan, and (iii) at StableX’s reasonable written request, from

time to time, provide StableX with information relating to the progress of the applicable Development Plan. If progress in respect of

the applicable Development Plan differs materially from that anticipated in the applicable Development Plan or a preceding Development

Report, Kopin shall endeavor to explain, in its Development Report, the reason therefor and may propose a modified Development Plan.

Kopin shall also make reasonable efforts to provide StableX with any reasonable additional data that StableX reasonably requires to evaluate

the performance of Kopin hereunder.

Page 5 of 22

(d)

StableX shall ensure that sufficient funds are available to meet its payment obligations as they fall due under this Agreement and shall

not withhold, defer, set off or otherwise delay any payments except as expressly permitted under this Agreement. Failure by StableX to

make any payment when due, or to maintain such committed funding, shall constitute a material breach of this Agreement.

(e)

Following achievement of a Successful Demo, the Parties shall engage in good faith negotiations for a period of 1 year to agree a Production

Plan (“Negotiation Period”), which is expected to include an additional payment by StableX of approximately

$15,000,000 to $25,000,000, subject to the agreed scope, specifications and deployment requirements. In negotiating the Production Plan,

the Parties shall take into account the results of the Successful Demo, the technical requirements for production deployment, and the

commercial objectives of the Parties. If the Parties do not reach agreement on the Production Plan within such Negotiation Period, or

if StableX does not commit to funding production deployment on terms agreed in the Production Plan, StableX shall be deemed to have elected

not to proceed with the Project for purposes of Section 9.5.

2.4

Additional Consideration; Preferred Equity. In further consideration of Kopin’s contributions to the development of the

Project Technology, StableX shall issue to Kopin shares of Convertible Preferred Stock (the “Convertible Preferred Stock”)

on the terms and conditions set forth in the applicable certificate of designations. The Parties acknowledge that such issuance is intended

to provide Kopin with a meaningful equity participation in StableX, and StableX shall take all actions reasonably necessary to give effect

to the agreed economic position of the Parties in connection with such issuance. The Parties acknowledge and agree that, following the

next or series of equity financing or capital raising by StableX of up to $50,000,000, Kopin is intended to hold equity securities representing

19.99% of StableX’s equity capitalization (including shares of common stock underlying unexercised options, warrants and other

common stock equivalents issued in connection with such financing transaction), and StableX shall work together in good faith to implement

such structure, including through the issuance of additional equity securities to Kopin. The Parties acknowledge that such issuance constitutes

material consideration for Kopin’s entry into this Agreement.

2.5

Marketing and Commercialization Support Plan. The Parties shall discuss in good faith and agree a marketing and commercialization

support plan for the Project Technology, including allocation of responsibilities and costs, following the Effective Date. Without limiting

the foregoing, the Parties intend that (a) Kopin shall be primarily responsible for developing and executing a robust marketing and sales

strategy for Military, Government and Defense Products on a worldwide basis, and (b) StableX shall be primarily responsible for developing

and executing a robust marketing and sales strategy for Products and Services in the Commercial Market (as defined in Section 4.4) on

a worldwide basis, in each case subject to further agreement between the Parties in the applicable plan. The Parties shall ensure that

any such plan is consistent with the allocation of rights set out in this Agreement.

Page 6 of 22

ARTICLE

III -– governance

3.1

Establishment of Joint Steering Committee. Within ten (10) business days after the Effective Date, the Parties shall establish

a joint steering committee to oversee and coordinate the performance of this Agreement. Each Party shall appoint two (2) representatives

to the JSC, each of whom is an officer or employee of the applicable Party having sufficient seniority within such Party to make decisions

arising within the scope of the JSC’s responsibilities. Kopin’s representatives shall include its CEO (presently Michael

Murray) as the titular Chairperson of the JSC. The Parties acknowledge that appropriate compensation arrangements for the Chairperson

of the JSC have not been finalized as of the Effective Date, and the Parties shall work together in good faith following the Effective

Date to determine and agree upon reasonable compensation for such role, which may include the entry into a consulting agreement or other

arrangement on mutually acceptable terms. Each Party may replace its JSC representatives upon written notice to the other Party provided

that such replacement meets the requirements set forth above. In addition, the JSC may, upon approval of the JSC, invite subject matter

experts to act as non-voting observers on the JSC.

3.2

Powers; Decision Making. Notwithstanding anything to the contrary in this Agreement, the JSC shall have oversight authority with

respect to the adoption and performance of any Development Plan, including review of the direction, scope, prioritization, and progress

of the Development Work. In the event of any dispute or disagreement between the Parties concerning the implementation and performance

of any Development Plan or any material matter relating to a Development Plan, such dispute shall be submitted to the JSC for resolution.

All decisions of the JSC shall be made by a majority vote, with each representative having one (1) vote; provided, however, that in the

event of a deadlock over a material aspect regarding the implementation and performance of a Development Plan and any matter relating

to changes in a Development Plan, such matter shall be escalated to the Chief Executive Officer (or equivalent senior executive) of each

Party. Such executives shall meet (in person or by videoconference) and use good faith efforts to resolve the deadlock within 10 business

days of such escalation. If the Parties are unable to resolve the deadlock within such period, then, notwithstanding Section 10.1, such

matter shall be finally resolved by arbitration before a panel of three (3) arbitrators. Each Party shall appoint one (1) arbitrator,

and the two party-appointed arbitrators shall appoint the third arbitrator, who shall act as chair. The arbitration shall be conducted

in New York, New York, in the English language, in accordance with the rules of the American Arbitration Association then in effect.

The decision of the arbitrators shall be final and binding on the Parties. All costs associated with such arbitration shall be borne

equally by the Parties.

3.3

Meetings. The JSC shall hold meetings at such times as it elects to do so, but in no event shall such meetings be held less frequently

than once per calendar quarter. Meetings of the JSC may be held in person or by video teleconference.

Page 7 of 22

ARTICLE

IV -INTELLECTUAL PROPERTY RIGHTS

4.1

Ownership of Intellectual Property Rights.

(a)

As between the Parties, Kopin owns all right, title and interest in all Kopin Background Technology, including all Intellectual Property

Rights relating thereto.

(b)

The Parties hereby agree to jointly and equally own all right, title and interest in any Project Technology, including all Intellectual

Property Rights arising therefrom and relating thereto, and to the extent one Party might solely own any Project Technology based on

inventorship each Party hereby agrees to assign, and does hereby assign, an undivided one-half ownership of such right, title, and interest,

to the other Party. Each Party agrees to execute, at no expense, any necessary documents to demonstrate such undivided ownership as reasonably

requested by the other Party.

(c)

Each employee, agent, or independent contractor of a Party or its Affiliates performing any work under a Development Plan will, prior

to commencing such work, be bound by invention assignment obligations, including: (i) promptly reporting any invention, discovery, process,

or other Technology; (ii) presently assigning to the applicable Party all of his or her rights, title, and interests in and to any invention,

discovery, process or other Technology; (iii) cooperating in the preparation, filing, prosecution, maintenance, and enforcement of any

patent or patent application; and (iv) performing all acts and signing, executing, acknowledging, and delivering any and all documents

required for effecting the obligations and purposes of this Agreement. It is understood and agreed that any such invention assignment

agreement need not reference or be specific to this Agreement.

4.2

Licenses to Background Technology. Subject to the terms of this Agreement, Kopin grants a non-exclusive, non-transferable (except

to Affiliates and permitted subcontractors, solely to the extent such Affiliates or subcontractors are required to execute the defined

responsibilities of StableX under this Agreement), non-sublicensable except as expressly permitted herein, royalty-free, worldwide, and

fully paid-up license under Kopin Background Technology to StableX for: (i) conducting the applicable Development Plan in accordance

with its terms and (ii) developing, commercializing and otherwise using the Project Technology solely within StableX’s rights expressly

granted under this Agreement, which includes (x) incorporation into Products and Services for the Commercial Market; and (y) marketing,

distributing and selling such Products and Services in the Commercial Market. For the avoidance of doubt, StableX shall not manufacture,

or have manufactured by any third party, any Products or Services incorporating any Kopin Background Technology or any Project Technology,

and all such Products and Services shall be manufactured exclusively by or on behalf of Kopin, irrespective of field of use, product

category, customer channel or route to market, in each case subject to and in accordance with the terms of the Supply Agreement. For

the purpose of clarity, Products and Services may be used and sold under this Section 4.2; provided that no license is granted under

this Section 4.2 with respect to Kopin Background Technology other than to the extent necessary for the exercise of StableX’s rights

in Project Technology under this Agreement. The license granted under this Section 4.2 shall terminate automatically upon termination

of this Agreement, except to the extent expressly preserved under Section 9.5. For the avoidance of doubt: (a) StableX shall not use

Kopin Background Technology to develop any products or technologies outside the scope of the Project Technology or following termination

of this Agreement, except as expressly permitted under Section 9.5 and (b) under no circumstances shall any right, title or interest

in Kopin Background Technology transfer to StableX, whether by termination, expiration, breach, operation of law or otherwise.

Page 8 of 22

4.3

Disclosure of Technology. Each Party shall use customary and reasonable measures to document and keep contemporaneous written

records of Development Work under the applicable Development Plan, including activities related to conception and reduction to practice

of Project Technology. Each Party shall promptly and fully disclose to the other Party in writing all Project Technology developed, created,

invented, authored, conceived or reduced to practice by or on behalf of such Party. Except as set forth in Section 4.5, each Party is

prohibited from making public disclosures or patent filings about such Project Technology without the prior written consent of the other

Party, which consent will not be unreasonably withheld, conditioned, or delayed.

4.4

Use of Project Technology. Notwithstanding any other provision of this Agreement and irrespective of the co-ownership of Project

Technology, neither Party shall have the right to commercialize or grant a license to any third party for any Project Technology or any

related Intellectual Property Right without the prior written consent of the other Party, which shall not be unreasonably withheld, conditioned,

or delayed; provided that: (a) Kopin shall have the exclusive worldwide rights to commercialize Military, Government and Defense Products

using Project Technology, including for all government, military, defense and government intelligence customers and through contractors,

integrators, resellers and other intermediaries serving such markets; and (b) StableX shall have the exclusive worldwide rights to commercialize

Products and Services using Project Technology in all markets and for all end users other than government, military, defense and government

intelligence customers (the “Commercial Market”). For the avoidance of doubt, each Party may commercialize

Project Technology within its respective exclusive field as set out above without further consent from the other Party.

4.5

Protection of Project Technology.

(a)

The Parties shall cooperate in developing a strategy for identifying and protecting any Project Technology, including, but not limited

to, registering or applying for patent and other intellectual property protection thereon (“Filings”). Kopin

will have the right, in its reasonable discretion, to make any Filings after good faith discussion with StableX in respect of Project

Technology, and Kopin will instruct its counsel to comply with the requirements of this Agreement regarding the protection, maintenance,

and enforcement of such Filings. If Kopin determines to file one or more patent applications, it shall instruct an appropriately qualified

patent attorney to draft, file and prosecute patent application(s), with the input of StableX. All reasonable costs and legal fees incurred

in connection with making, prosecuting, and maintaining Filings will be borne equally by the Parties, unless otherwise agreed in writing

by the Parties with respect to a particular Filing or jurisdiction. For the avoidance of doubt, each Party’s share of such costs

shall be borne separately and shall not be deducted from, credited against, or otherwise included within the Development Funds or any

amounts payable by StableX to Kopin for Development Work under this Agreement. Each Party will cooperate and supply any information that

is reasonably necessary to assist the other in the sharing, preparation, and filing of documentation necessary to protect, maintain,

and enforce the Project Technology. Such cooperation will include, but not be limited to, the execution of any and all documentation

necessary to properly complete any Filing. Such patent counsel shall represent Kopin only, unless the Parties expressly agree otherwise

in writing, and StableX may retain separate counsel at its own expense.

Page 9 of 22

(b)

In the event that Kopin has an opportunity to protect any specific Project Technology or a specific Intellectual Property Right related

thereto in any given jurisdiction and Kopin declines in writing to do so in that jurisdiction, it will provide at least 30 days’

notice to StableX, which will then, in its sole discretion, take whatever action it deems appropriate at its sole cost and expense, including

without limitation, by making such Filings as it deems appropriate, or pursuing or maintaining such Filings, to protect any aspect of

the Project Technology in such jurisdiction.

(c)

Each Party will cooperate and supply any information that is reasonably necessary to assist the other in the sharing, preparation, and

filing of documentation necessary to protect the Project Technology. Such cooperation will include, but not be limited to, the execution

of any and all documentation necessary to properly complete any Filing.

4.6

Enforcement of Rights in Project Technology.

(a)

Primary Right to Enforce/Protect. If either Party believes that any right in the Project Technology is being infringed, misappropriated,

or misused by a third party, such party shall promptly notify the other Party of such infringement or misuse, along with all the relevant

non-privileged facts then in its possession, and Kopin will have the primary right, within sixty (60) days from the date it becomes aware

of the infringement, misappropriation, or misuse, to proceed to protect or enforce the Project Technology, including as to the filing

and maintenance of a claim, demand, investigation, suit or other proceeding against such third party (an “Action”),

as appropriate, regarding such infringement, misappropriation, or misuse. Such Action shall be conducted at the joint cost and expense

of the Parties, with each Party bearing fifty percent (50%) of all out-of-pocket costs and expenses incurred in connection with such

Action. StableX agrees to cooperate as reasonably necessary in support of any such Action. All damages, profits, awards and royalties

obtained in connection with such Action shall be applied first to reimburse the Parties for their respective out-of-pocket costs and

expenses incurred in connection with such Action, and any remaining amounts shall be shared equally between the Parties. If required

by law, Kopin is authorized to pursue the Action in the name of StableX; provided however, that if Kopin takes action in the name

of StableX, it shall indemnify and hold StableX harmless from and against any and all monetary damages, fines, fees, penalties, obligations,

deficiencies, losses and out-of-pocket expenses that StableX incurs or is subject to directly as a result of such Action. StableX agrees

that, if required for standing, it may be joined to such Action involving litigation, arbitration, or such other dispute proceeding.

Kopin shall keep StableX reasonably informed regarding the conduct of any such Action and shall not settle any such Action in a manner

that materially adversely affects StableX’s rights in the Project Technology without StableX’s prior written consent (not

to be unreasonably withheld, conditioned or delayed).

Page 10 of 22

(b)

Secondary Right to Enforce/Protect. If Kopin declines to proceed with an Action within such (60) day period, then StableX may

proceed in its sole discretion, at the joint cost and expense of the Parties, with each Party bearing fifty percent (50%) of all out-of-pocket

costs and expenses incurred in connection with such Action, to file and prosecute such Action in its own name, or if required by law,

jointly with Kopin (and in such event, StableX is hereby authorized to take action in the name of Kopin); provided however, that

if StableX takes action in the name of Kopin, it shall indemnify and hold Kopin harmless from and against any and all monetary damages,

fines, fees, penalties, obligations, deficiencies, losses and out-of-pocket expenses that Kopin incurs or is subject to directly as a

result of such Action. Any damages, profits, awards and royalties recovered in connection with such Action shall be applied first to

reimburse the Parties for their respective out-of-pocket costs and expenses incurred in connection with such Action, and any remaining

amounts shall be shared equally between the Parties. If required for standing, Kopin hereby agrees to be joined to such Action involving

litigation, arbitration, or such other dispute proceeding.

4.7

Third-Party Challenge to Intellectual Property Rights in Project Technology. In the event a third party challenges the (i) validity,

(ii) enforceability, (iii) scope, or (iv) ownership of any of the co-owned Intellectual Property Rights in Project Technology before

any governmental authority with authority to determine the validity, enforceability, scope or ownership of such rights (an “IP

Challenge”), Kopin will have the primary right to manage such IP Challenge; provided that all reasonable out-of-pocket

costs and expenses incurred in connection with such IP Challenge shall be borne equally by the Parties. Kopin shall keep StableX reasonably

informed regarding the conduct of any such IP Challenge and shall not settle or compromise any such IP Challenge in a manner that materially

adversely affects StableX’s rights in the Project Technology without StableX’s prior written consent (not to be unreasonably

withheld, conditioned or delayed). Kopin will instruct its counsel to copy StableX on all relevant correspondence, to provide StableX

copies of draft responses at least 20 days before any deadline to permit StableX to provide input on such proposed responses, and to

review and consider any such input in good faith when finalizing and filing any such responses. If Kopin elects not to manage, or fails

to act sufficiently promptly with respect to, such IP Challenge, StableX shall have the secondary right to manage such IP Challenge on

substantially the same terms, mutatis mutandis.

ARTICLE

V -CONFIDENTIALITY

5.1

Confidentiality. Each Party agrees to use at least the same degree of care to keep confidential all proprietary ideas, plans and

information, including information of a technological or business nature received from the other Party at any time in connection with

this Agreement (“Confidential Information”) as such Party would use to keep confidential its own confidential

information, which degree of care will require at least commercially reasonable efforts. Each Party will only use the other Party’s

Confidential Information in furtherance of the joint development under this Agreement, and is only permitted to disclose the other Party’s

Confidential Information to its employees and agents who are performing work under this Agreement and have a need to know such Confidential

Information. These obligations of confidentiality shall not apply to: (a) information that, at the time of disclosure or thereafter becomes

publicly known through no fault of the receiving Party; (b) information that, at the time of disclosure, is already known to the receiving

Party (other than through the disclosing Party) as evidenced by written documents in its possession at the time; or (c) information that

is developed independently by the receiving Party without reference to or use of the disclosing Party’s Confidential Information.

Page 11 of 22

5.2

Required Disclosure. If Confidential Information is required to be disclosed by the receiving Party pursuant to law, rule or regulation

or a governmental authority, including pursuant to a valid and effective subpoena or court order, such Confidential Information may be

disclosed, provided that the receiving Party being required to disclose the Confidential Information: (i) promptly notifies the disclosing

Party of the disclosure requirement (to the extent legally permitted), (ii) reasonably cooperates with the disclosing Party’s efforts

to resist or narrow the disclosure (including to obtain an order or other reliable assurance that confidential treatment will be accorded

to the disclosing Party’s Confidential Information) at the disclosing Party’s request and expense, and (iii) furnishes only

that portion of the Confidential Information that is legally required to be disclosed.

5.3

Ownership of Confidential Information. The Parties acknowledge that each has a valuable proprietary interest in its Confidential

Information. The Parties acknowledge that neither has any right, title, or interest in the other’s Confidential Information except

as expressly set out in this Agreement.

5.4

Employees, Agents and Consultants. The Parties agree that their respective employees, financial or legal consultants or representatives,

or any Affiliates, having access to any of the other Party’s Confidential Information must be subject to a valid, binding and enforceable

arrangement to maintain the obligations of confidentiality and non-use of this Article V before receiving any such Confidential Information

of a disclosing Party, and the Parties shall be liable for any breach of any such obligation by their employees, consultants, or representatives

or those of their Affiliates. Each Party may disclose the terms of this Agreement in confidence to its professional advisors, attorneys,

insurers, financing sources and investors, and in confidence in connection with bona fide strategic transactional discussions with third

parties.

5.5

Injunctive Relief. The Parties acknowledge that the breach or threatened breach of this Article V may result in irreparable injury

to the disclosing Party and that, in addition to its other remedies, the disclosing Party will be entitled to seek injunctive relief

to restrain any threatened or continued breach of this Article V. The Parties hereby waive any requirement for the posting of a bond

or other security in connection with the granting to the disclosing Party of such injunctive relief.

5.6

Survivability. The provisions of this Article V shall survive the termination of this Agreement.

Page 12 of 22

ARTICLE

VI -SUBCONTRACTORS AND AFFILIATES

6.1

Subcontractors. Each Party agrees that it will perform its activities under a Development Plan through its own employees and may engage

independent contractors or subcontractors without prior consent, provided that such Party remains responsible for such entities’

compliance with the terms of this Agreement and ensures that such contractors are bound by written obligations of confidentiality and,

where applicable, invention assignment, no less protective than those set out in this Agreement.

6.2

Performance by Affiliates. Each Party may exercise its rights and perform its obligations under this Agreement directly or through

one or more of its Affiliates. Each Party’s Affiliates will have the benefit of all rights (including all licenses) of such Party

under this Agreement; provided that any exercise of rights by an Affiliate shall remain subject to the same field, purpose and other

restrictions applicable to such Party. Each Party will remain responsible for the acts and omissions of its respective Affiliates.

ARTICLE

VII -REPRESENTATIONS AND WARRANTIES

7.1

Project Technology. Neither Party makes any representations or warranties of any kind, either express or implied, and assumes

no responsibilities whatsoever with respect to the use, sale, or other disposition by the other Party of that other Party’s products

or services whether or not such products or services relate to Project Technology.

7.2

Kopin Representations and Warranties. Kopin hereby represents and warrants that: (a) Kopin has all necessary consents, approvals,

authorizations, licenses and permits to carry on and conduct the Development Work under each Development Plan and to grant the rights

to StableX as expressly set out herein; (b) Kopin has the right to grant the license under Section 4.2 without conflict with the rights

of any third party, and has secured all necessary and appropriate consents to grant such license; (c) the Kopin Background Technology

is not, to Kopin’s knowledge, the subject of any pending litigation or administrative proceeding that would reasonably be expected

to materially impair Kopin’s ability to grant the rights expressly granted under this Agreement; and (d) Kopin shall perform this

Agreement and exercise its rights hereunder in accordance with applicable law, including without limitation applicable export control

laws.

7.3

StableX Representations and Warranties. StableX hereby represents and warrants that:

7.4

(a) StableX has all necessary consents, approvals, authorizations, licenses and permits to perform its obligations under this Agreement

and to grant the rights to Kopin as expressly set out herein;

Page 13 of 22

7.5

(b) the Convertible Preferred Stock issued to Kopin are in amount equal to 19.99% of the pro forma fully-diluted outstanding shares of

common stock of StableX (excluding shares of common stock underlying unexercised options, warrants and other common stock equivalents),

and the common stock issuable upon conversion thereof, are, or when issued will be, duly authorized, validly issued, fully paid and non-assessable.

The authorized, issued and outstanding capitalization of StableX is as set forth in StableX’s most recently filed periodic reports

with the U.S. Securities and Exchange Commission (the “SEC”), and since the date of such filing, there has

been no change in the capitalization of StableX other than as disclosed in subsequent filings with the SEC or as contemplated by this

Agreement and no Person has any right to acquire any equity securities of StableX other than as disclosed in the SEC Reports or as contemplated

by this Agreement;

7.6

(c) StableX shall perform this Agreement and exercise its rights hereunder in accordance with applicable law;

7.7

StableX is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite

corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted

and as contemplated by this Agreement;

7.8

the Convertible Preferred Stock to be issued to Kopin pursuant to Section 2.4 has been duly authorized by all necessary corporate action

on the part of StableX, and when issued and delivered in accordance with the terms of this Agreement and the applicable certificate of

designations, such Convertible Preferred Stock will be validly issued, fully paid and non-assessable, free and clear of all liens, encumbrances

and restrictions, other than restrictions on transfer under applicable securities laws and the organizational documents of StableX;

7.9

the shares of common stock to be issued to Kopin upon conversion of the Convertible Preferred Stock have been duly authorized by all

necessary corporate action on part of StableX, and when issued and delivered in accordance with the terms of this Agreement and the applicable

certificate of designations, such shares of common stock will be validly issued, fully paid and non-assessable, free and clear of all

liens, encumbrances and restrictions, other than restrictions on transfer under applicable securities laws and the organizational documents

of StableX;

7.10

StableX has timely filed all required reports, schedules, forms, statements and other documents with the SEC (collectively, the “SEC

Reports”), and each SEC Report, as of the date of its filing (or, if amended or superseded by a subsequent filing, as of

the date of the last such amendment or superseding filing prior to the Effective Date), complied in all material respects with the applicable

requirements of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, and the rules and regulations

promulgated thereunder, and none of the SEC Reports, as of their respective dates, contained any untrue statement of a material fact

or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the

circumstances under which they were made, not misleading, and the financial statements included in the SEC Reports were prepared in accordance

with United States generally accepted accounting principles applied on a consistent basis throughout the periods involved (except as

may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by applicable SEC rules) and fairly present

in all material respects the financial condition, results of operations and cash flows of StableX as of the dates and for the periods

indicated;

Page 14 of 22

7.11

since the date of the most recent balance sheet included in StableX’s most recently filed periodic report with the SEC prior to

the Effective Date, there has been no event, occurrence, development or circumstance that, individually or in the aggregate, has had

or would reasonably be expected to have a material adverse effect on (i) the business, assets, liabilities, financial condition or results

of operations of StableX and its subsidiaries, taken as a whole, or (ii) StableX’s ability to consummate the transactions contemplated

by this Agreement and to perform its obligations hereunder; and

7.12

the execution, delivery and performance of this Agreement by StableX and the consummation of the transactions contemplated hereby do

not and will not (i) conflict with or violate any provision of the certificate of incorporation, bylaws or other organizational documents

of StableX, (ii) conflict with, or constitute a default (or an event that, with notice or lapse of time or both, would become a default)

under, result in the creation of any lien upon any of the properties or assets of StableX, or give to others any rights of termination,

amendment, acceleration or cancellation of, any material agreement, contract, lease, license or instrument to which StableX is a party

or by which any property or asset of StableX is bound or affected, in each case as disclosed or filed as an exhibit in the SEC Reports,

or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws)

applicable to StableX or by which any property or asset of StableX is bound or affected.

7.13

EXCEPT AS EXPRESSLY WARRANTED HEREIN, EACH PARTY DISCLAIMS ALL OTHER WARRANTIES, EITHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING WITHOUT

LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY AND OF FITNESS FOR A PARTICULAR PURPOSE, REGARDING THE JOINT DEVELOPMENT UNDER THIS

AGREEMENT OR ANY RESULTING PRODUCTS OR PROCESSES ARISING THEREFROM OR ANY OTHER MATTER RELATING TO THIS AGREEMENT.

ARTICLE

VIII -LIABILITY AND INDEMNIFICATION

8.1

Indemnification. Each Party shall defend, indemnify and hold harmless the other Party and its directors, officers, employees and

agents (“Indemnitees”) from and against any claim, suit, or action brought by a third party against any such

Indemnitees, and shall pay all losses, damages, liabilities, judgments, fines, penalties, costs and expenses (including reasonable attorneys’

fees and litigation costs) payable to such third party, to the extent arising out of: (a) the gross negligence or willful misconduct

of such Party; (b) the material breach of this Agreement by such Party; (c) the violation of applicable law by such Party; (d) personal

injury, death or damage to tangible property caused by such Party’s gross negligence; or (e) any claim that materials, technology

or Products supplied by such Party under this Agreement infringe or violate any third-party intellectual property rights, except to the

extent such claim arises from (i) modifications by the other Party or (ii) use outside the scope of this Agreement.

Page 15 of 22

8.2

Process. The Party seeking indemnification from a Claim shall notify the other Party promptly upon becoming aware of the Claim

(provided that failure to promptly notify shall not relieve the indemnifying Party of its obligation to defend the Claim unless such

failure materially prejudices its ability to defend the Claim) and permit the other Party to control the defense and settlement of the

Claim, and shall reasonably cooperate with the indemnifying Party in such efforts (at the indemnifying Party’s request and expense).

The indemnified Party may not consent to the settlement or entry of judgment in such Claim without the indemnifying Party’s prior

written consent. The indemnified Party may participate in the defense of the Claim with its own counsel at its own expense.

8.3

Insurance. During the term of this Agreement, each Party shall maintain insurance coverage of the kind and in the amounts customary

for similarly situated companies operating in its industry and performing obligations of a similar nature.

8.4

No Special Damages. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, AND EXCEPT WITH RESPECT TO LOSSES PAYABLE BY A

PARTY TO A THIRD PARTY PURSUANT TO ITS INDEMNIFICATION OBLIGATIONS IN SECTION 8.1 AND EXCEPT FOR DAMAGES CAUSED BY A PARTY’S BREACH

OF ARTICLE V (CONFIDENTIALITY), NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY OR ANY OF ITS AFFILIATES FOR ANY SPECIAL, PUNITIVE,

INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR FOR LOST PROFITS OR LOST REVENUES, WHETHER UNDER ANY CONTRACT, WARRANTY, NEGLIGENCE,

STRICT LIABILITY OR OTHER LEGAL OR EQUITABLE THEORY, AND WHETHER OR NOT SUCH DAMAGES WERE FORESEEABLE.

8.5

Limitation of Liability. Except with respect to (i) a Party’s breach of Article V (Confidentiality), (ii) a Party’s indemnification

obligations under Section 8.1, and (iii) a Party’s fraud or willful misconduct, in no event shall a Party’s total aggregate

liability under this Agreement exceed the greater of: (a) the total amounts paid or payable by StableX under this Agreement; and (b)

$15,000,000.

ARTICLE

IX -TERM AND TERMINATION

9.1

Term. This Agreement shall commence on the Effective Date and shall remain in full force and effect until terminated by either

Party in accordance with this Article IX.

9.2

Termination for Material Breach. In the event that a Party materially breaches any provision of this Agreement, the non-breaching

Party shall have the right to terminate this Agreement by serving on such breaching Party sixty (60) days written notice specifying such

breach; provided, however, that the breaching Party shall have the right to cure such breach during such notice period if such breach

is capable of cure.

Page 16 of 22

9.3

Termination for Bankruptcy Event. Either Party may terminate this Agreement immediately upon written notice to the other Party

if a Bankruptcy Event occurs with respect to such other Party. All rights and licenses granted under or pursuant to this Agreement are,

and shall otherwise be deemed to be, for purposes of Section 365(n) of Title 11 of the United States Code and other similar laws in any

jurisdiction outside the U.S. (collectively, the “Bankruptcy Laws”), licenses of rights to “intellectual

property” as defined under the Bankruptcy Laws. If a case is commenced during the Term by or against a Party under Bankruptcy Laws

then, unless and until this Agreement is rejected as provided in such Bankruptcy Laws, such Party (in any capacity, including debtor-in-possession)

and its successors and assigns (including a trustee) shall perform all obligations provided in this Agreement to be performed by such

Party. If this Agreement is rejected as provided in the Bankruptcy Laws and a Party in its capacity as a licensee elects to retain its

rights granted hereunder as provided in the Bankruptcy Laws, then the other Party (in any capacity, including debtor-in-possession) and

its successors and assigns shall promptly provide to the Party exercising its license rights all materials and embodiments of such intellectual

property reasonably required to enable such Party to exercise its rights under this Agreement. Without limiting the foregoing and subject

to applicable Bankruptcy Laws, the Parties acknowledge and agree that all licenses and rights granted under this Agreement are intended

to be, and shall be deemed to be, licenses of rights to “intellectual property” for purposes of Section 365(n) of the United

States Bankruptcy Code (and any analogous provisions of applicable law). In the event that this Agreement is rejected by a Party in a

case under Bankruptcy Laws, the other Party, as a licensee, shall be entitled to elect to retain its rights under this Agreement as provided

in Section 365(n), and the rejecting Party (and any trustee, receiver or debtor-in-possession) shall, upon written request, promptly

provide to the other Party all embodiments of such intellectual property and other materials reasonably necessary to enable the other

Party to exercise its rights, including source code (if applicable), technical documentation, specifications, know-how and other information.

Each Party further agrees that it shall not interfere with the other Party’s exercise of its rights under this Agreement, including

any rights retained pursuant to Section 365(n), following any such rejection.

9.4

Performance Related Termination. Either Party may terminate this Agreement upon written notice if the other Party has materially

failed to perform its obligations under the applicable Development Plan; provided that: (a) such failure is measured against the objective

criteria set out in the applicable Development Plan; (b) the non-performing Party has been given written notice specifying such failure

in reasonable detail; and (c) the non-performing Party has failed to cure such failure, or to propose and implement a reasonable remediation

plan, within thirty (30) days following such notice. For the avoidance of doubt, a Party may not terminate this Agreement solely on the

basis that the Project Technology may not result in a commercially viable product. For the avoidance of doubt, a material failure by

StableX to operate in the Ordinary Course of Business to the extent that it materially impacts the Project shall constitute a failure

to perform for the purposes of this Section 9.4.

9.5

Effect of Termination and Expiration.

(a)

Termination for Breach or Bankruptcy (by non-breaching Party). In the event of termination of this Agreement pursuant to Section 9.2

or Section 9.3: (i) the non-breaching Party shall retain its rights in the Project Technology in accordance with this Agreement; and

(ii) to the extent the terminating Party is Kopin and such termination arises from StableX’s breach, failure to fund amounts due

under this Agreement, or Bankruptcy Event, Kopin shall have the right to continue to develop, use and commercialize the Project Technology

without restriction, and StableX shall assign (and hereby assigns) to Kopin all of its right, title and interest in and to the Project

Technology.

Page 17 of 22

(b)

Termination following Performance Issues. In the event of termination pursuant to Section 9.4: (i) where termination arises from Kopin’s

uncured material breach, StableX shall retain a non-exclusive, non-transferable license to use the Project Technology within its permitted

Field, subject to the terms of this Agreement; and (ii) where termination arises from StableX’s failure to perform its obligations

(including failure to fund), the consequences set out in Section 9.5(a) shall apply.

(c)

Post-Demo Position. If StableX is deemed not to proceed with the Project pursuant to Section 2.3(e) then: (i) Kopin shall have the right

to continue the development, commercialization and exploitation of the Project Technology in any commercial field, irrespective of any

field or market restrictions otherwise applicable to StableX under this Agreement; and (ii) the Parties shall discuss in good faith whether

StableX should retain a limited license or economic participation (such as a royalty) in respect of the Project Technology, taking into

account the level of funding actually provided by StableX and the circumstances in which the Project did not proceed.

(d)

Background Technology. Under no circumstances shall ownership of Kopin Background Technology transfer to StableX. Any license granted

under Section 4.2 shall terminate upon termination of this Agreement, except to the extent necessary to give effect to any surviving

rights in Project Technology under this Section 9.5.

(e)

Accrued Rights. Termination shall not affect any rights or obligations accrued prior to the effective date of termination, including

any payment obligations.

(f)

Failure to Proceed. For the purposes of this Section 9.5, after the Negotiation Period of 1 year pursuant to Section 2.3(e), the following

shall be deemed a failure by StableX to proceed with the Project: (i) failure to fund amounts when due under Section 2.3; (ii) election

not to proceed following a Successful Demo; (iii) failure to engage in good faith discussions under Section 2.3(e); (iv) failure to operate

in the Ordinary Course of Business in a manner that materially impacts the Project; or (v) a Bankruptcy Event or cessation of active

operations. In each such case, Kopin shall have the rights set out in Section 9.5(a).

9.6

Survival. The provisions of Articles I, IV, V, VIII, X and Section 9.5 shall survive termination of this Agreement.

ARTICLE

X -MISCELLANEOUS

10.1

Rights Amendment Plan. StableX covenants and agrees that, concurrently with the execution and delivery of this Agreement, StableX

shall execute and deliver an amendment to that certain Rights Agreement (the “Rights Plan”), dated as of July

31, 2025, by and between StableX and Equiniti Trust Company, LLC, as rights agent (“Rights Agent”), whereby

the board shall have the authority to designate any Person (as defined in the Rights Plan) as an “Exempt Person” (or similar

designation) under the Rights Plan by adopting resolutions waiving the applicability of the Rights Plan to such Person. The board has

adopted such resolutions in connection with the transactions contemplated by this Agreement and, accordingly, that the Rights Plan shall

not apply to Kopin or any of its Affiliates or any future acquiror of Kopin in connection with the transactions contemplated by this

Agreement or the other Transaction Agreements, and such waiver remains in full force and effect as of the date hereof.

10.2

Applicable Law. This Agreement shall be governed by and interpreted in accordance with the laws of the State of Delaware, without

reference to its choice of law provisions. The Parties agree that, except as otherwise provided in this Agreement, should there be a

dispute arising from or related to this Agreement, it shall be brought before the courts in New York. The Parties hereby consent to the

New York courts’ personal jurisdiction and waive any objection on the basis of inconvenient forum or venue.

Page 18 of 22

10.3

Notices. All notices shall be in writing and delivered personally, by overnight express courier, or by registered or certified

mail, postage prepaid, to the following addresses of the respective Parties (or to any other address given by any Party to the other

Party by proper notice):

Kopin:

Kopin

Corporation

125 North Drive

Westborough, MA 01581

Attn:

Michael Murray

With

a copy (which will not constitute notice) to:

Morgan

Lewis & Bockius LLP

One

Federal Street

Boston,

MA 02110

Attn:

John J. Concannon

StableX:

StableX

Technologies, Inc.

1185 Avenue of the

Americas

New York, New York

10036

Attention:

Josh Silverman

With

a copy (which will not constitute notice) to:

Haynes

and Boone, LLP

30 Rockefeller Plaza

Floor 22

New

York, New York 10112

Attn:

Greg Kramer

Notices

shall be effective upon receipt if personally delivered, on the date of receipt if by express courier, or on the third (3rd)

business day following the date of mailing if actually received. Any change of address or contact name of a Party shall be promptly communicated

in writing to the other Party.

Page 19 of 22

10.4

Assignment. Neither Party may assign, transfer or otherwise dispose of any of its rights or obligations under this Agreement without

the prior written consent of the other Party, such consent not to be unreasonably withheld, conditioned or delayed, and any attempted

assignment in breach of this Section shall be void ab initio; provided, however, that: (a) Kopin may assign this Agreement in its entirety,

without consent, in connection with a bona fide sale of all or substantially all of its business, assets or equity to which this Agreement

relates, or to an Affiliate, upon written notice to StableX; (b) StableX may assign this Agreement in its entirety only with Kopin’s

prior written consent in connection with a bona fide sale of all or substantially all of its business, assets or equity to which this

Agreement relates, or to an Affiliate, such consent not to be unreasonably withheld, conditioned or delayed; and (c) no assignment (including

by way of merger, acquisition or sale of equity) shall be permitted to a direct competitor of the other Party without that Party’s

prior written consent. Any permitted assignee shall assume all obligations of the assigning Party under this Agreement. No assignment

shall relieve the assigning Party of responsibility for the performance of any accrued obligations hereunder prior to the effective date

of such assignment. For the avoidance of doubt, a change of control of a Party shall be deemed to be an assignment for the purposes of

this Section. In the event of a change of control of StableX, Kopin shall have the right to terminate this Agreement upon written notice.

In the event of a change of control of Kopin, this Agreement shall continue in full force and effect and shall be binding on the successor

entity in accordance with this Section.

10.5

Force Majeure. Except for the making of required payments, if the performance of, or any obligation under, this Agreement is prevented,

restricted, or interfered with by reason of fire, flood, explosion, or other casualty, accident, or act of God; general strikes or labor

disturbances; war, whether declared or not, or other violence; sabotage; or any law, order, proclamation, regulation, ordinance, demand,

or requirement of any government agency or court, or other cause beyond a Party’s reasonable control, the affected Party, upon

giving prompt notice to the other Party, shall be excused from such performance to the extent and for the duration of such prevention,

restriction, or interference. The affected Party shall use its commercially reasonable efforts to avoid or remove such cause of non-performance

or to limit the impact of the event on such Party’s performance and shall continue performance with commercially reasonable efforts

whenever such cause(s) are sufficiently diminished or removed.

10.6

Publicity. Each Party agrees not to directly or indirectly issue any press release or make any public announcement relating to

the subject matter or terms of this Agreement without the prior written consent of the other Party, such consent not to be unreasonably

withheld, conditioned or delayed, except as a Party believes in good faith is required by applicable law, rule, or regulation, including

any listing or trading requirement concerning its publicly-traded securities (in which case, the Party seeking to disclose the information

shall give reasonable notice to the other Party of its intent to make such a disclosure and afford the other Party an opportunity to

review and comment on such notice, if feasible).

10.7

Entire Agreement; Independent Counsel. This Agreement along with the Transaction Agreements sets forth the entire agreement between

the Parties and supersedes all previous agreements and understandings, whether oral or written, between the Parties with respect to the

subject matter of this Agreement. The Agreement may be executed in counterparts or electronically, each of which is deemed an original

and the same instrument. Each Party has had an opportunity to consult with counsel in negotiating this Agreement and the Parties have

jointly drafted and negotiated this Agreement. As such, the interpretation or construction of any provisions in this Agreement will not

be strictly construed against either Party.

Page 20 of 22

10.8

Amendment. This Agreement may not be modified or amended except by a written agreement signed by an authorized representative

of each Party.

10.9

Severability. The provisions of this Agreement are severable. If any provision in this Agreement is found or held to be invalid

or unenforceable in any tribunal, then the meaning of that provision shall be construed, to the extent feasible, to render the provision

enforceable, and the other provisions shall be unaffected, and the Parties shall negotiate in good faith a valid and enforceable provision

that most closely reflects the original intent.

10.10

Non-Waiver. No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise in any one or more

instances, shall be deemed to be or construed as a further or continuing waiver of any such term, provision or condition or of any other

term, provision or condition of this Agreement. Waivers must be in writing signed by the waiving Party to be enforceable.

10.11

Relationship of Parties. Each of the Parties hereto is an independent contractor and nothing herein shall be deemed to constitute

the relationship of partners, joint venturers, nor of principal and agent between the Parties hereto, and nothing in this Agreement shall

be deemed to create any partnership, joint venture or fiduciary relationship between the Parties.

10.12

Succession. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted successors

and assigns.

10.13

Authority. Each Party has the full right, power, and authority to execute and deliver this Agreement and to perform its terms.

The execution and delivery of this Agreement and the consummation of the transactions required by this Agreement will not violate or

conflict with: (i) any charter provision or bylaw of either Party or any of its Affiliates, or (ii) any agreement with any third party.

Each Party has taken all required corporate actions to approve and adopt this Agreement. Each Party represents and warrants that the

person or persons executing this Agreement on its behalf are duly authorized and empowered to do so.

10.14

Construction. The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity

or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties.

10.15

Standstill. During the Term of this Agreement and for a period of three (3) years thereafter, StableX and its Affiliates shall

not, directly or indirectly: (a) acquire beneficial ownership of more than 9.9% of the outstanding voting securities of Kopin; (b) make

or participate in any tender offer, exchange offer, merger or other business combination involving Kopin; (c) solicit proxies or consents

with respect to securities of Kopin; or (d) otherwise seek to obtain control of Kopin other than through a transaction approved by Kopin’s

board of directors. Any proposed transaction involving a change of control of Kopin shall be initiated and conducted solely through Kopin’s

board of directors or its authorised representatives.

Page 21 of 22

IN

WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed as of the Effective Date.

KOPIN CORPORATION

STABLEX TECHNOLOGIES, INC.

By: /s/

Michael Murray

By:

/s/ Joshua Silverman

Name: Michael

Murray

Name:

Josh Silverman

Title: President

and CEO

Title:

Executive Chairman

Page 22 of 22

EX-10.2

EX-10.2

Filename: ex10-2.htm · Sequence: 12

Exhibit 10.2

EXECUTION

VERSION

COMMERCIAL

SUPPLY Agreement

This

Commercial Supply Agreement (the “Agreement”), dated as of April 27, 2026 (“Effective Date”), is

entered into by and between StableX Technologies, Inc., a Delaware corporation, located at 1185 Avenue of the Americas, New York, New

York 10036 (“StableX”), and Kopin Corporation, a Delaware corporation, with offices at 125 North Drive, Westborough,

MA 01581 (“Kopin,” and together with StableX, the “Parties”, and each, a “Party”).

Recitals

WHEREAS,

Kopin is an electronics manufacturer specializing in high-resolution microdisplays and optical components;

WHEREAS,

the Parties have executed and delivered that certain Joint Development & License Agreement of even date herewith (the “Development

Agreement”) pursuant to which the Parties will develop and commercialize one or more, and own or control rights to the Products

(as defined below) and intend for this agreement to be the commercial supply agreement referred to therein.

WHEREAS,

Kopin will use its procurement, engineering and manufacturing expertise to produce the Products and StableX wishes to purchase the Products

from Kopin and resell these Products to End Users, in accordance with the terms and conditions of this Agreement; and

NOW,

THEREFORE, in consideration of the mutual covenants, terms, and conditions set out in this Agreement, and for other good and valuable

consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

ARTICLE

I

Definitions

“Affiliate”

of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or

is under common control with, such Person. The term “control” (including the terms “controlled by” and “under

common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management

and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

“Business

Day” means any day except Saturday, Sunday, or a federal holiday.

“Defective”

means, with respect to a Product, a failure to conform in any material respect to the warranties in Section 15.02 (Limited Product Warranty).

“Defective

Product(s)” means Products that are Defective. For the avoidance of doubt, where a Product is accepted under Section 9.04 (Inspection),

any failure that would have been reasonably apparent on visual inspection at the time of delivery shall not be treated as a Defect unless

it constitutes a breach of the warranties in Section 15.02.

“End

User” means the final purchaser that has acquired a Product, directly or indirectly, for its own or its Affiliate’s internal

use and not for resale, remarketing, or distribution. For the avoidance of doubt, End Users shall not include any purchaser that is a

Governmental Authority or that is acquiring Products for use in connection with military, defense or automotive applications.

“Governmental

Authority” means any federal, state, local, or foreign government or political subdivision thereof, or any agency or instrumentality

of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental

authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any arbitrator,

arbitration panel, court, or tribunal of competent jurisdiction.

“Inability

to Supply Event” means the occurrence of any of the following: (a) Kopin’s failure

to deliver at least 90% of the quantity of Products ordered by StableX in an accepted Purchase Order within the applicable Lead Times

(plus a grace period of 30 days), in each case other than where such failure is due to (x) supply constraints, component shortages or

manufacturing limitations, or (y) compliance with Kopin’s other contractual, legal or regulatory obligations; (b) Kopin’s

written notice to StableX that Kopin will be unable to fulfill a material portion of any Purchase Order; (c) Kopin’s failure, over

two (2) consecutive quarters, to use commercially reasonable efforts to maintain manufacturing capacity sufficient to support StableX’s

forecasted requirements, as agreed between the Parties; or (d) Kopin’s discontinuation of manufacturing operations for the Products

for a period of sixty (60) or more consecutive days (other

than for scheduled maintenance disclosed to StableX in advance); provided, however, that none of the foregoing shall constitute an Inability

to Supply Event to the extent directly caused by: (i) a Force Majeure Event (as defined below); (ii) StableX’s failure to perform

any of its obligations under this Agreement; (iii) Kopin’s compliance with any contractual, legal or regulatory obligation to prioritize

supply to governmental, military or defense customers; (iv) any increase in Purchase Orders or forecasted requirements by StableX that

is not consistent with the most recent forecast provided to Kopin or that exceeds agreed ramp-up parameters between the Parties; or (v)

any Purchase Order or requested delivery date that does not comply with the applicable Lead Times.

“Law”

means any statute, law, ordinance, regulation, rule, code, constitution, treaty, common law, any order, writ, judgment, injunction, decree,

stipulation, award, or determination entered by or with any Governmental Authority, or other requirement or rule of law of any Governmental

Authority.

“Person”

means any individual, partnership, corporation, trust, limited liability entity, unincorporated organization, association, Governmental

Authority or any other entity.

“Personnel”

means agents, employees, or subcontractors engaged or appointed by Kopin or StableX.

“Products”

means one or more products incorporating the Project Technology developed under the Development Agreement.

“Project

Technology” has the meaning set forth in the Development Agreement.

“Purchase

Order” means a purchase order issued by StableX for Products in accordance with this Agreement.

“Representatives”

means, with respect to a Party, its Affiliates and its and their respective employees, officers, directors, partners, agents, attorneys,

and professional advisors.

“Product

Specifications” means the acceptance criteria agreed in writing by the Parties, including any applicable numerical limits,

ranges or other objective criteria for the Products, as set forth in the Development Agreement or otherwise expressly agreed in writing

by the Parties.

“Territory”

means the entire world, excluding any country or territory that is subject to comprehensive trade or economic sanctions, embargoes or

similar restrictions administered or enforced by the United States (including by the U.S. Department of the Treasury’s Office of

Foreign Assets Control, the U.S. Department of State or the U.S. Department of Commerce).

“Warranty

Period” means a period of 12 months from delivery of the relevant Product to the End User.

2

ARTICLE

II

Appointment OF StableX

Section

2.01 Exclusive Appointment and Exclusive Supply. Kopin hereby appoints StableX,

and StableX accepts the appointment, to act as an exclusive seller of Products to End Users located in the Territory during the Term

solely in accordance with the terms and conditions of this Agreement. Kopin may, directly or indirectly, in its sole discretion: (i)

sell the Products to any Person (including resellers, retailers and End Users) outside the scope of StableX’s exclusivity under

this Agreement; (ii) sell Products directly to Government Authorities; and (iii) manufacture Products in any location (including within

the Territory) for sale or resale to such Persons. StableX will purchase its entire requirements from Kopin under this Agreement except

following an Inability to Supply Event, provided that an Inability to Supply Event shall not occur in the event a Force Majeure Event

is in effect. Notwithstanding the foregoing, Kopin shall retain exclusive supply and distribution rights with respect to the sale of

Products to the automotive, military and defence markets, and such markets shall be excluded from the scope of StableX’s appointment

hereunder. For the avoidance of doubt, Kopin shall have the right, in its sole discretion, to prioritise supply to such markets.

Section

2.02 Limited Contingent StableX Right to Manufacture.

In the event of an Inability to Supply Event as defined in this Agreement, and subject to the Parties

agreeing in writing the scope and duration of such event, StableX may, solely to the extent necessary to address such Inability to Supply

Event, manufacture Products in the Territory for sale or resale in the Territory. Any such right shall be limited to the duration and

quantities reasonably required to address the applicable Inability to Supply Event and shall terminate immediately upon Kopin’s

ability to resume supply. StableX shall use commercially reasonable efforts to ensure that no Affiliate, distributor, sub-contractor,

End User, or other agent sells, leases, or otherwise transfers, or assists any third party to do the foregoing, outside the Territory.

Kopin shall use commercially reasonable efforts to remedy the applicable Inability to Supply Event as soon as reasonably practicable.

If such Inability to Supply Event continues for a period of six (6) months (taking into account the applicable Lead Times), the Parties

shall discuss in good faith appropriate modifications to this Agreement, including with respect to exclusivity and supply arrangements.

ARTICLE

III

No Franchise or Business Opportunity Agreement

Section

3.01 No Franchise or Business Opportunity Agreement. The

Parties to this Agreement are independent contractors and nothing in this Agreement shall be deemed or constructed as creating a joint

venture, partnership, agency relationship, franchise, or business opportunity between Kopin and StableX. Neither Party, by virtue of

this Agreement, will have any right, power, or authority to act or create an obligation, express or implied, on behalf of the other Party.

Each Party assumes responsibility for the actions of their personnel under this Agreement and will be solely responsible for their supervision,

daily direction and control, wage rates, withholding income taxes, disability benefits, or the manner and means through which the work

under this Agreement will be accomplished. Except as provided otherwise in this Agreement, StableX has the sole discretion to determine

its methods of operation, accounting practices, the types and amounts of insurance StableX carries, personnel practices, advertising

and promotion, customers, and service areas and methods. If any provision of this Agreement is deemed to create a franchise relationship

between the Parties, then the Parties shall negotiate in good faith to modify this Agreement so as to effect the Parties’ original

intent as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as a

product seller agreement and not a franchise agreement.

ARTICLE

IV

Terms of Agreement Prevail Over StableX’s Purchase Order

Section

4.01 Terms of Agreement Prevail Over StableX’s Purchase Order. This

Agreement is expressly limited to the terms set out herein. The terms of this Agreement shall prevail over any terms or conditions contained

in any other documentation related to the subject matter of this Agreement and expressly exclude any additional or conflicting terms

and conditions contained in any Purchase Order or other document issued by StableX, whether or not such document is acknowledged or accepted

by Kopin.

3

ARTICLE

V

General

StableX Performance Obligations

Section

5.01 Marketing and Reselling Products. StableX shall, at its own expense:

(a) exert

commercially reasonable efforts to market, advertise, promote, and resell the Products to End Users located in the Territory consistent

with good business practice, in each case using its best efforts to maximize the sales volume of the Products;

(b) have

sufficient knowledge of the industry and products competitive with each Product (including specifications, features and benefits) so

as to be able to explain in detail to the End Users information on standard protocols and features of each Product;

(c) observe

all reasonable directions and instructions given to it by Kopin in relation to the marketing, advertisement, promotion and proper use

of the Products to the extent that these marketing materials, advertisements, or promotions refer to the Products;

(d) divulge,

in any and all contact between StableX and any End User, StableX’s full legal name, trade name, or both;

(e) market,

advertise, promote and resell Products and conduct business in a manner that reflects favorably at all times on Products and the good

name, goodwill, and reputation of Kopin; and

(f) promptly

notify Kopin of any complaint about any Product or its use of which StableX becomes aware.

Section

5.02 Authority to Perform Under this Agreement. StableX

shall, at its own expense, obtain and maintain required certifications, credentials, licenses, and any other permits necessary to conduct

business in accordance with this Agreement and applicable Law.

Section

5.03 Limited End User Support. During the Term

of this Agreement StableX shall, at its own expense:

(a) ensure

that an adequate number of trained, capable, and qualified technical Personnel with sufficient knowledge of the Product are available

during normal business hours to assist End Users; and

(b) respond

to the End Users regarding the general operation and use of the Product, including, without limitation:

(i) acting

as a liaison between the End User and Kopin in matters requiring Kopin’s participation;

(ii) providing

general Product information and configuration support on standard protocols and features; and

(iii) collecting

relevant technical problem identification information and relaying the same to Kopin or its designees.

Except

as expressly authorized by Kopin in writing or as otherwise set out in this Agreement or in a separate written agreement with Kopin,

StableX may not service, repair, modify, alter, replace, reverse engineer, or otherwise change the Products it sells to End Users.

4

Section

5.04 Prohibited Acts. Notwithstanding anything to the contrary in this Agreement,

neither StableX nor StableX’s Personnel shall directly or indirectly: (a) make any representations, warranties, guarantees, claims

or commitments on behalf of Kopin or with respect to the Products, except those expressly authorized by Kopin or as are set forth in

Kopin’s literature or other promotional materials that have been authorized by Kopin in writing for distribution to third parties;

(b) engage in any unfair, anti-competitive, misleading, or deceptive practices with respect to the Products, Kopin, or any third party,

including, without limitation, product disparagement and any trade libel of Kopin or any third party; or (c) during the Term, market,

advertise, promote, sell, or distribute other substantially similar products or products that materially compete with the Products to

any End Users in the Territory, except to the extent this restriction is prohibited by applicable Law, in which case StableX must promptly

notify Kopin of such restriction. Whether a product or product line is deemed to compete with the Products shall be determined acting

reasonably by Kopin.

ARTICLE

VI

Kopin

Obligations

Section

6.01 Kopin Obligations. During the Term, Kopin

shall:

(a) provide

such information and support as Kopin reasonably determines is appropriate, upon reasonable request by StableX, regarding the marketing,

advertising, promotion, and sale of Products sold to StableX under this Agreement; and

(b) make

available to StableX, at Kopin’s discretion, materials, such as samples, prototypes, documentation, brochures, and other items

that Kopin, in its sole discretion, deems necessary or appropriate for the promotion and sale of the Products in the Territory (“Materials”),

which may include, for example, samples, prototypes, documentation, brochures, and other promotional materials. Kopin shall retain all

rights, title, and interest in and to all Materials. StableX shall promptly return all Materials to Kopin upon Kopin’s request

or on the expiration or earlier termination of this Agreement as provided for in Article XIV (Term; Termination).

ARTICLE

VII

MANUFACTURING RAMP-UP and COOPERATION

The

Parties acknowledge that, as of the Effective Date, the Products remain under development and that the final specifications, costs, required

components, and tooling necessary for commercial-scale manufacturing have not yet been determined. The Parties agree to cooperate in

good faith to develop and implement a mutually acceptable manufacturing ramp-up plan (the “Ramp-Up Plan”), which shall

include: (a) identification and procurement of tooling, equipment, and other capital assets required for factory production of the Products;

(b) qualification and sourcing of components and raw materials necessary for manufacture of the Products; (c) establishment of a timeline

for the commencement and scaling of commercial manufacturing operations; (d) a detailed budget setting forth the estimated costs associated

with each element of the Ramp-Up Plan (the “Ramp-Up Budget”); (e) the pricing to be charged by Kopin to StableX for

the Products (the “Supply Price”), which pricing shall be determined based on Kopin’s actual costs of production

plus a reasonable profit margin; and (f) suggested retail pricing or pricing guidelines for the sale of Products by StableX to End Users

(the “End User Price”), which pricing shall take into account the Supply Price and StableX’s costs of distribution,

marketing, and sales, and shall be designed to enable StableX to achieve a reasonable profit margin on such sales. The Parties shall

use commercially reasonable efforts to seek to finalize the Ramp-Up Plan and Ramp-Up Budget within one (1) year following the completion

of the product development phase under the Development Agreement. Each Party shall designate a representative to serve as the primary

point of contact for matters relating to the Ramp-Up Plan, and such representatives shall meet on a regular basis (and no less frequently

than monthly) to review progress, address issues, and coordinate activities. In addition, the Parties shall cooperate in good faith with

respect to financing the manufacturing ramp-up, including by sharing information reasonably requested by the other Party or by potential

financing sources and participating in discussions with lenders or investors, and taking such other actions as the Parties may agree

in writing are appropriate to support efforts to obtain financing for the implementation of the Ramp-Up Plan. The Parties agree that

as part of the manufacturing ramp-up, the Parties will negotiate creating manufacturing capacity dedicated to StableX designed to reduce

the likelihood of an Inability to Supply Event arising out of Kopin’s need to comply with any other contractual, legal or regulatory

obligations, including the need to prioritize supply to governmental, military or defense customers. The Parties further agree to negotiate

the Supply Price and End User Price in good faith, with the mutual objective of ensuring that both Kopin and StableX are able to realize

a reasonable return on their respective investments in the development, manufacture, and distribution of the Products. The Parties shall

review the Supply Price and End User Price on a periodic basis (and no less frequently than annually), taking into account changes in

production costs, market conditions, and other relevant factors.

5

ARTICLE

VIII

Orders Procedure

Section

8.01 Purchase Order. StableX shall issue all Purchase

Orders to Kopin in written form via email or using the notice procedures identified herein under Section 20.02, or such other address

Kopin may specify from time to time. By placing a Purchase Order, StableX makes an offer to purchase Products under the terms and conditions

of this Agreement, and on no other terms. Any purported variations made to the terms and conditions of this Agreement by StableX in any

Purchase Order are void and have no effect.

Section

8.02 Purchase Order Transaction Terms.  StableX

shall specify the following information in each Purchase Order:

(a) a

list of Products to be purchased, including make/model number;

(b) quantities

of each Product ordered; and

(c) (c)

requested delivery date, provided that such requested delivery date complies with the applicable lead times agreed between the Parties

from time to time (the “Lead Times”).

Section

8.03 Binding Effect. A Purchase Order shall become binding on Kopin only upon written

acceptance by Kopin, which acceptance shall not be unreasonably withheld and shall be subject to availability, capacity, compliance with

this Agreement and consistency with the Lead Times. Kopin shall accept or reject each Purchase Order within ten (10) Business Days of

receipt; failure to respond within such period shall be deemed acceptance, provided that any such deemed acceptance shall be subject

to the Lead Times.

Section

8.04 Forecasts. Beginning on the first day of the calendar quarter immediately following the

achievement of a successful demonstration prototype under the Development Agreement, StableX shall provide Kopin with a forecast of its

anticipated demand for the Products on a semi-annual basis. All such forecasts are provided for planning purposes only and shall be non-binding.

ARTICLE

IX

Shipment and Delivery

Section

9.01 Shipment. Unless expressly agreed to by the

Parties in writing, StableX shall select the method of shipment of and the carrier for the Products. Kopin may, in its sole discretion,

without liability or penalty, provide partial shipments of Products to StableX. Each shipment constitutes a separate sale, and StableX

shall pay for the units provided to the carrier for shipping, whether the shipment is in whole or partial fulfillment of a Purchase Order.

StableX shall be responsible for any loss or damage to Products occurring in transit following delivery to the carrier.

Section

9.02 Delivery. Unless expressly agreed to by the

Parties, Kopin shall deliver the Products to StableX’s carrier, using Kopin’s standard methods for packaging and providing

the Products. All Prices are FCA (Incoterms 2020) where StableX shall be fully responsible for arranging and payment for the carrier.

6

Section

9.03 Late Delivery. Any time quoted for delivery

is an estimate only; provided, however, that Kopin will use commercially reasonable efforts to deliver all Products on or before

the requested delivery date. Subject to StableX’s rights under this Section, no delay in the shipment or delivery of any Product

relieves StableX of its obligations under this Agreement, including accepting delivery of any remaining installment or other orders of

Products.

Section

9.04 Inspection. StableX shall inspect Products received under this Agreement within

ten (10) Business Days of receipt (the “Inspection Period”) of the Products and either accept or, if any Products

are Defective Products, reject these Products. StableX will be deemed to have accepted the Products unless it notifies Kopin in writing

of any Defective Products during the Inspection Period and furnishes written evidence or other documentation as reasonably required by

Kopin. If StableX timely notifies Kopin of any Defective Products, Kopin shall determine, in its reasonable discretion, whether the Products

are Defective Products. If Kopin, acting reasonably, determines that the Products are Defective Products, it shall either, in its sole

discretion, (i) replace such Defective Products with conforming Products, or (ii) refund the Price invoiced or paid, as applicable. StableX

shall ship, at its expense, all Defective Products to Kopin’s facility. If Kopin exercises its option to replace Defective Products,

Kopin shall provide the replacement(s) to StableX at Kopin’s expense.

StableX

acknowledges and agrees that the remedies set out in this Section are StableX’s exclusive remedy for the delivery of Defective

Products, subject to StableX’s rights under Section 15.02 and Section 15.04 regarding any Defective Products for which StableX

accepted delivery under this Section.

Section

9.05 Limited Right of Return. Except as provided

under Section 9.04 (Inspection), Section 15.02 (Limited Product Warranty) and Section 15.04 (Extent of Liability), all sales of Products

to StableX under this Agreement are made on a one-way basis and StableX has no right to return Products purchased under this Agreement.

Section

9.06 Title and Risk of Loss.  Title to Products shipped under any Purchase

Order passes to StableX on Kopin’s providing such Products to the carrier at Kopin’s facility, provided that Kopin reserves

all rights to recover unpaid Products to the extent permitted by applicable law. Risk of loss to Products shipped under any Purchase

Order passes to StableX upon Kopin’s delivery of such Products to the carrier.

ARTICLE

X

Price and Payment

Section

10.01 Shipping Charges, Insurance and Taxes. StableX

shall pay for shipping charges and insurance costs in accordance with the commercial terms set forth in ARTICLE IX (Shipment and Delivery).

All Prices are exclusive of all sales, use, and excise taxes, and any other similar taxes, duties, and charges of any kind imposed by

any Governmental Authority on any amounts payable by StableX under this Agreement. StableX is responsible for all charges, costs, and

taxes.

Section

10.02 Payment Terms. Kopin will issue monthly invoices to StableX for all Products

ordered in the previous month. StableX shall pay all invoiced amounts due to Kopin within thirty (30) calendar days from the invoice

date, except for any amounts disputed by StableX in good faith and in accordance with Section 10.03. StableX shall make all payments

in US dollars by wire transfer or via any other method Kopin designates in writing to StableX. Any undisputed amounts not paid when due

shall accrue interest at a rate of 1% per month and 12% per annum (or the maximum rate permitted by applicable law, if lower), from the

due date until payment. All amounts payable by StableX under this Agreement

shall be paid in full without any set-off, counterclaim, deduction or withholding (other than as required by applicable law).

7

Section

10.03 Invoice Disputes. StableX shall notify Kopin

in writing of any dispute with any invoice (along with substantiating documentation) within thirty (30) calendar days after the date

of the invoice. StableX will be deemed to have accepted all invoices for which Kopin does not receive timely notice of disputes, and

shall pay all undisputed amounts due under these invoices within the period set out in Section 10.02 (Payment Terms). The Parties shall

seek to resolve all disputes expeditiously and in good faith. Notwithstanding the foregoing, StableX shall continue to pay all undisputed

amounts in accordance with this Agreement.

ARTICLE

XI

Resale of the Products

Section

11.01 Credit Risk on Resale to End Users. StableX

is responsible for all credit risks regarding, and for collecting payment for, all Products sold to third parties (including End Users),

whether or not StableX has made full payment to Kopin for the Products. The inability of StableX to collect the purchase price for any

product does not affect StableX’s obligation to pay Kopin for any Product.

Section

11.02 Resale Prices. StableX shall establish its

own resale prices and terms regarding Products it sells, subject to and in accordance with the provisions of the first paragraph of Article

VII.

ARTICLE

XII

Compliance with Laws

Section

12.01 General Compliance With Laws Representation and Warranty; Covenant. Each

Party represents and warrants to the other Party that it is in material compliance with all Laws applicable to this Agreement, the Products

and the operation of its business. Each Party shall at all times comply with all applicable Laws.

ARTICLE

XIII

Term; Termination

Section

13.01 Term. The term of this Agreement shall commence

on the Effective Date and, unless earlier terminated in accordance with this Agreement, shall continue for an initial period of four

(4) years, after which it shall automatically renew for successive periods of one (1) year unless either Party gives written notice of

non-renewal not less than ninety (90) days prior to the end of the then-current term (the “Term”).

Section

13.02 Effect of Expiration or Termination.

(a) The

Term’s expiration or earlier termination does not affect any rights or obligations that:

(i) are

to survive the expiration or earlier termination of this Agreement; and

(ii) were

incurred by the Parties before the expiration or earlier termination; provided that all indebtedness of StableX to Kopin of any kind

is immediately due and payable on the effective date of the Term’s expiration or earlier termination without further notice to

StableX.

(b) Any

Notice of termination will automatically operate as a cancellation of any pending Purchase Orders that have not been accepted by Kopin

and any deliveries of Products to StableX that are scheduled to be made after the effective date of termination. Regarding any Products

that are still in transit on termination of this Agreement, Kopin may require, in its sole and absolute discretion, that all sales and

deliveries of the Products be made on a cash in advance or certified funds basis.

(c) On

the expiration or earlier termination of this Agreement, StableX shall promptly cease to represent itself as Kopin’s authorized

representative regarding the Products in the Territory, and shall otherwise desist from all conduct or representations that might lead

the public to believe that StableX is authorized by Kopin to sell the Products or in any way associated with Kopin;

8

(i) return

to Kopin all documents and tangible materials (and any copies) containing, reflecting, incorporating or based on Kopin’s Confidential

Information; and

(ii) permanently

erase all of Kopin’s Confidential Information from its computer systems; and

(d) Subject

to Section 13.02(a), the Party terminating this Agreement, or in the case of the expiration of this Agreement, each Party, shall not

be liable to the other Party for any damage of any kind (whether direct or indirect) incurred by the other Party by reason of the expiration

or earlier termination of this Agreement, except for (i) accrued payment obligations, (ii) breaches of this Agreement, or (iii) any liability

that cannot be excluded under applicable Law.

ARTICLE

XIV

Confidentiality

Section

14.01 Confidentiality. All non-public, confidential or proprietary information (“Confidential

Information”) that a Party (the “Disclosing Party”) may disclose or make available to the other Party (the

“Receiving Party”) relating to the Disclosing Party, including but not limited to names or addresses of customers,

sales techniques, distribution strategies, sales terms or conditions, delivery or scheduling terms or conditions, costs, pricing, manufacturing

or processing methods, and any new product development plans the Disclosing Party may establish or issue from time to time, whether disclosed

orally or disclosed or accessed in written, electronic, or other form or media, and whether or not marked, designated, or otherwise identified

as “confidential,” in connection with this Agreement, shall be kept confidential and used solely for the Receiving Party’s

performance of its obligations under this Agreement and may not be disclosed to any third party without the Disclosing Party’s

prior written consent. The Receiving Party agrees to use commercially reasonable efforts to protect such Confidential Information, and

not to use or disclose such Confidential Information other than as permitted under this Agreement. The Receiving Party may disclose Confidential

Information to its Affiliates, employees, agents and contractors who have a need to know such information for the purposes of this Agreement,

provided that such persons are subject to confidentiality obligations no less protective than those set out in this Agreement. The Receiving

Party shall be responsible for any breach of this Section by such persons. If any unauthorized disclosure of Confidential Information

occurs or is suspected, the Receiving Party shall promptly notify the Disclosing Party and provide reasonable details of such disclosure.

To the extent the Receiving Party receives confidential information of a third party in connection with this Agreement, it shall comply

with any applicable restrictions notified to it by the Disclosing Party in relation to such information. Confidential Information excludes

information that: (a) is or becomes generally available to the public other than as a result of a breach of this Agreement; (b) is obtained

by the Receiving Party on a non-confidential basis from a third party that is not under any obligation of confidentiality; or (c) was

lawfully in the Receiving Party’s possession prior to disclosure by the Disclosing Party. The Receiving Party may disclose Confidential

Information to the extent required by applicable Law or by a governmental authority, provided that (to the extent legally permitted)

it gives the Disclosing Party reasonable prior notice and reasonably cooperates, at the Disclosing Party’s expense, with any request

to limit or protect such disclosure..

Section

14.02 Upon the earlier of the Disclosing Party’s request or the expiration or termination of this Agreement, the Receiving

Party shall return or destroy all documents and materials (and any copies) containing the Disclosing Party’s Confidential Information,

save that the Receiving Party may retain copies to the extent required by applicable Law or for internal compliance purposes, subject

to the confidentiality obligations in this Agreement. The Parties acknowledge that a breach of this Section may result in irreparable

harm, and that the Disclosing Party shall be entitled to seek injunctive or other equitable relief in respect of any such breach. Nothing

in this Agreement shall prevent disclosure of Confidential Information to the extent permitted under applicable law, including pursuant

to the Defend Trade Secrets Act of 2016.

9

Section

14.03 The obligations set out in this Article XIV shall survive the expiration or termination of this Agreement for a period of

five (5) years, or, in the case of trade secrets, for so long as such information remains a trade secret under applicable Law.

ARTICLE

XV

Representations and Warranties

Section

15.01 StableX’s Representations and Warranties. StableX

represents and warrants to Kopin that:

(a) it

is a duly organized, validly existing and in good standing in the jurisdiction of its formation;

(b) it

is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required for purposes of

this Agreement, except where the failure to be so qualified, in the aggregate, would not reasonably be expected to adversely affect its

ability to perform its obligations under this Agreement;

(c) it

has the full right, power and authority to enter into this Agreement and to perform its obligations under this Agreement;

(d) the

execution of this Agreement by its Representative whose signature is set out at the end hereof has been duly authorized by all necessary

action of StableX;

(e) when

executed and delivered by each of Kopin and StableX, this Agreement will constitute the legal, valid and binding obligation of StableX,

enforceable against StableX in accordance with its terms.

Section

15.02 Limited Product Warranty. Subject to the

provisions of Section 15.03, Section 15.04 and Section 15.05, Kopin shall make certain limited warranties regarding the Products (“Limited

Warranties”) solely to and for the End User’s benefit, which shall be, in Kopin’s sole discretion, either:

(a) a

written warranty statement included with the Product;

(b) that

the Products have been manufactured according to the agreed Product specifications and in accordance with applicable Law; or

(c) Kopin’s

standard limited warranty in force when the Product is delivered by StableX to End User.

No

warranty is extended to StableX under this Agreement. StableX shall not provide any warranty regarding any Product other than the Kopin

warranty described in this Section.

Section

15.03 Warranty Limitations. Limited Warranties

do not apply where the Product:

(a) has

been subjected to abuse, misuse, neglect, negligence, accident, improper testing, improper installation, improper storage, improper handling,

abnormal physical stress, abnormal environmental conditions, or use contrary to any instructions issued by Kopin;

(b) has

been reconstructed, repaired, or altered by Persons other than Kopin or its authorized Representative; or

(c) has

been used with any third-party product, hardware or product that has not been previously approved in writing by Kopin.

10

Section

15.04 Extent of Liability. During the Warranty

Period, regarding any Defective Products:

(a) notwithstanding

anything in this Agreement to the contrary, Kopin’s liability under the Limited Warranty is discharged, in Kopin’s sole discretion

and at its expense, by:

(i) repairing

or replacing any Defective Product(s); or

(ii) crediting

or refunding the Price of the Defective Product(s) invoiced or paid, as applicable (i.e., less any applicable discounts, rebates, or

credits).

(b) StableX

is responsible for all costs and risk of loss associated with the delivery of Defective Product(s) to Kopin (subject to change on receipt

of notice from Kopin) for warranty repair or replacement;

(c) Kopin

is responsible for all costs and risk of loss associated with the delivery of repaired or replaced products to the Delivery Point; and

(d) StableX

is responsible for all costs and risk of loss associated with the delivery and return of the repaired or replaced Products to End User.

All

claims for breach of the Limited Warranty must be received by Kopin no later than thirty (30) Business Days after the expiration of the

limited warranty period of the Product.

StableX

has no right to return for repair, replacement, credit, or refund any Product except as set out in this Section (or if otherwise applicable,

Section 9.04 (Inspection) and Section 15.02). StableX shall not reconstruct, repair, alter, or replace any Product, in whole or in part,

either itself or by or through any third party.

THIS

SECTION SETS FORTH StableX’S SOLE REMEDY AND StableX’S ENTIRE LIABILITY FOR ANY BREACH OF ANY WARRANTY RELATING TO THE PRODUCTS.

Except

as explicitly authorized in this Agreement or in a separate written agreement with Kopin, StableX shall not service, repair, modify,

alter, replace, reverse engineer, or otherwise change the Products it sells to End Users.

Section

15.05 Warranties Disclaimer; Non-reliance. EXCEPT

FOR THE LIMITED EXPRESS WARRANTIES DESCRIBED IN Section 15.01 AND Section 15.02, (A) NEITHER KOPIN NOR ANY PERSON ON KOPIN’S BEHALF

HAS MADE OR MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY WHATSOEVER, INCLUDING ANY WARRANTIES OF: (i) MERCHANTABILITY; OR

(ii) FITNESS FOR A PARTICULAR PURPOSE; OR (iii) TITLE; OR (iv) NON-INFRINGEMENT; OR (v) PERFORMANCE OF PRODUCTS TO STANDARDS SPECIFIC

TO THE COUNTRY OF IMPORT, WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, ALL OF WHICH

ARE EXPRESSLY DISCLAIMED; AND (B) STABLEX ACKNOWLEDGES THAT IT HAS NOT RELIED ON ANY REPRESENTATION OR WARRANTY MADE BY KOPIN, OR ANY

OTHER PERSON ON KOPIN’S BEHALF, EXCEPT AS SPECIFICALLY DESCRIBED IN SECTION 15.02 (Limited Product Warranty) OF THIS AGREEMENT.

ARTICLE

XVI

Indemnification

Section

16.01 StableX General Indemnification. In accordance

with the terms and conditions of this Agreement, StableX shall indemnify, hold harmless, and defend (at Kopin’s election) Kopin

and its Affiliates, and each of the foregoing’s officers, directors, partners, members, shareholders, employees, agents, successors

and assigns (collectively, “Kopin Indemnified Party”) against any and all losses, damages, liabilities, deficiencies,

claims, actions, judgments, settlements, interest, awards, penalties, fines, costs, or expenses of whatever kind, including reasonable

attorneys’ fees, fees, and the costs of enforcing any right to indemnification under this Agreement and the cost of pursuing any

insurance providers (collectively, “Losses”), incurred by the Kopin Indemnified Party, arising out of or relating

to any Claim of a third party:

11

(a) relating

to a breach or non-fulfillment of any representation, warranty, or covenant under this Agreement by the StableX or its Personnel;

(b) alleging

or relating to any act or omission of StableX or its Personnel (including any gross negligence, recklessness, or willful misconduct)

in connection with the performance of its obligations under this Agreement; or

(c) alleging

or relating to any bodily injury, death of any Person or damage to real or tangible personal property caused by the willful or grossly

negligent acts or omissions of StableX or its Personnel.

Section

16.02 Kopin General Indemnification. In accordance

with the terms and conditions of this Agreement, Kopin shall indemnify, hold harmless, and defend (at StableX’s election) StableX

and its Affiliates, and each of the foregoing’s officers, directors, partners, members, shareholders, employees, agents, successors

and assigns (collectively, “StableX Indemnified Party”) against any and all Losses incurred by the StableX Indemnified

Party, arising out of or relating to any Claim of a third party:

(a) relating

to a breach or non-fulfillment of any representation, warranty, or covenant under this Agreement by the Kopin or its Personnel;

(b) alleging

or relating to any act or omission of Kopin or its Personnel (including any gross negligence, recklessness, or willful misconduct) in

connection with the performance of its obligations under this Agreement;

(c) alleging

or relating to any bodily injury, death of any Person or damage to real or tangible personal property caused by the willful or grossly

negligent acts or omissions of Kopin or its Personnel; or

(d) any

claim that a Product supplied by Kopin is a Defective Product.

ARTICLE

XVII

Limitation of Liability

Section

17.01 No Liability for Consequential or Indirect Damages. IN NO EVENT IS EITHER

PARTY OR ITS REPRESENTATIVES LIABLE FOR CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE OR ENHANCED DAMAGES, LOST PROFITS

OR REVENUES OR DIMINUTION IN VALUE, ARISING OUT OF OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF: (A) WHETHER THE DAMAGES

WERE FORESEEABLE; (B) WHETHER OR NOT SUCH PARTY WAS ADVISED OF THE POSSIBILITY OF THE DAMAGES; OR (C) THE LEGAL OR EQUITABLE THEORY (CONTRACT,

TORT OR OTHERWISE) ON WHICH THE CLAIM IS BASED, AND NOTWITHSTANDING THE FAILURE OF ANY AGREED OR OTHER REMEDY OF ITS ESSENTIAL PURPOSE.

Section

17.02 Limitation of Liability. Except for liability arising from (i) a Party’s breach

of its confidentiality obligations under this Agreement, (ii) a Party’s indemnification obligations under Article XVI, and (iii)

a Party’s fraud or willful misconduct, each Party’s total aggregate liability arising out of or relating to this Agreement,

whether in contract, tort (including negligence), or otherwise, shall not exceed the total amounts paid or payable by StableX to Kopin

under this Agreement in the twelve (12) months preceding the event giving rise to the claim.

12

ARTICLE

XVIII

Insurance

Section

18.01 StableX Insurance Obligations. During the

Term each Party shall, at its own expense, maintain and carry in full force and effect, all types and amounts of insurance required by

applicable Law and all such insurance as is necessary to satisfy such Party’s obligations under this Agreement, including general

commercial liability insurance and product liability limits, in reasonable and customary amounts, with financially sound and reputable

insurers.

ARTICLE

XIX

Miscellaneous

Section

19.01 Entire Agreement.  In accordance with the language in ARTICLE IV (Terms

of Agreement Prevail Over StableX’s Purchase Order), this Agreement, including and together with related exhibits, schedules, attachments,

and appendices, along with the Development Agreement between the Parties, constitutes the sole and entire agreement between the Parties

with respect to the subject matter of this Agreement, and supersedes all prior and contemporaneous understandings, agreements, representations,

and warranties, both written and oral, regarding such subject matter.

Section

19.02 Notices. All notices under this Agreement

shall be made in writing and shall be deemed duly given if delivered either in person, by certified or registered mail, return receipt

requested and postage prepaid, or by recognized overnight courier service. All notices shall be addressed to the Parties at their respective

addresses first set forth above (or to such other address that the receiving Party may designate from time to time in accordance with

this Section). Notices shall be effective on receipt.

Section

19.03 Severability. If any term or provision

of this Agreement is found by a court of competent jurisdiction to be invalid, illegal, or unenforceable, such invalidity, illegality,

or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or

provision in any other jurisdiction.

Section

19.04 Amendment and Modification. The Parties

may not amend this Agreement except by written instrument signed by the Parties.

Section

19.05 Waiver.  No waiver by any Party of any of the provisions of this Agreement

shall be effective unless explicitly set forth in writing and signed by the Party so waiving. Except as otherwise set forth in this Agreement,

no failure to exercise, or delay in exercising, any right, remedy, power, or privilege arising from this Agreement shall operate or be

construed as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude

any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.

Section

19.06 Cumulative Remedies. All rights and remedies

provided in this Agreement are cumulative and not exclusive, and the exercise by either Party of any right or remedy does not preclude

the exercise of any other rights or remedies that may now or later be available at law, in equity, by statute, in any other agreement

between the Parties or otherwise.

Section

19.07 Equitable Remedies. Each Party, as Receiving

Party, acknowledges and agrees that (a) a breach or threatened breach by such Party of any of its obligations under ARTICLE XIV (Confidentiality)

would give rise to irreparable harm to Disclosing Party for which monetary damages would not be an adequate remedy and (b) in the event

of a breach or a threatened breach by Receiving Party of any of these obligations, Disclosing Party shall, in addition to any and all

other rights and remedies that may be available to Disclosing Party at law, at equity, or otherwise in respect of this breach, be entitled

to equitable relief, including a temporary restraining order, an injunction, specific performance and any other relief that may be available

from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove

actual damages or that monetary damages do not afford an adequate remedy. Each Party, as Receiving Party, agrees that it will not oppose

or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting

equitable relief, in either case, consistent with the terms of this Section.

13

Section

19.08 Assignment; Successors and Assigns. Neither

Party may assign any of its rights or delegate any of its obligations under this Agreement without the prior written consent of the other

Party, except for a sale of all or substantially all of the business assets of such Party to which this Agreement relates. In such a

sale, the purported Assignee must agree to be bound in writing by the obligations of this Agreement and a copy of such writing and such

assignment must be provided to the other Party at least ten (10) Business Days before such a transaction is executed. Any purported assignment

or delegation in violation of this Section is null and void. No assignment or delegation relieves the assigning or delegating Party of

any of the Party’s obligations under this Agreement.

Section

19.09 Choice of Law; Choice of Forum. Section

10.1 of the Development Agreement is incorporated herein by reference and made a part hereof.

Section

19.10 Counterparts. This Agreement may be executed

in counterparts, each of which is deemed an original, but all of which together are deemed to be one and the same agreement. A signed

copy of this Agreement delivered by facsimile, e-mail, or other means of electronic transmission is deemed to have the same legal effect

as delivery of an original signed copy of this Agreement.

Section

19.11 Force Majeure. No Party shall be liable or responsible to the other Party,

nor be deemed to have defaulted under or breached this Agreement, for any failure or delay in fulfilling or performing any term of this

Agreement (except as to the payment of consideration), when and to the extent such failure or delay is caused by or results from acts

beyond the affected Party’s reasonable control, including, without limitation: (a) acts of God; (b) flood, fire, earthquake, or

explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or acts, riot, or other civil unrest; (d)

Law; (e) actions, embargoes, or blockades in effect on or after the date of this Agreement; (f) action by any Governmental Authority;

(g) national or regional emergency; (h) general strikes, labor stoppages or slowdowns, or other industrial disturbances; (i) shortage

of adequate power or transportation facilities; (j) epidemic or pandemic, excluding however, circumstances directly related to COVID-19

conditions as they exist at the Effective Date, and (k) U.S. military customer requiring the majority of Kopin’s manufacturing

capacity such that Kopin is unable to supply StableX with Product for so long as such requirement persists (each a “Force Majeure

Event”).

14

IN

WITNESS WHEREOF, the Parties hereto have executed this Agreement by their proper and duly authorized representatives as of the Effective

Date.

STABLEX

TECHONOLOGIES, INC.

KOPIN

CORPORATION

By:

/s/Joshua

Silverman

By:

/s/

Michael Murray

Name:

Josh

Silverman

Name:

Michael

Murray

Title:

Executive

Chairman

Title:

President

and CEO

15

EX-10.3

EX-10.3

Filename: ex10-3.htm · Sequence: 13

Exhibit

10.3

SECURITIES

PURCHASE AGREEMENT

This

SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 27, 2026, is by and among StableX Technologies,

Inc., a Delaware corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached

hereto (individually, a “Buyer” and collectively, the “Buyers”).

RECITALS

A.

The Company has authorized a new series of convertible preferred stock of the Company, designated as Series K Convertible Preferred Stock,

par value $0.0001 per share, the terms of which are set forth in the certificate of designations for such series of preferred stock (the

“Certificate of Designations”) in the form attached hereto as Exhibit A (together with any convertible

preferred shares issued in replacement thereof in accordance with the terms thereof, the “Series K Preferred Stock”),

which Series K Preferred Stock shall be convertible into shares of the Company’s common stock, par value $0.0001 per share (the

“Common Stock”), in accordance with the terms of the Certificate of Designations.

B.

Each Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, pursuant to the

exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”)

and Rule 506(b) of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission

(the “SEC”) under the 1933 Act, (1) such aggregate number of shares of Series K Preferred Stock set forth opposite

such Buyer’s name in column (3) on the Schedule of Buyers (which aggregate amount for all Buyers shall be 21,500 Preferred Shares

and shall be referred to herein as the “Preferred Shares”) and (2) a warrant to initially acquire up to that aggregate

number of additional shares of Common Stock set forth opposite such Buyer’s name in column (4) on the Schedule of Buyers, substantially

in the form attached hereto as Exhibit B (the “Warrants”). The shares of Common Stock issuable pursuant

to the Preferred Shares, including, without limitation, upon conversion or otherwise, are herein referred to as the “Conversion

Shares.” The shares of Common Stock issuable upon exercise of the Warrants are herein referred to as the “Warrant

Shares.” The Conversion Shares and Warrant Shares are collectively herein referred to as the “Shares.”

C.

On the Closing Date, the parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto as Exhibit

C (the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide certain registration

rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933 Act and the rules

and regulations promulgated thereunder, and applicable state securities laws.

D.

The Preferred Shares, the Conversion Shares, the Warrants and the Warrant Shares are collectively referred to herein as the “Securities.”

AGREEMENT

NOW,

THEREFORE, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration,

the receipt and sufficiency of which are hereby acknowledged, the Company and each Buyer hereby agree as follows:

1.

PURCHASE AND SALE OF PREFERRED SHARES AND WARRANTS.

(a)

Purchase of Preferred Shares and Warrants. Subject to the satisfaction (or waiver) of the conditions set forth in Sections

6 and 7 below, the Company shall issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees to purchase

from the Company on the Closing Date (as defined below), such aggregate number of Preferred Shares as is set forth opposite such Buyer’s

name in column (3) on the Schedule of Buyers along with Warrants to initially acquire up to that aggregate number of Warrant Shares as

is set forth opposite such Buyer’s name in column (4) on the Schedule of Buyers.

1

(b)

Closing. The closing (the “Closing”) of the purchase of the Preferred Shares and the Warrants by the Buyers

shall occur remotely by the electronic transfer of Closing documentation. The date and time of the Closing (the “Closing Date”)

shall be 10:00 a.m., New York time, on the first (1st) Business Day on which the conditions to the Closing set forth in Sections 6

and 7 below are satisfied or waived (or such other date as is mutually agreed to by the Company and each Buyer). As used herein

“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New

York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not

be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential

employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental

authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York

generally are open for use by customers on such day.

(c)

Purchase Price. The aggregate purchase price for the Preferred Shares and the Warrants to be purchased by each Buyer (the “Purchase

Price”) shall be the amount set forth opposite such Buyer’s name in column (5) on the Schedule of Buyers.

(d)

Form of Payment. On the Closing Date, (i) each Buyer shall pay its respective Purchase Price (less, in the case of the lead Buyer,

the amounts withheld pursuant to Section 4(g)) to the Company for the Preferred Shares and the Warrants to be issued and sold to such

Buyer at the Closing, by wire transfer of immediately available funds in accordance with the Company’s written wire instructions)

and (ii) the Company shall deliver to each Buyer (A) such aggregate number of Preferred Shares as is set forth opposite such Buyer’s

name in column (3) of the Schedule of Buyers, and (B) a Warrant pursuant to which such Buyer shall have the right to initially acquire

up to such aggregate number of Warrant Shares as is set forth opposite such Buyer’s name in column (4) of the Schedule of Buyers,

in each case, duly executed on behalf of the Company and registered in the name of such Buyer or its designee.

2.

BUYER’S REPRESENTATIONS AND WARRANTIES.

Each

Buyer, severally and not jointly, represents and warrants to the Company with respect to only itself that, as of the date hereof and

as of the Closing Date:

(a)

Organization; Authority. Such Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction

of its organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction

Documents (as defined below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder.

(b)

No Public Sale or Distribution. Such Buyer (i) is acquiring its Preferred Shares and Warrants, (ii) upon conversion of its Preferred

Shares will acquire the Conversion Shares issuable upon conversion thereof, and (iii) upon exercise of its Warrants (other than pursuant

to a Cashless Exercise (as defined in the Warrants)) will acquire the Warrant Shares issuable upon exercise thereof, in each case, for

its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof in violation of

applicable securities laws, except pursuant to sales registered or exempted under the 1933 Act; provided, however, by making

the representations herein, such Buyer does not agree, or make any representation or warranty, to hold any of the Securities for any

minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration

statement or an exemption from registration under the 1933 Act. Such Buyer does not presently have any agreement or understanding, directly

or indirectly, with any Person to distribute any of the Securities in violation of applicable securities laws. For purposes of this Agreement,

“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,

an unincorporated organization, any other entity and any Governmental Entity (as defined below) or any department or agency thereof.

(c)

Accredited Investor Status; Experience. Such Buyer is an “accredited investor” as that term is defined in Rule 501(a)

of Regulation D. Such Buyer, either alone or together with its representatives, has such knowledge, sophistication and experience in

business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,

and has so evaluated the merits and risks of such investment. Such Buyer is able to bear the economic risk of an investment in the Securities

and, at the present time, is able to afford a complete loss of such investment.

2

(d)

Reliance on Exemptions. Such Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions

from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the

truth and accuracy of, and such Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings

of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of such Buyer to acquire

the Securities.

(e)

Information. Such Buyer acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits

and schedules thereto) and the SEC Documents (as defined below). Such Buyer and its advisors, if any, have been furnished with all materials

relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities that

have been requested by such Buyer. Such Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company.

Neither such inquiries nor any other due diligence investigations conducted by such Buyer or its advisors, if any, or its representatives

shall modify, amend or affect such Buyer’s right to rely on the Company’s representations and warranties contained herein.

Such Buyer understands that its investment in the Securities involves a high degree of risk. Such Buyer has sought such accounting, legal

and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.

(f)

No Governmental Review. Such Buyer understands that no United States federal or state agency or any other government or governmental

agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in

the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

(g)

Transfer or Resale. Such Buyer understands that except as provided in the Registration Rights Agreement and Section 4(h)

hereof: (i) the Securities have not been and are not being registered under the 1933 Act or any state securities laws, and may not be

offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) such Buyer shall have delivered to

the Company (if requested by the Company) an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such

Securities to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such registration,

or (C) such Buyer provides the Company with reasonable assurance that such Securities can be sold, assigned or transferred pursuant to

Rule 144 or Rule 144A promulgated under the 1933 Act (or a successor rule thereto) (collectively, “Rule 144”); (ii)

any sale of the Securities made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule

144 is not applicable, any resale of the Securities under circumstances in which the seller (or the Person through whom the sale is made)

may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the

1933 Act or the rules and regulations of the SEC promulgated thereunder; and (iii) neither the Company nor any other Person is under

any obligation to register the Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions

of any exemption thereunder. Notwithstanding the foregoing, the Securities may be pledged in connection with a bona fide margin account

or other loan or financing arrangement secured by the Securities and such pledge of Securities shall not be deemed to be a transfer,

sale or assignment of the Securities hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company

with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document (as

defined in Section 3(b)), including, without limitation, this Section 2(g).

(h)

Validity; Enforcement. This Agreement and the Registration Rights Agreement, as applicable, have been duly and validly authorized,

executed and delivered on behalf of such Buyer and shall constitute the legal, valid and binding obligations of such Buyer enforceable

against such Buyer in accordance with their respective terms, except as such enforceability may be limited by general principles of equity

or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally,

the enforcement of applicable creditors’ rights and remedies.

(i)

No Conflicts. The execution, delivery and performance by such Buyer of this Agreement and the Registration Rights Agreement and

the consummation by such Buyer of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational

documents of such Buyer, or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would

become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture

or instrument to which such Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree

(including federal and state securities laws) applicable to such Buyer, except in the case of clauses (ii) and (iii) above, for such

conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be expected to have a material

adverse effect on the ability of such Buyer to perform its obligations hereunder.

3

(j)

No Reliance on Placement Agent. Such Buyer acknowledges and agrees that neither the Placement Agent (as defined below) nor any

affiliate of the Placement Agent has provided such Buyer with any information or advice with respect to the Securities nor is such information

or advice necessary or desired. Neither the Placement Agent nor any affiliate has made or makes any representation as to the Company

or the quality of the Securities and the Placement Agent and any affiliate may have acquired non-public information with respect to the

Company which such Buyer agrees need not be provided to it. In connection with the issuance of the Securities to such Buyer, neither

the Placement Agent nor any of its affiliates has acted as a financial advisor or fiduciary to such Buyer.

(k)

Residency. Such Buyer is a resident of that jurisdiction specified below its address on the Schedule of Buyers.

(l)

General Solicitation. Buyer represents that (i) Buyer was contacted regarding the sale of the Securities by the Placement Agent

or the Company (or authorized representative thereof) and the Buyer had a prior pre-existing relationship with the Company under the

U.S. securities laws and interpretations, (ii) to the knowledge of such Buyer, no Securities were offered or sold to it by means of any

form of general solicitation, and Buyer is not, to such Buyer’s knowledge, purchasing the Securities as a result of any advertisement,

article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over

television or radio or presented at any seminar or, to the knowledge of such Buyer, any other general solicitation or general advertisement.

Buyer has not become interested in the offering of the Securities as a result of any registration statement of the Company filed with

the SEC or any other securities agency or regulator.

(m)

Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Buyer has not,

nor has any Person acting on behalf of or pursuant to any understanding with such Buyer, directly or indirectly executed any purchases

or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Buyer first received

a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the

transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case

of a Buyer that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Buyer’s

assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other

portions of such Buyer’s assets, the representation set forth above shall only apply with respect to the portion of assets managed

by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other

Persons party to this Agreement or to such Buyer’s representatives, including, without limitation, its officers, directors, partners,

legal and other advisors, employees, agents and affiliates, such Buyer has maintained the confidentiality of all disclosures made to

it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the

avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to

locating or borrowing shares in order to effect Short Sales or similar transactions in the future. “Short Sales” means

all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating

and/or borrowing shares of Common Stock).

4

3.

REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

The

Company represents and warrants to each of the Buyers that, as of the date hereof and as of the Closing Date:

(a)

Organization and Qualification. Each of the Company and each of its Subsidiaries are entities duly organized and validly existing

and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power and authority to own their

properties and to carry on their business as described in the SEC Documents. Each of the Company and each of its Subsidiaries is duly

qualified as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property or the

nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or

be in good standing would not reasonably be expected to have a Material Adverse Effect (as defined below). As used in this Agreement,

“Material Adverse Effect” means any material adverse effect on (i) the business, properties, assets, liabilities,

operations (including results thereof), condition (financial or otherwise) or prospects of the Company and its Subsidiaries (as defined

below), taken as a whole, (ii) the transactions contemplated hereby or in any of the other Transaction Documents or any other agreements

or instruments to be entered into in connection herewith or therewith or (iii) the authority or ability of the Company or any of its

Subsidiaries to perform any of their respective obligations under any of the Transaction Documents (as defined below). “Subsidiaries”

means any Person in which the Company, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar

interest of such Person or (II) controls or operates all or any part of the business, operations or administration of such Person, and

each of the foregoing, is individually referred to herein as a “Subsidiary.”

(b)

Authorization; Enforcement; Validity. The Company has the requisite power and authority to enter into and perform its obligations

under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms hereof and thereof.

Each Subsidiary has the requisite power and authority to enter into and perform its obligations under the Transaction Documents to which

it is a party. The execution and delivery of this Agreement and the other Transaction Documents by the Company and its Subsidiaries,

and the consummation by the Company and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation,

the issuance by the Company of the Preferred Shares and the reservation for issuance and issuance of the Conversion Shares issuable upon

conversion of the Preferred Shares and the issuance of the Warrants and the reservation for issuance and issuance of the Warrant Shares

issuable upon exercise of the Warrants) have been duly authorized by the Company’s board of directors and, to the extent applicable,

each of its Subsidiaries’ board of directors or other governing body, as applicable, and (other than the filing with the SEC of

a Form D or of one or more Registration Statements (as defined in the Registration Rights Agreement) in accordance with the requirements

of the Registration Rights Agreement, the filing of the Certificate of Designations and any other filings as may be required by any state

securities agencies) no further filing, consent or authorization is required by the Company, its Subsidiaries, their respective boards

of directors or their stockholders or other governing body. This Agreement has been, and the other Transaction Documents to which it

is a party will be prior to the Closing, duly executed and delivered by the Company, and each constitutes the legal, valid and binding

obligations of the Company, enforceable against the Company in accordance with its respective terms, except as such enforceability may

be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws

relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification

and to contribution may be limited by federal or state securities law. Prior to the Closing, the Transaction Documents to which each

Subsidiary is a party will be duly executed and delivered by each such Subsidiary, and shall constitute the legal, valid and binding

obligations of each such Subsidiary, enforceable against each such Subsidiary in accordance with their respective terms, except as such

enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation

or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as

rights to indemnification and to contribution may be limited by federal or state securities law. “Transaction Documents”

means, collectively, this Agreement, the Certificate of Designations, the Warrants, the Registration Rights Agreement, the Irrevocable

Transfer Agent Instructions (as defined below) and each of the other agreements and instruments entered into or delivered by the Company

or any of its Subsidiaries in connection with the transactions contemplated hereby and thereby, as may be amended from time to time.

5

(c)

Issuance of Securities. The issuance of the Preferred Shares and the Warrants are duly authorized and upon issuance in accordance

with the terms of the Transaction Documents shall be validly issued, fully paid and non-assessable and free from all preemptive or similar

rights, mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other

encumbrances (collectively “Liens”) with respect to the issuance thereof. As of the Closing, the Company shall have

reserved from its duly authorized share capital not less than the sum of (i) 200% of the maximum number of Conversion Shares issuable

upon conversion of the Preferred Shares (assuming for purposes hereof that the Preferred Shares are convertible at the Floor Price (as

defined in the Certificate of Designations) then in effect and without taking into account any limitations on the conversion of the Preferred

Shares set forth in the Certificate of Designations), and (ii) the maximum number of Warrant Shares initially issuable upon exercise

of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth therein). Upon issuance or conversion

in accordance with the Preferred Shares or exercise in accordance with the Warrants (as the case may be), the Conversion Shares and the

Warrant Shares, respectively, when issued, will be validly issued, fully paid and nonassessable and free from all preemptive or similar

rights or Liens with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of shares of Common

Stock (other than restrictions on transfer as described in Section 2(g)). The Company is eligible to use Form S-3 under the 1933

Act and it meets the transaction requirements as set forth in General Instruction I.B.6 of Form S-3. Subject to the accuracy of the representations

and warranties of the Buyers in this Agreement, the offer and issuance by the Company of the Securities is exempt from registration under

the 1933 Act.

(d)

No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries and the

consummation by the Company and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation,

the issuance of the Preferred Shares, the Warrants, the Conversion Shares and the Warrant Shares and the reservation for issuance of

the Conversion Shares and the Warrant Shares) will not (i) result in a violation of the Certificate of Incorporation (as defined below),

Bylaws (as defined below) or other organizational documents of the Company or any of its Subsidiaries, or any capital stock or other

securities of the Company or any of its Subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or lapse

of time or both would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration or

cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in

a violation of any law, rule, regulation, order, judgment or decree and including all applicable foreign, federal and state securities

laws, rules and regulations, and the rules and regulations of The Nasdaq Capital Market (the “Principal Market”) applicable

to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected;

except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse

Effect.

(e)

Consents. Neither the Company nor any Subsidiary is required to obtain any consent from, authorization or order of, or make any

filing or registration with (other than the filing with the SEC of one or more registration statements in accordance with the requirements

of the Registration Rights Agreement, a Form D with the SEC and any other filings as may be required by any state securities agencies,

the notice and/or application(s) to the Principal Market for the issuance and sale of the Securities and the listing of the Conversion

Shares and Warrant Shares for trading thereon in the time and manner required thereby), any Governmental Entity (as defined below) or

any regulatory or self-regulatory agency or any other Person in order for it to execute, deliver or perform any of its respective obligations

under or contemplated by the Transaction Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations,

orders, filings and registrations which the Company or any Subsidiary is required to obtain prior to the Closing Date pursuant to the

preceding sentence have been or will be obtained or effected on or prior to the Closing Date, and neither the Company nor any of its

Subsidiaries are aware of any facts or circumstances which might prevent the Company or any of its Subsidiaries from obtaining or effecting

any of the registration, application or filings contemplated by the Transaction Documents. The Company is not in violation of the requirements

of the Principal Market and has no knowledge of any facts or circumstances which could reasonably lead to delisting or suspension of

the Common Stock in the foreseeable future. “Governmental Entity” means any nation, state, county, city, town, village,

district, or other political jurisdiction of any nature, federal, state, local, municipal, foreign, or other government, governmental

or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court

or other tribunal), multi-national organization or body; or body exercising, or entitled to exercise, any administrative, executive,

judicial, legislative, police, regulatory, or taxing authority or power of any nature or instrumentality of any of the foregoing, including

any entity or enterprise owned or controlled by a government or a public international organization or any of the foregoing.

6

(f)

Acknowledgment Regarding Buyer’s Purchase of Securities. The Company acknowledges and agrees that each Buyer is acting solely

in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby

and thereby and that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an “affiliate”

(as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a “beneficial owner” of more

than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the

“1934 Act”)). The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the

Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated

hereby and thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents

and the transactions contemplated hereby and thereby is merely incidental to such Buyer’s purchase of the Securities. The Company

further represents to each Buyer that the Company’s and each Subsidiary’s decision to enter into the Transaction Documents

to which it is a party has been based solely on the independent evaluation by the Company, each Subsidiary and their respective representatives.

(g)

No General Solicitation; Placement Agent’s Fees. Neither the Company, nor any of its Subsidiaries or affiliates, nor any

Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation

D) in connection with the offer or sale of the Securities. The Company shall be responsible for the payment of any placement agent’s

fees, financial advisory fees, or brokers’ commissions (other than for Persons engaged by any Buyer or its investment advisor)

relating to or arising out of the transactions contemplated hereby, including, without limitation, the advisory fees payable to GP Nurmenkari

Inc. (the “Placement Agent”) in connection with the sale of the Securities. The Company shall pay, and hold each Buyer

harmless against, any liability, loss or expense (including, without limitation, attorney’s fees and out-of-pocket expenses) arising

in connection with any such claim. The Company acknowledges that it has engaged the Placement Agent in connection with the sale of the

Securities. Other than the Placement Agent, neither the Company nor any of its Subsidiaries has engaged any placement agent or other

agent in connection with the offer or sale of the Securities.

(h)

No Integrated Offering. None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on their behalf

has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances

that would require registration of the issuance of any of the Securities under the 1933 Act, whether through integration with prior offerings

or otherwise, or caused this offering of the Securities to require approval of stockholders of the Company for purposes of the 1933 Act

or under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations of any exchange

or automated quotation system on which any of the securities of the Company are listed or designated for quotation. None of the Company,

its Subsidiaries, their affiliates nor any Person acting on their behalf will take any action or steps that would require registration

of the issuance of any of the Securities under the 1933 Act (other than pursuant to the Registration Rights Agreement) or cause the offering

of any of the Securities to be integrated with other offerings of securities of the Company.

(i)

Dilutive Effect. The Company understands and acknowledges that the number of Conversion Shares and Warrant Shares will increase

in certain circumstances. The Company further acknowledges that its obligation to issue the Conversion Shares pursuant to the terms of

the Certificate of Designations in accordance with this Agreement and Warrant Shares upon exercise of the Warrants in accordance with

this Agreement, the Preferred Shares and the Warrants is, in each case, absolute and unconditional regardless of the dilutive effect

that such issuance may have on the ownership interests of other stockholders of the Company.

(j)

Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary action,

if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison pill (including,

without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover provision under

the Certificate of Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise

which is or could become applicable to any Buyer as a result of the transactions contemplated by this Agreement, including, without limitation,

the Company’s issuance of the Securities and any Buyer’s ownership of the Securities. The Company and its board of directors

have taken all necessary action, if any, in order to render inapplicable any stockholder rights plan or similar arrangement relating

to accumulations of beneficial ownership of shares of Common Stock or a change in control of the Company or any of its Subsidiaries.

7

(k)

SEC Documents; Financial Statements. During the two (2) years prior to the date hereof, the Company has timely filed all reports,

schedules, forms, proxy statements, statements and other documents required to be filed by it with the SEC pursuant to the reporting

requirements of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and

financial statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the

“SEC Documents”). The Company has delivered or has made available to the Buyers or their respective representatives

true, correct and complete copies of each of the SEC Documents not available on the EDGAR system. As of their respective dates, the SEC

Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated

thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue

statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements

therein, in the light of the circumstances under which they were made, not misleading. As of their respective dates, the financial statements

of the Company included in the SEC Documents complied in all material respects with applicable accounting requirements and the published

rules and regulations of the SEC with respect thereto as in effect as of the time of filing. Such financial statements have been prepared

in accordance with U.S. generally accepted accounting principles (“GAAP”), consistently applied, during the periods

involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited

interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material

respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods

then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually

or in the aggregate). No other information provided by or on behalf of the Company to any of the Buyers which is not included in the

SEC Documents (including, without limitation, information referred to in Section 2(e) of this Agreement or in the disclosure schedules

to this Agreement) contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the

statements therein not misleading, in the light of the circumstances under which they are or were made. The Company is not currently

contemplating to amend or restate any of the financial statements (including, without limitation, any notes or any letter of the independent

accountants of the Company with respect thereto) included in the SEC Documents (the “Financial Statements”), nor is

the Company currently aware of facts or circumstances which would require the Company to amend or restate any of the Financial Statements,

in each case, in order for any of the Financial Statements to be in compliance with GAAP and the rules and regulations of the SEC. The

Company has not been informed by its independent accountants that they recommend that the Company amend or restate any of the Financial

Statements or that there is any need for the Company to amend or restate any of the Financial Statements.

(l)

Absence of Certain Changes. Except as disclosed in the SEC Documents, since the date of the Company’s most recent audited

financial statements contained in a Form 10-K, there has been no material adverse change and no material adverse development in the business,

assets, liabilities, properties, operations (including results thereof), condition (financial or otherwise) or prospects of the Company

or any of its Subsidiaries. Since the date of the Company’s most recent audited financial statements contained in a Form 10-K,

neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets, individually or in the

aggregate, outside of the ordinary course of business or (iii) made any capital expenditures, individually or in the aggregate, outside

of the ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to

any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company

or any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy

proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually

and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur

at the Closing, will not be Company Insolvent (as defined below). For purposes of this Section 3(l), “Company Insolvent”

means, with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the Company’s

and its Subsidiaries’ assets is less than the amount required to pay the Company’s and its Subsidiaries’ total Indebtedness

(as defined below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent or otherwise,

as such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend to incur or believe that they

will incur debts that would be beyond their ability to pay as such debts mature. Neither the Company nor any of its Subsidiaries has

engaged in any business or in any transaction, and is not about to engage in any business or in any transaction, for which the Company’s

or such Subsidiary’s remaining assets constitute unreasonably small capital with which to conduct the business in which it is engaged

as such business is now conducted and is proposed to be conducted.

8

(m)

No Undisclosed Events, Liabilities, Developments or Circumstances. To the Company’s knowledge, no event, liability, development

or circumstance has occurred or exists that is reasonably likely to have a Material Adverse Effect.

(n)

Conduct of Business; Regulatory Permits. Neither the Company nor any of its Subsidiaries is in violation of any term of or in

default under its Certificate of Incorporation, organizational documents, any certificate of designations, preferences or rights of any

other outstanding series of preferred stock of the Company or any of its Subsidiaries or Bylaws, their organizational charter, certificate

of formation, memorandum of association, articles of association or certificate of incorporation or bylaws or other organizational documents,

respectively. Neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance,

rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct

its business in violation of any of the foregoing, except in all cases for possible violations which could not, individually or in the

aggregate, have a Material Adverse Effect. Without limiting the generality of the foregoing, the Company is not in violation of any of

the rules, regulations or requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably

lead to delisting or suspension of the Common Stock by the Principal Market in the foreseeable future. Since May 29, 2020, (i) the Common

Stock has been listed or designated for quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by

the SEC or the Principal Market and (iii) except as disclosed in the SEC Documents, the Company has received no communication, written

or oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from the Principal Market. The

Company and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities

necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would

not have, individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any

notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement,

commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any

of its Subsidiaries is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any

business practice of the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries or

the conduct of business by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in

the aggregate, which have not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its

Subsidiaries.

(o)

Foreign Corrupt Practices. Neither the Company, the Company’s subsidiary or any director, officer, agent, employee, nor

any other person acting for or on behalf of the foregoing (individually and collectively, a “Company Affiliate”) have

violated the U.S. Foreign Corrupt Practices Act (the “FCPA”) or any other applicable anti-bribery or anti-corruption

laws, nor has any Company Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised

to give, or authorized the giving of anything of value, to any officer, employee or any other person acting in an official capacity for

any Governmental Entity to any political party or official thereof or to any candidate for political office (individually and collectively,

a “Government Official”) or to any person under circumstances where such Company Affiliate knew or was aware of a

high probability that all or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to

any Government Official, for the purpose of:

(i)

influencing any act or decision of such Government Official in his/her official capacity, (A) inducing such Government Official to do

or omit to do any act in violation of his/her lawful duty, (B) securing any improper advantage, or (C) inducing such Government Official

to influence or affect any act or decision of any Governmental Entity, or

(ii)

assisting the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its

Subsidiaries.

(p)

Sarbanes-Oxley Act. The Company and each Subsidiary is in compliance with any and all applicable requirements of the Sarbanes-Oxley

Act of 2002, as amended, and any and all applicable rules and regulations promulgated by the SEC thereunder.

9

(q)

Transactions With Affiliates. Except as disclosed in the SEC Documents or for which no disclosure is required in the SEC Documents,

no current or former employee, partner, director, officer or stockholder (direct or indirect) of the Company or its Subsidiaries, or

any associate, or, to the knowledge of the Company, any affiliate of any thereof, or any relative with a relationship no more remote

than first cousin of any of the foregoing, is presently, or has ever been, (i) a party to any transaction with the Company or its Subsidiaries

(including any contract, agreement or other arrangement providing for the furnishing of services by, or rental of real or personal property

from, or otherwise requiring payments to, any such director, officer or stockholder or such associate or affiliate or relative Subsidiaries

(other than for ordinary course services as employees, officers or directors of the Company or any of its Subsidiaries)) or (ii) the

direct or indirect owner of an interest in any corporation, firm, association or business organization which is a competitor, supplier

or customer of the Company or its Subsidiaries (except for a passive investment (direct or indirect) in less than 5% of the common equity

of a company whose securities are traded on or quoted through an Eligible Market (as defined in the Certificate of Designations)), nor

does any such Person receive income from any source other than the Company or its Subsidiaries which relates to the business of the Company

or its Subsidiaries or should properly accrue to the Company or its Subsidiaries. No employee, officer, stockholder or director of the

Company or any of its Subsidiaries or member of his or her immediate family is indebted to the Company or its Subsidiaries, as the case

may be, nor is the Company or any of its Subsidiaries indebted (or committed to make loans or extend or guarantee credit) to any of them,

other than (i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses incurred on behalf of the Company,

and (iii) for other standard employee benefits made generally available to all employees or executives (including stock option agreements

outstanding under any stock option plan approved by the Board of Directors of the Company).

(r)

Equity Capitalization. As of the date hereof, the authorized capital stock of the Company consists solely of (i) 1,200,000,000

shares of Common Stock, of which, 1,455,975 shares of Common Stock are issued and outstanding and 34,263,605 shares are reserved for

issuance pursuant to outstanding Convertible Securities (as defined below) (other than the Preferred Shares and the Warrants); and (ii)

20,000,000 shares of Preferred Stock, of which 8 shares of Series H Convertible Preferred Stock are issued and outstanding, 1,234 shares

of Series H-3 Convertible Preferred Stock are issued and outstanding, 50 shares of Series H-6 Convertible Preferred Stock are issued

and outstanding, 829.4 shares of Series H-7 Convertible Preferred Stock are issued and outstanding, no shares of Series A Junior Participating

Preferred Stock are issued and outstanding, 7,000 shares of Series I Convertible Preferred Stock are issued and outstanding, and 51,575

shares of Series J Convertible Preferred Stock are issued and outstanding. “Convertible Securities” means any capital

stock or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly or indirectly

convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital stock or other

security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries. All of such outstanding shares are

duly authorized and have been, or upon issuance will be, validly issued and are fully paid and non-assessable. Except as disclosed in

the SEC Documents, (i) none of the Company’s or any Subsidiary’s capital stock is subject to preemptive rights or any other

similar rights or any liens or encumbrances suffered or permitted by the Company or any Subsidiary; (ii) there are no outstanding options,

warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible

into, or exercisable or exchangeable for, any capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings

or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional capital stock of the Company

or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating

to, or securities or rights convertible into, or exercisable or exchangeable for, any capital stock of the Company or any of its Subsidiaries;

(iii) there are no outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments

evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may become

bound; (iv) there are no financing statements securing obligations in any amounts filed in connection with the Company or any of its

Subsidiaries; (v) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register

the sale of any of their securities under the 1933 Act (except pursuant to the Registration Rights Agreement); (vi) there are no outstanding

securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are

no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem

a security of the Company or any of its Subsidiaries; (vii) there are no securities or instruments containing anti-dilution or similar

provisions that will be triggered by the issuance of the Securities; (viii) neither the Company nor any Subsidiary has any stock appreciation

rights or “phantom stock” plans or agreements or any similar plan or agreement; and (ix) neither the Company nor any of its

Subsidiaries have any liabilities or obligations required to be disclosed in the SEC Documents which are not so disclosed in the SEC

Documents, other than those incurred in the ordinary course of the Company’s or its Subsidiaries’ respective businesses and

which, individually or in the aggregate, do not or could not have a Material Adverse Effect. The Company has furnished to the Buyers

true, correct and complete copies of the Company’s Certificate of Incorporation, as amended and as in effect on the date hereof

(the “Certificate of Incorporation”), and the Company’s bylaws, as amended and as in effect on the date hereof

(the “Bylaws”), and the terms of all Convertible Securities convertible into, or exercisable or exchangeable for,

shares of Common Stock and the material rights of the holders thereof in respect thereto.

10

(s)

Indebtedness and Other Contracts. Neither the Company nor any of its Subsidiaries, (i) has any outstanding debt securities, notes,

credit agreements, credit facilities or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its

Subsidiaries or by which the Company or any of its Subsidiaries is or may become bound, (ii) is a party to any contract, agreement or

instrument, the violation of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably

be expected to result in a Material Adverse Effect, (iii) has any financing statements securing obligations in any amounts filed in connection

with the Company or any of its Subsidiaries; (iv) is in violation of any term of, or in default under, any contract, agreement or instrument

relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in a Material

Adverse Effect, or (v) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance of which, in

the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect. For purposes of this Agreement: (x)

“Indebtedness” of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations

issued, undertaken or assumed as the deferred purchase price of property or services (including, without limitation, “finance leases”

in accordance with GAAP) (other than trade payables entered into in the ordinary course of business consistent with past practice), (C)

all reimbursement or payment obligations, currently due and payable, with respect to letters of credit, surety bonds and other similar

instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred

in connection with the acquisition of property, assets or businesses, (E) all indebtedness created or arising under any conditional sale

or other title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the

proceeds of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default

are limited to repossession or sale of such property), (F) all monetary obligations under any leasing or similar arrangement which, in

connection with GAAP, consistently applied for the periods covered thereby, is classified as a finance lease, (G) all indebtedness referred

to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise,

to be secured by) any Lien upon or in any property or assets (including accounts and contract rights) owned by any Person, even though

the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent

Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above; and (y) “Contingent

Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect

to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such

liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or

discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in

whole or in part) against loss with respect thereto.

(t)

Litigation. There is no material action, suit, arbitration, proceeding, inquiry or investigation before or by the Principal Market,

any court, public board, other Governmental Entity, self-regulatory organization or body pending or, to the knowledge of the Company,

threatened against or affecting the Company or any of its Subsidiaries, the Common Stock or any of the Company’s or its Subsidiaries’

officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such, except as disclosed in the SEC

Documents. To its knowledge, no director, officer or employee of the Company or any of its subsidiaries has willfully violated 18 U.S.C.

§1519 or engaged in spoliation in reasonable anticipation of litigation. Without limitation of the foregoing, there has not been,

and to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company, any of

its Subsidiaries or any current or former director or officer of the Company or any of its Subsidiaries relating to the Company. Neither

the Company nor any of its Subsidiaries is subject to any order, writ, judgment, injunction, decree, determination or award of any Governmental

Entity.

11

(u)

Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such

losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the

Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought

or applied for, and neither the Company nor any such Subsidiary has any reason to believe that it will be unable to renew its existing

insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue

its business at a cost that would not have a Material Adverse Effect.

(v)

Employee Matters; Benefit Plans.

(i)

The Company and its Subsidiaries have complied in all material respects with all applicable laws relating to wages, hours, equal opportunity,

collective bargaining, workers’ compensation insurance and the payment of social security and other taxes. The Company is not aware

that any officer, key employee or group of employees intends to terminate his, her or their employment with the Company or its Subsidiaries,

as the case may be, nor does the Company have a present intention, or know of a present intention of its Subsidiaries, to terminate the

employment of any officer or key employee. There are no pending or, to the knowledge of the Company, threatened employment discrimination

charges or complaints against or involving the Company or its Subsidiaries before any federal, state, or local board, department, commission

or agency, or unfair labor practice charges or complaints, disputes or grievances affecting the Company or its Subsidiaries.

(ii)

No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could

reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a

member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor

any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships

with their employees are good.

(iii)

The Company and its Subsidiaries are in compliance in all material respects with the applicable provisions of the Employee Retirement

Income Security Act of 1974, as amended (“ERISA”). No benefit plan of the Company or any Subsidiary (a) is subject

to the provisions of Section 412 of the Code or Part 3 of Subtitle B of Title I of ERISA, (b) is subject to Title IV of ERISA, (c) is

a “multiemployer plan” (within the meaning of Section 3(37) of ERISA). Since inception, neither the Company, its Subsidiaries,

nor any business or entity treated as a single employer with the Company or its Subsidiaries for purposes of Title IV of ERISA contributed

to or was obliged to contribute to a pension plan that was at any time subject to Title IV of ERISA.

(w)

Assets; Title. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them

and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,

in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially

interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment

of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which

is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries

are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in material compliance.

(x)

Intellectual Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,

trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights

and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Documents and

which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”).

None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property

Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the

date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements

included within the SEC Documents, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate

or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect.

To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another

Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect

the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually

or in the aggregate, reasonably be expected to have a Material Adverse Effect.

12

(y)

Environmental Laws. The Company and its Subsidiaries (A) are in compliance with any and all Environmental Laws (as defined below),

(B) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective

businesses and (C) are in compliance with all terms and conditions of any such permit, license or approval where, in each of the foregoing

clauses (A), (B) and (C), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material

Adverse Effect. The term “Environmental Laws” means all federal, state, local or foreign laws relating to pollution

or protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface

or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals,

pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the

environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling

of Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices

or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.

(z)

Subsidiary Rights. The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations imposed

by applicable law) to receive dividends and distributions on, all capital securities of its Subsidiaries as owned by the Company or such

Subsidiary.

(aa)

Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a

Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income

and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)

has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such

returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material

taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material

amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no

basis for any such claim.

(bb)

Internal Accounting and Disclosure Controls. Other than as disclosed in the SEC Documents, the Company and each of its Subsidiaries

maintains internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is effective

to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external

purposes in accordance with GAAP, including that (i) transactions are executed in accordance with management’s general or specific

authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and

to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with

management’s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with

the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. Other than

as disclosed in the SEC Documents, the Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e)

under the 1934 Act) that are effective in ensuring that information required to be disclosed by the Company in the reports that it files

or submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms

of the SEC, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the

Company in the reports that it files or submits under the 1934 Act is accumulated and communicated to the Company’s management,

including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow timely

decisions regarding required disclosure. Since January 1, 2025, other than as disclosed in the SEC Documents, neither the Company nor

any of its Subsidiaries has received any notice or correspondence from any accountant, Governmental Entity or other Person relating to

any material weakness or significant deficiency in any part of the internal controls over financial reporting of the Company or any of

its Subsidiaries.

13

(cc)

Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its

Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act

filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.

(dd)

Investment Company Status. The Company is not, and upon consummation of the sale of the Securities will not be, an “investment

company,” an affiliate of an “investment company,” a company controlled by an “investment company” or an

“affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company”

as such terms are defined in the Investment Company Act of 1940, as amended.

(ee)

Acknowledgement Regarding Buyers’ Trading Activity. It is understood and acknowledged by the Company that (i) following

the public disclosure of the transactions contemplated by the Transaction Documents, in accordance with the terms thereof, none of the

Buyers have been asked by the Company or any of its Subsidiaries to agree, nor has any Buyer agreed with the Company or any of its Subsidiaries,

to desist from effecting any transactions in or with respect to (including, without limitation, purchasing or selling, long and/or short)

any securities of the Company, or “derivative” securities based on securities issued by the Company or to hold any of the

Securities for any specified term; (ii) any Buyer, and counterparties in “derivative” transactions to which any such Buyer

is a party, directly or indirectly, presently may have a “short” position in the Common Stock which was established prior

to such Buyer’s knowledge of the transactions contemplated by the Transaction Documents; (iii) each Buyer shall not be deemed to

have any affiliation with or control over any arm’s length counterparty in any “derivative” transaction; and (iv) each

Buyer may rely on the Company’s obligation to timely deliver shares of Common Stock upon conversion, exercise or exchange, as applicable,

of the Securities as and when required pursuant to the Transaction Documents for purposes of effecting trading in the Common Stock of

the Company. The Company further understands and acknowledges that following the public disclosure of the transactions contemplated by

the Transaction Documents pursuant to the 8-K Filing (as defined below) one or more Buyers may engage in hedging and/or trading activities

(including, without limitation, the location and/or reservation of borrowable shares of Common Stock) at various times during the period

that the Securities are outstanding, including, without limitation, during the periods that the value and/or number of the Warrant Shares

or Conversion Shares, as applicable, deliverable with respect to the Securities are being determined and such hedging and/or trading

activities (including, without limitation, the location and/or reservation of borrowable shares of Common Stock), if any, can reduce

the value of the existing stockholders’ equity interest in the Company both at and after the time the hedging and/or trading activities

are being conducted. The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute a breach of

this Agreement, the Certificate of Designations, the Warrants or any other Transaction Document or any of the documents executed in connection

herewith or therewith.

(ff)

Manipulation of Price. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting

on their behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation

of the price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii)

sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities (other than the Placement Agent),

(iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company or

any of its Subsidiaries or (iv) paid or agreed to pay any Person for research services with respect to any securities of the Company

or any of its Subsidiaries.

(gg)

U.S. Real Property Holding Corporation. Neither the Company nor any of its Subsidiaries is, or has ever been a U.S. real property

holding corporation within the meaning of Section 897 of the Code, and the Company and each Subsidiary shall so certify upon any Buyer’s

request.

(hh)

Registration Eligibility. Except for rights pursuant to the Registration Rights Agreement, no Person has any right to cause the

Company or any Subsidiary to effect the registration under the 1933 Act of any securities of the Company or any Subsidiary. The Company

is eligible to register the Registrable Securities (as defined in the Registration Rights Agreement) for resale by the Buyers using Form

S-3 promulgated under the 1933 Act.

14

(ii)

Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required

to be paid in connection with the issuance, sale and transfer of the Securities to be sold to each Buyer hereunder will be, or will have

been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.

(jj)

Bank Holding Company Act. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956,

as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal

Reserve”). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent

(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of

a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries

or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and

to regulation by the Federal Reserve.

(kk)

Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).

(ll)

Illegal or Unauthorized Payments; Political Contributions. Neither the Company nor any of its Subsidiaries nor, to the best of

the Company’s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors, employees, agents

or other representatives of the Company or any of its Subsidiaries or any other business entity or enterprise with which the Company

or any Subsidiary is or has been affiliated or associated, has, directly or indirectly, made or authorized any payment, contribution

or gift of money, property, or services, whether or not in contravention of applicable law, (i) as a kickback or bribe to any Person

or (ii) to any political organization, or the holder of or any aspirant to any elective or appointive public office except for personal

political contributions not involving the direct or indirect use of funds of the Company or any of its Subsidiaries.

(mm)

Money Laundering. The Company and its Subsidiaries are in compliance with, and have not previously violated, the USA Patriot Act

of 2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws,

regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not

limited, to (i) Executive Order 13224 of September 23, 2001 entitled, “Blocking Property and Prohibiting Transactions With Persons

Who Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001)) and (ii) any regulations contained in 31 CFR,

Subtitle B, Chapter V.

(nn)

Stock Option Plans. Each stock option granted by the Company was granted (i) in accordance with the terms of the applicable stock

option plan of the Company and (ii) with an exercise price at least equal to the fair market value of the shares of Common Stock on the

date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s stock

option plan has been backdated. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company

to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public

announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.

(oo)

No Disagreements with Accountants and Lawyers. There are no material disagreements of any kind presently existing, or reasonably

anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company

and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company’s ability

to perform any of its obligations under any of the Transaction Documents. In addition, on or prior to the date hereof, the Company had

discussions with its accountants about its financial statements previously filed with the SEC. Based on those discussions, the Company

has no reason to believe that it will need to restate any such financial statements or any part thereof.

15

(pp)

No Disqualification Events. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the 1933

Act (“Regulation D Securities”), none of the Company, any of its predecessors, any affiliated issuer, any director,

executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more

of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term

is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an “Issuer

Covered Person” and, together, “Issuer Covered Persons”) is subject to any of the “Bad Actor”

disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a “Disqualification Event”), except

for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any

Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure

obligations under Rule 506(e), and has furnished to the Buyers a copy of any disclosures provided thereunder.

(qq)

Other Covered Persons. The Company is not aware of any Person (other than the Placement Agent) that has been or will be paid (directly

or indirectly) remuneration for solicitation of Buyers or potential purchasers in connection with the sale of any Regulation D Securities.

(rr)

No Additional Agreements. The Company does not have any agreement or understanding with any Buyer with respect to the transactions

contemplated by the Transaction Documents other than as specified in the Transaction Documents.

(ss)

Public Utility Holding Act. None of the Company nor any of its Subsidiaries is a “holding company,” or an “affiliate”

of a “holding company,” as such terms are defined in the Public Utility Holding Act of 2005.

(tt)

Federal Power Act. None of the Company nor any of its Subsidiaries is subject to regulation as a “public utility”

under the Federal Power Act, as amended.

(uu)

Cybersecurity. The Company and its Subsidiaries’ information technology assets and equipment, computers, systems, networks,

hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate

and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries

as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants

that would reasonably be expected to have a Material Adverse Effect on the Company’s business. The Company and its Subsidiaries

have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards

to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all

IT Systems and data, including “Personal Data,” used in connection with their businesses. “Personal Data” means

(i) a natural person’s name, street address, telephone number, e-mail address, photograph, social security number or tax identification

number, driver’s license number, passport number, credit card number, bank information, or customer or account number; (ii) any

information which would qualify as “personally identifying information” under the Federal Trade Commission Act, as amended;

(iii) “personal data” as defined by the European Union General Data Protection Regulation (“GDPR”) (EU

2016/679); (iv) any information which would qualify as “protected health information” under the Health Insurance Portability

and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, “HIPAA”);

and (v) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection

or analysis of any data related to an identified person’s health or sexual orientation. Since January 1, 2025, there have been

no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material

cost or liability or the duty to notify any other person or such, nor any incidents under internal review or investigations relating

to the same except in each case, where such would not, either individually or in the aggregate, reasonably be expected to result in a

Material Adverse Effect. The Company and its Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments,

orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations

relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from

unauthorized use, access, misappropriation or modification except in each case, where such would not, either individually or in the aggregate,

reasonably be expected to result in a Material Adverse Effect.

16

(vv)

Compliance with Data Privacy Laws. The Company and its Subsidiaries are in compliance with all applicable state and federal data

privacy and security laws and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have taken commercially

reasonable actions to prepare to comply with, and since May 25, 2018, have been and currently are in compliance with, the GDPR (EU 2016/679)

(collectively, the “Privacy Laws”) except in each case, where such would not, either individually or in the aggregate,

reasonably be expected to result in a Material Adverse Effect. To ensure compliance with the Privacy Laws, the Company and its Subsidiaries

have in place, comply with, and take appropriate steps reasonably designed to ensure compliance in all material respects with their policies

and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal

Data (the “Policies”). The Company and its Subsidiaries have made all disclosures to users or customers required by

applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy have, to the knowledge

of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect.

The Company further certifies that neither it nor any Subsidiary: (i) has received notice of any actual or potential liability under

or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would

reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation,

remediation, or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes

any obligation or liability under any Privacy Law.

(ww)

Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers

or their agents or counsel with any information that constitutes or could reasonably be expected to constitute material, non-public information

concerning the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the

other Transaction Documents. The Company understands and confirms that each of the Buyers will rely on the foregoing representations

in effecting transactions in securities of the Company. All disclosure provided to the Buyers regarding the Company and its Subsidiaries,

their businesses and the transactions contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the

Company or any of its Subsidiaries is true and correct and does not contain any untrue statement of a material fact or omit to state

any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made,

not misleading. Each press release issued by the Company or any of its Subsidiaries during the twelve (12) months preceding the date

of this Agreement did not at the time of release contain any untrue statement of a material fact or omit to state a material fact required

to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made,

not misleading. Other than with respect to the transactions contemplated by this Agreement and the other Transaction Documents, no event

or circumstance has occurred or information exists with respect to the Company or any of its Subsidiaries or its or their business, properties,

liabilities, prospects, operations (including results thereof) or conditions (financial or otherwise), which, under applicable law, rule

or regulation, requires public disclosure at or before the date hereof or announcement by the Company but which has not been so publicly

disclosed. The Company acknowledges and agrees that no Buyer makes or has made any representations or warranties with respect to the

transactions contemplated hereby other than those specifically set forth in Section 2.

4.

COVENANTS.

(a)

Best Efforts. Each Buyer shall use its best efforts to timely satisfy each of the covenants hereunder and conditions to be satisfied

by it as provided in Section 6 of this Agreement. The Company shall use its best efforts to timely satisfy each of the covenants

hereunder and conditions to be satisfied by it as provided in Section 7 of this Agreement.

(b)

Form D and Blue Sky. The Company shall file a Form D with respect to the Securities as required under Regulation D and to provide

a copy thereof to each Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action as the Company

shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities for sale to the Buyers at

the Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of the states of the United States

(or to obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the Buyers on or prior

to the Closing Date. Without limiting any other obligation of the Company under this Agreement, the Company shall timely make all filings

and reports relating to the offer and sale of the Securities required under all applicable securities laws (including, without limitation,

all applicable federal securities laws and all applicable “Blue Sky” laws), and the Company shall comply with all applicable

federal, foreign, state and local laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities

to the Buyers.

17

(c)

Reporting Status. From the date hereof until the date on which the Buyers shall have sold all of the Registrable Securities (the

“Reporting Period”), the Company shall timely file all reports required to be filed with the SEC pursuant to the 1934

Act, and the Company shall not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or

the rules and regulations thereunder would no longer require or otherwise permit such termination. The Company shall take all actions

necessary to maintain its eligibility to register the Registrable Securities for resale by the Buyers on Form S-3.

(d)

Use of Proceeds. The Company shall use the proceeds from the sale of the Securities for general corporate purposes, but not, directly

or indirectly, for (i) the satisfaction of any indebtedness of the Company or any of its Subsidiaries outstanding on the date hereof

or (ii) the settlement of any litigation outstanding on the date hereof.

(e)

Financial Information. The Company agrees to send the following to each Investor (as defined in the Registration Rights Agreement)

during the Reporting Period (i) unless the following are filed with the SEC through EDGAR and are available to the public through the

EDGAR system, within one (1) Business Day after the filing thereof with the SEC, a copy of its Annual Report on Form 10-K, Quarterly

Reports on Form 10-Q, any other interim reports or any consolidated balance sheets, income statements, stockholders’ equity statements

and/or cash flow statements for any period other than any annual report, any Current Reports on Form 8-K and any registration statements

(other than on Form S-8) or amendments filed pursuant to the 1933 Act, (ii) unless the following are either filed with the SEC through

EDGAR or are otherwise widely disseminated via a recognized news release service (such as PR Newswire), on the same day as the release

thereof, e-mail copies of all press releases issued by the Company or any of its Subsidiaries and (iii) unless the following are filed

with the SEC through EDGAR, copies of any notices and other information made available or given to the stockholders of the Company, as

applicable, generally, contemporaneously with the making available or giving thereof to the stockholders.

(f)

Listing. The Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the Registrable

Securities upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed

or designated for quotation (as the case may be) (subject to official notice of issuance) and shall maintain such listing or designation

for quotation (as the case may be) of all Registrable Securities from time to time issuable under the terms of the Transaction Documents

on such national securities exchange or automated quotation system. The Company shall maintain the Common Stock’s listing or authorization

for quotation (as the case may be) on the Principal Market, The New York Stock Exchange, the NYSE American, the Nasdaq Global Market

or the Nasdaq Global Select Market (each, an “Eligible Market”). Neither the Company nor any of its Subsidiaries shall

take any action which could be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal Market.

The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 4(f).

(g)

Fees. The Company shall reimburse the lead Buyer a non-accountable amount of $50,000 for all costs and expenses incurred by it

or its affiliates in connection with the structuring, documentation, negotiation and closing of the transactions contemplated by the

Transaction Documents (including, without limitation, as applicable, all reasonable legal fees of outside counsel and disbursements of

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (“Buyer Counsel”), counsel to the lead Buyer, any other reasonable

fees and expenses in connection with the structuring, documentation, negotiation and closing of the transactions contemplated by the

Transaction Documents and due diligence and regulatory filings in connection therewith) (the “Transaction Expenses”)

and shall be withheld by the lead Buyer from its Purchase Price at the Closing. The Company shall be responsible for the payment of any

placement agent’s fees, financial advisory fees, transfer agent fees, DTC (as defined below) fees or broker’s commissions

(other than for Persons engaged by any Buyer) relating to or arising out of the transactions contemplated hereby (including, without

limitation, any fees or commissions payable to the Placement Agent). The Company shall pay, and the Company shall hold each Buyer harmless

against, any liability, loss or expense (including, without limitation, reasonable attorneys’ fees and out-of-pocket expenses)

arising in connection with any claim relating to any such payment. Except as otherwise set forth in the Transaction Documents, each party

to this Agreement shall bear its own expenses in connection with the sale of the Securities to the Buyers.

18

(h)

Pledge of Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees

that the Securities may be pledged by a Buyer in connection with a bona fide margin agreement or other loan or financing arrangement

that is secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities

hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise

make any delivery to the Company pursuant to this Agreement or any other Transaction Document, including, without limitation, Section

2(g) hereof; provided that a Buyer and its pledgee shall be required to comply with the provisions of Section 2(g)

hereof in order to effect a sale, transfer or assignment of Securities to such pledgee. The Company hereby agrees to execute and deliver

such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such pledgee

by a Buyer.

(i)

Disclosure of Transactions and Other Material Information.

(i)

Disclosure of Transaction. The Company shall no later than 9:30 a.m., New York time, on the Business Day following the date of

this Agreement, file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by the Transaction

Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation, this

Agreement (and all schedules to this Agreement, to the extent material), the form of Certificate of Designations, the form of the Warrant

and the form of the Registration Rights Agreement) (including the attachments thereto, the “8-K Filing”). From and

after the filing of the 8-K Filing, the Company shall have disclosed all material, non-public information (if any) provided to any of

the Buyers by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents in connection

with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company

acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between

the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand,

and any of the Buyers or any of their affiliates, on the other hand, shall terminate.

(ii)

Limitations on Disclosure. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their

respective officers, directors, employees and agents not to, provide any Buyer with any material, non-public information regarding the

Company or any of its Subsidiaries from and after the date hereof without the express prior written consent of such Buyer (which may

be granted or withheld in such Buyer’s sole discretion). In the event of a breach of any of the foregoing covenants, including,

without limitation, Section 4(o) of this Agreement, or any of the covenants or agreements contained in any other Transaction Document,

by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees and agents (as determined in

the reasonable good faith judgment of such Buyer), in addition to any other remedy provided herein or in the Transaction Documents, such

Buyer shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such breach

or such material, non-public information, as applicable, without the prior approval by the Company, any of its Subsidiaries, or any of

its or their respective officers, directors, employees or agents. No Buyer shall have any liability to the Company, any of its Subsidiaries,

or any of its or their respective officers, directors, employees, affiliates, stockholders or agents, for any such disclosure. To the

extent that the Company, directly or indirectly, delivers any material, non-public information to a Buyer without such Buyer’s

consent, the Company hereby covenants and agrees that such Buyer shall not have any duty of confidentiality with respect to, or a duty

not to trade on the basis of, such material, non-public information. Subject to the foregoing, neither the Company, its Subsidiaries

nor any Buyer shall issue any press releases or any other public statements with respect to the transactions contemplated hereby; provided,

however, the Company shall be entitled, without the prior approval of any Buyer, to make any press release or other public disclosure

with respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is required

by applicable law and regulations (provided that in the case of clause (i) each Buyer shall be consulted by the Company in connection

with any such press release or other public disclosure prior to its release). Without the prior written consent of the applicable Buyer

(which may be granted or withheld in such Buyer’s sole discretion), the Company shall not (and shall cause each of its Subsidiaries

and affiliates to not) disclose the name of such Buyer in any filing, announcement, release or otherwise. Notwithstanding anything contained

in this Agreement to the contrary and without implication that the contrary would otherwise be true, the Company expressly acknowledges

and agrees that no Buyer shall have (unless expressly agreed to by a particular Buyer after the date hereof in a written definitive and

binding agreement executed by the Company and such particular Buyer (it being understood and agreed that no Buyer may bind any other

Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not to trade on the basis of, any material, non-public

information regarding the Company and/or any of its Subsidiaries.

19

(j)

Additional Registration Statements. From the date hereof until the Applicable Date (as defined below) and at any time thereafter

while any Registration Statement (as defined in the Registration Rights Agreement) is not effective or the prospectus contained therein

is not available for use or any Current Public Information Failure (as defined in the Registration Rights Agreement) exists, the Company

shall not file a registration statement or an offering statement under the 1933 Act relating to securities that are not the Registrable

Securities (other than a registration statement on Form S-8 or such supplements or amendments to registration statements that are outstanding

and have been declared effective by the SEC as of the date hereof (solely to the extent necessary to keep such registration statements

effective and available and not with respect to any Subsequent Placement)). “Applicable Date” means the earlier of

(x) the first date on which the resale by the Buyers of all the Registrable Securities required to be filed on the initial Registration

Statement pursuant to the Registration Rights Agreement is declared effective by the SEC (and each prospectus contained therein is available

for use on such date) or (y) the first date on which all of the Registrable Securities are eligible to be resold by the Buyers pursuant

to Rule 144 (or, if a Current Public Information Failure has occurred and is continuing, such later date after which the Company has

cured such Current Public Information Failure).

(k)

Additional Issuance of Securities. So long as any Buyer beneficially owns any Preferred Shares or Warrants, the Company will not,

without the prior written consent of the Required Holders, directly or indirectly, issue any other securities that would cause a breach

or default under the Certificate of Designations or the Warrants. The Company agrees that unless Stockholder Approval (as defined herein)

is obtained, the Company shall not affect any Dilutive Issuance (as defined in the Certificate of Designations). The Company further

agrees that for the period commencing on the date hereof and ending on the date that is ninety (90) days following the Applicable Date

(provided that such period shall be extended by the number of calendar days during such period and any extension thereof contemplated

by this Section 4(k) on which any Registration Statement is not effective or any prospectus contained therein is not available

for use or any Current Public Information Failure exists) (the “Restricted Period”), neither the Company nor any of

its Subsidiaries shall directly or indirectly issue, offer, sell, grant any option or right to purchase, or otherwise dispose of (or

announce any issuance, offer, sale, grant of any option or right to purchase or other disposition of) any equity security or any equity-linked

or related security (including, without limitation, any “equity security” (as that term is defined under Rule 405 promulgated

under the 1933 Act), any Convertible Securities (as defined below), any preferred stock or any purchase rights) (any such issuance, offer,

sale, grant, disposition or announcement (whether occurring during the Restricted Period or at any time thereafter), is referred to as

a “Subsequent Placement”). Notwithstanding the foregoing, this Section 4(k) shall not apply in respect of the

issuance of (i) shares of Common Stock or other awards convertible, exercisable for or exchangeable for shares of Common Stock issued

or issuable to directors, officers, employees or other service providers of the Company in their capacity as such pursuant to an Approved

Stock Plan (as defined below), provided that (1) all such issuances (taking into account the shares of Common Stock issuable upon exercise

of such awards) do not, in the aggregate, exceed more than 10.0% of the shares of Common Stock issued and outstanding immediately prior

to such issuance and (2) the exercise price of any such options is not lowered and none of such options are amended to increase the number

of shares issuable thereunder or extend the term of such options; (ii) shares of Common Stock issued or issuable upon the conversion

or exercise of Convertible Securities (other than shares of Common Stock issued or issuable pursuant to an Approved Stock Plan that are

covered by clause (i) above) issued prior to the date hereof, provided that the conversion, exercise or other method of issuance (as

the case may be) of any such Convertible Security is made solely pursuant to the conversion, exercise or other method of issuance (as

the case may be) provisions of such Convertible Security that were in effect on the date immediately prior to the date of this Agreement,

the conversion, exercise or issuance price of any such Convertible Securities (other than standard options to purchase shares of Common

Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered, none of such Convertible Securities

are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such Convertible Securities

(other than those issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed in

any manner that materially adversely affects any of the Buyers; (iii) securities issued as consideration for the acquisition of another

entity by the Company by merger, purchase of substantially all of the assets or other reorganization or bona fide joint venture agreement,

provided that such issuance is approved by the majority of the disinterested directors of the Company and provided that such securities

are issued as “restricted securities” (as defined in Rule 144) and carry no registration rights that require or permit the

filing of any registration statement in connection therewith during the Restricted Period and such issuance does not, in the aggregate,

exceed more than 5% of the shares of Common Stock issued and outstanding immediately prior to the date hereof; (iv) the issuance of the

payment of dividends of preferred share purchase rights (the “Rights”), with each such Right entitling the holder

to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock, par value $0.0001 per share

(the “Series A Preferred Stock”), of the Company, declared by the board of directors of the Company on July 31, 2025,

to stockholders of record at the close of business on August 11, 2025; (v) the Series A Preferred Stock, pursuant to that certain Certificate

of Designations establishing the rights, preferences, restrictions and other matters relating to the Series A Preferred Stock (the “Series

A Certificate of Designations”); (vi) shares of Common Stock as payment of dividends on the Series A Preferred Stock in accordance

with the Series A Certificate of Designations; (vii) shares of Series J Convertible Preferred Stock, par value $0.0001 per share (the

“Series J Preferred Stock”), pursuant to that certain Certificate of Designations establishing the rights, preferences,

restrictions and other matters relating to the Series J Preferred Stock (the “Series J Certificate of Designations”)

(each of the foregoing in clauses (i) through (vii), collectively the “Excluded Securities”); (viii) shares of Common

Stock issuable upon conversion of the Company’s Series I Convertible Preferred Stock, par value $0.0001 per share (the “Series

I Preferred Stock”) or as payment of dividends thereon, pursuant to that certain Certificate of Designations establishing the

rights, preferences, restrictions and other matters relating to the Series I Preferred Stock (the “Series I Certificate of Designations”);

(ix) shares of Common Stock issuable upon conversion of the Company’s Series H-7 Convertible Preferred Stock, par value $0.0001

per share (the “Series H-7 Preferred Stock”) or as payment of dividends thereon, pursuant to that certain Certificate

of Designations establishing the rights, preferences, restrictions and other matters relating to the Series H-7 Preferred Stock (the

“Series H-7 Certificate of Designations”); (x) shares of Common Stock issuable upon conversion of the Company’s

Series J Preferred Stock pursuant to the Series J Certificate of Designations or as payment of dividends thereon; (xi) the Preferred

Shares; (xii) the Conversion Shares; (xiii) the Warrant Shares and any other securities issued or issuable pursuant to this Agreement

or any of the Transaction Documents, including, without limitation, any shares of Common Stock issued or issuable pursuant to Section

9 of the Certificate of Designations (each of the foregoing in clauses (viii) through (xiii), collectively the “Additional Excluded

Securities” and, the Additional Excluded Securities together with the Excluded Securities, the “Exempted Securities”);

and (xiv) provided the closing price of the Common Stock on the Trading Market equals or exceeds 200% of the initial Conversion Price

(as defined in the Certificate of Designations) for three consecutive Trading Days, sales of shares of Common Stock or Convertible Securities

at a per share purchase price in excess of 160% of the initial Conversion Price (as defined in the Certificate of Designations) (as adjusted

for stock splits, stock dividends, stock combinations, recapitalizations and similar events; provided that if 90% of the aggregate

Stated Value (as defined in the Certificate of Designations) of the Preferred Shares has been paid in full to the Buyers or otherwise

converted to Common Stock, then the Company may sell shares of Common Stock at a per share purchase price in excess of 130% of the exercise

price of the Warrants). “Approved Stock Plan” means any employee benefit plan which has been approved by the board

of directors of the Company prior to or subsequent to the date hereof pursuant to which shares of Common Stock or other awards convertible,

exercisable for or exchangeable for shares of Common Stock may be issued to any employee, officer, director or other service provider

for services provided to the Company and/or a Subsidiary in their capacity as such.

20

(l)

Reservation of Shares. So long as any of the Preferred Shares or Warrants remain outstanding, the Company shall take all action

necessary to at all times have authorized, and reserved for the purpose of issuance, no less than the sum of (i) 200% of the maximum

number of shares of Common Stock issuable upon conversion of all the Preferred Shares then outstanding (assuming for purposes hereof

that (x) the Preferred Shares are convertible at the Floor Price (as defined in the Certificate of Designations) then in effect and (y)

any such conversion shall not take into account any limitations on the conversion of the Preferred Shares set forth in the Certificate

of Designations), and (ii) the maximum number of Warrant Shares issuable upon exercise of all the Warrants then outstanding (without

regard to any limitations on the exercise of the Warrants set forth therein) (collectively, the “Required Reserve Amount”);

provided that at no time shall the number of shares of Common Stock reserved pursuant to this Section 4(l) be reduced other

than proportionally in connection with any conversion, exercise and/or redemption, as applicable of Preferred Shares and Warrants. If

at any time the number of shares of Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserve

Amount, the Company will promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including,

without limitation, calling a special meeting of stockholders to authorize additional shares to meet the Company’s obligations

pursuant to the Transaction Documents, in the case of an insufficient number of authorized shares, obtain stockholder approval of an

increase in such authorized number of shares, and voting the management shares of the Company in favor of an increase in the authorized

shares of the Company to ensure that the number of authorized shares is sufficient to meet the Required Reserve Amount.

(m)

Conduct of Business. The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance

or regulation of any Governmental Entity, except where such violations would not reasonably be expected to result, either individually

or in the aggregate, in a Material Adverse Effect.

(n)

Restriction on Variable Securities. Commencing on the date hereof until no Warrants remain outstanding, the Company and each Subsidiary

shall be prohibited from effecting or entering into an agreement to effect any Subsequent Placement involving a Variable Rate Transaction.

“Variable Rate Transaction” means a transaction in which the Company or any Subsidiary (i) issues or sells any Convertible

Securities either (A) at a conversion, exercise or exchange rate or other price that is based upon and/or varies with the trading prices

of or quotations for the shares of Common Stock at any time after the initial issuance of such Convertible Securities, or (B) with a

conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such Convertible

Securities or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or

the market for the Common Stock, other than pursuant to a customary “weighted average” anti-dilution provision or (ii) enters

into any agreement (including, without limitation, an equity line of credit or an “at-the-market” offering) whereby the Company

or any Subsidiary may sell securities at a future determined price (other than standard and customary “preemptive” or “participation”

rights). Each Buyer shall be entitled to obtain injunctive relief against the Company and its Subsidiaries to preclude any such issuance,

which remedy shall be in addition to any right to collect damages.

(o)

Participation Right. At any time after the Closing Date and until Preferred Shares are no longer outstanding, neither the Company

nor any of its Subsidiaries shall, directly or indirectly, effect any Subsequent Placement unless the Company shall have first complied

with this Section 4(o). The Company acknowledges and agrees that the right set forth in this Section 4(o) is a right granted

by the Company, separately, to each Buyer.

(i)

At least five (5) Trading Days prior to any proposed or intended Subsequent Placement, the Company shall deliver to each Buyer a written

notice (each such notice, a “Pre-Notice”), which Pre-Notice shall not contain any information (including, without

limitation, material, non-public information) other than: (A) if the proposed Offer Notice (as defined below) constitutes or contains

material, non-public information, a statement asking whether the Buyer is willing to accept material non-public information or (B) if

the proposed Offer Notice does not constitute or contain material, non-public information, (x) a statement that the Company proposes

or intends to effect a Subsequent Placement, (y) a statement that the statement in clause (x) above does not constitute material, non-public

information and (z) a statement informing such Buyer that it is entitled to receive an Offer Notice (as defined below) with respect to

such Subsequent Placement upon its written request. Upon the written request of a Buyer within three (3) Trading Days after the Company’s

delivery to such Buyer of such Pre-Notice, and only upon a written request by such Buyer, the Company shall promptly, but no later than

one (1) Trading Day after such request, deliver to such Buyer an irrevocable written notice (the “Offer Notice”) of

any proposed or intended issuance or sale or exchange (the “Offer”) of the securities being offered (the “Offered

Securities”) in a Subsequent Placement, which Offer Notice shall (A) identify and describe the Offered Securities, (B) describe

the price and other terms upon which they are to be issued, sold or exchanged, and the number or amount of the Offered Securities to

be issued, sold or exchanged, (C) identify the Persons (if known) to which or with which the Offered Securities are to be offered, issued,

sold or exchanged and (D) offer to issue and sell to or exchange with such Buyer in accordance with the terms of the Offer such Buyer’s

pro rata portion of 50% of the Offered Securities, provided that the number of Offered Securities which such Buyer shall have the right

to subscribe for under this Section 4(o) shall be (x) based on such Buyer’s pro rata portion of the aggregate stated value

of the Preferred Shares purchased hereunder by all Buyers (the “Basic Amount”), and (y) with respect to each Buyer

that elects to purchase its Basic Amount, any additional portion of the Offered Securities attributable to the Basic Amounts of other

Buyers as such Buyer shall indicate it will purchase or acquire should the other Buyers subscribe for less than their Basic Amounts (the

“Undersubscription Amount”), which process shall be repeated until each Buyer shall have an opportunity to subscribe

for any remaining Undersubscription Amount.

21

(ii)

To accept an Offer, in whole or in part, such Buyer must deliver a written notice to the Company prior to the end of the fifth (5th)

Business Day after such Buyer’s receipt of the Offer Notice (the “Offer Period”), setting forth the portion

of such Buyer’s Basic Amount that such Buyer elects to purchase and, if such Buyer shall elect to purchase all of its Basic Amount,

the Undersubscription Amount, if any, that such Buyer elects to purchase (in either case, the “Notice of Acceptance”).

If the Basic Amounts subscribed for by all Buyers are less than the total of all of the Basic Amounts, then each Buyer who has set forth

an Undersubscription Amount in its Notice of Acceptance shall be entitled to purchase, in addition to the Basic Amounts subscribed for,

the Undersubscription Amount it has subscribed for; provided, however, if the Undersubscription Amounts subscribed for

exceed the difference between the total of all the Basic Amounts and the Basic Amounts subscribed for (the “Available Undersubscription

Amount”), each Buyer who has subscribed for any Undersubscription Amount shall be entitled to purchase only that portion of

the Available Undersubscription Amount as the Basic Amount of such Buyer bears to the total Basic Amounts of all Buyers that have subscribed

for Undersubscription Amounts, subject to rounding by the Company to the extent it deems reasonably necessary. Notwithstanding the foregoing,

if the Company desires to modify or amend the terms and conditions of the Offer prior to the expiration of the Offer Period, the Company

may deliver to each Buyer a new Offer Notice and the Offer Period shall expire on the fifth (5th) Business Day after such Buyer’s

receipt of such new Offer Notice.

(iii)

The Company shall have five (5) Business Days from the expiration of the Offer Period above (A) to offer, issue, sell or exchange all

or any part of such Offered Securities as to which a Notice of Acceptance has not been given by a Buyer (the “Refused Securities”)

pursuant to a definitive agreement(s) (the “Subsequent Placement Agreement”), but only to the offerees described in

the Offer Notice (if so described therein) and only upon terms and conditions (including, without limitation, unit prices and interest

rates) that are not more favorable to the acquiring Person or Persons or less favorable to the Company than those set forth in the Offer

Notice and (B) to publicly announce (x) the execution of such Subsequent Placement Agreement, and (y) either (I) the consummation of

the transactions contemplated by such Subsequent Placement Agreement or (II) the termination of such Subsequent Placement Agreement,

which shall be filed with the SEC on a Current Report on Form 8-K with such Subsequent Placement Agreement and any documents contemplated

therein filed as exhibits thereto.

(iv)

In the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the terms

specified in Section 4(o)(iii) above), then each Buyer may, at its sole option and in its sole discretion, withdraw its Notice

of Acceptance or reduce the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall

be not less than the number or amount of the Offered Securities that such Buyer elected to purchase pursuant to Section 4(o)(ii)

above multiplied by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually proposes

to issue, sell or exchange (including Offered Securities to be issued or sold to Buyers pursuant to this Section 4(o) prior to

such reduction) and (ii) the denominator of which shall be the original amount of the Offered Securities. In the event that any Buyer

so elects to reduce the number or amount of Offered Securities specified in its Notice of Acceptance, the Company may not issue, sell

or exchange more than the reduced number or amount of the Offered Securities unless and until such securities have again been offered

to the Buyers in accordance with Section 4(o)(i) above.

(v)

Upon the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, such Buyer shall acquire from the

Company, and the Company shall issue to such Buyer, the number or amount of Offered Securities specified in its Notice of Acceptance,

as reduced pursuant to Section 4(o)(iv) above if such Buyer has so elected, upon the terms and conditions specified in the Offer.

The purchase by such Buyer of any Offered Securities is subject in all cases to the preparation, execution and delivery by the Company

and such Buyer of a separate purchase agreement relating to such Offered Securities reasonably satisfactory in form and substance to

such Buyer and its counsel.

22

(vi)

Any Offered Securities not acquired by a Buyer or other Persons in accordance with this Section 4(o) may not be issued, sold or

exchanged until they are again offered to such Buyer under the procedures specified in this Agreement.

(vii)

The Company and each Buyer agree that if any Buyer elects to participate in the Offer, (x) neither the Subsequent Placement Agreement

with respect to such Offer nor any other transaction documents related thereto (collectively, the “Subsequent Placement Documents”)

shall include any term or provision whereby such Buyer shall be required to agree to any restrictions on trading as to any securities

of the Company or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in

connection with, any agreement previously entered into with the Company or any instrument received from the Company, and (y) any registration

rights set forth in such Subsequent Placement Documents shall be similar in all material respects to the registration rights contained

in the Registration Rights Agreement.

(viii)

Notwithstanding anything to the contrary in this Section 4(o) and unless otherwise agreed to by such Buyer, the Company shall

either confirm in writing to such Buyer that the transaction with respect to the Subsequent Placement has been abandoned or shall publicly

disclose its intention to issue the Offered Securities, in either case, in such a manner such that such Buyer will not be in possession

of any material, non-public information, by the fifth (5th) Business Day following delivery of the Offer Notice. If by such fifth (5th)

Business Day, no public disclosure regarding a transaction with respect to the Offered Securities has been made, and no notice regarding

the abandonment of such transaction has been received by such Buyer, such transaction shall be deemed to have been abandoned and such

Buyer shall not be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries. Should

the Company decide to pursue such transaction with respect to the Offered Securities, the Company shall provide such Buyer with another

Offer Notice and such Buyer will again have the right of participation set forth in this Section 4(o). The Company shall not be

permitted to deliver more than one such Offer Notice to such Buyer in any sixty (60) day period, except as expressly contemplated by

the last sentence of Section 4(o)(ii).

(ix)

The restrictions contained in this Section 4(o) shall not apply in connection with the issuance of any Exempted Securities.

(p)

Dilutive Issuances. For so long as any Preferred Shares or Warrants remain outstanding, the Company shall not, in any manner,

enter into or affect any Dilutive Issuance (as defined in the Certificate of Designations) if the effect of such Dilutive Issuance is

to cause the Company to be required to issue upon conversion of any Preferred Shares or exercise of any Warrant any shares of Common

Stock in excess of that number of shares of Common Stock which the Company may issue upon conversion of the Preferred Shares and exercise

of the Warrants without breaching the Company’s obligations under the rules or regulations of the Principal Market.

(q)

Restriction of Redemption and Cash Dividends. So long as any Preferred Shares are outstanding, except as provided in the Certificate

of Designations, the Company shall not, directly or indirectly, redeem, or declare or pay any cash dividend or distribution on, any securities

of the Company without the prior express written consent of the Buyers.

(r)

Corporate Existence. So long as any Buyer beneficially owns any Preferred Shares or Warrants, the Company shall not be party to

any Fundamental Transaction (as defined in the Certificate of Designations) unless the Company is in compliance with the applicable provisions

governing Fundamental Transactions set forth in the Certificate of Designations and the Warrants.

(s)

Stock Splits. Until the Preferred Shares are no longer outstanding, the Company shall not effect any stock combination, reverse

stock split or other similar transaction (or make any public announcement or disclosure with respect to any of the foregoing) without

the prior written consent of the Required Holders (as defined below); provided, however, that the Company may effect a

stock combination, reverse stock split or other similar transaction if necessary to comply with the requirements of the Principal Market

without the prior written consent of the Required Holders.

23

(t)

Conversion and Exercise Procedures. Each of the form of Exercise Notice (as defined in the Warrants) included in the Warrants

and the form of Conversion Notice (as defined in the Certificate of Designations) included in the Certificate of Designations set forth

the totality of the procedures required of the Buyers in order to exercise the Warrants or convert the Preferred Shares. Except as provided

in Section 5(d), no additional legal opinion, other information or instructions shall be required of the Buyers to exercise their

Warrants or convert their Preferred Shares. The Company shall honor exercises of the Warrants and conversions of the Preferred Shares

and shall deliver the Conversion Shares and Warrant Shares in accordance with the terms, conditions and time periods set forth in the

Certificate of Designations and Warrants.

(u)

Regulation M. The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with the distribution

of the Securities contemplated hereby.

(v)

General Solicitation. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act) or any person

acting on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities by means of any form

of general solicitation or general advertising within the meaning of Regulation D, including: (i) any advertisement, article, notice

or other communication published in any newspaper, magazine or similar medium or broadcast over television or radio; and (ii) any seminar

or meeting whose attendees have been invited by any general solicitation or general advertising.

(w)

Stockholder Approval. The Company shall provide each stockholder entitled to vote at a special meeting of stockholders of the

Company (the “Stockholder Meeting”), which shall be held no later than June 26, 2026 (the “Stockholder Meeting

Deadline”), a proxy statement, in a form reasonably acceptable to the Buyers, at the expense of the Company, soliciting each

such stockholder’s affirmative vote at the Stockholder Meeting for approval of resolutions (“Stockholder Resolutions”)

providing for the issuance of the Securities in compliance with the rules and regulations of the Principal Market (the “Stockholder

Approval”, and the date the Stockholder Approval is obtained, the “Stockholder Approval Date”), and the

Company shall use its reasonable best efforts to solicit its stockholders’ approval of such Stockholder Resolutions and to cause

the board of directors of the Company to recommend to the stockholders that they approve such Stockholder Resolutions. The Company shall

be obligated to seek to obtain the Stockholder Approval by the Stockholder Meeting Deadline. If, despite the Company’s reasonable

best efforts the Stockholder Approval is not obtained on or prior to the Stockholder Meeting Deadline, the Company shall cause an additional

Stockholder Meeting to be held within 90 days later. If, despite the Company’s reasonable best efforts the Stockholder Approval

is not obtained after such subsequent stockholder meetings, the Company shall cause an additional Stockholder Meeting to be held semi-annually

thereafter until such Stockholder Approval is obtained. Notwithstanding the above, the Company shall not be required to hold a Stockholder

Meeting or seek Stockholder Approval any time following the time when the Preferred Shares are no longer outstanding if upon full exercise

of the Warrants, the shares of Common Stock issued pursuant to the Preferred Shares and Warrants would not exceed the Exchange Cap (as

defined in the Certificate of Designations).

(x)

Integration. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act), or any person acting on

behalf of the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any

security (as defined in the 1933 Act) which will be integrated with the sale of the Securities in a manner which would require the registration

of the Securities under the 1933 Act, and the Company will take all action that is appropriate or necessary to assure that its offerings

of other securities will not be integrated for purposes of the 1933 Act or the rules and regulations of the Principal Market, with the

issuance of Securities contemplated hereby.

(y)

Notice of Disqualification Events. The Company will notify the Buyers in writing, prior to the Closing Date of (i) any Disqualification

Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event

relating to any Issuer Covered Person.

(z)

Books and Records. The Company will keep proper books of record and account, in which full and correct entries shall be made of

all financial transactions and the asset and business of the Company and its Subsidiaries in accordance with GAAP.

(aa)

Closing Documents. On or prior to twenty (20) calendar days after the Closing Date, the Company agrees to deliver, or cause to

be delivered, to each Buyer and Buyer Counsel a complete closing set of the executed Transaction Documents (which may be delivered in

electronic format), Securities and any other document required to be delivered to any party pursuant to Section 7 hereof or otherwise.

24

5.

REGISTER; TRANSFER AGENT INSTRUCTIONS; LEGEND.

(a)

Register. The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may

designate by notice to each holder of Securities), a register for the Preferred Shares and the Warrants in which the Company shall record

the name and address of the Person in whose name the Preferred Shares and the Warrants have been issued (including the name and address

of each transferee), the principal amount of the Preferred Shares held by such Person, the number of Conversion Shares issuable pursuant

to the terms of the Preferred Shares and the number of Warrant Shares issuable upon exercise of the Warrants held by such Person. The

Company shall keep the register open and available at all times during business hours for inspection of any Buyer or its legal representatives.

(b)

Transfer Agent Instructions. On or prior to the Closing Date, the Company shall issue irrevocable instructions to its transfer

agent and any subsequent transfer agent (as applicable, the “Transfer Agent”) in a form acceptable to each of the

Buyers (the “Irrevocable Transfer Agent Instructions”) to issue certificates or credit shares (to the extent unrestricted

shares are issued) to the applicable balance accounts at The Depository Trust Company (“DTC”), registered in the name

of each Buyer or its respective nominee(s), for the Conversion Shares and the Warrant Shares in such amounts as specified from time to

time by each Buyer to the Company upon conversion of the Preferred Shares or the exercise of the Warrants (as the case may be). The Company

represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(b),

and stop transfer instructions to give effect to Section 2(g) hereof, will be given by the Company to its transfer agent with

respect to the Securities, and that the Securities shall otherwise be freely transferable on the books and records of the Company, as

applicable, to the extent provided in this Agreement and the other Transaction Documents. If a Buyer effects a sale, assignment or transfer

of the Securities in accordance with Section 2(g), the Company shall permit the transfer and shall promptly instruct its transfer

agent to issue one or more certificates or credit shares to the applicable balance accounts at DTC in such name and in such denominations

as specified by such Buyer to effect such sale, transfer or assignment. In the event that such sale, assignment or transfer involves

Conversion Shares or Warrant Shares sold, assigned or transferred pursuant to an effective registration statement or in compliance with

Rule 144, the transfer agent shall issue such shares to such Buyer, assignee or transferee (as the case may be) without any restrictive

legend in accordance with Section 5(d) below. The Company acknowledges that a breach by it of its obligations hereunder will cause

irreparable harm to a Buyer. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this

Section 5(b) will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of

this Section 5(b), that a Buyer shall be entitled, in addition to all other available remedies, to an order and/or injunction

restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without any

bond or other security being required. The Company shall cause its counsel to issue the legal opinion referred to in the Irrevocable

Transfer Agent Instructions to the Company’s transfer agent on each Effective Date (as defined in the Registration Rights Agreement).

Any fees (with respect to the transfer agent, counsel to the Company or otherwise) associated with the issuance of such opinion or the

removal of any legends on any of the Securities shall be borne by the Company.

(c)

Legends. Each Buyer understands that the Securities have been issued (or will be issued in the case of the Shares) pursuant to

an exemption from registration or qualification under the 1933 Act and applicable state securities laws, and except as set forth below,

the Securities shall bear any legend as required by the “blue sky” laws of any state and a restrictive legend in substantially

the following form (and a stop-transfer order may be placed against transfer of such stock certificates):

[NEITHER

THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE][EXERCISABLE]

HAVE BEEN][THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR

APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A)

AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO

THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID

ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES

MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

25

(d)

Removal of Legends. Certificates evidencing the Shares shall not be required to contain the legend set forth in Section 5(c)

above or any other legend (i) while a registration statement (including a Registration Statement) covering the resale of such Shares

is effective under the 1933 Act, (ii) following any sale of such Shares pursuant to Rule 144 (assuming the transferor is not an affiliate

of the Company), (iii) if such Shares are eligible to be sold, assigned or transferred under Rule 144 (provided that a Buyer provides

the Company with reasonable assurances that such Shares are eligible for sale, assignment or transfer under Rule 144 which shall not

include an opinion of Buyer’s counsel), (iv) in connection with a sale, assignment or other transfer (other than under Rule 144),

provided that such Buyer provides the Company with an opinion of counsel to such Buyer, in a generally acceptable form, to the effect

that such sale, assignment or transfer of the Shares may be made without registration under the applicable requirements of the 1933 Act

or (v) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation, controlling judicial

interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall no later

than one (1) Trading Day (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the

settlement of a trade initiated on the date such Buyer delivers such legended certificate representing such Shares to the Company) following

the delivery by a Buyer to the Company or the transfer agent (with notice to the Company) of a legended certificate representing such

Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or

transfer, if applicable), together with any other deliveries from such Buyer as may be required above in this Section 5(d) or

as reasonably required by the Company’s transfer agent, as directed by such Buyer, either: (A) provided that the Company’s

transfer agent is participating in the DTC Fast Automated Securities Transfer Program (“FAST”), credit the aggregate

number of shares of Common Stock to which such Buyer shall be entitled to such Buyer’s or its designee’s balance account

with DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company’s transfer agent is not participating in FAST,

issue and deliver (via reputable overnight courier) to such Buyer, a certificate representing such Shares that is free from all restrictive

and other legends, registered in the name of such Buyer or its designee (the date by which such credit is so required to be made to the

balance account of such Buyer’s or such Buyer’s designee with DTC or such certificate is required to be delivered to such

Buyer pursuant to the foregoing is referred to herein as the “Required Delivery Date”, and the date such shares of

Common Stock are actually delivered without restrictive legend to such Buyer or such Buyer’s designee with DTC, as applicable,

the “Share Delivery Date”). The Company shall be responsible for any transfer agent fees or DTC fees with respect

to any issuance of Securities or the removal of any legends with respect to any Securities in accordance herewith.

(e)

[Reserved.]

(f)

FAST Compliance. While any Warrants remain outstanding, the Company shall maintain a transfer agent that participates in FAST.

6.

CONDITIONS TO THE COMPANY’S OBLIGATION TO SELL.

The

obligation of the Company hereunder to issue and sell the Preferred Shares and the related Warrants to each Buyer at the Closing is subject

to the satisfaction, at or before the Closing Date, of each of the following conditions, provided that these conditions are for the Company’s

sole benefit and may be waived by the Company at any time in its sole discretion by providing each Buyer with prior written notice thereof:

(a)

Such Buyer shall have executed each of the other Transaction Documents to which it is a party and delivered the same to the Company.

26

(b)

Such Buyer and each other Buyer shall have delivered to the Company the Purchase Price (less, in the case of any Buyer, the amounts withheld

pursuant to Section 4(g)) for the Preferred Shares and the related Warrants being purchased by such Buyer at the Closing by wire

transfer of immediately available funds in accordance with the wire instructions provided by the Company.

(c)

The representations and warranties of such Buyer shall be true and correct in all material respects as of the date when made and as of

the Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date,

which shall be true and correct as of such specific date), and such Buyer shall have performed, satisfied and complied in all material

respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such

Buyer at or prior to the Closing Date.

(d)

No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed

by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated

by the Transaction Documents.

7.

CONDITIONS TO EACH BUYER’S OBLIGATION TO PURCHASE.

The

obligation of each Buyer hereunder to purchase its Preferred Shares and its related Warrants at the Closing is subject to the satisfaction,

at or before the Closing Date, of each of the following conditions, provided that these conditions are for each Buyer’s sole benefit

and may be waived by such Buyer at any time in its sole discretion by providing the Company with prior written notice thereof:

(a)

The Company and each Subsidiary (as the case may be) shall have duly executed and delivered to such Buyer each of the Transaction Documents

to which it is a party and the Company shall have duly delivered to such Buyer (A) such aggregate number of Preferred Shares as is set

forth across from such Buyer’s name in column (3) of the Schedule of Buyers, and (B) a Warrant initially exercisable for such aggregate

number of Warrant Shares as is set forth across from such Buyer’s name in column (4) of the Schedule of Buyers, in each case, as

being purchased by such Buyer at the Closing pursuant to this Agreement.

(b)

Such Buyer shall have received the opinion of Haynes and Boone, LLP, the Company’s counsel, dated as of the Closing Date, addressed

to each Buyer, in the form acceptable to such Buyer.

(c)

The Company shall have delivered to such Buyer a copy of the Irrevocable Transfer Agent Instructions, which instructions shall have been

delivered to and acknowledged in writing by the Company’s transfer agent.

(d)

The Company shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company in its jurisdiction

of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation as of a date within ten (10) days

of the Closing Date.

(e)

The Company shall have delivered to such Buyer a certified copy of the Certificate of Incorporation as certified by the Delaware Secretary

of State within ten (10) days of the Closing Date.

(f)

The Company shall have delivered to such Buyer a certificate, in the form acceptable to such Buyer, executed by the Secretary of the

Company and dated as of the Closing Date, as to (i) the resolutions consistent with Section 3(b) as adopted by the Company’s

board of directors in a form reasonably acceptable to such Buyer, (ii) the Certificate of Incorporation of the Company and (iii) the

Bylaws of the Company as in effect at the Closing.

(g)

Each and every representation and warranty of the Company shall be true and correct as of the date when made and as of the Closing Date

as though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true

and correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants,

agreements and conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. Such Buyer

shall have received a certificate, duly executed by the Chief Executive Officer or Chief Financial Officer of the Company, dated as of

the Closing Date, to the foregoing effect.

27

(h)

The Company shall have delivered to such Buyer a letter from the Company’s transfer agent certifying the number of shares of Common

Stock outstanding on the Closing Date immediately prior to the Closing.

(i)

The Common Stock (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been

suspended, as of the Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by the

SEC or the Principal Market have been threatened, as of the Closing Date, either (I) in writing by the SEC or the Principal Market or

(II) by falling below the minimum maintenance requirements of the Principal Market.

(j)

The Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of

the Securities, including without limitation, those required by the Principal Market, if any.

(k)

No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed

by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated

by the Transaction Documents.

(l)

Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result

in a Material Adverse Effect, provided, however, that the definition of “Material Adverse Effect” for the purpose

of this clause (l), will not include any change or effect that results from (A) changes in law or interpretations thereof, or regulatory

policy or interpretation, by any Governmental Entity so long as such change does not have a disproportionate effect on the Company, (B)

changes in applicable accounting rules or principles, including changes in GAAP, so long as such change does not have a disproportionate

effect on the Company, (C) changes in general economic conditions, and events or conditions generally affecting the industries in which

the Company operates, so long as such change does not have a disproportionate effect on the Company, or (D) national or international

hostilities, acts of terror or acts of war.

(m)

The Company shall have filed a Notification: Listing of Additional Shares with the Principal Market and shall not have received any objection

thereto to list the Shares.

(n)

Such Buyer shall have received the wire transfer instructions of the Company.

(o)

The Company and its Subsidiaries shall have delivered to such Buyer such other documents, instruments or certificates relating to the

transactions contemplated by this Agreement as such Buyer or its counsel may reasonably request.

8.

TERMINATION.

This

Agreement may be terminated (i) by the mutual consent of each of the Company and the Buyers, (ii) if the Closing shall not have occurred

by May 11, 2026 (provided that no party shall have the right to terminate if they were the proximate cause of the failure to close by

such date), or (iii) with respect to a Buyer, if the Company has breached the terms of this Agreement in a manner that would cause the

failure of the conditions to closing hereunder to be met (and such breach remains uncured after 30 days’ notice). Upon any termination

in accordance with this Section 8 by a Buyer, such party shall have the right to terminate its obligations under this Agreement

with respect to itself at any time on or after the close of business on such date (without liability of such Buyer to any other party);

provided, however, the abandonment of the sale and purchase of the Preferred Shares and Warrants by such Buyer shall be

applicable only to such Buyer providing such written notice, provided further that no such termination by any party shall affect any

obligation of the Company under this Agreement to reimburse such Buyer for the expenses described in Section 4(g) above. Nothing

contained in this Section 8 shall be deemed to release any party from any liability for any breach by such party of the terms

and provisions of this Agreement or the other Transaction Documents or to impair the right of any party to compel specific performance

by any other party of its obligations under this Agreement or the other Transaction Documents.

28

9.

MISCELLANEOUS.

(a)

Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of

this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict

of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of

any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state

and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection

herewith or under any of the other Transaction Documents or with any transaction contemplated hereby or thereby, and hereby irrevocably

waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of

any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding

is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,

action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that

such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to

limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude

any Buyer from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company’s

obligations to such Buyer or to enforce a judgment or other court ruling in favor of such Buyer. EACH PARTY HEREBY IRREVOCABLY WAIVES

ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION

DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY

OR THEREBY.

(b)

Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the

same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event

that any signature is delivered by facsimile or electronic transmission (including DocuSign and similar) or by an e-mail which contains

a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation

of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were

an original thereof.

(c)

Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation

of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine,

neuter, singular and plural forms thereof. The terms “including,” “includes,” “include”

and words of like import shall be construed broadly as if followed by the words “without limitation.” The terms “herein,”

“hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the

provision in which they are found.

(d)

Severability; Maximum Payment Amounts. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid

or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall

be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such

provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues

to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature,

invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal

obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties

will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),

the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s). Notwithstanding anything

to the contrary contained in this Agreement or any other Transaction Document (and without implication that the following is required

or applicable), it is the intention of the parties that in no event shall amounts and value paid by the Company and/or any of its Subsidiaries

(as the case may be), or payable to or received by any of the Buyers, under the Transaction Documents (including without limitation,

any amounts that would be characterized as “interest” under applicable law) exceed amounts permitted under any applicable

law. Accordingly, if any obligation to pay, payment made to any Buyer, or collection by any Buyer pursuant the Transaction Documents

is finally judicially determined to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed

to have been made by mutual mistake of such Buyer, the Company and its Subsidiaries and such amount shall be deemed to have been adjusted

with retroactive effect to the maximum amount or rate of interest, as the case may be, as would not be so prohibited by the applicable

law. Such adjustment shall be effected, to the extent necessary, by reducing or refunding, at the option of such Buyer, the amount of

interest or any other amounts which would constitute unlawful amounts required to be paid or actually paid to such Buyer under the Transaction

Documents. For greater certainty, to the extent that any interest, charges, fees, expenses or other amounts required to be paid to or

received by such Buyer under any of the Transaction Documents or related thereto are held to be within the meaning of “interest”

or another applicable term to otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which

they relate.

29

(e)

Entire Agreement; Amendments. This Agreement, the other Transaction Documents and the schedules and exhibits attached hereto and

thereto and the instruments referenced herein and therein supersede all other prior oral or written agreements between the Buyers, the

Company, its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation, any transactions by any

Buyer with respect to shares of Common Stock or the Securities, and the other matters contained herein and therein, and this Agreement,

the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein

contain the entire understanding of the parties solely with respect to the matters covered herein and therein; provided, however,

nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements

any Buyer has entered into with, or any instruments any Buyer has received from, the Company or any of its Subsidiaries prior to the

date hereof with respect to any prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend in any respect

any obligations of the Company or any of its Subsidiaries, or any rights of or benefits to any Buyer or any other Person, in any agreement

entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Buyer, or any instruments any

Buyer received from the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments shall

continue in full force and effect. Except as specifically set forth herein or therein, neither the Company nor any Buyer makes any representation,

warranty, covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this Agreement.

No provision of this Agreement may be amended other than by an instrument in writing signed by the Company and the Required Holders (as

defined below), and any amendment to any provision of this Agreement made in conformity with the provisions of this Section 9(e)

shall be binding on all Buyers and holders of Securities, as applicable; provided that no such amendment shall be effective to

the extent that it (A) applies to less than all of the holders of the Securities then outstanding or (B) imposes any obligation or liability

on any Buyer without such Buyer’s prior written consent (which may be granted or withheld in such Buyer’s sole discretion).

No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party, provided that the

Required Holders may waive any provision of this Agreement, and any waiver of any provision of this Agreement made in conformity with

the provisions of this Section 9(e) shall be binding on all Buyers and holders of Securities, as applicable, provided that no

such waiver shall be effective to the extent that it (1) applies to less than all of the holders of the Securities then outstanding (unless

a party gives a waiver as to itself only) or (2) imposes any obligation or liability on any Buyer without such Buyer’s prior written

consent (which may be granted or withheld in such Buyer’s sole discretion). No consideration (other than reimbursement of legal

fees) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless

the same consideration also is offered to all of the parties to the Agreement. The Company has not directly or indirectly, made any agreements

with any Buyers relating to the terms or conditions of the transactions contemplated by the Transaction Documents except as set forth

in the Transaction Documents. Without limiting the foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer

has made any commitment or promise or has any other obligation to provide any financing to the Company, any Subsidiary or otherwise.

As a material inducement for each Buyer to enter into this Agreement, the Company expressly acknowledges and agrees that (x) no due diligence

or other investigation or inquiry conducted by a Buyer, any of its advisors or any of its representatives shall affect such Buyer’s

right to rely on, or shall modify or qualify in any manner or be an exception to any of, the Company’s representations and warranties

contained in this Agreement or any other Transaction Document and (y) unless a provision of this Agreement or any other Transaction Document

is expressly preceded by the phrase “except as disclosed in the SEC Documents,” nothing contained in any of the SEC Documents

shall affect such Buyer’s right to rely on, or shall modify or qualify in any manner or be an exception to any of, Company’s

representations and warranties contained in this Agreement or any other Transaction Document. “Required Holders” means

(I) prior to the Closing Date, each Buyer entitled to purchase, in the aggregate, at least a majority of the number of Preferred Shares

at the Closing and (II) on or after the Closing Date, holders of a majority of the Registrable Securities as of such time (excluding

any Registrable Securities held by the Company or any of its Subsidiaries as of such time) issued or issuable hereunder or pursuant to

the Certificate of Designations and/or the Warrants (or the Buyers, with respect to any waiver or amendment of Section 4(o));

provided, however, that in each case, each of Iroquois Master Fund Ltd. and Iroquois Capital Investment Group, LLC (each, an “Iroquois

Fund”) shall be among the Required Holders voting for such amendment or waiver, provided further that if an Iroquois Fund no

longer beneficially owns (directly or indirectly) Series K Preferred Stock, its vote shall not be required for any such amendment or

waiver.

30

(f)

Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement

must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent

by electronic mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the

sending party does not receive an automatically generated message from the recipient’s email server that such e-mail could not

be delivered to such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery

specified, in each case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications

shall be:

If

to the Company:

StableX

Technologies, Inc.

1185

Avenue of the Americas

New

York, New York 10036

Telephone:

(512) 994-4917

Attention:

Chief Executive Officer

E-Mail:

jsilverman@parkfieldfund.com

With

a copy (for informational purposes only) to:

Haynes

and Boone, LLP

30

Rockefeller Plaza, 26th Floor

New

York, New York 10112

Telephone:

(212) 659-7300

Attention:

Rick Werner

E-mail:

rick.werner@haynesboone.com

If

to the Transfer Agent:

Equiniti

Trust Company LLC

1110

Centre Point Curve, Suite 101

Telephone:

919-744-2722

Attention:

Direct Transfer Compliance

E-Mail:

transfer-ID@equiniti.com

If

to a Buyer, to its mailing address and e-mail address set forth on the Schedule of Buyers, with copies to such Buyer’s representatives

as set forth on the Schedule of Buyers

with

a copy (for informational purposes only) to:

Mintz,

Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

919

Third Avenue

New

York, New York 10022

Telephone:

(212) 935-3000

Attention:

Jeffrey P. Schultz

31

or

to such other mailing address and/or e-mail address and/or to the attention of such other Person as the recipient party has specified

by written notice given to each other party five (5) days prior to the effectiveness of such change, provided that Buyer Counsel shall

only be provided copies of notices sent to the lead Buyer. Written confirmation of receipt (A) given by the recipient of such notice,

consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s e-mail containing the time,

date and recipient’s e-mail or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt

by e-mail or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.

(g)

Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors

and assigns, including any purchasers of any of the Preferred Shares and Warrants. The Company shall not assign this Agreement or any

rights or obligations hereunder without the prior written consent of the Required Holders, including, without limitation, by way of a

Fundamental Transaction (as defined in the Warrants) (unless the Company is in compliance with the applicable provisions governing Fundamental

Transactions set forth in the Warrants) or a Fundamental Transaction (as defined in the Certificate of Designations) (unless the Company

is in compliance with the applicable provisions governing Fundamental Transactions set forth in the Certificate of Designations). A Buyer

may assign some or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of the Company,

in which event such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.

(h)

No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted

successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than the

Indemnitees referred to in Section 9(k) and the Placement Agent.

(i)

Survival. The representations, warranties, agreements and covenants shall survive the Closing. Each Buyer shall be responsible

only for its own representations, warranties, agreements and covenants hereunder.

(j)

Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and

shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request

in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated

hereby.

(k)

Indemnification. In consideration of each Buyer’s execution and delivery of the Transaction Documents and acquiring the

Securities thereunder and in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall

defend, protect, indemnify and hold harmless each Buyer and each holder of any Securities and all of their stockholders, partners, members,

officers, directors, employees and direct or indirect investors and any of the foregoing Persons’ agents or other representatives

(including, without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the

“Indemnitees”) from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees,

liabilities and damages, and expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for

which indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified

Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (i) any misrepresentation or breach

of any representation or warranty made by the Company or any Subsidiary in any of the Transaction Documents, (ii) any breach of any covenant,

agreement or obligation of the Company or any Subsidiary contained in any of the Transaction Documents or (iii) any cause of action,

suit, proceeding or claim brought or made against such Indemnitee by a third party (including for these purposes a derivative action

brought on behalf of the Company or any Subsidiary) or which otherwise involves such Indemnitee that arises out of or results from (A)

the execution, delivery, performance or enforcement of any of the Transaction Documents, (B) any transaction financed or to be financed

in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities, (C) any disclosure properly made by

such Buyer pursuant to Section 4(i), or (D) the status of such Buyer or holder of the Securities either as an investor in the

Company pursuant to the transactions contemplated by the Transaction Documents or as a party to this Agreement (including, without limitation,

as a party in interest or otherwise in any action or proceeding for injunctive or other equitable relief). To the extent that the foregoing

undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction

of each of the Indemnified Liabilities which is permissible under applicable law. Except as otherwise set forth herein, the mechanics

and procedures with respect to the rights and obligations under this Section 9(k) shall be the same as those set forth in Section

6 of the Registration Rights Agreement.

32

(l)

Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual

intent, and no rules of strict construction will be applied against any party. No specific representation or warranty shall limit the

generality or applicability of a more general representation or warranty. Each and every reference to share prices, shares of Common

Stock and any other numbers in this Agreement that relate to the shares of Common Stock shall be automatically adjusted for any stock

splits, stock dividends, stock combinations, recapitalizations or other similar transactions that occur with respect to the Common Stock

after the date of this Agreement. Notwithstanding anything in this Agreement to the contrary, for the avoidance of doubt, nothing contained

herein shall constitute a representation or warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement

to borrow, identification of the availability of, and/or securing of, securities of the Company in order for such Buyer (or its broker

or other financial representative) to effect short sales or similar transactions in the future.

(m)

Remedies. Each Buyer and in the event of assignment by Buyer of its rights and obligations hereunder, each holder of Securities,

shall have all rights and remedies set forth in the Transaction Documents and all rights and remedies which such holders have been granted

at any time under any other agreement or contract and all of the rights which such holders have under any law. Any Person having any

rights under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security),

to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore,

the Company recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge any or all of its or such

Subsidiary’s (as the case may be) obligations under the Transaction Documents, any remedy at law would inadequate relief to the

Buyers. The Company therefore agrees that the Buyers shall be entitled to specific performance and/or temporary, preliminary and permanent

injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual

damages and without posting a bond or other security. The remedies provided in this Agreement and the other Transaction Documents shall

be cumulative and in addition to all other remedies available under this Agreement and the other Transaction Documents, at law or in

equity (including a decree of specific performance and/or other injunctive relief).

(n)

Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction

Documents, whenever any Buyer exercises a right, election, demand or option under a Transaction Document and the Company or any Subsidiary

does not timely perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw, in its

sole discretion from time to time upon written notice to the Company or such Subsidiary (as the case may be), any relevant notice, demand

or election in whole or in part without prejudice to its future actions and rights.

(o)

Payment Set Aside; Currency. To the extent that the Company makes a payment or payments to any Buyer hereunder or pursuant to

any of the other Transaction Documents or any of the Buyers enforce or exercise their rights hereunder or thereunder, and such payment

or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent

or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company,

a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal law,

common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended

to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff

had not occurred. Unless otherwise expressly indicated, all dollar amounts referred to in this Agreement and the other Transaction Documents

are in United States Dollars (“U.S. Dollars”), and all amounts owing under this Agreement and all other Transaction

Documents shall be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall be converted into the U.S. Dollar

equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange Rate” means, in relation

to any amount of currency to be converted into U.S. Dollars pursuant to this Agreement, the U.S. Dollar exchange rate as published in

the Wall Street Journal on the relevant date of calculation.

33

(p)

Judgment Currency.

(i)

If for the purpose of obtaining or enforcing judgment against the Company in connection with this Agreement or any other Transaction

Document in any court in any jurisdiction it becomes necessary to convert into any other currency (such other currency being hereinafter

in this Section 9(p) referred to as the “Judgment Currency”) an amount due in US Dollars under this Agreement,

the conversion shall be made at the Exchange Rate prevailing on the Trading Day immediately preceding:

(1)

the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction

that will give effect to such conversion being made on such date: or

(2)

the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of

which such conversion is made pursuant to this Section 9(p)(i)(2) being hereinafter referred to as the “Judgment Conversion

Date”).

(ii)

If in the case of any proceeding in the court of any jurisdiction referred to in Section 9(p)(i)(2) above, there is a change in

the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party

shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange

Rate prevailing on the date of payment, will produce the amount of US Dollars which could have been purchased with the amount of Judgment

Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.

(iii)

Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained

for any other amounts due under or in respect of this Agreement or any other Transaction Document.

(q)

Independent Nature of Buyers’ Obligations and Rights. The obligations of each Buyer under the Transaction

Documents are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance

of the obligations of any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document,

and no action taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company each acknowledge

that the Buyers do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create

a presumption that the Buyers are in any way acting in concert or as a group or entity, and the Company shall not assert any such claim

with respect to such obligations or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges

that the Buyers are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations

or the transactions contemplated by the Transaction Documents. The decision of each Buyer to purchase Securities pursuant to the Transaction

Documents has been made by such Buyer independently of any other Buyer. Each Buyer acknowledges that no other Buyer has acted as agent

for such Buyer in connection with such Buyer making its investment hereunder and that no other Buyer will be acting as agent of such

Buyer in connection with monitoring such Buyer’s investment in the Securities or enforcing its rights under the Transaction Documents.

The Company and each Buyer confirms that each Buyer has independently participated with the Company and its Subsidiaries in the negotiation

of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently

protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction

Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose.

The use of a single agreement to effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of

the Company, not the action or decision of any Buyer, and was done solely for the convenience of the Company and its Subsidiaries and

not because it was required or requested to do so by any Buyer. It is expressly understood and agreed that each provision contained in

this Agreement and in each other Transaction Document is between the Company, each Subsidiary and a Buyer, solely, and not between the

Company, its Subsidiaries and the Buyers collectively and not between and among the Buyers.

[signature

pages follow]

34

IN

WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as

of the date first written above.

STABLEX TECHNOLOGIES, INC.

By:

Name:

Joshua Silverman

Title:

Chief Executive Officer

35

[PURCHASER

SIGNATURE PAGES TO SBLX SECURITIES PURCHASE AGREEMENT]

IN

WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories

as of the date first indicated above.

Name

of Purchaser: _______________________________________________________________________________

Signature

of Authorized Signatory of Purchaser: _________________________________________________________

Name

of Authorized Signatory: ______________________________________________________________________

Title

of Authorized Signatory: _______________________________________________________________________

Email

Address of Authorized Signatory: _______________________________________________________________

Address

for Notice to Purchaser: ____________________________________________________________________

Address

for Delivery of Shares to Purchaser (if not same as address for notice): _________________________________

Subscription

Amount: $ ________________________

Preferred

Shares: _____________________________

Warrant

Shares: ______________________________

EIN

Number: ________________________________

36

SCHEDULE

OF BUYERS

(1)

(2)

(3)

(4)

(5)

(6)

Buyer

Address

and Facsimile Number

Aggregate

Number of Preferred Shares

Aggregate

Number of Warrant Shares

Purchase

Price

Legal

Representative’s Address and Facsimile Number

[LEAD

INVESTOR]

[OTHER

BUYERS]

TOTAL

37

EX-10.4

EX-10.4

Filename: ex10-4.htm · Sequence: 14

Exhibit

10.4

REGISTRATION

RIGHTS AGREEMENT

This

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 27, 2026, is by and among StableX Technologies,

Inc., a Delaware corporation (the “Company”), and the undersigned buyers (each, a “Buyer,” and

collectively, the “Buyers”).

RECITALS

A. In

connection with the Securities Purchase Agreement by and among the parties hereto, dated as of April 27, 2026 (the “Securities

Purchase Agreement”), the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement,

to issue and sell to each Buyer (i) the Preferred Shares (as defined in the Securities Purchase Agreement) which will be convertible

into Conversion Shares (as defined in the Securities Purchase Agreement) in accordance with the terms of the Certificate of Designations

(as defined in the Securities Purchase Agreement) and (ii) the Warrants (as defined in the Securities Purchase Agreement) which will

be exercisable to purchase Warrant Shares (as defined in the Securities Purchase Agreement) in accordance with the terms of the Warrants.

B. To

induce the Buyers to consummate the transactions contemplated by the Securities Purchase Agreement, the Company has agreed to provide

certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor

statute (collectively, the “1933 Act”), and applicable state securities laws.

AGREEMENT

NOW,

THEREFORE, in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration,

the receipt and sufficiency of which are hereby acknowledged, the Company and each of the Buyers hereby agree as follows:

1.

Definitions.

Capitalized

terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.

As used in this Agreement, the following terms shall have the following meanings:

(a) “Business

Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized

or required by law to remain closed; provided, however, for clarification, commercial

banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,

“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the

direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial

banks in The City of New York generally are open for use by customers on such day.

(b) “Closing

Date” shall have the meaning set forth in the Securities Purchase Agreement.

(c) “Effective

Date” means the date that the applicable Registration Statement has been declared effective by the SEC.

(d) “Effectiveness

Deadline” means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the earlier

of the (A) 60th calendar day after the Closing Date (or, in the event of a “full review” by the SEC, the 90h

calendar day after the Closing Date) and (B) 2nd Business Day after the date the Company is notified (orally or in writing, whichever

is earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject to further review; provided, that,

in case of clause (B) if Stockholder Approval is not received by such date, the 2nd Business Day following the Stockholder Approval Date

and (ii) with respect to any additional Registration Statements which may be required hereunder, the earlier of the (I) 30th calendar

day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a “full

review” by the SEC, the 60th calendar day following the date such additional Registration Statement is required to be filed hereunder)

and (II) 2nd Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration

Statement will not be reviewed or will not be subject to further review, provided, further, if such Effectiveness Deadline falls on a

day that is not a Trading Day, then the Effectiveness Deadline shall be the next succeeding Trading Day.

(e) “Filing

Deadline” means (i) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the 30th

calendar day after the Closing Date and (ii) with respect to any additional Registration Statements that may be required to be filed

by the Company pursuant to this Agreement, the date on which the Company was required to file such additional Registration Statement

pursuant to the terms of this Agreement; provided, that, if such Filing Deadline falls on a day that is not a Trading Day, then the Filing

Deadline shall be the next succeeding Trading Day.

(f) “Investor”

means a Buyer or any transferee or assignee of any Registrable Securities, Preferred Shares or Warrants, as applicable, to whom a Buyer

assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with Section

9 and any transferee or assignee thereof to whom a transferee or assignee of any Registrable Securities, Preferred Shares or Warrants,

as applicable, assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance

with Section 9.

(g) “Person”

means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization

or a government or any department or agency thereof.

(h) “register,”

“registered,” and “registration” refer to a registration effected by preparing and filing one or

more Registration Statements in compliance with the 1933 Act and pursuant to Rule 415 and the declaration of effectiveness of such Registration

Statement(s) by the SEC.

(i) “Registrable

Securities” means (i) the Conversion Shares, (ii) the Warrant Shares and (iii) any capital stock of the Company issued or issuable

with respect to the Conversion Shares, the Warrant Shares, the Preferred Shares or the Warrants, including, without limitation, (1) as

a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) any capital stock of the

Company into which the shares of Common Stock are converted or exchanged and capital stock of a Successor Entity (as defined in the Warrants)

into which the shares of Common Stock are converted or exchanged, in each case, without regard to any limitations on conversion of the

Preferred Shares or exercise of the Warrants; provided, however, that any such Registrable Securities shall cease to be Registrable Securities

(and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect

thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by

the SEC under the 1933 Act and such Registrable Securities have been disposed of by the Investor in accordance with such effective Registration

Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible

for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144, including paragraph

(i) of Rule 144, as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Company’s

transfer agent and the affected Investors (assuming that such securities and any securities issuable upon exercise, conversion or exchange

of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company).

(j) “Registration

Statement” means a registration statement or registration statements of the Company filed under the 1933 Act covering Registrable

Securities.

(k) “Required

Holders” shall have the meaning as set forth in the Securities Purchase Agreement.

(l) “Required

Registration Amount” means, as of any time of determination, the sum of (i) 200% of the maximum number of Conversion Shares

issuable upon conversion of the Preferred Shares (assuming for purposes hereof that (x) the Preferred Shares are convertible at the Floor

Price (as defined in the Certificate of Designations), and (y) any such conversion shall not take into account any limitations on the

conversion of the Preferred Shares set forth in the Certificate of Designations) and (ii) 200% of the maximum number of Warrant Shares

issuable upon exercise of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth therein),

all subject to adjustment as provided in Section 2(d) and/or Section 2(f); provided, that if the SEC informs the Company either orally

or in writing (including, but not limited to, pursuant to any receipt of comments by the SEC or the staff of the SEC (the “Staff”))

that it is not permitted to register the total amount required pursuant to clause (i) and (ii) of this Section 1(l), then the Required

Registration Amount shall be such lesser amount as the SEC permits to be registered.

2

(m) “Rule

144” means Rule 144 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any other

similar or successor rule or regulation of the SEC that may at any time permit the Investors to sell securities of the Company to the

public without registration.

(n) “Rule

415” means Rule 415 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any other

similar or successor rule or regulation of the SEC providing for offering securities on a continuous or delayed basis.

(o) “SEC”

means the United States Securities and Exchange Commission or any successor thereto.

2.

Registration.

(a)

Mandatory Registration. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline,

file with the SEC an initial Registration Statement on Form S-3 covering the resale of all of the Registrable Securities, provided that

such initial Registration Statement shall register for resale at least the number of shares of Common Stock equal to the Required Registration

Amount as of the date such Registration Statement is initially filed with the SEC; provided further that if Form S-3 is unavailable for

such a registration, the Company shall use such other form as is required by Section 2(c). Such initial Registration Statement, and each

other Registration Statement required to be filed pursuant to the terms of this Agreement, shall contain (except if otherwise directed

by the Required Holders) the “Selling Stockholders” and “Plan of Distribution” sections in substantially

the form attached hereto as Exhibit A and Exhibit B, respectively. The Company shall use its best efforts to have such

initial Registration Statement, and each other Registration Statement required to be filed pursuant to the terms of this Agreement, declared

effective by the SEC as soon as practicable, but in no event later than the applicable Effectiveness Deadline for such Registration Statement.

(b)

Legal Counsel. Subject to Section 5 hereof, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel solely to the lead Buyer

(“Legal Counsel”), shall be provided a copy of any registration, solely on behalf of the lead Buyer, pursuant to this

Section 2.

(c)

Ineligibility to Use Form S-3. In the event that Form S-3 is not available for the registration of the resale of Registrable Securities

hereunder, the Company shall (i) register the resale of the Registrable Securities on Form S-1 or another appropriate form reasonably

acceptable to the Required Holders and (ii) undertake to register the resale of the Registrable Securities on Form S-3 as soon as such

form is available, provided that the Company shall maintain the effectiveness of all Registration Statements then in effect until such

time as a Registration Statement on Form S-3 covering the resale of all the Registrable Securities has been declared effective by the

SEC and the prospectus contained therein is available for use.

(d)

Sufficient Number of Shares Registered. In the event the number of shares available under any Registration Statement is insufficient

to cover all of the Registrable Securities required to be covered by such Registration Statement or an Investor’s allocated portion

of the Registrable Securities pursuant to Section 2(h), the Company shall amend such Registration Statement (if permissible), or file

with the SEC a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover at least the

Required Registration Amount less any securities that are no longer Registrable Securities as of the Trading Day immediately preceding

the date of the filing of such amendment or new Registration Statement, in each case, as soon as practicable, but in any event not later

than fifteen (15) days after the necessity therefor arises. The Company shall use its best efforts to cause such amendment to such Registration

Statement and/or such new Registration Statement (as the case may be) to become effective as soon as practicable following the filing

thereof with the SEC, but in no event later than the applicable Effectiveness Deadline for such Registration Statement. For purposes

of the foregoing provision, the number of shares available under a Registration Statement shall be deemed “insufficient to cover

all of the Registrable Securities” if at any time the number of shares of Common Stock available for resale under the applicable

Registration Statement is less than the product determined by multiplying (i) the Required Registration Amount as of such time by (ii)

0.90. The calculation set forth in the foregoing sentence shall be made without regard to any limitations on conversion of the Preferred

Shares or exercise of the Warrants (and such calculation shall assume (A) that the Preferred Shares are then convertible in full into

shares of Common Stock at the Floor Price (as defined in the Certificate of Designations) and (B) the Warrants are then exercisable in

full into shares of Common Stock at the then prevailing Exercise Price (as defined in the Warrants)).

3

(e)

Effect of Failure to File and Obtain and Maintain Effectiveness of any Registration Statement. If (i) a Registration Statement

covering the resale of all of the Registrable Securities required to be covered thereby (disregarding any reduction pursuant to Section

2(f)) and required to be filed by the Company pursuant to this Agreement is (A) not filed with the SEC on or before the Filing Deadline

for such Registration Statement (a “Filing Failure”) (it being understood that if the Company files a Registration

Statement without affording each Investor the opportunity to review and comment on the same as required by Section 3(c) hereof, the Company

shall be deemed to not have satisfied this clause (i)(A) and such event shall be deemed to be a Filing Failure) or (B) not declared effective

by the SEC on or before the Effectiveness Deadline for such Registration Statement (an “Effectiveness Failure”) (it

being understood that if on the Business Day immediately following the Effective Date for such Registration Statement the Company shall

not have filed a “final” prospectus for such Registration Statement with the SEC under Rule 424(b) in accordance with Section

3(b) (whether or not such a prospectus is technically required by such rule), the Company shall be deemed to not have satisfied this

clause (i)(B) and such event shall be deemed to be an Effectiveness Failure), (ii) other than during an Allowable Grace Period (as defined

below), on any day after the Effective Date of a Registration Statement sales of all of the Registrable Securities required to be included

on such Registration Statement (disregarding any reduction pursuant to Section 2(f)) cannot be made pursuant to such Registration Statement

(including, without limitation, because of a failure to keep such Registration Statement effective, a failure to disclose such information

as is necessary for sales to be made pursuant to such Registration Statement, a suspension or delisting of (or a failure to timely list)

the Common Stock on the Principal Market or any other limitations imposed by the Principal Market, or a failure to register a sufficient

number of shares of Common Stock or by reason of a stop order) or the prospectus contained therein is not available for use for any reason

(a “Maintenance Failure”), or (iii) if a Registration Statement is not effective for any reason or the prospectus

contained therein is not available for use for any reason, and either (x) the Company fails for any reason to satisfy the requirements

of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information requirement under Rule 144(c)

or (y) the Company has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall

fail to satisfy any condition set forth in Rule 144(i)(2) (a “Current Public Information Failure”) as a result of

which any of the Investors are unable to sell Registrable Securities without restriction under Rule 144 (including, without limitation,

volume restrictions), then, as partial relief for the damages to any holder by reason of any such delay in, or reduction of, its ability

to sell the underlying shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity,

including, without limitation, specific performance), the Company shall pay to each holder of Registrable Securities relating to such

Registration Statement an amount in cash equal to two percent (2%) of such Investor’s respective Purchase Price on the Closing

Date (1) on the date of such Filing Failure, Effectiveness Failure, Maintenance Failure or Current Public Information Failure, as applicable,

and (2) on every thirty (30) day anniversary of (I) a Filing Failure until such Filing Failure is cured; (II) an Effectiveness Failure

until such Effectiveness Failure is cured; (III) a Maintenance Failure until such Maintenance Failure is cured; and (IV) a Current Public

Information Failure until the earlier of (i) the date such Current Public Information Failure is cured and (ii) such time that such public

information is no longer required pursuant to Rule 144 (in each case, prorated for periods totaling less than thirty (30) days). The

payments to which a holder of Registrable Securities shall be entitled pursuant to this Section 2(e) are referred to herein as “Registration

Delay Payments.” Following the initial Registration Delay Payment for any particular event or failure (which shall be paid

on the date of such event or failure, as set forth above), without limiting the foregoing, if an event or failure giving rise to the

Registration Delay Payments is cured prior to any thirty (30) day anniversary of such event or failure, then such Registration Delay

Payment shall be made on the third (3rd) Business Day after such cure. In the event the Company fails to make Registration Delay Payments

in a timely manner in accordance with the foregoing, such Registration Delay Payments shall bear interest at the rate of one and one

half percent (1.5%) per month (prorated for partial months) until paid in full. Notwithstanding the foregoing, no Registration Delay

Payments shall be owed to an Investor (other than with respect to a Maintenance Failure resulting from a suspension or delisting of (or

a failure to timely list) the Common Stock on the Principal Market) with respect to any period during which all of such Investor’s

Registrable Securities may be sold by such Investor without restriction under Rule 144 (including, without limitation, volume restrictions)

and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable).

4

(f)

Offering. Notwithstanding anything to the contrary contained in this Agreement, but subject to the payment of the Registration

Delay Payments pursuant to Section 2(e), in the event the Staff or the SEC seeks to characterize any offering pursuant to a Registration

Statement filed pursuant to this Agreement as constituting an offering of securities by, or on behalf of, the Company, or in any other

manner, such that the Staff or the SEC do not permit such Registration Statement to become effective and used for resales in a manner

that does not constitute such an offering and that permits the continuous resale at the market by the Investors participating therein

(or as otherwise may be acceptable to each Investor) without being named therein as an “underwriter,” then the Company shall

reduce the number of shares to be included in such Registration Statement by all Investors until such time as the Staff and the SEC shall

so permit such Registration Statement to become effective as aforesaid. In making such reduction, the Company shall reduce the number

of shares to be included by all Investors on a pro rata basis (based upon the number of Registrable Securities otherwise required to

be included for each Investor) unless the inclusion of shares by a particular Investor or a particular set of Investors are resulting

in the Staff or the SEC’s “by or on behalf of the Company” offering position, in which event the shares held by such

Investor or set of Investors shall be the only shares subject to reduction (and if by a set of Investors on a pro rata basis by such

Investors or on such other basis as would result in the exclusion of the least number of shares by all such Investors); provided, that,

with respect to such pro rata portion allocated to any Investor, such Investor may elect the allocation of such pro rata portion among

the Registrable Securities of such Investor. In addition, in the event that the Staff or the SEC requires any Investor seeking to sell

securities under a Registration Statement filed pursuant to this Agreement to be specifically identified as an “underwriter”

in order to permit such Registration Statement to become effective, and such Investor does not consent to being so named as an underwriter

in such Registration Statement, then, in each such case, the Company shall reduce the total number of Registrable Securities to be registered

on behalf of such Investor, until such time as the Staff or the SEC does not require such identification or until such Investor accepts

such identification and the manner thereof. Any reduction pursuant to this paragraph will first reduce all Registrable Securities other

than those issued pursuant to the Securities Purchase Agreement. In the event of any reduction in Registrable Securities pursuant to

this paragraph, an affected Investor shall have the right to require, upon delivery of a written request to the Company signed by such

Investor, the Company to file a registration statement within twenty (20) days of such request (subject to any restrictions imposed by

Rule 415 or required by the Staff or the SEC) for resale by such Investor in a manner acceptable to such Investor, and the Company shall

following such request cause to be and keep effective such registration statement in the same manner as otherwise contemplated in this

Agreement for registration statements hereunder, in each case until such time as: (i) all Registrable Securities held by such Investor

have been registered and sold pursuant to an effective Registration Statement in a manner acceptable to such Investor or (ii) all Registrable

Securities may be resold by such Investor without restriction (including, without limitation, volume limitations) pursuant to Rule 144

(taking account of any Staff position with respect to “affiliate” status) and without the need for current public information

required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or (iii) such Investor agrees to be named as an underwriter in any such

Registration Statement in a manner acceptable to such Investor as to all Registrable Securities held by such Investor and that have not

theretofore been included in a Registration Statement under this Agreement (it being understood that the special demand right under this

sentence may be exercised by an Investor multiple times and with respect to limited amounts of Registrable Securities in order to permit

the resale thereof by such Investor as contemplated above).

(g)

Piggyback Registrations. Without limiting any obligation of the Company hereunder or under the Securities Purchase Agreement,

if there is not an effective Registration Statement covering all of the Registrable Securities or the prospectus contained therein is

not available for use and the Company shall determine to prepare and file with the SEC a registration statement or offering statement

relating to an offering for its own account or the account of others under the 1933 Act of any of its equity securities (other than on

Form S-4 or Form S-8 (each as promulgated under the 1933 Act) or their then equivalents relating to equity securities to be issued solely

in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company’s share

option or other employee benefit plans), then the Company shall deliver to each Investor a written notice of such determination and,

if within fifteen (15) days after the date of the delivery of such notice, any such Investor shall so request in writing, the Company

shall include in such registration statement or offering statement all or any part of such Registrable Securities such Investor requests

to be registered; provided, however, the Company shall not be required to register any Registrable Securities pursuant to this Section

2(g) that are eligible for resale pursuant to Rule 144 without restriction (including, without limitation, volume restrictions) and without

the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or that are the subject of a then-effective

Registration Statement.

5

(h)

Allocation of Registrable Securities. The initial number of Registrable Securities included in any Registration Statement and

any increase in the number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number

of Registrable Securities held by each Investor at the time such Registration Statement covering such initial number of Registrable Securities

or increase thereof is declared effective by the SEC. In the event that an Investor sells or otherwise transfers any of such Investor’s

Registrable Securities, each transferee or assignee (as the case may be) that becomes an Investor shall be allocated a pro rata portion

of the then-remaining number of Registrable Securities included in such Registration Statement for such transferor or assignee (as the

case may be). Any shares of Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to

hold any Registrable Securities covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based

on the number of Registrable Securities then held by such Investors which are covered by such Registration Statement.

(i)

No Inclusion of Other Securities. Other than with respect to (i) the shares of Common Stock issuable upon exercise of the Placement

Agent Warrants, and (ii) the shares of Common Stock issuable upon conversion of the Company’s Series J Preferred Stock, the Company

shall in no event include any securities other than Registrable Securities on any Registration Statement filed in accordance herewith

without the prior written consent of the Required Holders. Until the Applicable Date, the Company shall not enter into any agreement

providing any registration rights to any of its security holders, except as otherwise permitted under the Securities Purchase Agreement.

3.

Related Obligations.

The

Company shall use its best efforts to effect the registration of the Registrable Securities in accordance with the intended method of

disposition thereof, and, pursuant thereto, the Company shall have the following obligations:

(a)

The Company shall promptly prepare and file with the SEC a Registration Statement with respect to all the Registrable Securities (but

in no event later than the applicable Filing Deadline) and use its best efforts to cause such Registration Statement to become effective

as soon as practicable after such filing (but in no event later than the Effectiveness Deadline). Subject to Allowable Grace Periods,

the Company shall keep each Registration Statement effective (and the prospectus contained therein available for use) pursuant to Rule

415 for resales by the Investors on a delayed or continuous basis at then-prevailing market prices (and not fixed prices) at all times

until the earlier of (i) the date as of which all of the Investors may sell all of the Registrable Securities required to be covered

by such Registration Statement (disregarding any reduction pursuant to Section 2(f)) without restriction pursuant to Rule 144 (including,

without limitation, volume restrictions) and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2),

if applicable) or (ii) the date on which the Investors shall have sold all of the Registrable Securities covered by such Registration

Statement (the “Registration Period”). Notwithstanding anything to the contrary contained in this Agreement, the Company

shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all amendments

and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto) used in connection

with such Registration Statement (1) shall not contain any untrue statement of a material fact or omit to state a material fact required

to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in

which they were made) not misleading and (2) will disclose (whether directly or through incorporation by reference to other SEC filings

to the extent permitted) all material information regarding the Company and its securities. The Company shall submit to the SEC, within

one (1) Business Day after the date that the Company learns that no review of a particular Registration Statement will be made by the

Staff or that the Staff has no further comments on a particular Registration Statement (as the case may be), a request for acceleration

of effectiveness of such Registration Statement to a time and date not later than two (2) Business Days after the submission of such

request (but taking account of any Staff position with respect to the date on which the Staff will permit such request for acceleration

to be filed with the SEC). The Company shall respond in writing to comments made by the SEC in respect of a Registration Statement as

soon as practicable, but in no event later than fifteen (15) days after the receipt of comments by or notice from the SEC that an amendment

is required in order for a Registration Statement to be declared effective.

6

(b)

Subject to Section 3(r) of this Agreement, the Company shall prepare and file with the SEC such amendments (including, without limitation,

post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each such Registration

Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the 1933 Act, as may be necessary to keep each such

Registration Statement effective at all times during the Registration Period for such Registration Statement, and, during such period,

comply with the provisions of the 1933 Act with respect to the disposition of all Registrable Securities of the Company required to be

covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance

with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement; provided, however,

by 8:30 a.m. (New York time) on the Business Day immediately following each Effective Date, the Company shall file with the SEC in accordance

with Rule 424(b) under the 1933 Act the final prospectus to be used in connection with sales pursuant to the applicable Registration

Statement (whether or not such a prospectus is technically required by such rule). In the case of amendments and supplements to any Registration

Statement which are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section 3(b)) by

reason of the Company filing a Current Report on Form 8-K, an Annual Report on Form 10-K, a Quarterly Report on Form 10-Q or any analogous

report under the Securities Exchange Act of 1934, as amended (the “1934 Act”), the Company shall, if permitted under

the applicable rules and regulations of the SEC, have incorporated such report by reference into such Registration Statement, if applicable,

or shall file such amendments or supplements with the SEC on the same day on which the 1934 Act report is filed which created the requirement

for the Company to amend or supplement such Registration Statement.

(c)

The Company shall (A) permit each Investor to review and comment upon (i) each Registration Statement at least five (5) days prior to

its filing with the SEC and (ii) all amendments and supplements to each Registration Statement (including, without limitation, the prospectus

contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any similar

or successor reports) within a reasonable number of days prior to their filing with the SEC, and (B) not file any Registration Statement

or amendment or supplement thereto in a form to which such Investor reasonably objects; provided, that the Company shall not have

any obligation to modify any information if the Company reasonably expects that so doing would cause (i) the Registration Statement to

contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make

the statements therein not misleading or (ii) any prospectus contained therein to contain an untrue statement of a material fact or to

omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made,

not misleading. The Company shall promptly furnish to each Investor, without charge, (i) copies of any correspondence from the SEC or

the Staff to the Company or its representatives relating to each Registration Statement, provided that such correspondence shall not

contain any material, non-public information regarding the Company or any of its Subsidiaries, (ii) after the same is prepared and filed

with the SEC, one (1) copy of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation,

financial statements and schedules, all documents incorporated therein by reference, if requested by an Investor, and all exhibits and

(iii) upon the effectiveness of each Registration Statement, one (1) copy of the prospectus included in such Registration Statement and

all amendments and supplements thereto, provided, that any such item which is available on the EDGAR system (or successor thereto) need

not be furnished. The Company shall reasonably cooperate with each Investor in performing the Company’s obligations pursuant to

this Section 3.

(d) The

Company shall promptly furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge,

(i) after the same is prepared and filed with the SEC, at least one (1) copy of each Registration Statement and any amendment(s) and

supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference,

if requested by an Investor, all exhibits and each preliminary prospectus, provided, that any such item which is available on the EDGAR

system (or successor thereto) need not be furnished.

(e) The

Company shall use its best efforts to (i) register and qualify, unless an exemption from registration and qualification applies, the

resale by Investors of the Registrable Securities covered by a Registration Statement under such other securities or “blue sky”

laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions, such amendments (including,

without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain

the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations

and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable

to qualify the Registrable Securities for sale in such jurisdictions; provided, however, the Company shall not be required in connection

therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify

but for this Section 3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service

of process in any such jurisdiction. The Company shall promptly notify Legal Counsel, legal counsel for each other Investor and each

Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the registration

or qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction

in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.

7

(f)

The Company shall notify each Investor in writing of the happening of any event, as promptly as practicable after becoming aware of such

event, as a result of which the prospectus included in a Registration Statement, as then in effect, may include an untrue statement of

a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the

light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material,

non-public information regarding the Company or any of its Subsidiaries), and, subject to Section 3(r), promptly prepare a supplement

or amendment to such Registration Statement and such prospectus contained therein to correct such untrue statement or omission and deliver

one (1) copy of such supplement or amendment to each Investor; provided, that any such item which is available on the EDGAR system (or

successor thereto) need not be furnished. The Company shall also promptly notify each Investor in writing (i) when a prospectus or any

prospectus supplement or post-effective amendment has been filed, when a Registration Statement or any post-effective amendment has become

effective (notification of such effectiveness shall be delivered to each Investor by e-mail on the same day of such effectiveness and

by overnight mail), and when the Company receives written notice from the SEC that a Registration Statement or any post-effective amendment

will be reviewed by the SEC, (ii) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus

or related information, (iii) of the Company’s reasonable determination that a post-effective amendment to a Registration Statement

would be appropriate; and (iv) of the receipt of any request by the SEC or any other federal or state governmental authority for any

additional information relating to the Registration Statement or any amendment or supplement thereto or any related prospectus. The Company

shall respond as promptly as practicable to any comments received from the SEC with respect to each Registration Statement or any amendment

thereto (it being understood and agreed that the Company’s response to any such comments shall be delivered to the SEC no later

than fifteen (15) Business Days after the receipt thereof).

(g)

The Company shall (i) use its best efforts to prevent the issuance of any stop order or other suspension of effectiveness of each Registration

Statement or the use of any prospectus contained therein, or the suspension of the qualification, or the loss of an exemption from qualification,

of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal

of such order or suspension at the earliest possible moment and (ii) notify each Investor who holds Registrable Securities of the issuance

of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.

(h) If

any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such

Investor consents to so being named an underwriter, at the request of any Investor, the Company shall furnish to such Investor, on the

date of the effectiveness of such Registration Statement and thereafter from time to time on such dates as an Investor may reasonably

request (i) a letter, dated such date, from the Company’s independent certified public accountants in form and substance as is

customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Investors,

and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form,

scope and substance as is customarily given in an underwritten public offering, addressed to the Investors.

(i) If

any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such

Investor consents to so being named an underwriter, upon the written request of such Investor, the Company shall make available for inspection

by (i) such Investor, (ii) legal counsel for such Investor and (iii) one (1) firm of accountants or other agents retained by such Investor

(collectively, the “Inspectors”), all pertinent financial and other records, and pertinent corporate documents and

properties of the Company (collectively, the “Records”), as shall be reasonably deemed necessary by each Inspector,

and cause the Company’s officers, directors and employees to supply all information which any Inspector may reasonably request;

provided, however, each Inspector shall agree in writing to hold in strict confidence and not to make any disclosure (except to such

Investor) or use of any Record or other information which the Company’s board of directors determines in good faith to be confidential,

and of which determination the Inspectors are so notified, unless (1) the disclosure of such Records is necessary to avoid or correct

a misstatement or omission in any Registration Statement or is otherwise required under the 1933 Act, (2) the release of such Records

is ordered pursuant to a final, non-appealable subpoena or order from a court or government body of competent jurisdiction, or (3) the

information in such Records has been made generally available to the public other than by disclosure in violation of this Agreement or

any other Transaction Document. Such Investor agrees that it shall, upon learning that disclosure of such Records is sought in or by

a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company and allow the Company,

at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, the Records deemed confidential.

Nothing herein (or in any other confidentiality agreement between the Company and such Investor, if any) shall be deemed to limit any

Investor’s ability to sell Registrable Securities in a manner which is otherwise consistent with applicable laws and regulations.

8

(j) The

Company shall hold in confidence and not make any disclosure of information concerning an Investor provided to the Company unless (i)

disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information

is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in

such Registration Statement pursuant to the 1933 Act, (iii) the release of such information is ordered pursuant to a subpoena or other

final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally

available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company agrees

that it shall, upon learning that disclosure of such information concerning an Investor is sought in or by a court or governmental body

of competent jurisdiction or through other means, give prompt written notice to such Investor and allow such Investor, at such Investor’s

expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.

(k) Without

limiting any obligation of the Company under the Securities Purchase Agreement, the Company shall use its best efforts either to (i)

cause all of the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which securities

of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted

under the rules of such exchange, (ii) secure designation and quotation of all of the Registrable Securities covered by each Registration

Statement on an Eligible Market, or (iii) if, despite the Company’s best efforts to satisfy the preceding clauses (i) or (ii) the

Company is unsuccessful in satisfying the preceding clauses (i) or (ii), without limiting the generality of the foregoing, to use its

best efforts to arrange for at least two market makers to register with the Financial Industry Regulatory Authority (“FINRA”)

as such with respect to such Registrable Securities. In addition, the Company shall cooperate with each Investor and any broker or dealer

through which any such Investor proposes to sell its Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule 5110

as requested by such Investor. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section

3(k).

(l) The

Company shall cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate the

timely preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to be offered

pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts (as the case may be) as the

Investors may reasonably request from time to time and registered in such names as the Investors may request.

(m) If

requested by an Investor, the Company shall as soon as practicable after receipt of notice from such Investor and subject to Section

3(r) hereof, (i) incorporate in a prospectus supplement or post-effective amendment such information as an Investor reasonably requests

to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with

respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of

the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement

or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment;

and (iii) supplement or make amendments to any Registration Statement or prospectus contained therein if reasonably requested by an Investor

holding any Registrable Securities.

(n) The

Company shall use its best efforts to cause the Registrable Securities covered by a Registration Statement to be registered with or approved

by such other United States governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable

Securities.

9

(o) The

Company shall make generally available to its security holders as soon as practical, but not later than ninety (90) days after the close

of the period covered thereby, an earnings statement (in form complying with, and in the manner provided by, the provisions of Rule 158

under the 1933 Act) covering a twelve-month period beginning not later than the first day of the Company’s fiscal quarter next

following the applicable Effective Date of each Registration Statement.

(p) The

Company shall otherwise use its best efforts to comply with all applicable rules and regulations of the SEC in connection with any registration

hereunder.

(q) Within

one (1) Business Day after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company

shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with

copies to the Investors whose Registrable Securities are included in such Registration Statement) confirmation that such Registration

Statement has been declared effective by the SEC in the form acceptable to the Transfer Agent.

(r) Notwithstanding

anything to the contrary herein (but subject to the last sentence of this Section 3(r)), at any time after the Effective Date of a particular

Registration Statement, the Company may delay the disclosure of material, non-public information concerning the Company or any of its

Subsidiaries the disclosure of which at the time is not, in the good faith opinion of the board of directors of the Company, in the best

interest of the Company and, in the opinion of counsel to the Company, otherwise required (a “Grace Period”), provided

that the Company shall promptly notify the Investors in writing of the (i) existence of material, non-public information giving rise

to a Grace Period (provided that in each such notice the Company shall not disclose the content of such material, non-public information

to any of the Investors) and the date on which such Grace Period will begin and (ii) date on which such Grace Period ends, provided further

that (I) no Grace Period shall exceed ten (10) consecutive days and during any three hundred sixty five (365) day period all such Grace

Periods shall not exceed an aggregate of thirty (30) days, (II) the first day of any Grace Period must be at least five (5) Trading Days

after the last day of any prior Grace Period and (III) no Grace Period may exist during the sixty (60) Trading Day period immediately

following the Effective Date of such Registration Statement (provided that such sixty (60) Trading Day period shall be extended by the

number of Trading Days during such period and any extension thereof contemplated by this proviso during which such Registration Statement

is not effective or the prospectus contained therein is not available for use) (each, an “Allowable Grace Period”).

For purposes of determining the length of a Grace Period above, such Grace Period shall begin on and include the date the Investors receive

the notice referred to in clause (i) above and shall end on and include the later of the date the Investors receive the notice referred

to in clause (ii) above and the date referred to in such notice. The provisions of Section 3(g) hereof shall not be applicable during

the period of any Allowable Grace Period. Upon expiration of each Grace Period, the Company shall again be bound by the first sentence

of Section 3(f) with respect to the information giving rise thereto unless such material, non-public information is no longer applicable.

Notwithstanding anything to the contrary contained in this Section 3(r), the Company shall cause its transfer agent to deliver unlegended

shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities Purchase Agreement in connection

with any sale of Registrable Securities with respect to which such Investor has entered into a contract for sale, and delivered a copy

of the prospectus included as part of the particular Registration Statement to the extent applicable, prior to such Investor’s

receipt of the notice of a Grace Period and for which the Investor has not yet settled.

(s) The

Company shall take all other reasonable actions necessary to expedite and facilitate disposition by each Investors of its Registrable

Securities pursuant to each Registration Statement.

(t) Neither

the Company nor any Subsidiary or affiliate thereof shall identify any Investor as an underwriter in any public disclosure or filing

with the SEC, the Principal Market or any Eligible Market and any Buyer being deemed an underwriter by the SEC shall not relieve the

Company of any obligations it has under this Agreement or any other Transaction Document; provided, however, that the foregoing shall

not prohibit the Company from including the disclosure found in the “Plan of Distribution” section attached hereto as Exhibit

A in the Registration Statement.

(u) Neither

the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after

the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights

granted to the Buyers in this Agreement or otherwise conflicts with the provisions hereof.

10

4.

Obligations of the Investors.

(a) At

least five (5) Business Days prior to the first anticipated filing date of each Registration Statement, the Company shall notify each

Investor in writing of the information the Company requires from each such Investor with respect to such Registration Statement. It shall

be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the

Registrable Securities of a particular Investor that such Investor shall furnish to the Company such information regarding itself, the

Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably

required to effect and maintain the effectiveness of the registration of such Registrable Securities and shall execute such documents

in connection with such registration as the Company may reasonably request.

(b) Each

Investor, by such Investor’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested

by the Company in connection with the preparation and filing of each Registration Statement hereunder, unless such Investor has notified

the Company in writing of such Investor’s election to exclude all of such Investor’s Registrable Securities from such Registration

Statement.

(c) Each

Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(g)

or the first sentence of Section 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to any

Registration Statement(s) covering such Registrable Securities until such Investor’s receipt of the copies of the supplemented

or amended prospectus contemplated by Section 3(g) or the first sentence of Section 3(f) or receipt of notice that no supplement or amendment

is required. Notwithstanding anything to the contrary in this Section 4(c) and subject to applicable law, the Company shall cause its

transfer agent to deliver unlegended shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities

Purchase Agreement in connection with any sale of Registrable Securities with respect to which such Investor has entered into a contract

for sale prior to the Investor’s receipt of a notice from the Company of the happening of any event of the kind described in Section

3(g) or the first sentence of Section 3(f) and for which such Investor has not yet settled.

5.

Expenses of Registration.

All

reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications

pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting

fees, FINRA filing fees (if any) and fees and disbursements of counsel for the Company shall be paid by the Company. In no event shall

the Company be responsible for any broker or similar commissions of any Investor or, except to the extent expressly provided for in the

Transaction Documents, any legal fees or other costs of the Investors.

11

6.

Indemnification.

(a)

To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor and each

of its directors, officers, stockholders, members, partners, employees, agents, advisors, representatives (and any other Persons with

a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person,

if any, who controls such Investor within the meaning of the 1933 Act or the 1934 Act and each of the directors, officers, stockholders,

members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person

holding such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each, an “Indemnified

Person”), against any losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges,

costs (including, without limitation, court costs, reasonable attorneys’ fees and costs of defense and investigation), amounts

paid in settlement or expenses, joint or several, (collectively, “Claims”) incurred in investigating, preparing or

defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental,

administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an Indemnified Person is or

may be a party thereto (“Indemnified Damages”), to which any of them may become subject insofar as such Claims (or

actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement

or alleged untrue statement of a material fact in a Registration Statement or any post-effective amendment thereto or in any filing made

in connection with the qualification of the offering under the securities or other “blue sky” laws of any jurisdiction in

which Registrable Securities are offered (“Blue Sky Filing”), or the omission or alleged omission to state a material

fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue

statement of a material fact contained in any preliminary prospectus if used prior to the effective date of such Registration Statement,

or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with

the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light

of the circumstances under which the statements therein were made, not misleading or (iii) any violation or alleged violation by the

Company of the 1933 Act, the 1934 Act, any other law, including, without limitation, any state securities law, or any rule or regulation

thereunder relating to the offer or sale of the Registrable Securities pursuant to a Registration Statement or (iv) any violation of

this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, “Violations”); provided,

however, that the Company shall not be liable in any such case to the extent that any such claim, loss, damage, liability, or expense

arises out of or is based upon such Indemnified Person’s gross negligence, willful misconduct or fraud or any untrue statement

or omission contained in such prospectus or other document based upon written information furnished to the Company by such Indemnified

Person expressly for use in connection with such Registration Statement. Subject to Section 6(c), the Company shall reimburse the Indemnified

Persons, promptly as such expenses are incurred and are due and payable, for reasonable legal fees or other reasonable expenses incurred

by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the

indemnification agreement contained in this Section 6(a): (i) shall not apply to a Claim by an Indemnified Person arising out of or based

upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by such Indemnified

Person for such Indemnified Person expressly for use in connection with the preparation of such Registration Statement or any such amendment

thereof or supplement thereto, if such prospectus was timely made available by the Company pursuant to Section 3(d); and (ii) shall not

apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which

consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless of any investigation

made by or on behalf of the Indemnified Person and shall survive the transfer of any of the Registrable Securities by any of the Investors

pursuant to Section 9.

(b)

In connection with any Registration Statement in which an Investor is participating, such Investor agrees to severally and not jointly

indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of

its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the

meaning of the 1933 Act or the 1934 Act (each, an “Indemnified Party”), against any Claim or Indemnified Damages to

which any of them may become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified Damages arise

out of or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs in reliance upon

and in conformity with written information furnished to the Company by such Investor expressly for use in connection with such Registration

Statement; and, subject to Section 6(c) and the below provisos in this Section 6(b), such Investor will reimburse an Indemnified Party

any legal or other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such Claim;

provided, however, the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in

Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent

of such Investor, which consent shall not be unreasonably withheld or delayed, provided further that such Investor shall be liable under

this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to such Investor as a result

of the applicable sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in full force and

effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of any of the Registrable

Securities by any of the Investors pursuant to Section 9.

12

(c)

Promptly after receipt by an Indemnified Person or Indemnified Party (as the case may be) under this Section 6 of notice of the commencement

of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Indemnified

Person or Indemnified Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under

this Section 6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have

the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly

noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person

or the Indemnified Party (as the case may be); provided, however, an Indemnified Person or Indemnified Party (as the case may be) shall

have the right to retain its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the

indemnifying party has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume

the defense of such Claim and to employ counsel reasonably satisfactory to such Indemnified Person or Indemnified Party (as the case

may be) in any such Claim; or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties) include

both such Indemnified Person or Indemnified Party (as the case may be) and the indemnifying party, and such Indemnified Person or such

Indemnified Party (as the case may be) shall have been advised by counsel that a conflict of interest is likely to exist if the same

counsel were to represent such Indemnified Person or such Indemnified Party and the indemnifying party (in which case, if such Indemnified

Person or such Indemnified Party (as the case may be) notifies the indemnifying party in writing that it elects to employ separate counsel

at the expense of the indemnifying party, then the indemnifying party shall not have the right to assume the defense thereof and such

counsel shall be at the expense of the indemnifying party, provided further that in the case of clause (iii) above the indemnifying party

shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for such Indemnified Person

or Indemnified Party (as the case may be). The Indemnified Party or Indemnified Person (as the case may be) shall reasonably cooperate

with the indemnifying party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall

furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person (as the case may

be) which relates to such action or Claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person (as the case

may be) reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying

party shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent; provided, however,

the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior

written consent of the Indemnified Party or Indemnified Person (as the case may be), consent to entry of any judgment or enter into any

settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such

Indemnified Party or Indemnified Person (as the case may be) of a release from all liability in respect to such Claim or litigation,

and such settlement shall not include any admission as to fault on the part of the Indemnified Party. Following indemnification as provided

for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person (as the case may

be) with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure

to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve

such indemnifying party of any liability to the Indemnified Person or Indemnified Party (as the case may be) under this Section 6, except

to the extent that the indemnifying party is materially and adversely prejudiced in its ability to defend such action.

(d)

The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation

or defense, as and when bills are received or Indemnified Damages are incurred.

(e)

The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified

Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject

to pursuant to the law.

7.

Contribution.

To

the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum

contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;

provided, however: (i) no contribution shall be made under circumstances where the maker would not have been liable for indemnification

under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable Securities which

Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) in connection with such sale shall

be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation;

and (iii) contribution by any seller of Registrable Securities shall be limited in amount to the amount of net proceeds received by such

seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement. Notwithstanding the provisions

of this Section 7, no Investor shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net

proceeds actually received by such Investor from the applicable sale of the Registrable Securities subject to the Claim exceeds the amount

of any damages that such Investor has otherwise been required to pay, or would otherwise be required to pay under Section 6(b), by reason

of such untrue or alleged untrue statement or omission or alleged omission.

13

8.

Reports Under the 1934 Act.

With

a view to making available to the Investors the benefits of Rule 144, the Company agrees to:

(a)

make and keep public information available, as those terms are understood and defined in Rule 144;

(b)

file with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act so long

as the Company remains subject to such requirements (it being understood and agreed that nothing herein shall limit any obligations of

the Company under the Securities Purchase Agreement) and the filing of such reports and other documents is required for the applicable

provisions of Rule 144; and

(c) furnish

to each Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company,

if true, that it has complied with the reporting, submission and posting requirements of Rule 144, the 1933 Act and the 1934 Act, (ii)

a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with

the SEC if such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably requested to permit

the Investors to sell such securities pursuant to Rule 144 without registration.

9.

Assignment of Registration Rights.

All

or any portion of the rights under this Agreement shall be automatically assignable by each Investor to any transferee or assignee (as

the case may be) of all or any portion of such Investor’s Registrable Securities, Preferred Shares or Warrants if: (i) such Investor

agrees in writing with such transferee or assignee (as the case may be) to assign all or any portion of such rights, and a copy of such

agreement is furnished to the Company within a reasonable time after such transfer or assignment (as the case may be); (ii) the Company

is, within a reasonable time after such transfer or assignment (as the case may be), furnished with written notice of (a) the name and

address of such transferee or assignee (as the case may be), and (b) the securities with respect to which such registration rights are

being transferred or assigned (as the case may be); (iii) immediately following such transfer or assignment (as the case may be) the

further disposition of such securities by such transferee or assignee (as the case may be) is restricted under the 1933 Act or applicable

state securities laws if so required; (iv) at or before the time the Company receives the written notice contemplated by clause (ii)

of this sentence such transferee or assignee (as the case may be) agrees in writing with the Company to be bound by all of the provisions

contained herein; (v) such transfer or assignment (as the case may be) shall have been made in accordance with the applicable requirements

of the Securities Purchase Agreement, the Certificate of Designations and the Warrants (as the case may be); and (vi) such transfer or

assignment (as the case may be) shall have been conducted in accordance with all applicable federal and state securities laws.

10.

Amendment of Registration Rights.

Provisions

of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively

or prospectively), only with the written consent of the Company and the Required Holders; provided that any such amendment or waiver

that complies with the foregoing, but that disproportionately, materially and adversely affects the rights and obligations of any Investor

relative to the comparable rights and obligations of the other Investors shall require the prior written consent of such adversely affected

Investor. Any amendment or waiver effected in accordance with this Section 10 shall be binding upon each Investor and the Company, provided

that no such amendment shall be effective to the extent that it (1) applies to less than all of the holders of Registrable Securities

or (2) imposes any obligation or liability on any Investor without such Investor’s prior written consent (which may be granted

or withheld in such Investor’s sole discretion). No waiver shall be effective unless it is in writing and signed by an authorized

representative of the waiving party. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification

of any provision of this Agreement unless the same consideration (other than the reimbursement of legal fees) also is offered to all

of the parties to this Agreement.

14

11.

Miscellaneous.

(a)

Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns, or is deemed

to own, of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more

Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received

from such record owner of such Registrable Securities.

(b)

Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in

writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic

mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party

does not receive an automatically generated message from the recipient’s email server that such e-mail could not be delivered to

such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each

case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:

If

to the Company:

StableX

Technologies, Inc.

1185

Avenue of the Americas, 3rd Floor

New

York, New York 10036

Telephone:

(973) 242-0005

Attention: Chief Executive Officer

E-Mail: jsilverman@parkfieldfund.com

With

a copy (for informational purposes only) to:

Haynes

and Boone, LLP

30

Rockefeller Plaza, 26th Floor

New

York, New York 10112

Telephone:

(212) 659-7300

Attention:

Rick Werner

E-mail:

rick.werner@haynesboone.com

If

to the Transfer Agent:

Equiniti

Trust Company LLC

1110

Centre Point Curve, Suite 101

Mendota

Heights MN 55120

Telephone:

919-744-2722

Attention:

Direct Transfer Compliance

E-Mail:

transfer-ID@equiniti.com

If

to Legal Counsel:

Mintz,

Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

919

Third Avenue

New

York, New York 10022

Telephone:

(212) 935-3000

Attention:

Jeffrey P. Schultz

E-Mail:

jpschultz@mintz.com

If to a Buyer, to its mailing address and/or email address set forth on the Schedule of Buyers attached to the Securities

Purchase Agreement, with copies to such Buyer’s representatives as set forth on the Schedule of Buyers, or to such other mailing

address and/or email address and/or to the attention of such other Person as the recipient party has specified by written notice given

to each other party five (5) days prior to the effectiveness of such change, provided that Legal Counsel shall only be provided notices

sent to the lead investor. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication,

(B) mechanically or electronically generated by the sender’s e-mail containing the time, date and recipient’s e-mail or (C)

provided by a courier or overnight courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt from

a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.

15

(c)

Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right

or remedy, shall not operate as a waiver thereof. The Company and each Investor acknowledge and agree that irreparable damage would occur

in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise

breached. It is accordingly agreed that each party hereto shall be entitled to an injunction or injunctions to prevent or cure breaches

of the provisions of this Agreement by any other party hereto and to enforce specifically the terms and provisions hereof (without the

necessity of showing economic loss and without any bond or other security being required), this being in addition to any other remedy

to which any party may be entitled by law or equity.

(d)

All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal

laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State

of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New

York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New

York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated

hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that

it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient

forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process

and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for

such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice

thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH

PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE

HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

(e)

If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent

jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest

extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity

of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change,

the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the

provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical

realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations

to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible

to that of the prohibited, invalid or unenforceable provision(s).

16

(f)

This Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced

herein and therein constitute the entire agreement among the parties hereto and thereto solely with respect to the subject matter hereof

and thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.

This Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced

herein and therein supersede all prior agreements and understandings among the parties hereto solely with respect to the subject matter

hereof and thereof; provided, however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed

to) (i) have any effect on any agreements any Investor has entered into with the Company or any of its Subsidiaries prior to the date

hereof with respect to any prior investment made by such Investor in the Company, (ii) waive, alter, modify or amend in any respect any

obligations of the Company or any of its Subsidiaries or any rights of or benefits to any Investor or any other Person in any agreement

entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Investor and all such agreements

shall continue in full force and effect or (iii) limit any obligations of the Company under any of the other Transaction Documents.

(g)

Subject to compliance with Section 9 (if applicable), this Agreement shall inure to the benefit of and be binding upon the permitted

successors and assigns of each of the parties hereto. This Agreement is not for the benefit of, nor may any provision hereof be enforced

by, any Person, other than the parties hereto, their respective permitted successors and assigns and the Persons referred to in Sections

6 and 7 hereof.

(h)

The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless

the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and

plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall

be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”

“hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.

(i)

This Agreement may be executed in two or more identical counterparts, each of which shall be deemed an original, but all of which shall

be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to

the other party. In the event that any signature is delivered by facsimile or electronic transmission (including DocuSign and similar)

or by an email which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create

a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect

as if such signature page were an original thereof.

(j)

Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all

such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent

and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

(k)

The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules

of strict construction will be applied against any party. Notwithstanding anything to the contrary set forth in Section 10, terms used

in this Agreement but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing Date in

such other Transaction Documents unless otherwise consented to in writing by each Investor.

(l)

All consents and other determinations required to be made by the Investors pursuant to this Agreement shall be made, unless otherwise

specified in this Agreement, by the Required Holders, determined as if all of the outstanding Preferred Shares then held by the Investors

have been converted for Registrable Securities without regard to any limitations on conversion of the Preferred Shares and the outstanding

Warrants then held by Investors have been exercised for Registrable Securities without regard to any limitations on exercise of the Warrants.

(m)

This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for

the benefit of, nor may any provision hereof be enforced by, any other Person.

(n)

The obligations of each Investor under this Agreement and the other Transaction Documents are several and not joint with the obligations

of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under

this Agreement or any other Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken

by any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as, and the Company acknowledges that the Investors

do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that

the Investors are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated

by the Transaction Documents or any matters, and the Company acknowledges that the Investors are not acting in concert or as a group,

and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement

or any of the other the Transaction Documents. Each Investor shall be entitled to independently protect and enforce its rights, including,

without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary

for any other Investor to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect

to the obligations of the Company contained herein was solely in the control of the Company, not the action or decision of any Investor,

and was done solely for the convenience of the Company and not because it was required or requested to do so by any Investor. It is expressly

understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and

an Investor, solely, and not between the Company and the Investors collectively and not between and among Investors.

[signature

page follows]

17

IN

WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Registration Rights Agreement to

be duly executed as of the date first written above.

STABLEX

TECHNOLOGIES, INC.

By:

Name: Joshua

Silverman

Title: Chief

Executive Officer

18

IN

WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Registration Rights Agreement to

be duly executed as of the date first written above.

BUYER:

[●]

By:

Name: [●]

Title: [●]

19

EXHIBIT

A

SELLING

STOCKHOLDERS

The

shares of common stock being offered by the selling stockholders are those issuable to the selling stockholders upon conversion of the

preferred shares and exercise of the warrants. For additional information regarding the issuance of the preferred shares and the warrants,

see “Private Placement of Preferred Shares and Warrants” above. We are registering the shares of common stock in order to

permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of the preferred shares and

the warrants issued pursuant to the Securities Purchase Agreement, the selling stockholders have not had any material relationship with

us within the past three years.

The

table below lists the selling stockholders and other information regarding the beneficial ownership (as determined under Section 13(d)

of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder) of the shares of common stock held by each

of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by the selling stockholders,

based on their respective ownership of shares of common stock, preferred shares and warrants, as of ________, [●], assuming conversion

of the preferred shares and exercise of the warrants held by each such selling stockholder on that date but taking account of any limitations

on conversion and exercise set forth therein.

The

third column lists the shares of common stock being offered by this prospectus by the selling stockholders and does not take in account

any limitations on (i) conversion of the preferred shares set forth therein or (ii) exercise of the warrants set forth therein.

In

accordance with the terms of a registration rights agreement with the holders of the preferred shares and the warrants, this prospectus

generally covers the resale of the sum of (i) the maximum number of shares of common stock issued or issuable pursuant to the preferred

shares and (ii) the maximum number of shares of common stock issued or issuable upon exercise of the warrants, in each case, determined

as if the outstanding preferred shares and warrants were converted or exercised (as the case may be) in full (without regard to any limitations

on conversion or exercise contained therein solely for the purpose of such calculation) at the floor price or exercise price (as the

case may be) calculated as of the trading day immediately preceding the date this registration statement was initially filed with the

SEC. Because the conversion price of the preferred shares and the exercise price of the warrants may be adjusted, the number of shares

that will actually be issued may be more or less than the number of shares being offered by this prospectus. The fourth column assumes

the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.

Under

the terms of the Certificate of Designations and the warrants, a selling stockholder may not convert the preferred shares or exercise

the warrants to the extent (but only to the extent) such selling stockholder or any of its affiliates would beneficially own a number

of shares of our shares of common stock which would exceed [4.99][9.99]% of the outstanding shares of the Company. The number of shares

in the second column reflects these limitations. The selling stockholders may sell all, some or none of their shares in this offering.

See “Plan of Distribution.”

20

Name

of Selling Stockholder

Number

of shares of

Common Stock Owned

Prior to Offering

Maximum

Number of shares of

Common Stock to be Sold Pursuant to

this Prospectus

Number

of shares of

Common Stock of Owned

After Offering

[LEAD INVESTOR] (1)

[OTHER

BUYERS]

(1) [  ]

21

EXHIBIT

B

PLAN

OF DISTRIBUTION

We

are registering the shares of common stock issuable upon conversion of the preferred shares and exercise of the warrants to permit the

resale of these shares of common stock by the holders of the preferred shares and warrants from time to time after the date of this prospectus.

We will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock, although we will receive

the exercise price of any warrants not exercised by the selling stockholders on a cashless exercise basis. We will bear all fees and

expenses incident to our obligation to register the shares of common stock.

The

selling stockholders may sell all or a portion of the shares of common stock held by them and offered hereby from time to time directly

or through one or more underwriters, broker-dealers or agents. If the shares of common stock are sold through underwriters or broker-dealers,

the selling stockholders will be responsible for underwriting discounts or commissions or agent’s commissions. The shares of common

stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices

determined at the time of sale or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block

transactions, pursuant to one or more of the following methods:

on

any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;

in

the over-the-counter market;

in

transactions otherwise than on these exchanges or systems or in the over-the-counter market;

through

the writing or settlement of options, whether such options are listed on an options exchange or otherwise;

ordinary

brokerage transactions and transactions in which the broker-dealer solicits purchasers;

block

trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as

principal to facilitate the transaction;

purchases

by a broker-dealer as principal and resale by the broker-dealer for its account;

an

exchange distribution in accordance with the rules of the applicable exchange;

privately

negotiated transactions;

short

sales made after the date the Registration Statement is declared effective by the SEC;

broker-dealers

may agree with a selling security holder to sell a specified number of such shares at a stipulated price per share;

a

combination of any such methods of sale; and

any

other method permitted pursuant to applicable law.

The

selling stockholders may also sell shares of common stock under Rule 144 promulgated under the Securities Act of 1933, as amended, if

available, rather than under this prospectus. In addition, the selling stockholders may transfer the shares of common stock by other

means not described in this prospectus. If the selling stockholders effect such transactions by selling shares of common stock to or

through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts,

concessions or commissions from the selling stockholders or commissions from purchasers of the shares of common stock for whom they may

act as agent or to whom they may sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers

or agents may be in excess of those customary in the types of transactions involved). In connection with sales of the shares of common

stock or otherwise, the selling stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short

sales of the shares of common stock in the course of hedging in positions they assume. The selling stockholders may also sell shares

of common stock short and deliver shares of common stock covered by this prospectus to close out short positions and to return borrowed

shares in connection with such short sales. The selling stockholders may also loan or pledge shares of common stock to broker-dealers

that in turn may sell such shares.

22

The

selling stockholders may pledge or grant a security interest in some or all of the preferred shares, warrants or shares of common stock

owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell

the shares of common stock from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or

other applicable provision of the Securities Act amending, if necessary, the list of selling stockholders to include the pledgee, transferee

or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer and donate

the shares of common stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will

be the selling beneficial owners for purposes of this prospectus.

To

the extent required by the Securities Act and the rules and regulations thereunder, the selling stockholders and any broker-dealer participating

in the distribution of the shares of common stock may be deemed to be “underwriters” within the meaning of the Securities

Act, and any commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions

or discounts under the Securities Act. At the time a particular offering of the shares of common stock is made, a prospectus supplement,

if required, will be distributed, which will set forth the aggregate amount of shares of common stock being offered and the terms of

the offering, including the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting compensation

from the selling stockholders and any discounts, commissions or concessions allowed or re-allowed or paid to broker-dealers.

Under

the securities laws of some states, the shares of common stock may be sold in such states only through registered or licensed brokers

or dealers. In addition, in some states the shares of common stock may not be sold unless such shares have been registered or qualified

for sale in such state or an exemption from registration or qualification is available and is complied with.

There

can be no assurance that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the registration

statement, of which this prospectus forms a part.

The

selling stockholders and any other person participating in such distribution will be subject to applicable provisions of the Securities

Exchange Act of 1934, as amended, and the rules and regulations thereunder, including, without limitation, to the extent applicable,

Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the shares of common stock by the selling

stockholders and any other participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged

in the distribution of the shares of common stock to engage in market-making activities with respect to the common stock. All of the

foregoing may affect the marketability of the common stock and the ability of any person or entity to engage in market-making activities

with respect to the common stock.

We

will pay all expenses of the registration of the shares of common stock pursuant to the registration rights agreement, estimated to be

$[●] in total, including, without limitation, Securities and Exchange Commission filing fees and expenses of compliance with state

securities or “blue sky” laws; provided, however, a selling stockholder will pay all underwriting discounts and selling commissions,

if any. We will indemnify the selling stockholders against liabilities, including some liabilities under the Securities Act in accordance

with the registration rights agreements or the selling stockholders will be entitled to contribution. We may be indemnified by the selling

stockholders against civil liabilities, including liabilities under the Securities Act that may arise from any written information furnished

to us by the selling stockholder specifically for use in this prospectus, in accordance with the related registration rights agreements

or we may be entitled to contribution.

Once

sold under the registration statement, of which this prospectus forms a part, the shares of common stock will be freely tradable in the

hands of persons other than our affiliates.

23

EX-10.5

EX-10.5

Filename: ex10-5.htm · Sequence: 15

Exhibit

10.5

OMNIBUS

Waiver, Consent, notice and AMENDMENT AGREEMENT

This

Omnibus Waiver, Consent, Notice and Amendment Agreement (this “Agreement”), dated as of April 27, 2026 is by and among

StableX Technologies, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page

attached hereto (the “Investor”).

WITNESSETH

Whereas,

the Company and the Investor are party to that certain Securities Purchase Agreement, dated as of August 7, 2023 (the “Purchase

Agreement”), pursuant to which the Company issued to the Investor shares of the Company’s H-7 Convertible Preferred Stock,

par value $0.0001 per share (the “Preferred Stock”), the terms of which are set forth in the Certificate of Designations

for the Series H-7 Convertible Preferred Stock (as amended, the “Certificate of Designations”), and warrants (the

“Warrants,” and, together with the Purchase Agreement and the Certificate of Designations, the “Transaction

Documents”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”);

WHEREAS,

the Company desires to enter into a securities purchase agreement, by and among the Company and certain investors party thereto (the

“Series K Purchase Agreement”), pursuant to which the Company will sell to such investors in a private placement,

(i) newly-designated shares of the Company’s Series K Convertible Preferred Stock, par value $0.0001 per share (the “Series

K Preferred Stock”), the terms of which are set forth in the Certificate of Designations for the Series K Preferred Stock attached

as Exhibit B hereto, and (ii) warrants (the “Series K Warrants”) to purchase shares of the Company’s

Common Stock (the “Private Placement”);

WHEREAS,

the Company intends to enter into a Joint Development and License Agreement, dated on or about the date hereof (the “JD&L

Agreement”), by and between Kopin Corporation, a Delaware corporation (“Kopin”), and the Company, pursuant

to which the parties will collaborate on the development and commercialization of certain proprietary technology, in connection therewith,

the Company will issue shares of its Series J Convertible Preferred Stock, par value $0.0001 per share (“Series J Preferred

Stock” and, together with the Series K Preferred Stock, the “Concurrent Preferred Stock”) to Kopin as additional

consideration for Kopin’s contributions to the development of the Project Technology (as defined in the JD&L Agreement)(collectively,

the “Collaboration”);

WHEREAS,

the Investor, together with certain other investors entering into similar Omnibus Waiver, Consent, Notice and Amendment Agreements of

even date hereof, constitute the Required Holders pursuant to each of the Transaction Documents; and

WHEREAS,

the Company and the Investor desire to waive the applicability of certain provisions of the Transaction Documents, consent to certain

actions of the Company in connection with the Private Placement, and to amend certain other provisions of the Transaction Documents.

1

Now,

therefore, in consideration of the premises and mutual

covenants and obligations hereinafter set forth, the parties hereto, intending legally to be bound, hereby agree as follows:

1. Definitions.

Capitalized terms used herein but not otherwise defined herein shall have the respective

meanings given such terms in the Purchase Agreement.

2. Amended

and Restated Certificate of Designations. The parties hereto hereby agree to amend and

restate the rights of the Preferred Stock as set forth in the Amended and Restated Certificate

of Designations attached as Exhibit A hereto (the “Amendment”).

Upon the effectiveness of this Agreement, the Company shall promptly file the Amendment and

provide a copy thereof to each Investor promptly after such filing.

3. Waivers.

(a) Waiver

of Variable Rate Transaction. Solely for the purposes of enabling the consummation of

the Private Placement and the Collaboration, the Investor hereby waives any right the Investor

is entitled to pursuant to Section 4(n) of the Purchase Agreement, relating to the Company’s

prohibition of effecting or entering into an agreement to effect any Subsequent Placement

involving a Variable Rate Transaction.

(b) Waiver

of Fundamental Transaction. The Investor hereby agrees that the issuance and sale by

the Company of the (i) newly designated shares of the Company’s Series K Preferred

Stock, and (ii) the Series K Warrants, pursuant to the Series K Purchase Agreement, shall

not constitute a Fundamental Transaction (as defined in the Certificate of Designations and

Warrants).

(c) Waiver

Related to Dividend Payments and Installment Payments. The Investor hereby waives any

default, breach or violation of the Certificate of Designations and any associated penalties

accrued and outstanding as of the date hereof, in each case, resulting from the Company’s

prior failure to timely make any payments of Dividends and/or any Installment Amount (as

each term is defined in the Certificate of Designations), whether by means of conversion

or redemption as set forth in the Certificate of Designations, on any applicable Dividend

Date and/or Installment Date, as applicable, and the Investor further agrees that such failure

to pay shall not otherwise trigger any right or remedy of the Investor.

(d) Waiver

of Change in Nature of Business. The Investor hereby waives, any breach or default arising,

or which may arise, under the covenant set forth in Section 15(g) of the Certificate of Designations,

regarding the Company’s obligation not to engage, directly or indirectly, in any material

line of business substantially different from those lines of business conducted by or publicly

contemplated to be conducted by the Company on the date of the Purchase Agreement, solely

to the extent necessary to permit the Company to engage in the development, commercialization,

and sale of microLED-based optical interconnect technology and related fabless semiconductor

technologies.

2

(e) Waiver

of Participation Rights. The Investor hereby waives any rights of first refusal or participation

rights with respect to the Private Placement and Collaboration, including, but not limited

to, the Investor’s participation rights under Section 4(o) of the Purchase Agreement

and the Investor’s Purchase Rights (as defined in the Certificate of Designations)

under Section 7 of the Certificate of Designations, and waives any applicable notices related

thereto.

4. Issuance

of Warrants. In consideration of the foregoing, the Company agrees to issue to the Investor warrants to purchase up to [ ] shares

of Common Stock, substantially in the form attached hereto as Exhibit C (the “Consideration Warrants”)1.

5. Representation

and Warranties of the Investor. In connection with the issuance of the Consideration

Warrants, the Investor hereby represents and warrants as of the date hereof to the Company

as follows:

(a)

The Investor is an “accredited investor” as defined in Rule 501(a) under Regulation D promulgated under the Securities Act

of 1933, as amended (the “Securities Act”).

(b)

The Investor is acquiring the Consideration Warrants (and the shares of Common Stock issuable upon exercise thereof (the “Warrant

Shares”)) for its own account, for investment purposes only, and not with a view toward, or for sale in connection with, any distribution

thereof, nor with any present intention of distributing or selling the same, and the Investor has no present or contemplated agreement,

undertaking, arrangement, obligation, indebtedness or commitment providing for the disposition thereof.

(c)

The Investor acknowledges that the Consideration Warrants (and the Warrant Shares) have not been registered under the Securities Act

or the securities laws of any state or other jurisdiction, and that the Consideration Warrants (and such Warrant Shares) may not be sold,

transferred, offered for sale, pledged, hypothecated or otherwise disposed of unless such sale, transfer, offer, pledge, hypothecation

or other disposition is pursuant to the terms of an effective registration statement under the Securities Act, or pursuant to an exemption

from registration under the Securities Act and applicable state securities laws.

(d)

The Investor has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the

merits and risks of the prospective investment in the Consideration Warrants (and the Warrant Shares), and has so evaluated the merits

and risks of such investment. The Investor is able to bear the economic risk of an investment in the Consideration Warrants (and Warrant

Shares) and, at the present time, is able to afford a complete loss of such investment.

(e)

The Investor has been furnished with or has had full access to all the information that it considers necessary or appropriate to make

an informed investment decision with respect to the Consideration Warrants (and the Warrant Shares). The Investor has had an opportunity

to ask questions of, and receive answers from, the Company regarding the terms and conditions of the offering of the Consideration Warrants

and the business, properties, prospects and financial condition of the Company.

1

NTD: The Company shall issue an aggregate number of warrants to purchase up to 1,000,000 shares of Common Stock to the Series H-7 Preferred

Stock holders and Series I Preferred Stock holders. Each investor is entitled to their pro rata portion of such warrants based on their

respective outstanding shares of preferred stock as of the date of this Agreement.

3

6. Consent.

Each Investor hereby consents, pursuant to Section 2 and Section 18 of the Certificate of

Designations relating to the Company’s creation, authorization (by reclassification

or otherwise), issuance, purchase, repurchase, redemption or repayment of any class or series

of Junior Stock (as defined in the Certificate of Designations), to the creation, authorization,

issuance, purchase, repurchase, redemption and/or repayment by the Company of the Concurrent

Preferred Stock. In addition, for the avoidance of doubt and notwithstanding anything to

the contrary contained in Section 15 of the Certificate of Designations, each Investor hereby

provides consent to the issuance of the Concurrent Preferred Stock and such issuance shall

not be deemed a violation of any covenant or limitation contained therein.

7. Notice.

The Investor hereby acknowledges that this Agreement constitutes notice, as required by Section

8(c) of the Certificate of Designations, to the Investor, to the extent the Concurrent Preferred

Stock constitutes Variable Price Securities (as defined in the Certificate of Designations),

of the Company’s intention to issue such Concurrent Preferred Stock pursuant to the

Private Placement or JD&L Agreement, as applicable.

8. Counterparts;

Facsimile Execution. This Agreement may be executed in one or more counterparts (including

by electronic mail, in PDF or by DocuSign or similar electronic signature), all of which

shall be considered one and the same agreement and shall become effective when one or more

counterparts have been signed by each of the parties and delivered to the other parties.

Counterparts may be delivered via facsimile, electronic mail (including any electronic signature

covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic

Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission

method and any counterpart so delivered shall be deemed to have been duly and validly delivered

and be valid and effective for all purposes.

9. Governing

Law. THIS AGREEMENT SHALL BE SUBJECT TO THE PROVISIONS

REGARDING GOVERNING LAW SET FORTH IN SECTION 9(a) OF THE Purchase AGREEMENT, AND SUCH PROVISIONS

ARE INCORPORATED HEREIN BY THIS REFERENCE, MUTATIS MUTANDIS.

10. Terms

and Conditions of the Transaction Documents. Except as modified and amended herein, all

of the terms and conditions of the Transaction Documents shall remain in full force and effect.

[Signature

pages follow immediately.]

4

IN

WITNESS WHEREOF, the undersigned has executed and delivered this Agreement as of the date first above written.

Company:

StableX

Technologies, Inc.

By:

Name: Joshua

Silverman

Title: Chief

Executive Officer

5

In

witness whereof, the undersigned has executed and delivered

this Agreement as of the date first above written.

Name

of Investor:

By:

Name

of signatory:

Title:

[Investor

Signature Page to Waiver and Amendment Agreement]

6

EXHIBIT

A

Form

of the Amended and Restated Certificate of Designations

of

Series H-7 Convertible Preferred Stock

7

EXHIBIT

B

Certificate

of Designations of Series K Convertible Preferred Stock

8

EXHIBIT

C

Form

of Warrant

9

EX-10.6

EX-10.6

Filename: ex10-6.htm · Sequence: 16

Exhibit 10.6

OMNIBUS

Waiver, Consent, notice and AMENDMENT AGREEMENT

This

Omnibus Waiver, Consent, Notice and Amendment Agreement (this “Agreement”), dated as of April 27, 2026 is by and among

StableX Technologies, Inc., a Delaware corporation (the “Company”), and the investor listed on the signature page

attached hereto (the “Investor”).

WITNESSETH

Whereas,

the Company and the Investor are party to that certain Securities Purchase Agreement, dated as of August 4, 2025 (the “Purchase

Agreement”), pursuant to which the Company issued to the Investor shares of the Company’s I Convertible Preferred Stock,

par value $0.0001 per share (the “Preferred Stock”), the terms of which are set forth in the Certificate of Designations

for the Series I Convertible Preferred Stock (the “Certificate of Designations”), and warrants (the “Warrants,”

and, together with the Purchase Agreement and the Certificate of Designations, the “Transaction Documents”) to purchase

shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”);

WHEREAS,

the Company desires to enter into a securities purchase agreement, by and among the Company and certain investors party thereto (the

“Series K Purchase Agreement”), pursuant to which the Company will sell to such investors in a private placement,

(i) newly-designated shares of the Company’s Series K Convertible Preferred Stock, par value $0.0001 per share (the “Series

K Preferred Stock”), the terms of which are set forth in the Certificate of Designations for the Series K Preferred Stock attached

as Exhibit B hereto, and (ii) warrants (the “Series K Warrants”) to purchase shares of the Company’s

Common Stock (the “Private Placement”);

WHEREAS,

the Company intends to enter into a Joint Development and License Agreement, dated on or about the date hereof (the “JD&L

Agreement”), by and between Kopin Corporation, a Delaware corporation (“Kopin”), and the Company, pursuant

to which the parties will collaborate on the development and commercialization of certain proprietary technology, in connection therewith,

the Company will issue shares of its Series J Convertible Preferred Stock, par value $0.0001 per share (“Series J Preferred

Stock” and, together with the Series K Preferred Stock, the “Concurrent Preferred Stock”) to Kopin as additional

consideration for Kopin’s contributions to the development of the Project Technology (as defined in the JD&L Agreement) (collectively,

the “Collaboration”);

WHEREAS,

the Investor, together with certain other investors entering into similar Omnibus Waiver, Consent, Notice and Amendment Agreements of

even date hereof, constitute the Required Holders pursuant to each of the Transaction Documents; and

WHEREAS,

the Company and the Investor desire to waive the applicability of certain provisions of the Transaction Documents, consent to certain

actions of the Company in connection with the Private Placement, and to amend certain other provisions of the Transaction Documents.

1

Now,

therefore, in consideration of the premises and mutual

covenants and obligations hereinafter set forth, the parties hereto, intending legally to be bound, hereby agree as follows:

1. Definitions.

Capitalized terms used herein but not otherwise defined herein shall have the respective

meanings given such terms in the Purchase Agreement.

2. Amended

and Restated Certificate of Designations. The parties hereto hereby agree to amend and

restate the rights of the Preferred Stock as set forth in the Amended and Restated Certificate

of Designations attached as Exhibit A hereto (the “Amendment”).

Upon the effectiveness of this Agreement, the Company shall promptly file the Amendment and

provide a copy thereof to the Investor promptly after such filing.

3. Waivers.

(a) Waiver

of Variable Rate Transaction. Solely for the purposes of enabling the consummation of

the Private Placement and the Collaboration, the Investor hereby waives any right the Investor

is entitled to pursuant to Section 4(n) of the Purchase Agreement, relating to the Company’s

prohibition of effecting or entering into an agreement to effect any Subsequent Placement

involving a Variable Rate Transaction.

(b) Waiver

of Fundamental Transaction. The Investor hereby agrees that the issuance and sale by

the Company of the (i) newly designated shares of the Company’s Series K Preferred

Stock, and (ii) the Series K Warrants, pursuant to the Series K Purchase Agreement, shall

not constitute a Fundamental Transaction (as defined in the Certificate of Designations and

Warrants).

(c) Waiver

of Participation Rights. The Investor hereby waives any rights of first refusal or participation

rights with respect to the Private Placement and Collaboration, including, but not limited

to, the Investor’s participation rights under Section 4(o) of the Purchase Agreement

and the Investor’s Purchase Rights (as defined in the Certificate of Designations)

under Section 7 of the Certificate of Designations, and waives any applicable notices related

thereto.

(d) Waiver

of Change in Nature of Business. The Investor hereby waives, any breach or default arising,

or which may arise, under the covenant set forth in Section 15(g) of the Certificate of Designations,

regarding the Company’s obligation not to engage, directly or indirectly, in any material

line of business substantially different from those lines of business conducted by or publicly

contemplated to be conducted by the Company on the date of the Purchase Agreement, solely

to the extent necessary to permit the Company to engage in the development, commercialization,

and sale of microLED-based optical interconnect technology and related fabless semiconductor

technologies.

(e) Waiver

Related to Dividend Payments and Installment Payments. The Investor hereby waives any

default, breach or violation of the Certificate of Designations and any associated penalties

accrued and outstanding as of the date hereof, in each case, resulting from the Company’s

prior failure to timely make any payments of Dividends and/or any Installment Amount (as

each term is defined in the Certificate of Designations), whether by means of conversion

or redemption as set forth in the Certificate of Designations, on any applicable Dividend

Date and/or Installment Date, as applicable, and the Investor further agrees that such failure

to pay shall not otherwise trigger any right or remedy of the Investor.

2

4. Issuance

of Warrant. In consideration of the foregoing, the Company agrees to issue to the Investor

warrants to purchase up to [ ] shares of Common Stock, substantially in the form attached

hereto as Exhibit C (the “Consideration Warrants”).1

5. Representation

and Warranties of the Investors. In connection with the issuance of the Consideration

Warrants, the Investor hereby represents and warrants as of the date hereof to the Company

as follows:

(a) The

Investor is an “accredited investor” as defined in Rule 501(a) under Regulation D promulgated under the Securities Act of

1933, as amended (the “Securities Act”).

(b) The

Investor is acquiring the Consideration Warrants (and the shares of Common Stock issuable upon exercise thereof (the “Warrant Shares”))

for its own account, for investment purposes only, and not with a view toward, or for sale in connection with, any distribution thereof,

nor with any present intention of distributing or selling the same, and the Investor has no present or contemplated agreement, undertaking,

arrangement, obligation, indebtedness or commitment providing for the disposition thereof.

(c) The Investor acknowledges that the Consideration Warrants (and the Warrant Shares) have not been registered under the Securities Act

or the securities laws of any state or other jurisdiction, and that the Consideration Warrants (and such Warrant Shares) may not be

sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of unless such sale, transfer, offer, pledge,

hypothecation or other disposition is pursuant to the terms of an effective registration statement under the Securities Act, or

pursuant to an exemption from registration under the Securities Act and applicable state securities laws.

(d)

The Investor has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating

the merits and risks of the prospective investment in the Consideration Warrants (and the Warrant Shares), and has so evaluated the

merits and risks of such investment. The Investor is able to bear the economic risk of an investment in the Consideration Warrants

(and Warrant Shares) and, at the present time, is able to afford a complete loss of such investment.

(e) The

Investor has been furnished with or has had full access to all the information that it considers necessary or appropriate to make an

informed investment decision with respect to the Consideration Warrants (and the Warrant Shares). The Investor has had an opportunity

to ask questions of, and receive answers from, the Company regarding the terms and conditions of the offering of the Consideration Warrants

and the business, properties, prospects and financial condition of the Company.

1

NTD: The Company shall issue an aggregate number of warrants to purchase up to 1,000,000 shares of Common Stock to the Series H-7 Preferred

Stock holders and Series I Preferred Stock holders. Each investor is entitled to their pro rata portion of such warrants based on their

respective outstanding shares of preferred stock as of the date of this Agreement.

3

6. Consent.

Each Investor hereby consents, pursuant to Section 2 and Section 18 of the Certificate of

Designations relating to the Company’s creation, authorization (by reclassification

or otherwise), issuance, purchase, repurchase, redemption or repayment of any class or series

of Junior Stock (as defined in the Certificate of Designations), to the creation, authorization,

issuance, purchase, repurchase, redemption and/or repayment by the Company of the Concurrent

Preferred Stock. In addition, for the avoidance of doubt and notwithstanding anything to

the contrary contained in Section 15 of the Certificate of Designations, each Investor hereby

provides consent to the issuance of the Concurrent Preferred Stock and such issuance shall

not be deemed a violation of any covenant or limitation contained therein.

7. Notice.

The Investor hereby acknowledges that this Agreement constitutes notice, as required by Section

8(c) of the Certificate of Designations, to the Investor, to the extent the Concurrent Preferred

Stock constitutes Variable Price Securities (as defined in the Certificate of Designations),

of the Company’s intention to issue such Concurrent Preferred Stock pursuant to the

Private Placement or JD&L Agreement, as applicable.

8. Counterparts;

Facsimile Execution. This Agreement may be executed in one or more counterparts (including

by electronic mail, in PDF or by DocuSign or similar electronic signature), all of which

shall be considered one and the same agreement and shall become effective when one or more

counterparts have been signed by each of the parties and delivered to the other parties.

Counterparts may be delivered via facsimile, electronic mail (including any electronic signature

covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic

Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission

method and any counterpart so delivered shall be deemed to have been duly and validly delivered

and be valid and effective for all purposes.

9. Governing

Law. THIS AGREEMENT SHALL BE SUBJECT TO THE PROVISIONS

REGARDING GOVERNING LAW SET FORTH IN SECTION 9(a) OF THE Purchase AGREEMENT, AND SUCH PROVISIONS

ARE INCORPORATED HEREIN BY THIS REFERENCE, MUTATIS MUTANDIS.

10. Terms

and Conditions of the Transaction Documents. Except as modified and amended herein, all

of the terms and conditions of the Transaction Documents shall remain in full force and effect.

[Signature

pages follow immediately.]

4

IN

WITNESS WHEREOF, the undersigned has executed and delivered this Agreement as of the date first above written.

Company:

StableX Technologies, Inc.

By:

Name:

Joshua Silverman

Title:

Chief Executive Officer

5

In

witness whereof, the undersigned has executed and delivered

this Agreement as of the date first above written.

Name of

Investor:

By:

Name of signatory:

Title:

[Investor

Signature Page to Waiver and Amendment Agreement]

6

EXHIBIT

A

Form

of the Amended and Restated Certificate of Designations of Series I Convertible Preferred Stock

7

EXHIBIT

B

Certificate

of Designations of Series K Convertible Preferred Stock

8

EXHIBT

C

Form

of Warrant

9

EX-10.7

EX-10.7

Filename: ex10-7.htm · Sequence: 17

Exhibit 10.7

AMENDED

AND RESTATED CONSULTING SERVICES AGREEMENT

This

Amended and Restated Consulting Services Agreement (the “Agreement”) is made effective as of April 27, 2026

(the “Effective Date”), by and between StableX Technologies, Inc., a Delaware corporation (f/k/a AYRO, Inc.)

(the “Company”) and JD Advisors, LLC, an Ohio limited liability company (the “Consultant”)

(collectively, the Company and the Consultant shall be referred to as, the “Parties” or individually as a “Party”).

WHEREAS,

the Consultant currently provides consulting services to the Company and the Consultant desires to continue to provide such consulting

services to the Company;

Whereas,

the Company and the Consultant desire to set forth in writing the terms and conditions of their agreement and understandings with respect

to the services of the Consultant, which shall amend, restate, and supersede in its entirety that certain Consulting Services Agreement,

dated as of August 4, 2025, by and between Z-List Media, Inc., Mr. James Altucher, and the Company (the “Prior Consulting

Agreement”); and

WHEREAS,

the Parties desire to enter into this Agreement, pursuant to which the Consultant will continue to provide consulting services to the

Company, subject to the terms and conditions set forth below.

NOW,

THEREFORE, in consideration of the mutual covenants and obligations contained herein, the Parties, intending to be legally bound,

hereby agree as follows:

A. Engagement

The

Consultant shall provide the Services defined below in Section C herein for the Company (the “Engagement”).

In this capacity, the Consultant agrees to devote its best efforts, energy and skill to the full discharge of the Consultant’s

duties and responsibilities.

B. Term

1. Term.

Services under this Agreement shall commence on the Effective Date and shall continue through the two (2) year anniversary of the Effective

Date, unless earlier terminated pursuant to Section B(2) hereof or upon the mutual written consent of the Parties (the “Term”).

The term of this Agreement shall be extended for additional terms upon mutual written consent.

2. Termination.

The Consultant or the Company may terminate this Agreement, effective immediately upon written notice to the other party to this Agreement,

if the other party materially breaches this Agreement, and such breach is incapable of cure, or with respect to a material breach capable

of cure, the other party does not cure such breach within 10 calendar days after receipt of written notice of such breach. For purposes

of clarity, a material breach shall include, without limitation, the Consultant’s failure to provide the Services contemplated

hereunder on a timely and reasonably satisfactory basis.

C. Services

to be Performed

1. Services.

The Services rendered pursuant to this Agreement shall be rendered to the Executive Chairman of the Board of Directors of the Company.

During the Term of this Agreement, the Consultant shall assist the Company in general corporate activities including, but not limited

to, the following (collectively, the “Services”):

● comprehensive

strategic and operational consulting services to the Company, including but not limited to:

contributing to product development and roadmap decisions; leading and advising on marketing

strategy, branding, and go-to-market execution; assisting with recruiting, hiring, and team-building

efforts; managing and guiding social media presence and communications; and supporting general

management initiatives across the business; and

1

● any

other consulting or advisory services which the Company reasonably requests that Consultant

provide to the Company.

2.

Exclusivity of Services. The Parties acknowledge and agree that this Agreement is a non- exclusive engagement for

Consultant’s services and that the Consultant shall have the right to engage in any other gainful activities and business; provided,

however, that, during the Term, the Consultant shall not, directly or indirectly, engage in any activities or business, or

engage or participate in or provide services to any business, with respect to or otherwise related to the development,

commercialization, or deployment of optical or photonic interconnect technologies for computing infrastructure. The Consultant

understands and acknowledges that this obligation is necessary and reasonable to protect legitimate business interests and is

provided as further inducement for Company to enter into this Agreement.

D. Compensation

for Services

1. Warrants.

In consideration for the Services rendered by the Consultant and the Consultant’s other obligations under this Agreement and

subject to the Consultant entering into the Warrant Cancellation Agreement in the form attached hereto as Exhibit A

for the purpose of cancelling previously issued warrants, the Company shall issue to the Consultant on the Effective Date warrants

to purchase shares of common stock of the Company (“Common Stock”), in the amounts as set forth on Exhibit

B attached hereto and in the form attached hereto as Exhibit C (the “Warrants”). The

Warrants shall be subject to the terms and conditions, including vesting and forfeiture conditions, as set forth therein. The

Company shall provide a PDF copy of the executed Warrants upon execution of this Agreement. The Consultant represents that it is not

and will not work with any persons and/or entities that have been convicted of or otherwise committed an act or omission

constituting any of the “bad actor” events listed in Rule 506(d) (as provided in Rule 506 of Regulation D of the

Securities Act of 1933, as amended (the “Act”)) (a “Bad Actor”). The Consultant

further represents, warranties and covenants to the Company that (i) the Consultant is an Accredited Investor (as defined under the

Act), and is acquiring the Warrants for investment purposes and not with a view towards distribution, (ii) understands and agrees

that the Warrants and the shares of Common Stock issuable upon exercise of the Warrants (the “Warrant

Shares”) are “restricted securities” as defined under Rule 144 of the Act and will contain a standard

restrictive legend and may only be sold and/or transferred pursuant to an effective registration statement covering the resale of

such Warrants and/or Warrant Shares or pursuant to an exemption from the registration requirements of the Act, and (iii) it will not

transfer any of the Warrants and/or Warrant Shares to any person and/or entity and no person and/or entity has any direct and/or

indirect interest in the Warrants and/or Warrant Shares or in the profits therefrom who is a Bad Actor. Assuming the Consultant has

complied with the provisions and requirements of Rule 144 promulgated under the Act, the Company agrees to assist the Consultant to

remove the restrictive legend from the Warrant Shares, including, without limitation, (i) authorizing the Company’s transfer

agent to remove the restrictive legend, (ii) obtaining a legal opinion from the Company’s authorized counsel at the

Company’s expense, and (iii) cooperating and communicating with Consultant, its broker and the transfer agent in order to

clear the Warrant Shares of restriction as soon as possible, in each case as further set forth in the Warrants.

2. Entire

Compensation. The Consultant acknowledges that the Warrants constitute the sole and entire compensation and reimbursements payable

for the Engagement and the provision of the Services of the Consultant, and the Parties specifically agree that no other compensation,

benefits or reimbursements of any other nature shall be paid or payable to the Consultant as a result of the provision of Services hereunder.

2

E. Nondisclosure

of Confidential and Proprietary Information.

1. Obligation

to Maintain Confidentiality. The Consultant acknowledges that it will have access to and possession of trade secrets, confidential

information, and proprietary information (collectively, as defined more extensively below, “Confidential Information”)

of the Company, its parents, subsidiaries, and affiliates and their respective business relations. The Consultant recognizes and acknowledges

that this Confidential Information is valuable, special, and unique to the Company’s business, and that access thereto and knowledge

thereof are essential to the Consultant’s performance of Services. During the Term and thereafter, the Consultant will keep secret

and will not use or disclose to any person or entity other than the Company, in any fashion or for any purpose whatsoever, any Confidential

Information, except at the request of the Company. The Consultant will use no less than a reasonable standard of care to prevent disclosing

to third parties any Confidential Information. This Section shall not preclude the Consultant from the use or disclosure of any and all

information known generally to the public or from disclosure of information required by law or court order, provided that the Company

is reasonably notified of any such disclosure required by law or court order in order for the Company to seek a protective order and

after all reasonable remedies for maintaining the Confidential Information in confidence have been examined, is afforded the opportunity,

to the extent practicable, to dictate the manner and timing of any such disclosure.

2. Third

Party Information. The Consultant further recognizes that the Company has received and in the future will receive from third parties

confidential or proprietary information (“Third Party Information”) subject to a duty on the Company’s

part to maintain the confidentiality of such information and to use it only for certain limited purposes. During the Term and thereafter,

the Consultant will hold Third Party Information in the strictest confidence and will not disclose Third Party Information to anyone

(other than Company personnel who need to know such information in connection with the Consultant’s work for the Company) or use

Third Party Information, except in connection with the services required under this Agreement for the Company, unless expressly authorized

by the Company in writing.

3. Treatment

and Ownership of Confidential Information. The Consultant shall store and maintain all Confidential Information in a secure place.

Such material at all times will remain the exclusive property of the Company, unless otherwise agreed to in writing by the Company. Upon

termination or expiration of the Term, the Consultant shall not make further use of any Confidential Information.

4. Use

of Information of Prior Employers. At no time will the Consultant improperly use or disclose any confidential information or trade

secrets, if any, of any former employer or any other person to whom the Consultant has an obligation of confidentiality, or bring onto

the premises of the Company any unpublished documents or any property belonging to any former employer or any other person to whom the

Consultant has an obligation of confidentiality unless consented to in writing by that former employer or person and agreed to by the

Company.

5. Defend

Trade Secrets Act. Pursuant to the Defend Trade Secrets Act of 2016, the Company hereby provides notice and the Consultant hereby

acknowledges that the Consultant may be held criminally or civilly liable under any federal or state trade secret law for the disclosure

of a trade secret that (i) is made (A) in confidence to a federal, state, or local government official, either directly or indirectly,

or to an attorney; and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint

or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if the Consultant files a lawsuit

or other court proceeding against the Company for retaliating against the Consultant, for reporting a suspected violation of law, the

Consultant, may disclose the trade secret to the attorney representing the Consultant and use the trade secret in the court proceeding,

so long as the Consultant files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant

to court order.

3

6. Return

of Company Property. Upon any termination of this Agreement, the Consultant will deliver to the Company (and will not keep in his

possession, recreate or deliver to anyone else) any and all Confidential Information, devices, records, recordings, data, notes, reports,

proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, computer materials, equipment, other documents

or property, together with all copies thereof (in whatever medium recorded), belonging to the Company, its successors or assigns. The

Consultant expressly acknowledges and agrees that any property situated on the Company’s premises and owned by the Company (including

computer disks and other digital, analog or hard copy storage media, filing cabinets or other work areas) is subject to inspection by

Company personnel at any time with or without notice.

F. Intellectual

Property. Any

know-how, inventions, discoveries, data, information, specifications, sketches, records, reports, proposals, software, charts, designs,

or other documents, whether or not of a technical, operational, or economic nature, and any United States and foreign patent applications

related thereto, which are or were conceived or developed by the Consultant, whether individually, or jointly with any Company employee,

and arising out of the services provided to the Company or out of exposure to Confidential Information, are hereby assigned, and shall

be assigned, to the Company, and shall be the sole property of the Company. The Consultant agrees to promptly notify the Company of any

patentable inventions which are conceived or reduced to practice by or for the Consultant, in connection with the services to the Company

provided by the Consultant. The Consultant shall perform such acts and execute such assignments, papers, agreements and instruments as

are necessary to vest, ensure and perfect the Company’s rights and title therein. Except as otherwise provided herein, the Consultant

further agrees that all reports, information, data and documents developed or generated during the Consultant’s services (including

any Confidential Information) shall be deemed works made for hire for the Company and shall be owned solely, exclusively and entirely

by the Company and shall be usable by the Company for any purpose. As to any such materials subject to the protection of the Copyright

Act of 1976 (including any of same which are not deemed works made for hire for any reason), the Consultant agrees that all rights to

copyright and reproduction shall be the property of the Company, and the Consultant shall execute any and all such assignments, papers,

agreements and instruments as are necessary to vest, ensure and perfect the Company’s title and copyright therein. Notwithstanding

the foregoing, this Section does not apply to any invention for which no equipment, supplies, facilities, or trade secret information

of the Company was used and which was developed entirely on the Consultant’s own time, unless (i) the invention relates to the

business of the Company or the Company’s actual or demonstrably anticipated research or development, or (ii) the invention results

from any work performed by the Consultant for the Company. The Consultant has attached hereto, as an exhibit, a list describing all inventions,

original works of authorship, developments, improvements, and trade secrets which were made by the Consultant, prior to Consultant’s

service (collectively referred to as “Prior Inventions”), which belong to the Consultant, which relate to the

Company’s business, products or research and development, and which are not assigned to the Company hereunder; or, if no such list

is attached, the Consultant represents that there are no such Prior Inventions.

G. Legal

and Equitable Remedies.

Because the Consultant’s services are personal and unique and because the Consultant has and will continue to have access to, and

become acquainted with, Confidential Information, the Consultant expressly acknowledges and agrees that (1) a breach or threatened breach

of any of Sections E or F by the Consultant would result in irreparable harm for which money damages would be an inadequate remedy, and

(2) the Company will have the right to enforce Sections E and F and any of their provisions by injunction, restraining order, specific

performance or other injunction relief, without posting a bond or other security, and without prejudice to any other rights and remedies

that the Company may have for a breach of this Agreement. The Company’s remedies under this Section G are not exclusive and shall

not prejudice or prohibit any other rights or remedies under this Agreement or otherwise.

4

H. Indemnification

1.

The Consultant shall not be liable to the Company or their subsidiaries or affiliates for any loss, liability, damage or expense

(collectively, a “Loss”) arising out of or in connection with the performance of services contemplated by

this Agreement, unless such Loss shall be proven to result directly from gross negligence, willful misconduct or bad faith on the

part of the Consultant. In no event will any of the parties hereto be liable to any other party hereto for any indirect, special,

incidental or consequential damages, including lost profits or savings, whether or not such damages are foreseeable, or in respect

of any liabilities relating to any third party claims (whether based in contract, tort or otherwise) other than for the Claims (as

defined below) relating to the Services which may be provided by the Consultant hereunder. The Company and its subsidiaries shall

defend, indemnify and hold harmless the Consultant from and against any and all Losses arising from any claim by any person with

respect to, or in any way related to, this Agreement (including attorneys’ fees) (collectively,

“Claims”) resulting from any act or omission of either of the Company other than for Claims which are a

result of gross negligence, bad faith or willful misconduct by the Consultant. The Company and its subsidiaries shall defend at its

own cost and expense any and all suits or actions (just or unjust) which may be brought against the Company or its subsidiaries and

the Consultant in which the Consultant may be included with others upon any Claims, or upon any matter, directly or indirectly,

related to or arising out of this Agreement or the performance hereof by the Consultant, except that if such damage is the result of

gross negligence, bad faith or willful misconduct by the Consultant then the Consultant shall reimburse the Company and their

subsidiaries for the reasonable costs of defense and other costs incurred by the Company and its subsidiaries (including any losses

as a result of such actions).

2.

The Parties further agree that they shall not, without the prior written consent of the other Party, settle, compromise or consent

to the entry of any judgment in any pending or threatened claim, action, suit or proceeding in respect of which defense and/or

indemnification may be sought hereunder unless such settlement, compromise or consent includes an unconditional release of the Party

seeking defense and/or indemnity from all liability arising out of such claim, action, suit or proceeding.

3.

The Party seeking defense or indemnification hereunder shall: (i) promptly notify the other Party of the matter for which defense or

indemnification is sought; (ii) subject to the immediately preceding sentence of this paragraph, provide the other Party with sole

control over the defense and/or settlement thereof, including but not limited to the selection of counsel; and (iii) at the request

of the Party providing defense and/or indemnification, fully cooperate in the provision of full and complete information and

reasonable assistance with respect to the defense of such matter.

I. Survival

The

obligations of the Parties pursuant to Sections E, F, and H shall survive the Termination of this Agreement, regardless of the reason

for such Termination, along with any and all other provisions that expressly provide for survival of Termination.

J. Relationship

of the Parties; Independent Contractor Status

The

Parties agree that the relationship created by this Engagement is one of an independent contractor. The Parties further agree that the

Consultant is not and shall not be considered an employee of the Company and is not and shall not be entitled to any of the rights and/or

benefits that the Company provides for the Company’s employees (including any employee pension, health, vacation pay, sick pay

or other fringe benefits offered by the Company under plan or practice) by virtue of the Services being rendered by the Consultant or

otherwise. The Consultant is responsible for all taxes, if any, imposed on it in connection with its performance of Services under this

Agreement, including any federal, state and local income, sales, use, excise and other taxes or assessments thereon.

5

K. Binding

Nature; Assignments

This

Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors, representatives, administrators,

heirs, executors and permitted assigns, except that the duties the Consultant are personal and shall not be assigned or subcontracted

without the Company’s prior written consent and any purported assignment without such written consent shall be deemed void and

unenforceable.

L. Entire

Agreement; Amendments

This

Agreement contains the entire understanding between the Parties with respect to its subject matter and supersedes all previous negotiations,

agreements or understandings between the Parties, whether written or verbal, including, without limitation, the Prior Consulting Agreement.

This Agreement may not be amended or modified, except in writing, executed by duly authorized representatives of the Parties hereto.

M. Counterparts

This

Agreement may be signed simultaneously in any number of counterparts, each of which shall be deemed an original, but all of which together

shall constitute one and the same document.

N. Governing

Law; Consent to Jurisdiction and Venue

This

Agreement shall be governed by the internal laws of the State of Delaware without regard to choice of law principles. Any dispute regarding

this Agreement shall be subject to the exclusive jurisdiction of the state and federal courts of the State of New York located in the

New York County, and of the United States District Court of the Southern District of New York and the parties agree to submit to the

personal jurisdiction and venue in these courts. Each Party waives the right to a trial by jury in any such dispute. The prevailing

or non-dismissing party in any such dispute shall be entitled to reimbursement of all reasonable expenses, including court costs and

attorney fees incurred in good faith.

O. Notices

All

notices, requests, demands and other communications hereunder must be in writing and shall be deemed to have been duly given (i) when

delivered personally to the party to receive the same, (ii) when mailed first class postage prepaid, by certified mail, return receipt

requested, or (iii) when transmitted by electronic mail, in each case addressed to the party to receive the same at his or its address

set forth below, or such other address as the party to receive the same shall have specified by written notice given in the manner provided

for in this Section O:

If

to the Company:

StableX

Technologies, Inc.

1185 Avenue

of the Americas

New York,

NY 10036

Attn: Joshua

Silverman, Chief Executive Officer

If to the

Consultant:

To the most

recent address of the Consultant in the Company’s records

P. Severability

If

any provision of this Agreement is found to be invalid or unenforceable for any reason by a court of competent jurisdiction, that provision

shall be stricken from this Agreement and that finding shall not invalidate any other terms of this Agreement, which terms shall remain

in full force and effect according to the surviving terms of this Agreement. In such an event, the Parties shall negotiate with one another

to agree on a provision which the Parties would have agreed if they had known of the defect when they signed this Agreement, in order

to achieve the same commercial outcome and objectives of this Agreement that were intended upon its execution.

[Signature

Page Follows]

6

IN

WITNESS WHEREOF, this Agreement has been duly executed by or on behalf of the Parties as of its Effective Date.

COMPANY:

StableX

Technologies, Inc.

By:

/s/Joshua

Silverman

Name:

Joshua Silverman

Title:

Chief

Executive Officer

CONSULTANT:

JD

Advisors, LLC

By:

/s/

James Altucher

Name:

James Altucher

Title:

Co-Manger

[Signature

Page to Consulting Services Agreement]

Exhibit

A

Warrant

Cancellation Agreement

Exhibit

B

Consulting Fee

1. Warrants

to purchase 300,000 shares of Common Stock, at an exercise price of $3.00 per share.

2. Warrants

to purchase 200,000 shares of Common Stock, at an exercise price of $6.00 per share.

3. Warrants

to purchase 200,000 shares of Common Stock, at an exercise price of $9.00 per share.

4. Warrants

to purchase 200,000 shares of Common Stock, at an exercise price of $12.00 per share.

Each

Warrant shall be subject to vesting, forfeiture and such other terms as set forth in the form of warrant agreement.

Exhibit

C

Forms

of Warrant

[provided

separately]

EX-99.1

EX-99.1

Filename: ex99-1.htm · Sequence: 18

Exhibit

99.1

Fabric.AI

(Nasdaq: SBLX) Launches Breakthrough MicroLED Interconnect Technology as First Step in Building Next-Generation “AI Factory”

Infrastructure. Partners with Leading MicroLED Developer Kopin Corporation (Nasdaq: KOPN)

Introducing

a new suite of fabless semiconductor technologies designed to power AI factories—smart data centers optimized for producing intelligence

at scale; Initial focus on MicroLED optical interconnects to take leadership in $100 Billion+ industry in partnership with Kopin Corporation,

the only company to produce programmable MicroLEDs. As part of the development deal, Kopin Corporation will own 19.9% of Fabric.AI

Company

raises $21.5 million led by existing investors

NEW

YORK, NY (April 28, 2026) – Fabric.AI, (Nasdaq: SBLX) formerly StableX Technologies Inc., (the “Company”

or, “Fabric.AI”), today announces its official launch, unveiling a breakthrough MicroLED-based optical interconnect technology

(an “interconnect”) designed to address one of the most critical bottlenecks in modern AI computing: the movement of data

between increasingly powerful compute systems.

Fabric.AI’s

initial technology, the Neural I/o™ chip, being developed in collaboration with Kopin Corporation, the only company to produce

programmable MicroLEDs, replaces traditional electrical interconnects with MicroLED-based optical links. This enables ultra-high-bandwidth,

low-latency communication between compute nodes while significantly improving energy efficiency. This represents the first in a broader

suite of fabless semiconductor technologies that Fabric.AI is developing to power AI factories (a term coined by Jensen Huang

at the Nvidia GTC Conference),smart data centers optimized for continuously producing intelligence at scale.

The

Neural I/o™ chip leverages Kopin’s proprietary MicroLED and patented bi-directional NeuralDisplay™ architecture, repurposing

programmable MicroLED pixels as ultra-high speed optical transceivers capable of moving data at ultra-high speeds while consuming considerably

less power per bit than existing copper or laser-based solutions.

“MicroLED

technology represents a powerful new frontier beyond displays,” said Michael Murray, CEO of Kopin Corporation. “Our collaboration

with Fabric.AI extends the reach of our technology into AI infrastructure, enabling a new class of interconnect solutions designed for

scale, efficiency, and performance. Performance that aims to far exceed that of laser- based or traditional copper-based interconnects.”

The

interconnect market is estimated at approximately $138B according to 360iResearch and is dominated by copper and electricity solutions

as opposed to faster, lower latency optical MicroLED solutions. Unlike traditional copper-based interconnects, which suffer from signal

degradation, heat generation, and power inefficiencies at scale, Fabric.AI’s optical approach enables more efficient data transmission—unlocking

higher system-level performance.

Building

on this foundation, Fabric.AI is developing a broader suite of fabless semiconductor technologies designed specifically for AI workloads.

“AI

is no longer just software—it’s an industrial process,” said Josh Silverman, Fabric.AI’s Chief Executive Officer.

“The defining challenge is no longer just compute performance, but how efficiently that compute can communicate and operate as

a unified system. We’re starting with interconnects because that’s where the bottleneck is most acute, but our vision is

much broader. Fabric.AI is building the semiconductor technologies that aim to power the next generation of smart data centers.”

Fabric.AI

also announced that it changed its corporate name from StableX Technologies, Inc. to Fabric.AI, Inc., effective today, to better reflect

its strategic transformation. In addition to its new name, Fabric.AI will also be changing its ticker to “FABC,” which will

commence trading under the new symbol on Nasdaq beginning with the market open on April 29, 2026.

Strategic

Collaboration with Kopin Corporation

Fabric.AI’s

interconnect technology, designed specifically for AI workloads, is being developed in close collaboration with Kopin Corporation,

leveraging Kopin’s proprietary MicroLED innovations as the foundation for next-generation optical communication systems.

This

collaboration combines Fabric.AI’s system-level design with Kopin’s deep expertise in MicroLED materials, process development,

and fabrication. Both companies will jointly develop and share in the intellectual property created through the partnership, accelerating

innovation while working to establish a defensible technology position in AI infrastructure.

Positioned

for the AI Infrastructure Era

Fabric.AI

is currently engaged in preliminary discussions with leading AI and hyperscale technology companies regarding the integration of its

MicroLED-based interconnect technology into next-generation systems. The Company believes this growing interest reflects a broader shift

toward smarter, more tightly integrated data centers optimized specifically for AI.

By

developing a suite of tightly integrated semiconductor technologies—beginning with interconnect and expanding into additional system-critical

components—Fabric.AI aims to become a foundational technology provider for the infrastructure powering the next era of artificial

intelligence.

Financing

Fabric.AI

also announces that it will be raising $21.5 million, mostly from existing shareholders with the sale in a private placement of 21,500

shares of its newly designated Series K convertible preferred stock ("preferred stock"), with a stated value of $1,000 per

share, convertible into shares of the Company’s common stock and accompanying warrants. The shares of preferred stock have

an initial conversion price of $2.51 per share. The warrants are exercisable immediately upon issuance, have an initial exercise price

of $2.51 per share and expire five years from the date of issuance. The transaction is expected to close on or about April 29, 2026,

subject to the satisfaction of customary closing conditions. The full conversion of the preferred stock and the full exercise of the

accompanying warrants are subject to stockholder approval.

The

financing will be more fully disclosed in the Company’s Current Report on Form 8-K to be filed with the SEC on or about April

28, 2026.

The

securities in the private placement were offered and sold in transactions exempt from the registration requirements of the Securities

Act of 1933, as amended (the “Securities Act”), pursuant to the exemption for transactions by an issuer not involving any

public offering under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar

exemptions under applicable state laws.

This

press release is not an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state

or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities

laws of any such state or jurisdiction.

About

Fabric.AI

Fabric.AI

is an infrastructure company building a suite of fabless semiconductor technologies to power AI factories—smart data centers optimized

for producing intelligence at scale. The Company has exited its prior digital asset treasury strategy and is now singularly focused on

capturing the significantly larger opportunity in AI infrastructure.

The

Company is reallocating capital to accelerate development of its core technologies. Fabric.AI is building MicroLED-based optical interconnects

and other system-critical semiconductor solutions designed to unlock faster, more efficient, and more scalable AI workloads.

In

connection with this transformation, the Company is changing its name to Fabric.AI and intends to change its stock symbol to FABC.

Fabric.AI’s

mission is to solve the bottlenecks of AI data centers using breakthrough technologies in AI infrastructure.

About

Kopin Corporation

Kopin

Corporation (Nasdaq: KOPN) is a leading developer and provider of innovative display and application-specific optical solutions sold

as critical components and subassemblies for defense, enterprise, professional and consumer products. Kopin’s portfolio includes

microdisplays, display modules, eyepiece assemblies, image projection modules and vehicle mounted and head-mounted display systems that

incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS)

displays, MicroLED displays (µLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics and low-power ASICs. For

more information, please visit Kopin’s website at www.kopin.com. Kopin is a trademark of Kopin Corporation.

Forward-Looking

Statements

This

press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section

21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve known and unknown risks, uncertainties

and other factors which may cause actual results, performance or achievements to be materially different from any expected future results,

performance or achievements. Words such as “anticipate,” “believe,” “could,” “estimate,”

“intend,” “expect,” “may,” “plan,” “will,” “would” and their

opposites and similar expressions are intended to identify forward-looking statements. Forward-looking statements in this press release

include, but are not limited to, statements regarding: the expected capabilities and performance of the Company’s MicroLED-based

optical interconnect technology; the Company’s plans to develop a broader suite of fabless semiconductor technologies for AI workloads;

the anticipated benefits of the Company’s collaboration with Kopin Corporation; the expected completion of the private placement

and satisfaction of customary closing conditions; and the Company’s strategic vision to become a foundational technology provider

for AI infrastructure. Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information

currently available to management.

Important

factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without

limitation: the Company’s MicroLED-based interconnect technology is at an early stage of development and may not achieve the anticipated

performance; the Company’s dependence on its collaboration with Kopin Corporation for critical MicroLED technology components and

intellectual property, and the risk that such collaboration may not produce commercially viable products or may be terminated; the Company

may be unable to successfully develop or commercialize additional semiconductor technologies; the markets for AI infrastructure and optical

interconnect technologies are rapidly evolving and highly competitive; the Company has limited operating history in the AI semiconductor

industry, which makes evaluating its business and future prospects difficult; the Company may require substantial additional capital

to fund the development and commercialization of its technologies, and such capital may not be available on acceptable terms or at all;

the Company’s transition from its prior digital asset treasury strategy involves risks; and the Company may face intellectual property

risks, including the ability to protect its proprietary technology and avoid infringement of third-party rights.

A

discussion of these and other factors with respect to the Company is set forth in the Company’s most recent Annual Report on Form

10-K and subsequent reports on Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements speak only as

of the date they are made, and the Company disclaims any intention or obligation to revise any forward-looking statements, whether as

a result of new information, future events or otherwise.

IR

Contact:

CORE IR

212-644-0924

ir@fabric-ai.co

Media

Contact:

Fabric.AI

press@fabric-ai.co

www.fabricai.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 23

v3.26.1

Cover

Apr. 27, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 27, 2026

Current Fiscal Year End Date

--12-31

Entity File Number

001-34643

Entity Registrant Name

StableX

Technologies, Inc.

Entity Central Index Key

0001086745

Entity Tax Identification Number

98-0204758

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

1185

Avenue of the Americas

Entity Address, City or Town

New

York

Entity Address, State or Province

NY

Entity Address, Postal Zip Code

10036

City Area Code

512

Local Phone Number

994-4917

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

stock, par value $0.0001 per share

Trading Symbol

SBLX

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

Entity Information, Former Legal or Registered Name

StableX

Technologies, Inc.

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name:

dei_CurrentFiscalYearEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:gMonthDayItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Former Legal or Registered Name of an entity

+ References

No definition available.

+ Details

Name:

dei_EntityInformationFormerLegalOrRegisteredName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration